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Screening for Diabetes  













Background: Screening for type 2 diabetes will potentially allow for early diagnosis and 
treatment. The current doctoral research focused on screening for diabetes in dental settings. 
The main objective of the research was to determine the impact of preliminary screening for 
diabetes using HbA1c information alongside a self-report questionnaire, in general dental 
practices on patient's health behaviours. 
Methods: A systematic review of 18 studies was carried out to identify the best ways to 
communicate individualised risk information to improve screening uptake. Following the 
completion of the review, a longitudinal study based in two dental practices invited dental 
patients over 45 years old to participate in preliminary screening for diabetes. The study 
aimed to determine the uptake of preliminary screening in the dental practice environment 
using the self-report questionnaire and HbA1c test, and to determine the uptake of further 
diabetes testing by the GP following the receipt of a high HbA1c reading and a positive result 
on the self-report questionnaire. A qualitative element of the project involved interviewing 
participating patients (n=18) and dentists (n=6) to gain insight into their views and 
experiences of screening in this setting. 
Results: The systematic review identified several important methods of risk communication 
(e.g. presenting in writing and in person) found to increase screening participation or its 
psychological predictors. These were used to inform the next stage of the research,   
The longitudinal study indicated that of 520 dental patients taking part, half were found to 
have an increased level of risk of developing diabetes in the next ten years, based on at least 
one screening measure looking at personalised diabetes risk, and were advised to seek a 
diagnostic blood test from their GP. Sixty percent of those referred to their GP following the 
personalised diabetes risk communication, followed the advice and did so; those who had 
received two positive screening tests as opposed to just one, were three times more likely to 
make contact with their GP. When assessing whether certain psychological variables can 
predict and explain uptake of further testing by the GP, fear of diabetes and vulnerability to 
developing diabetes were found to be able to explain why some patients made contact with 
their GP whereas severity, intention, and self efficacy for example, were not associated with 
attendance at the GP. The qualitative data revealed that dentists and patients both reported 
positive experiences and patients offered explanations as to why they had or had not 
contacted their GP for further testing.  
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Conclusion: the set of studies demonstrated a well-tolerated and largely acceptable 
personalised diabetes risk screening method, with more than half of those recommended to do 
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This thesis describes a series of studies which explore screening for diabetes in a dental 
setting and the effect that screening has on an individual’s subsequent decision to receive 
diagnostic testing.  
The main objective of this thesis was to investigate use of a self-report screening measure and 
glycated haemoglobin A1c (HbA1c) information as preliminary screening tools for possible 
diabetes in general dental practice, and the affect this has on patients’ health behaviour.  
In particular, the following research questions (RQ) were set. 
1. What is the most effective way to communicate individualised risk information to 
increase screening participation or its psychological predictors?  
2. What proportion of dental patients accept an offer to be screened for type 2 diabetes 
in a primary care dental setting? 
3. What is the risk of type 2 diabetes in primary care dental patients as assessed through 
self-report and physiological measures? 
4. What is the effect of personalised diabetes risk communication on subsequent health 
behaviours? 
5. What is the psychological profile of patients at risk of diabetes? 
6. To what extent do psychological variables predict post-screening further testing or 
health behaviours? 
7. What are patients’ and dentists’ views on screening for diabetes in dental settings, and 
can this help to further explain post-screening further testing or health behaviours? 
 
Chapter 2 presents the background to the project and describes in detail the existing literature 
on what diabetes is, the prevalence of diabetes, through to how it is diagnosed and treated. 
The debate of the worth of diabetes screening is then discussed, followed by the 
psychological effect of health screening and the psychological predictors of screening 
participation. Subsequently, the methods of diabetes screening are explored and research 
investigating various settings as a suitable place for diabetes screening are described. From 
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this, it is argued that diabetes screening within a dental setting is a viable option that needs to 
be explored further.  
Chapter 3 details a systematic literature review that explored RQ1 - What is the most 
effective way to communicate individualised risk information to increase screening 
participation or its psychological predictors? A search of five databases was conducted to 
identify randomised controlled trials (RCTs) that examined the effect of individualised risk 
communication interventions on screening uptake or its psychological predictors. A total of 
twenty-one articles met the inclusion criteria, reporting eighteen studies. These studies were 
then reviewed systematically to determine the effectiveness of these interventions which is 
fully described in chapter 3. 
Chapter 4 provides a detailed account of the methods employed in the empirical studies that 
were conducted within this doctoral research. It describes the methods for two quantitative 
studies and one qualitative study and outlines how the methodology was considered and then 
adopted in order to answer RQ 2-7.  
Chapter 5 describes the first of two quantitative studies conducted. The study described in 
this chapter addresses RQ 2-4, and explains the proportion of dental patients who took part in 
the screening programme offered to them at their dental appointment. It also explains the risk 
of diabetes in these dental patients as assessed through a self-report risk questionnaire and a 
finger prick blood test. Finally, it describes the effect of these screening tests on subsequent 
diagnostic test follow-up behaviour.  
Chapter 6 then goes on to describe the second quantitative study addressing RQ 5 and 6. 
After assessing the psychological profile of those found to be at risk of diabetes from the 
screening tests conducted, the chapter describes the extent to which psychological constructs 
are able to explain why some dental patients made contact with their GP for a diagnostic test.  
Chapter 7 describes the qualitative study exploring dental patients and dental practitioner’s 
views on screening for diabetes in the dental setting. Additionally, this work probed further 
into the findings of the quantitative studies and explored why some dental patients contacted 
their GP for a diagnostic test, whilst other did not, from the patient perspective. 
Chapter 8, the final chapter in this thesis provides a detailed discussion of the topic of 
screening for diabetes in the dental setting following a brief summary of the findings from the 
studies conducted for this thesis and their contribution to the existing literature. It discusses 
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the practicalities of conducting diabetes screening as demonstrated in the current studies, as 
well as the methodological strengths and limitations of the procedure adopted in these 
studies. Finally, the chapter makes suggestions for future research that are needed before 





Introduction and Literature Review 
 
The studies included in this thesis look at the effect of preliminary screening for diabetes in 
dental settings on subsequent diabetes testing behaviour. Therefore, this introductory chapter 
outlines and describes diabetes, how it is identified, treated and managed by the individual. 
The chapter introduces and discusses the debate on screening for the condition to date, and 
why or why not it is recommended. The case for diabetes screening is put forward to support 
the rationale for the set of studies that follow in this thesis. When describing the effects of 
diabetes on a person’s health, the discussion is weighted toward the effects on a person’s oral 
health due to the nature of the focus of the doctoral studies, therefore when describing 
research looking at screening for diabetes, and where this might take place, there is a focus on 
research which has been conducted within the dental setting in order to investigate the 
potential for further study in this setting. Both dentist and dental patients’ views about 
diabetes screening within the dental setting has been studied, therefore this research has also 
been considered in this introductory chapter.  
 
What is Diabetes? 
Diabetes mellitus comprises a heterogeneous group of disorders characterised by high blood 
glucose levels. Four major types of diabetes have been defined:  
• insulin- dependent diabetes; now known as type 1 diabetes mellitus (T1D; (Mendosa, 
2010);  
• non-insulin- dependent diabetes mellitus, also now known as type 2 diabetes (T2D; 
(Mendosa, 2010); 
• gestational diabetes mellitus (GDM); and  
• diabetes secondary to other conditions (Harris, 1995). 
These are each outlined below. Impaired glucose tolerance (‘pre-diabetes’) is also considered. 
In T1D, the cause is an absolute deficiency of insulin secretion. Insulin is a hormone which 
works as a chemical messenger that helps the body use the glucose in the blood to give the 
body energy. When the body does not produce insulin, the body cannot use glucose to 
provide energy and so it tries to get it from elsewhere and starts to break down stores of fat 
and protein instead. Because the body does not use the glucose, it ends up passing into the 
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urine. Individuals at increased risk of developing this type of diabetes can often be identified 
by serological evidence of an autoimmune pathologic process occurring in the pancreatic 
islets or by genetic markers.  
In the much more prevalent category, T2D, the cause is a combination of resistance to insulin 
action and an inadequate compensatory insulin secretory response (Burggraaf & Castro 
Cabezas, 2017). The result is often hyperglycaemia; a high level of blood glucose, a 
consequence of what happens when the body has too little insulin or when the body cannot 
use insulin properly. In T2D, a degree of hyperglycaemia enough to cause pathologic and 
functional changes in various target tissues, but without clinical symptoms, may be present 
for a long period of time before diabetes is detected. During this asymptomatic period, it is 
possible to demonstrate an abnormality in carbohydrate metabolism by measurement of 
plasma glucose in the fasting state or after a challenge with an oral glucose load (Expert 
Committee On The Diagnosis And Classification Of Diabetes Mellitus, 2002; Sami, Ansari, 
Butt, & Hamid, 2017). 
 
GDM is defined as glucose intolerance that is first diagnosed in pregnancy (Eades, Cameron, 
& Evans, 2017).  In some women, GDM occurs because the body cannot produce enough 
insulin to meet the extra needs of pregnancy. In other women, GDM may be found during the 
first trimester of pregnancy. GDM is also associated with an increased risk of complications 
for mother and child during pregnancy and birth (Horvath et al., 2010). Women with a history 
of GDM are at high risk for developing T2D. In studies with long periods of follow up, 
diabetes incidence of up to 70% has been reported (Kasher-Meron & Grajower, 2017).  
 
Diabetes can also be associated with certain conditions or syndromes, where hyperglycaemia 
occurs in relation to other disease states such as pancreatic diseases, drug or chemical-
induced diabetes, insulin-receptor disorders and certain genetic syndromes (American 
Diabetes Association, 1992; Penfornis & Kury-Paulin, 2006). 
 
Impaired glucose tolerance (IGT) is where there is an abnormality in glucose levels, often 
referred to as an intermediate stage between normal glucose homeostasis and overt T2D (Di 
Pino, Urbano, Piro, Purrello, & Rabuazzo, 2016). Also known as Pre-diabetes, it occurs when 
glucose levels are higher than normal but not high enough for the person to be diagnosed as 
having diabetes, yet indicating the relatively high risk for the future development of diabetes. 
Having prediabetes causes no symptoms, and has been shown to put a person at risk of 
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having heart disease (Nathan et al., 2007). Pre-diabetes is of public health importance. This is 
because the risk of cardiovascular disease (CVD) is increased in people with prediabetes 
compared with people with normal glucose tolerance, and because many people with pre-
diabetes will go on to develop diabetes. In terms of absolute numbers of heart attacks, pre-
diabetes is a greater problem than diabetes, because, although the risk of heart disease is 
somewhat higher with diabetes, there are far more people with pre-diabetes than with 
undiagnosed diabetes (Waugh, Shyangdan, Taylor-Phillips, Suri, & Hall, 2013). 
 
Risk factors 
Risk factors in the development of diabetes include; obesity (a body mass index higher than 
27 kilograms per square metre), a high-risk ethnic background (such as African-American or 
Asian), hypertension, high-density lipoprotein level lower than 35 milligrams per decilitre or 
a triglyceride level higher than 250 mg/dL, a first-degree relative with diabetes, history of 
gestational diabetes or delivery of a baby weighing more than nine pounds, impaired glucose 
tolerance or impaired fasting glycaemia (history of blood sugar level between 110 and 126 
mg/dL), and a history of vascular disease or polycystic ovarian disease (Robertson, Drexler, 
& Vernillo, 2003). T2D is associated with irreversible risk factors such as age, genetics, race, 
and ethnicity and reversible factors such as diet, physical activity and smoking ((Sami et al., 
2017). T2D is considered preventable; there is strong randomised trial evidence that 
intervention either by pharmacological or lifestyle methods in patients with pre-diabetes, can 




Studies indicate T2D can also be prevented in high-risk individuals through lifestyle 
modification, pharmacologic interventions, and bariatric surgery, however, the translation of 
this research to a population level, especially finding the most effective methods of 
preventing T2DM in various societies and cultural settings is challenging, but is a crucial 
priority (Portero McLellan, Wyne, Villagomez, & Hsueh, 2014).  
Findings from observational and experimental studies now provide consistent evidence that 
reducing and frequently breaking up prolonged sitting with light-intensity physical activities 
and standing may be practical strategies for improving T2D prevention and management 
(Dempsey, Owen, Yates, Kingwell, & Dunstan, 2016).  
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A recent systematic review looking at diabetes prevention sought to answer the following 
question. What is the efficacy of preventive interventions (lifestyle and/or metformin) in 
those identified as high risk by screening (Barry et al., 2017)? A meta-analysis showed that 
lifestyle interventions reduced the relative risk of developing diabetes by 31% (95% 
confidence interval 15% to 44%) if the intervention lasted six months to two years. This 
translates to 69 (95% confidence interval 56 to 85) out of 1000 people in the lifestyle 
intervention group developing diabetes compared with 100 out of 1000 without the 
intervention, or a number needed to treat (NNT) of 33 (95% confidence interval 23 to 67). 
Lifestyle interventions lasting three to six years showed a 37% (28% to 46%) reduction in 
relative risk, equating to 151 out of 1000 people in the lifestyle intervention group developing 
diabetes compared with 239 of 1000 in the control group (NNT 12). The overall relative risk 
reduction of developing diabetes after lifestyle interventions was 36%. Because of the small 
number of follow-up studies it is difficult to assess the reduction in risk of diabetes after the 
completion of lifestyle interventions.  
Meta-analysis evaluating the impact of metformin showed a relative risk reduction of 26% 
(95% confidence interval 16% to 35%) while participants were taking this drug, translating to 
218 (95% confidence interval 192 to 248) out of 1000 developing diabetes while taking 
metformin compared with 295 of 1000 not receiving this drug (NNT 14 (95% confidence 
interval 10 to 22)). The benefits of metformin were assessed at the end of the trial periods 
once the participants had been taking the drug for a specified length of time. There were no 
follow-up studies examining for persistence of benefit once metformin had been 
discontinued, but the authors reported the US DPP study which had shown some 
improvements in reduction in incidence of diabetes with long term metformin use. 
In conclusion, both individually targeted lifestyle interventions and metformin have been 
found to have some efficacy in preventing or delaying the onset of T2D, though the 
protective effect of the lifestyle interventions is greatest in longer interventions (three to six 
years) (Barry et al., 2017). 
A systematic review on the cost-effectiveness of lifestyle modification interventions showed 
that interventions targeting adult subjects at high risk for diabetes were cost-effective despite 
different assumptions regarding disease progression and variations in the delivery of these 
interventions (Alouki et al., 2016). The results of this systematic review are consistent with 
conclusions of former reviews, confirming the importance of lifestyle interventions 
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combining diet and physical activity to prevent diabetes in at-risk population groups. 
However, the authors believed that lifestyle interventions should be further stressed as an 
effective strategy to prevent or delay diabetes (Alouki et al., 2016). 
 
Symptoms 
Before diabetes is diagnosed, the main symptoms of undiagnosed diabetes can include; more 
frequent urination, especially at night, increased thirst, extreme tiredness, unexplained weight 
loss, genital itching or regular episodes of thrush, slow healing of cuts and wounds, and 
blurred vision (Clark, Fox, & Grandy, 2007). These signs and symptoms of diabetes are often 
disregarded because of the chronic progression of the disease. People do not consider this as a 
serious problem because unlike many other diseases the consequences of hyperglycaemia are 
not manifested immediately and are not that obviously debilitating (Ramachandran, 2014). In 
T1D the signs and symptoms are usually very obvious and develop very rapidly, typically 
over a few weeks (Atkinson & Eisenbarth, 2001). The symptoms are quickly relieved once 
the diabetes is treated and under control (Daneman, 2006; WHO, 2016). In T2D the signs and 
symptoms may not be so obvious, as the condition develops slowly over a period of years and 
may only be picked up during a routine medical check-up. Symptoms that are mild or have 
gradual development could also remain unnoticed (Ramachandran, 2014). 
Prevalence of Diabetes 
The global prevalence of diabetes in adults has been increasing over recent decades 
(Ogurtsova et al., 2017) Previously it had been reported that the number was increasing due 
to population growth, aging, urbanization, and increasing prevalence of obesity and physical 
inactivity (Wild, Roglic, Green, Sicree, & King, 2004). Most recently , in addition to the 
reported increase, it has also been reported that the dramatic increase in diabetes has been 
seen to have occurred in all countries, and in rural as well as urban areas (Ogurtsova et al., 
2017).  
 
Accurate global, regional, and country-level estimates and projections of diabetes prevalence 
are necessary for prevention and treatment strategies to be planned and monitored. T2D is 
much more common than T1D (BeLue et al., 2009). T2D accounts for around 90% of all 
diabetes worldwide (Kahn, 1998). Reports of T2D in children – previously rare – have 
increased worldwide (Hsia et al., 2009). In some countries, it accounts for almost half of 
newly diagnosed cases in children and adolescents (WHO, 2014). In a recent review by the 
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International Diabetes Federation, it was estimated that in 2015 there were 415 million people 
with diabetes aged 20–79 years, 5.0 million deaths attributable to diabetes, and a total global 
health expenditure due to diabetes of 673 billion US dollars. The number of people with 
diabetes aged 20– 79 years was predicted to rise to 642 million by 2040 (Ogurtsova et al., 
2017). 
 
The prevalence of diabetes in the UK was estimated to be approximately 400,000 people with 
T1D and 3.4 million people with T2D (Hex, Bartlett, Wright, Taylor, & Varley, 2012).  
Research conducted more recently has reported that since 1996, the number of people 
diagnosed with diabetes in the UK has more than doubled, from 1.4 million to almost 3.5 
million. In 2015, over 2.9 million people were diagnosed with diabetes in England alone, 
90% of whom have T2D (Holden et al., 2017). Using Office for National Statistics 
projections, it has been estimated that in the UK, the prevalence of T1D will rise to 
approximately 650,000 people and over 5.6 million people with T2D by 2035. 
 
Diagnosis of Diabetes  
Different biomarkers have been used to define when diabetes is present, including fasting 
plasma glucose (FPG), 2-h plasma glucose in an oral glucose tolerance test (2hOGTT), and, 
more recently, HbA1c (NCD Risk Factor Collaboration, 2015).  
Several recognised tests that are used to diagnose diabetes are described below.  
 
- Fasting plasma glucose - measures plasma, or blood, glucose levels after a person has 
fasted (Harris, 1995). 
 
- Random capillary blood glucose – this test is the most convenient way to reach out to a 
large number of people (Somannavar, Ganesan, Deepa, Datta, & Mohan, 2009). However, 
although it is an established diagnostic criterion for diabetes, it is very insensitive, requiring 
diabetes to be in poor glycaemic control (Saudek et al., 2008). Therefore, this test may well 
not effectively identify pre-diabetes.  
 
- Oral glucose tolerance test - is used to determine whether the body has difficulty 
metabolising the intake of sugar/carbohydrate. The patient is asked to take a glucose drink 
and their blood glucose level is measured before and at intervals after the sugary drink is 
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taken. The oral glucose tolerance test (OGTT) is costly and time-consuming, but is seen as 
the gold-standard test (Olson et al., 2010; Phillips, 2012).  
- HbA1c - The A1C test is universally considered one of the best, if not the best, measure of 
the quality of healthcare provided to people with diabetes (Kahn, 2011). The most recent 
measure used in diagnosing diabetes, HbA1c testing does not require a person to fast and 
therefore does not need to be restricted to certain times of the day (Bloomgarden, 2009). 
The WHO Consultation in 2009 concluded that HbA1c can be used as a diagnostic test for 
diabetes, provided that stringent quality assurance tests are in place and assays are 
standardised to criteria aligned to the international reference values, and there are no 
conditions present which preclude its accurate measurement (WHO, 2011). 
 
 
The latest guidelines recommended for a diagnosis of diabetes by WHO (WHO, 2006) and 
ADA (ADA, 2012) are: 
 
- A fasting plasma glucose (FPG) level of ≥ 126 mg/dl (7.0 mmol/l) or  
- Symptoms (such as polyuria, polydipsia, unexplained weight loss) and  
- A casual plasma glucose/ random plasma glucose level ≥ 200 mg/dl (11.1 mmol/l) or 
- A plasma glucose level of ≥ 200 mg/dl (11.1 mmol/l) two hours after a 75g glucose load, or  
- HbA1c value of ≥ 6.5%. 
 
Once the diagnosis is confirmed, an attempt is made to classify the type of diabetes. 
Distinction between the two major types of diabetes, that being T1D and T2D, can be 
difficult. However, signs and symptoms such as, an acute onset, onset at an early age, rapid 
weight loss and ketonuria (ketones present in urine), generally favour the diagnosis of T1D. 
Factors favouring a diagnosis of T2D usually include the absence of classical symptoms of 
diabetes and onset during later life at an older age (WHO, 1994, 2016). 
Criteria have also been set for those considered to have prediabetes: 
- Impaired fasting glucose (IFG) (fasting plasma glucose level of 100 - 125mg/dl (5.6 - 
6.9mmol/l); or  
- Impaired glucose tolerance (IGT) (two hours after taking the oral glucose tolerance test 
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(OGTT)): 140 mg/dl - 199 mg/dl (7.8 - 11.0 mmol/l); or 
-HbA1c value of 5.7 - 6.4%.  
 
Management of diabetes 
Diabetes is not a curable disease. Once diabetes is detected and has been diagnosed, the main 
aim for both the patient and healthcare provider is to ensure tight glycaemic control by means 
of lifestyle modification and pharmacological therapy, in order to prevent the development of 
diabetes-related complications (Chatterjee & Davies, 2015). Treatment after early detection 
of T2D has been said to yield benefits superior to those obtained when treatment is delayed 
(Engelgau, Narayan, & Herman, 2000). The Diabetes Control and Complications Trial 
(DCCT) in T1D and the United Kingdom Diabetes Prospective Study (UKPDS) in T2D have 
shown that intensive glycaemic control improves patient outcomes especially for 
microvascular complications (Holman, Paul, Bethel, Matthews, & Neil, 2008; Nathan et al., 
2005).  
 
Diet control is the first step in individuals with Type 2 diabetes, reducing the intake of refined 
sugar and foods high in fat. Weight loss and exercise may also be advocated in order to 
reduce body fat. Oral hypoglycaemic agents such as metformin hydrochloride, are used when 
dietary measures are unsuccessful. These aim to promote insulin release from the pancreas, 
encourage insulin uptake in the target organs and suppress appetite (Defronzo, 2009). Insulin 
therapy is required in T1D, severely uncontrolled T2D and for T2D patients with decreased 
insulin production. Modern insulin therapy combines the use of short acting, rapid onset 
insulin with a longer acting form, so that glucose levels are maintained with minimal peaks 
and troughs through the day (Bjelland, Bray, Gupta, & Hirscht, 2002). Hypoglycaemia and 
weight gain remain the two significant side effects of intensive insulin therapy. Reluctance to 
commence insulin therapy is an issue in treatment, due to factors such as fear of 
hypoglycaemia, weight gain and needle phobia in patients and clinical inertia on the part of 
healthcare professionals (Chatterjee & Davies, 2015). 
 
Structured education programmes are considered essential to improve patient motivation, 
self-management skills and empowerment (Chatterjee & Davies, 2015). To ensure 
appropriate management, the basic knowledge and skills should be 
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acquired by the patient and their family, and the health care team should work closely with 
the patient to achieve this objective and to promote self-care. The person with diabetes 
should also be involved in setting therapeutic targets for weight, blood pressure and blood 
sugar control in order to self-manage the condition (WHO, 2016). The teaching of 
carbohydrate counting principles and insulin management skills in the Dose Adjustment for 
Normal Eating (DAFNE) programme to patients with T1D has been shown to improve 
quality of life and glycaemic control and is also cost-effective (Cooke et al., 2013). 
Structured education on reduced calorie intake and increased physical activity for T2D is 
provided through self-management and lay educator support in the Diabetes Education and 
Self-Management for Ongoing and Newly Diagnosed (DESMOND) programme. It has 
demonstrated significant improvement in weight loss, smoking rates, depression levels and 
cardiovascular risk scores (Davies et al., 2008). Self-management training is required 
according to a systematic review by Norris and colleagues. In a review of 72 studies, 
evidence supported the effectiveness of self-management training in T2D, particularly in the 
short term, with positive effects on knowledge, frequency and accuracy of blood glucose, 
dietary habits, and glycaemic control (Norris, Engelgau, & Narayan, 2001). Diabetes 
necessitates that a person be proficient in self-management skills; and in order for people to 
learn the skills necessary to be effective at self-managing their condition, diabetes self-
management education is critical at laying the foundation with ongoing support to maintain 
the benefits and progress made during education. The ADA posit that all individuals with 
diabetes receive diabetes self-management education and support at the time of diagnosis and 
as needed thereafter (Powers et al., 2015).   
 
Diabetes Complications 
The characteristic metabolic disorder in diabetes is hyperglycaemia, and when poorly 
controlled is the principal cause of the incidence and progression of microvascular 
complications such as retinopathy, nephropathy, and neuropathy in people with diabetes 
(Taylor, 2003). The underlying pathophysiology of diabetes-related long-term complications 
largely arises from the effects of chronic hyperglycaemia, tissue glycosylation, changes in 
collagen metabolism and oxidative stress (Nishimura, Soga, Iwamoto, Kudo, & Murayama, 
2005). Chronic complications are the major cause of diabetic morbidity. The complications of 
diabetes are far less common and less severe in people who have well-controlled blood sugar 
levels (Nathan et al., 2005). In 2012 diabetes was the direct cause of 1.5 million deaths 
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(WHO, 2014). At time of diagnosis, around 50% of people with T2D have a complication 
related to diabetes, and cardiovascular disease accounts for 50% of premature mortality seen 
in people with T2D (Spijkerman et al., 2003). Diabetes is predicted to become the 7th leading 
cause of death in the world by the year 2030. Total deaths from diabetes are projected to rise 
by more than 50% in the next 10 years (WHO, 2014). 
 
Diabetic Neuropathy is a common complication of T1D and T2D. It is characterised by injury 
or dysfunction of nerve fibres usually in the feet (Javed, Alam, & Malik, 2015). It causes 
clinical manifestations and disabilities of diverse spectrum and considerable severity. Both 
peripheral nerves (sensory and motor) and the autonomic nervous system can be affected. 
Often due to a combination of sensory neuropathy and vascular damage, there is an increased 
rate of skin ulcers and infection and, in serious cases, necrosis and gangrene. Diabetic 
neuropathy can have a significant and negative impact on quality of life, impair physical and 
psychological functioning and lead to anxiety and sleep disturbances (Javed et al., 2015). 
Diabetic foot is the reason why those with diabetes are prone to leg and foot infections and 
why it takes longer for them to heal from leg and foot wounds and is the most common cause 
of non-traumatic adult amputation, usually of toes and, or feet, in the developed world 
(Veves, Backonja, & Malik, 2008). 
 
Diabetic nephropathy is damage to the kidneys which can lead to chronic renal failure, 
eventually requiring dialysis (Harris, 1995). Diabetic nephropathy is the most common cause 
of end stage renal disease in most of the countries worldwide (Sharaf El Din, Salem, & 
Abdulazim, 2017). It increases the overall 10-year mortality among diabetic patients at least 6 
folds compared to healthy age matched non-diabetic individuals (Afkarian et al., 2013).  
Diabetic retinopathy is the leading cause of visual disability. Diabetes remains the most 
common cause of blindness in the working age group of the Western world (Chatterjee & 
Davies, 2015). Significant retinopathy is rarely encountered in the first five years of insulin-
dependent diabetes mellitus, however, over the subsequent two decades, the vast majority of 
people with diabetes develop retinal changes. The establishment of national retinal screening 
programmes in the UK has improved the detection and early referral to ophthalmology 
services of patients with diabetic retinopathy (Gupta et al., 2013). Panretinal 
photocoagulation and newer therapies such as injectable inhibitors of vascular endothelial 
growth factor can prevent worsening of proliferative retinopathy and onset of visual 
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impairment (Marozas & Fort, 2014). In individuals with T2D, up to 20% may be found to 
have retinopathy at the time of first diagnosis of diabetes and most develop some degree of 
retinopathy over subsequent decades (Gupta et al., 2013).  
Cardiovascular diseases (CVD; coronary heart disease and strokes) are the leading causes of 
death in the diabetic population, responsible for between 50% and 80% of deaths in people 
with diabetes (Ding, Sun, & Shan, 2017). In contrast to people with no diabetes, heart disease 
appears earlier in life, affects women almost as often as men, and is more often fatal in 
people with diabetes. Around 50% of deaths of people with diabetes are due to ischemic heart 
disease (Harris, 1995). Diabetes has become one of the major causes of premature illness and 
death in most countries, mainly through the increased risk of CVD (WHO, 2014). 
 
A recent case report by King and colleagues reported a further complication of diabetes. 
Liver disease in those with diabetes is common and is frequently the result of hepatic 
steatosis; an accumulation of fat in the liver. Diabetic hepatosclerosis is a relatively recent 
microvascular complication observed in liver biopsies of people with diabetes presenting 
with cholestasis (King et al., 2016). However, its effect on morbidity and mortality is not yet 
known.  
 
Diabetes and Oral Health 
The complications described above are well known, but the awareness of oral health-related 
complications is less common. However, diabetes is a significant risk factor for serious, 
progressive periodontal disease (Southerland, Taylor, & Offenbacher, 2005). Likewise, 
periodontal disease may contribute to the progression of impaired glucose tolerance in 
diabetes (Loe, 1993; Pontes Andersen, Flyvbjerg, Buschard, & Holmstrup, 2007). Loe (1993) 
for example, described periodontal disease as 'the sixth complication' of diabetes. It has also 
been described as a complication of diabetes that is often overlooked as it is not often 
included in the management of diabetes, education programmes or in the screening of 
complications (Dunning, 2009).  
 
Periodontal disease 
Periodontal diseases are collectively a very common group of oral diseases. Periodontal 
disease is predominantly caused by plaque-induced inflammatory lesions and includes 
gingivitis, in which the inflammation is confined to the gingiva, and is reversible with good 
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oral hygiene, and periodontitis, in which the inflammation extends and results in tissue 
destruction and alveolar bone resorption (Chauhan & Haslam, 2012). Tissue destruction in 
periodontitis causes breakdown of the collagen fibres of the periodontal ligament, resulting in 
the formation of a periodontal pocket between the gingiva and the tooth (Preshaw et al., 
2012). Periodontitis is a slow progressing disease but the tissue destruction that occurs tends 
to be irreversible. In the early stages, the condition is typically asymptomatic; it is not usually 
painful, and many patients are unaware of its presence until the condition has progressed 
enough that the teeth have become mobile. The pockets deepen as a result of the further 
damage of fibres of the periodontal ligament and the resorption of the alveolar bone that 
occurs alongside the progressing attachment loss. Advanced periodontitis is characterised by 
gingival erythema and oedema, gingival bleeding, gingival recession, tooth mobility, drifting 
of teeth, suppuration from periodontal pockets, and tooth loss (Preshaw et al., 2012).  
 
Prevalence of periodontal disease 
The condition is very common; periodontal diseases are prevalent both in developed and 
developing countries and affect about 20-50% of the global population (Nazir, 2017). 
Periodontitis is therefore a highly prevalent, but largely hidden, chronic inflammatory 
disease. Furthermore, it has negative and profound impacts on many aspects of an 
individuals’ daily living and quality of life, affecting confidence, social interactions and even 
food choices (O'Dowd, Durham, McCracken, & Preshaw, 2010). 
 
The negative impact of periodontal disease on oral health related quality of life (OHRQoL) 
has been investigated less than other oral problems, such as dental caries and tooth loss. A 
better understanding regarding the impact of periodontal disease can help ensure planning 
and treatment meets the needs and concerns of the patient. A recently performed systematic 
review of the literature aimed to find consistent evidence regarding the negative impact of 
periodontal disease on OHRQoL among adolescents, adults and older adults (Ferreira, Dias-
Pereira, Branco-de-Almeida, Martins, & Paiva, 2017). This review of thirty-four studies 
found that severe periodontitis had a significantly greater impact on OHRQoL than mild to 
moderate periodontitis. Gingivitis also exerted an impact, albeit less than periodontitis, and 
was associated with pain as well as difficulties involving tooth brushing and wearing 
dentures, demonstrating a negative correlation with comfort. Whilst the review had its 
limitations such as the inclusion of observational studies which generally have a greater risk 
of bias and confounding variables, which can compromise the internal and external validity 
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of the findings,, it did conclude that having greater knowledge regarding the impact of 
periodontal disease would allow periodontists to clarify to patients the importance of 
periodontal treatment to overcome this impact (Ferreira et al., 2017). 
 
Periodontal disease and diabetes 
Periodontitis is said to be the most common chronic inflammatory disease seen in humans, 
affecting nearly half of adults in the UK and 60% of those over 65 years (Chapple, 2014). 
Between 60% to 65% of the U.S. population has periodontal disease, and the prevalence 
increases to 85% to 90% in individuals with diabetes (Iacopino, 2001). The risk of 
periodontitis is also described as increasing by approximately threefold in diabetic 
individuals compared with non-diabetic individuals (Mealey & Ocampo, 2007). In the US 
National Health and Nutrition Examination Survey (NHANES) III, adults with poorer 
diabetes control had a significantly higher prevalence of severe periodontitis than those 
without diabetes after controlling for age, ethnicity, education, sex and smoking (Tsai, Hayes, 
& Taylor, 2002). The chronic effect of hyperglycaemia enhances the formation of 
biologically active glycosylated proteins and lipids, which endorse inflammation and 
increases the likelihood of periodontal infection (Lalla, Lamster, Drury, Fu, & Schmidt, 
2000). In addition, lipopolysaccharide, a bacterial endotoxin, plays a role via the actions of 
Toll-like protein receptors, which stimulate the inflammatory response and the immediate 
immune response (Takeda & Akira, 2005). The immune response to infection is therefore 
altered in the presence of hyperglycaemia, so that white cell mobility and phagocytic capacity 
is reduced. 
 
Once periodontal disease and diabetes occur together, a vicious cycle develops: diabetes 
predisposes the individual to periodontal disease, which in turn contributes to 
hyperglycaemia, which affects other tissues and organs, including the oral cavity. Preventing 
and/or effectively managing periodontal disease can reduce hyperglycaemia, subsequent 
insulin requirements, and overall HbA1c (Danesh, Collins, Appleby, & Peto, 1998). 
Periodontal infection is also associated with other long-term diabetes complications, such as 
atherosclerosis (Nichols, Fischer, Deliargyris, & Baldwin, 2001) and nephropathy 
(Choudhury & Luna-Salazar, 2008). 
 
Diabetes is one of several systemic diseases that contributes to periodontal disease in the oral 
cavity by exaggerating the host response to the local microbial factors, for example 
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endotoxin, resulting in destructive periodontal breakdown (Ryan, Carnu, & Kamer, 2003). 
Metabolic control is important in people with diabetes because they are more susceptible to 
infections than those without diabetes (Hayes, Leal, Gray, Holman, & Clarke, 2013).   
 
Periodontal infection may adversely affect glycaemic control. In a systematic review, Taylor 
(2003) reviewed the evidence of how the treatment of periodontal disease can positively 
affect glycaemic control. Although results were limited in terms of quantity, breadth and 
strength of evidence, there was still support for the notion that treating periodontal infections 
with adjuvant antibiotics could have a beneficial effect on glycaemic control, such as, 
improved HbA1c values, in both T1D and T2D. They concluded that it is important for health 
professionals to incorporate a thorough oral examination and necessary periodontal care, in 
terms of prevention and treatment in management regimes for people with diabetes. Older 
studies have shown that scaling and root planing with systemic doxycycline therapy is 
associated with an improvement in periodontal health as well as a significant improvement in 
glycaemic control, as measured by HbA1c (Grossi et al., 1997; Grossi et al., 1996). To this 
finding, Ronningen and colleagues, in a review of diabetes and oral health added that 
periodontal therapy should primarily consist of a systematic treatment by mechanical 
debridement without the use of antibiotics (Ronningen & Enersen, 2012). They also 
concluded that the goal of therapy for oral manifestations is to promote oral health in those 
already diagnosed with diabetes, to help prevent and diagnose diabetes in undiagnosed dental 
patients receiving routine stomatological care and to enhance the quality of life for patients 
with this incurable disease. In cases where the response to the conventional treatment is 
inferior, the use of antibiotics as a supplement should always be based on a microbial 
diagnosis and susceptibility testing of the microbiota. Thus, by reducing the inflammation 
after periodontal therapy, insulin sensitivity may be restored, therefore improve glycaemic 
control (Mealey & Rose, 2008).  
 
One of the most recent Cochrane systematic reviews published in the area of periodontal 
disease and diabetes looked into the suggestion that a bidirectional relationship exists 
between glycaemic control and periodontal disease. Therefore, the objective of this Cochrane 
review was to investigate the effect of periodontal therapy on glycaemic control in people 
with diabetes (Simpson et al., 2015). RCTs were found whereby participants had diabetes and 
a diagnosis of periodontitis, and where interventions involved periodontal treatment. 
Outcome data was collected on blood glucose levels measured by HbA1c. Of the thirty-five 
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studies found, the authors concluded that there was low quality evidence that the treatment of 
periodontal disease actually improved glycaemic control in people with diabetes, with a mean 
percentage reduction in HbA1c of 0.29% at 3-4 months. There was insufficient evidence to 
demonstrate that this was maintained after four months. There was no evidence to support 
that one periodontal therapy was more effective than another in improving glycaemic control. 
It would thus appear that ongoing professional periodontal treatment is required to maintain 
clinical improvements beyond 6 months.  
 
As well as periodontal diseases such as gingivitis and periodontitis which are modifiers of 
glycaemic control, there are several other oral manifestations of diabetes including, burning 
mouth syndrome, candidiasis, dental caries and salivary dysfunction (Ronningen & Enersen, 
2012; Ship, 2003).  
 
 
Financial cost of diabetes 
Management of diabetes is expensive and set to get costlier. Managing the condition and its 
devastating complications imposes a huge societal and economic toll on healthcare systems 
worldwide (Chowdhury & Bennett-Richards, 2013). Diabetes UK report that 10% (around 
£11 billion) of the UK healthcare expenditure is on management of diabetes and its attendant 
complications, although the actual cost may be double this figure if indirect costs are 
included (Diabetes UK, 2012). However, it has been reported that annual costs of diabetes to 
the NHS are estimated at £23.7bn and projected to rise to £39.8bn by 2035 (Hex et al., 2012). 
In a recent study, the cost of severe hypo-glycaemia in patients with T2D in England was 
calculated, and the authors reported that hospitalisation as a result of severe hypoglycaemic 
events was associated with considerable financial costs to the NHS (Holbrook et al., 2017). 
 
Preventing diabetes-related complications 
The development of diabetic complications is strictly related to metabolic control (Wang, 
Lau, & Chalmers, 1993). Nicolucci and colleagues found several factors related to the 
development of major diabetic complications when they compared 886 patients with long-
term diabetic complications and 1,888 control participants without complications (Nicolucci 
et al., 1996). Among patient characteristics, male sex and age for patients between 50 and 69 
years of age as opposed to those younger than 50 years of age were associated with an 
increased risk of diabetes-related complications. The type and duration of diabetes were the 
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most important clinical predictors of diabetic complications. They also found that the 
presence of hypertension was associated with the development of diabetic complications, 
particularly when it was poorly controlled by treatment. Patients who needed help to reach a 
health care facility and those who did not regularly attend such a facility were at higher risk 
of developing complications, educational aspects were also related to the outcome: patients 
who did not receive any kind of educational intervention had an increased risk of developing 
complications, while self-management of insulin therapy had a protective effect. It was 
summarised that by removing avoidable risk factors, the number of diabetic complications 
considered could be reduced by more than one-third (Nicolucci et al., 1996).  
 
To date, the most successful strategy for preventing complications of diabetes is intensive 
treatment of hyperglycaemia. The DCCT demonstrated the value of this approach with a 
curvilinear relationship between glycosylated haemoglobin and the incidence of retinopathy, 
thus demonstrating that the incidence of retinopathy, nephropathy, and neuropathy could be 
reduced by intensive treatment (Clark & Lee, 1995; Colwell, 1994). A similar trial was 
conducted in the UK; The UK Prospective Diabetes Study (UKPDS) was a randomised, 
multicentre trial of glycaemic therapies in 5,102 patients with newly diagnosed T2D, running 
for twenty years in 23 UK clinical sites and showed conclusively that the complications of 
T2D previously often regarded as inevitable, could be reduced by improving blood glucose 
and/or blood pressure control (Stratton et al., 2000). Research such as this clearly 
demonstrates the need for early intervention in the form of treatment and tight glucose 
control, therefore screening for undiagnosed diabetes is one way to begin this process. On the 
basis of this work, the National Diabetes Prevention Programme (NDPP) was launched. It is 
an evidence-based lifestyle change program which has been demonstrated to delay or prevent 
the development of type 2 diabetes among people at high risk. NHS England, Public Health 
England (PHE) and Diabetes UK initiated a UK national diabetes prevention programme in 
2015. The National Health Service Diabetes Prevention Programme (NDPP) commenced 
during 2016 with a first wave of 27 areas covering 26 million people, half of the population, 
making up to 20,000 places available for people to receive tailored, personalised help to 
reduce their risk of T2D including education on healthy eating and lifestyle, help to lose 
weight and bespoke physical exercise programmes (National Cardiovascular Intelligence 




Improved glucose control has been a treatment mainstay in the management of diabetes, and 
the number of pharmacological and non-pharmacological strategies to control glucose levels 
has increased substantially in the past decade (Zoungas et al., 2017). Despite the growing 
number of therapeutic options, there is uncertainty regarding the clinical benefits and risks of 
varying intensities of glucose control for patients with T2D (Hemmingsen et al., 2013). 
Intensive glucose control is understood to prevent complications in adults with T2D. 
Therefore a meta-analysis was conducted to estimate the effects of more intensive glucose 
control, compared with less intensive glucose control, on the risk of microvascular events; 
specifically kidney events, eye events and nerve events (Zoungas et al., 2017). Participant 
data was collected from RCTs with a total of more than 27,000 participants. Compared with 
less intensive glucose control, more intensive glucose control resulted in an absolute 
difference of –0·90% (95% CI –1·22 to –0·58) in mean HbA1c at completion of follow-up. 
The relative risk was reduced by 20% for kidney events, and by 13% for eye events. There 
was no reduction in nerve events. More intensive glucose control over 5 years reduced both 
kidney and eye events, and was important for the prevention of long-term microvascular 
complications in adults with T2D. 
 
 
Screening for Diabetes  
In view of the steady increase of life expectancy and the corresponding rise of chronic 
disease rates during the past decade, health promotion and primary and secondary preventive 
health services have become more and more important (Shippee et al., 2012). There is now an 
emphasis on services which aim to prevent disease and illness through disease surveillance, 
and surveillance for disability and other health problems, providing advice and counselling 
on good health maintenance and well-being through living a healthy lifestyle (DoH, 1989). 
This is often demonstrated in screening programmes that have been developed to comply 
with the idea of health checks and surveillance.  
 
Screening is a process of identifying apparently healthy people who may be at increased risk 
of a disease or condition (Edwards et al., 2013). They can then be offered information, further 
tests and appropriate treatment to reduce their risk or any complications arising from the 
disease or condition (Waugh et al., 2013). 
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Screening is not the same as diagnosis: most screening programmes look for risk factors for a 
particular disease of condition. Some individuals with these risk factors will never develop 
the condition or disease, and some who develop the disease or condition will not be picked up 
by screening. When choosing who to screen and for which conditions, the benefits are 
weighed against the harms (Gilmer & O'Connor, 2010; UK National Screening Committee, 
2014). 
It is well-recognised that T2D has become a huge burden for the worldwide general adult 
population (UK National Screening Committee, 2008, 2014). The review by the National 
Screening Committee in 2014 found that interest in screening had been stimulated by a 
number of factors including the rising number of people with diabetes and with people with 
raised blood sugar who do not meet the formal level for a diagnosis of diabetes. The 
committee recognised that primary prevention measures (such as lifestyle change) were 
having a limited effect, increased understanding of how raised blood sugar (at any level) 
related to a broad range of vascular risk, change in international views on testing, 
improvement in management of diagnosed diabetes and developments in treatment of people 
with raised blood sugar but who were not diabetic. The review came to the conclusion that, 
on the balance of the evidence, universal screening was not recommended. However, the 
report suggested that this did not rule out the value of early detection in high risk groups or, 
in England, the NHS Health Check; a free check-up of your overall health which assesses 
whether a person is at higher risk of getting certain health problems, such as heart disease, 
diabetes, kidney disease and stroke. 
 
Screening for T2D will potentially allow for early diagnosis and treatment. This is considered 
to be important as early diagnosis and treatment could prevent future associated 
microvascular and macrovascular complications. An estimated 50% of people with diabetes 
are currently undiagnosed (International Diabetes Federation, 2013). According to several 
major studies, around 20–30% of people with T2D have already developed complications at 
diagnosis (Marre & Travert, 2010). The approach could be either to screen for T2D alone, or 
to anticipate the progression to diabetes from pre-diabetic states and therefore work with a 
lower threshold to allow screening for both impaired glucose tolerance (IGT) and T2D. In 
addition, for earlier diagnosis of T2D, interventions could be designed for those identified 
with IGT in order to attempt to delay the onset of T2D and/or to prevent complications 





The diabetes screening debate 
The World Health Organization defined the minimal criteria to propose a disease for an early 
detection programme (Wilson, Jungner, & WHO, 1968). The five main reasons for 
recommending a disease for a screening programme are: 
1. The disease should represent an important health economic concern. 
2. The natural history of the disease and the prognosis when not treated should be known. 
3. There should be a latent preclinical time before the occurrence of symptomatic disease 
during which diagnosis is possible. 
4. There should exist reliable and safe diagnostic tests which are acceptable for screening 
the population. 
5. The disease should be able to be efficiently treated when diagnosed; the earlier the 
treatment is started the more efficient it is. 
 
With respect to these early detection criteria, there is plethora of opinion suggesting as to why 
diabetes is a condition that should be screened for. The following section outlines some 
arguments for and against screening for diabetes.  
 
T2D is typically a disease characterised by a latent phase before the occurrence of the clinical 
symptoms. This has been demonstrated by various epidemiological surveys and during 
detection programmes. Moreover, at the time of clinical diagnosis, often due to the symptoms 
of hyperglycaemia, a percentage of these newly diagnosed diabetic patients already have 
complications, especially retinopathy (2–39%), nephropathy (8–18%) or neuropathy (5–
13%). From this, research has now estimated that the preclinical phase can last from 7 to 12 
years (Engelgau et al., 2000). This means there a severe delay in diagnosis and treatment. 
During this preclinical stage, there is a possibility of making an earlier diagnosis since 
hyperglycaemia may remain asymptomatic for years. Performing a blood glucose assessment 
is relatively easy and acceptable to individuals being screened (Friman, Hultin, Nilsson, & 
Wardh, 2015). A frequent question when considering the need to screen for T2D is, does a 
treatment started at the phase of screening result in better outcomes? The evidence is said to 
be weak and there is not much research to demonstrate that screening for diabetes provides a 





The rest of this section outlines chronologically, the arguments that have been put forward for 
and against screening for diabetes. Formal screening dates back to the 1940s, where the 
findings of a population study in Massachusetts showed that for every known diabetic case, 
there was another person with undiagnosed diabetes (Wilkerson & Krall, 1953). From this, 
large-scale screening detection programmes emerged and the current urine tests were 
replaced by blood-based methods. The American Diabetes Association subsequently 
endorsed blood glucose screening programmes, and local diabetes organisations facilitated 
these programmes. Although the screening programmes uncovered plenty of new cases of 
diabetes, negative aspects of the programmes also emerged. They were inadequately 
organised, and cases of chronic hyperglycaemia often would go unrecognised or 'lost' in the 
system. Referrals were delayed evoking criticism from patients and professionals. The cost of 
regular evaluations, the side effects of inappropriately using oral hypoglycaemic agents and 
issues related to employability and insurability added to the negative view of the usefulness 
of diabetes screening programmes, and led to the medicine and federal agencies to re-
evaluate the worth of these programmes. As a consequence, in 1979 Herron noted that 
glucose intolerance should not be screened for in non-pregnant populations (Herron, 1979). 
Although his report did not escape criticism, it reflected a change in the number of screening 
programmes and impacted on diabetes organisation across the world.  
 
According to O'Sullivan and Kannel (1983), proper evaluation of the worth of screening for 
diabetes depends partly on the stage of diabetes to be detected. Not many have questioned the 
worth of screening for and detecting the obvious stage of diabetes, where it is well developed 
and characterised by chronic hyperglycaemia, as there is obvious value in preventing the 
acute complications of diabetes. However, the detection of asymptomatic hyperglycaemia 
poses a number of difficult problems. In order to improve upon the problems created in past 
screening programs, O'Sullivan and Kannel (1983) suggested defining hyperglycaemia less 
equivocally, and in addition, the management of the individual and the programme as a whole 
should be in terms of risk evaluation. They also suggested using the term "impaired glucose 
tolerance" (IGT) rather than diabetes to lessen the extent of anxiety and other adverse social 
and psychological aspects created in earlier screening programmes. The health benefits for 
the individual is fundamental to questioning the worth of such a programme, therefore, 
O’Sullivan and Kannel (1983) suggested that possible benefit of screening for diabetes could 
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best be accrued from focussing on a subset of the population, those most vulnerable to 
developing diabetes. Screening programmes would be worthwhile for the individuals who are 
obese, those with a family history of diabetes, those at risk for cardiovascular disease and 
pregnant individuals. They were of the opinion that screening the general population should 
be carried out with caution and should only be done if the activity is part of a diabetes or 
cardiovascular disease health education or prevention programme, and if the term diabetes is 
used cautiously by requiring blood glucose screening levels to be obviously high. Finally, 
they made a suggestion, that lowering the blood glucose levels for screening in the future 
should be considered if there is to be a shift from just detecting diabetes to preventing the 
development of diabetes.  
   
In 1997, the American Diabetes Association proposed the screening of all patients aged over 
45 years by measuring fasting blood glucose every three years, in addition to screening 
patients from high-risk ethnic groups, and younger patients with hypertension, obesity, a 
family history of diabetes in a first degree relative, or a family history of gestational diabetes 
(Mellitus, 1997). Such a policy has major resource implications for the NHS, and so the 
debate on whether to screen for diabetes in the UK continued (Wareham & Griffin, 2001).  
 
Screening for diabetes has the potential to detect pre-diabetes, a condition in which a person’s 
blood sugar levels are higher than normal, but not yet at a level to be classified as diabetes. 
Being diagnosed with pre-diabetes is important because having pre-diabetes and subsequently 
making the necessary lifestyle changes can greatly reduce the chances of the condition 
developing into diabetes. However, despite this information, other researchers have stated 
that there is insufficient evidence to recommend screening for diabetes and that we still need 
to know whether treating asymptomatic people with slightly raised glucose concentrations is 
effective (Stolk, 2007).  
 
According to Engelgau, Narayan & Herman (2000), T2D fails to meet all of the criteria for 
suitability for screening. Lamont and colleagues undertook a study to explore the views of 
general practitioners (GPs) and practice nurses towards the benefits and barriers of screening 
for T2D (Lamont, Whitford, & Crosland, 2002). Semi-structured interviews were carried out 
with 10 GPs and nine practice nurses in eight general practices in the UK. Participants 
answered open-ended questions about benefits of screening for T2D, the impact of screening 
40 
 
on primary care, barriers to implementing screening and the consequences for patients of 
screening.  
 
Despite the growing expression concerning the practice of evidence-based medicine 
(Niessen, Grijseels, & Rutten, 2000), only two GPs constructed their beliefs about the 
effectiveness of screening for T2D from a scientific evidence-based approach. They 
expressed uncertainty as to whether any real benefits would come from a screening 
programme and were more inclined to wait until there was clear evidence available. Their 
views did not include the trust generated by earlier detection, but were more likely to mention 
provoking anxiety in patients and the social impact of screening. However, there was a 
contrasting belief in that screening for T2D is worthwhile. This belief came from a complex 
interaction of factors including perceptions of patient desires, previous experience and 
evidence from other sources. A lack of resources in terms of time and finance were seen as 
the major barrier to implementing screening. Results also demonstrated a belief among 
primary care practitioners that patients exert little effort in gaining or maintaining lifestyle 
changes. Combined with reluctance among the GPs to place these patients on multiple 
medications, an issue was created as to whether screen-detected cases would benefit if they 
were not then subsequently intensively treated. The chances that the elderly and socially 
deprived, who may benefit most from screening and subsequent interventions, would be 
targeted was undermined by the doubt about the effectiveness of treatment in such sub-
groups. Screening for T2D can be seen from this study as reinforcing a paternalistic medical 
model, whereby a "knowledgeable doer", in the "best interests" of the patient, subjects the 
patient to a test with little consent but possible major consequences. A major motivator 
towards the introduction of screening in this study appeared to be the perception that 
screening was reflecting the desire of patients for earlier detection of disease (Lamont et al., 
2002). In conclusion, the authors stated that the belief that screening for T2D is worthwhile 
was based not on evidence for the effectiveness of such a screening programme, but rather on 
an intricate interaction of factors including perceptions of patient desires, previous 
experience, and evidence from other sources (Lamont et al., 2002). 
 
Later on, Gilmer and O'Connor (2010) discussed the growing importance of diabetes 
screening following recent trials which quantified the risks of intensive glycaemic control 
such as, high treatment costs, weight gain, increased risk of severe hypoglycaemia and even 
an increased risk of death (Gilmer & O'Connor, 2010). They pointed out that more attention 
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is needed on primary prevention of T2D and the identification of cases of diabetes and its 
dangerous progenitor pre-diabetes. Those then identified with pre-diabetes may benefit from 
lifestyle or pharmacological intervention that could potentially prevent or delay the onset of 
diabetes.   
 
At around the same time, Chatterjee and colleagues investigated the economic justification 
for screening for pre-diabetes and diabetes and reported that population-based screening for 
diabetes may be cost saving (Chatterjee, Narayan, Lipscomb, & Phillips, 2010). The 
economic costs of hyperglycaemia are substantial. Early detection of the disease can allow 
management to prevent or delay the development of diabetes and diabetes-related 
complications. Participants aged 40-74 years without a previous diagnosis of diabetes were 
recruited for diabetes screening. The projected health system and societal costs over 3 years 
for 1,259 adults were calculated, comparing costs associated with five opportunistic 
screening tests. They concluded that screening can be cost-saving compared to no screening 
from a health system perspective, but not necessarily from a societal perspective.  
 
It is now established that microvascular and macrovascular complications are sometimes 
present at diagnosis, even in prediabetes following an impaired fasting glucose or impaired 
glucose tolerance (Diabetes Prevention Program Research Group et al., 2007; Nguyen, Wang, 
& Wong, 2007).  As many as 25% of people with a new diagnosis of diabetes already have 
established diabetic retinopathy or microalbuminuria, which has been interpreted to mean that 
there is on average a 7-year gap between the actual onset and the diagnosis of T2D (Harris, 
1993; Thompson et al., 1996). To this end, the reality remains that there is a crucial need to 
identify diabetes and its precursors earlier and more efficiently, and therefore screening for 
diabetes is crucial. 
 
To conclude, at present, a systematic national screening program for diabetes is not 
recommended in the UK; however, the National Screening Committee does recommend 
selective screening as part of overall vascular risk assessment (Waugh et al., 2013). 
Accordingly, the current NICE guidelines advise health practitioners to carry-out a two-stage 
strategy, involving the use of screening questionnaires in stage one, followed by a blood test 
at stage two if necessary (Guess, Caengprasath, Dornhorst, & Frost, 2015). For people at low 
risk of diabetes, the guidance recommends a short consultation to advise the patient of their 
current low risk status and to offer brief risk reduction advice. For people with a high risk 
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score, but normal blood glucose control, a discussion of the patient’s particular risk factors is 
recommended, alongside lifestyle advice to address modifiable risk factors. People with a 
high-risk score should be offered a referral to a local, evidence-based intensive lifestyle-
change programme (NICE, 2012). 
 
 
Screening tests for Diabetes 
There is no global consensus on the screening strategy and test for detection of 
diabetes(Zhang, Hu, Zhang, Mayo, & Chen, 2015). Ideally, a screening test should be both 
sensitive (have a high probability of being positive when the subject truly has the disease) 
and specific (have a high probability of being negative when the subject does not have the 
disease) (Maxim, Niebo, & Utell, 2014). However, increasing sensitivity reduces specificity, 
and increasing specificity reduces sensitivity. Screening tests should also be reliable and 
reproducible (Engelgau et al., 2000). 
 
A systematic review by Bennett, and colleagues in 2007 did not find clear evidence to 
suggest that one test, HbA1c or FPG, was superior to the other in screening for diabetes or 
IGT (Bennett, Guo, & Dharmage, 2007). HbA1c and FPG were found to be equally effective 
screening tools for the detection of T2D. On the whole, HbA1c had slightly lower sensitivity 
but higher specificity than the FPG in detecting diabetes, but neither was effective in 
detecting IGT though neither FPG nor HbA1c involve a glucose challenge, so they are 
unlikely to detect IGT. 
 
The measurement of HbA1c provides an assessment of long-term (around 3 months) 
glycaemic control and is regularly used in diabetes management. The WHO in their 2006 
report did not recommend using HbA1c for the diagnosis of T2D because HbA1c 
measurement was not widely available in many countries throughout the world, global 
consistency in its measurement was problematic, and also because the HbA1c result was said 
to be influenced by several factors including anaemia and abnormalities of haemoglobin. 
More recently however, it was recommended by the ADA and the International Expert 




Conversely, it was recommended that A1C not be used as a primary diagnostic test; instead, 
it has been argued that it should be considered an optional diagnostic tool or used as a 
screening test that may suggest the need for additional glucose measurements (American 
Association of Clinical Endocrinologists Board of Directors & American College of 
Endocrinologists Board of Trustees, 2010). HbA1c level is not affected by short-term 
lifestyle changes, whereas a few days or weeks of dieting or increased exercise prior to 
screening can significantly affect FPG and OGTT, therefore, HbA1c probably accurately 
reflects longer-term glycaemia (Tahara & Shima, 1993). In a review of diagnostic tests, it 
was recommended that this long-established and universally accepted measure of chronic 
glycaemia, should be used to screen and diagnose diabetes (Saudek et al., 2008).  
 
Fasting plasma glucose (FPG) has been a commonly used tool in screening diabetes, but it 
has a large random variation, it only reflects current glycaemic status, and requires people to 
fast for at least 8 hours before the test. Oral glucose tolerance test (OGTT) has been shown to 
be the most valid tool for diagnosing diabetes (Schwarz et al., 2009). However, OGTT is 
more expensive, inconvenient, and has weak reproducibility, making it practically 
unacceptable for most patients and providers as the first line of screening tool (Waugh et al., 
2007). Glycosylated haemoglobin reflects long-term glycaemic control and is a more accurate 
and stable measure than FPG levels (Goldstein et al., 2004). In 2010, the International Expert 
Committee recommended the use of HbA1C, a non-fasting test, to diagnose diabetes (ADA, 
2010). The recommendations imply that the practical advantages of HbA1c over FPG and 
OGTT will make diabetes screening more widespread. However, the sensitivity of using 
HbA1c alone in detecting diabetes is unacceptably low, ranged from 63.2% at a cut-off value 
of 6.1% to 28.3% at a cut-off value of 7.0% in different populations (Buell, Kermah, & 
Davidson, 2007). 
 
Multivariate risk scores have been developed in recent years to predict diabetes risk for 
healthy individuals (Buijsse, Simmons, Griffin, & Schulze, 2011). Simple, practical, non-
invasive and inexpensive methods are needed to identify individuals at high risk for diabetes 
and to limit the proportion of the population requiring diagnostic glucose tolerance tests 
(Alberti, Zimmet, & Shaw, 2007). The use of FPG levels as a population-level screening tool 
is not recommended due to the variability of its plasma levels and its low cost-effectiveness 
(Waugh et al., 2007). However, the cost-effectiveness improves when used in high-risk 
subgroups (i.e. age over 45 years, history of gestational diabetes, family history of diabetes or 
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obesity). Salinero-Fort and colleagues reported that there was no consensus on the selection 
of the optimal high-risk subgroups or on how regularly these screens should be performed 
(Salinero-Fort et al., 2015). As a consequence, risk scores have been developed in order to 
better identify high risk participants.  The IDF recommends the use of brief patient 
questionnaires to help healthcare professionals to quickly identify people who may be at a 
higher risk and who need to have their level of risk further investigated. This type of 
questionnaire could also be used by individuals for self-assessment. Using a diabetes risk 
score questionnaires for screening undiagnosed and/or pre-diabetes have been developed and 
validated in different populations worldwide (Zhang, Wang, et al., 2015). Some diabetes risk 
scores are based on demographic, clinical information and modifiable lifestyle factors such as 
diet and physical activity, and do not require blood draws and laboratory tests. Therefore, 
they are cheap and easy to be applied in the primary care setting and in large scope screening 
programs. Although collecting data from a questionnaire is likely less costly and more 
acceptable than methods of screening involving more invasive measures such as blood 
glucose testing, difficulties in distributing questionnaires, the time required to complete them, 
the complexity of computing the results, issues related to reporting bias, and unavailability of 
some required information may hamper their population-wide application. Questionnaires 
may also create anxiety or false reassurance (Buijsse et al., 2011). The most well-known 
scores are those developed by the ADA (Bang, Edwards, Bomback, & et al., 2009), the 
German Institute of Human Nutrition (Schulze et al., 2007), and the Finnish Diabetes 
Association (FINDRISC) (Lindstrom et al., 2003). They all have certain common advantages: 
the variables are simple to collect; they have open access via websites; they are inexpensive 
and quick, and can be self-administered. All have a similar diagnostic accuracy, with 
equivalent AUC for ROC, compared with those that add laboratory variables (Aekplakorn et 
al., 2006; Schmidt et al., 2005). 
 
Noble and colleagues discussed the properties of seven validated diabetes risk scores which 
they judged to be most promising for use in clinical or public health practice (Noble, Mathur, 
Dent, Meads, & Greenhalgh, 2011). These included for example, the Cambridge Risk Score 
(Rahman, Simmons, Harding, Wareham, & Griffin, 2008), Ausdrisk (L. Chen et al., 2010), 
QDScore (Hippisley-Cox, Coupland, Robson, Sheikh, & Brindle, 2009), FINDRISC 
(Lindstrom et al., 2003; Stern, Williams, & Haffner, 2002), and San Antonio Risk Score 
(Stern et al. 2002). The seven risk scores were classified as having high potential for use in 
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practice, offered broadly similar components and had similar discriminatory properties (area 
under receiver operating characteristic curve varied from 0.74 to 0.85.   
 
Despite their widespread use, few studies have directly compared the performance of the 
different scores. However, in one particular cross-sectional study of 2759 Taiwanese 
participants, Lin and colleagues evaluated the performance of different risk scores for 
detecting T2D, metabolic syndrome and chronic kidney disease. Their data showed the 
FINDRISC to be one of the more superior scores for identifying the risk of undiagnosed 
diabetes (Lin et al., 2009). 
 
What are the psychological predictors of screening participation? 
Understanding the principle determinants in preventive health practices such as screening 
attendance, is of major importance in order to optimise any kind of preventive health strategy 
(Brunner-Ziegler et al., 2013). If attendance rates at such screening programmes are to be 
increased it is imperative that the factors which may lead to non-attendance be identified and 
managed (Norman & Connor, 1993). 
 
Following several decades of research, a number of models of health behaviour have 
been designed in an attempt to map out the mediators of sociodemographic variables and 
identify proximal determinants of health behaviour. They provide a clear theoretical 
background to research, guiding the selection of variables to measure, the procedure for 
developing reliable and valid measures, and how these variables are combined in order to 
predict health behaviours and outcomes. Additionally, to the extent which they identify the 
variables important in predicting health behaviours and outcomes, they further our 
understanding of health (Abraham, Sheeran, & Henderson, 2011).  
 
Motivational models unsurprisingly focus on the motivational factors such as protection 
motivation or threat that may underpin individuals’ decisions to perform or not to perform 
certain health behaviours. Research associated with motivational models employs measures 
of intention as the dependent variable of interest suggesting that motivation is adequate for 
the action of successful behaviour. Models designed to account for the relatively poor 
correspondence between motivational variables such as intentions, and subsequent behaviour 
were then designed; this second group of social cognition models focus on connecting 
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motivation and behaviour. They focus on action control strategies that are designed to ensure 
that motivation leads to action. Then, at the most complex level, there are multi-stage theories 
that describe processes which both facilitate the action of behaviour and offer strategies for 
maintenance of a particular behaviour, such as screening attendance (Armitage & Conner, 
2000; Power et al., 2008; St Quinton & Brunton, 2017). 
 
Social cognition models may be employed to identify those variables which are important in 
reaching a decision to follow a health-related action in general, and to attend a health check 
in particular (St Quinton & Brunton, 2017). Understanding the factors that promote 
attendance in screening is important for the development of health promotion interventions 
aimed at improving the effectiveness of screening programmes.  
 
In relation to breast cancer screening for example, results show that women who receive 
regular mammograms feel more personally susceptible to the disease than women who do not 
receive regular mammograms (Halabi et al., 2000; Lagerlund, Hedin, Sparen, Thurfjell, & 
Lambe, 2000). This supports the notion that screening for a particular disease can lead to 
negative psychological consequences. Other cognitive variables found to be associated with 
having had repeated mammograms include, perceived barriers or costs (Lagerlund et al., 
2000; Lerman, Rimer, Trock, Balshem, & Engstrom, 1990; Taylor, Taplin, Urban, White, & 
Peacock, 1995); perceived benefits or effectiveness of mammograms (Lagerlund et al., 2000; 
Marshall, 1994); and perceived ease of screening re-attendance (Marshall, 1994). In a study 
following this, Drossaert and colleagues utilised the Theory of Planned Behaviour (TPB; 
(Ajzen, 1991)) as a theoretical framework to predict repeat attendance and patterns of 
attendance in breast cancer screening (Drossaert, Boer, & Seydel, 2002). A group of 2657 
women completed a baseline questionnaire, approximately 8 weeks after receiving an 
invitation for an initial screening in the Dutch Breast Cancer Screening Programme. Data on 
actual attendance in second and third screening round were subsequently collected. Personal 
variables such as a family history of breast cancer, breast cancer in someone close and a fear 
of breast cancer were not related to repeat attendance. However, the TPB variables could 
explain approximately 17% of the variance in attendance in the second and third attendance 
rounds. Maintenance behaviour as measured by consistent attendance vs. dropout, was related 
to the TPB variables, but the amount of variance explained was only 6%. Initiation of 
behaviour as measured by consistent refusal vs. delayed attendance, was also related to TPB 
variables, with a considerably higher amount of explained variance than with the 
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maintenance behaviour. These results signify that the TPB variables are more related to the 
initiation of screening behaviour than to the maintenance of screening behaviour. 
 
In a similar study looking to identify predictors of uptake into a screening programme, Bish, 
Sutton and Golombok (2000) looked at psychological predictors of uptake of women to a 
cervical screening programme. Among 142 women in London, the Health Belief Model 
(HBM; (Becker, 1974) and the TPB (Ajzen, 1991) were assessed in addition to the 
anticipated effect following non-attendance for screening. Results showed that a positive 
attitude towards having a smear test was the best predictor of an intention to be screened, 
being considerably more influential than a perception of a threat to health or perceived social 
pressure (Bish, Sutton, & Golombok, 2000). However, the TPB emerged as the superior 
model for predicting screening intentions, explaining 51% of the variance in comparison with 
only 4% explained by the HBM variables. Conversely, neither model was able to predict a 
significant amount of variance in uptake of screening three months later. 
 
It is now known that patient acceptability of a screening programme will affect uptake (Webb 
et al., 2011), therefore it is crucial to ascertain patients’ views as to why or not they 
participate. Eborall, Stone, Aujla, Taub, Davies and Khunti (2012) highlighted the barriers to 
uptake of the oral glucose tolerance test as a screening method, by qualitatively exploring the 
perspectives of those invited to attend the MY-WAIST screening study for type 2 diabetes, 
particularly the explanations for attending or not attending. Screening involved taking a self-
measured waist circumference and completing a questionnaire to identify a risk-score, 
followed by a subsequent oral glucose tolerance test.  Semi-structured interviews were 
conducted with 24 individuals aged 40-69 years, comprising 13 who attended and 11 who did 
not attend the screening. Reply slips from 73 individuals who declined the offer of screening 
were also analysed.  
 
The researchers found two categories of influence on the decision about attending screening 
to emerge. The first was beliefs about T2D candidacy. T2D was more common among those 
who had attended, and lack of perceived severity of T2D was more common among those 
who did not attend (Eborall et al., 2012). The second was practical aspects about the 
screening strategy, in terms of the lengthy, early morning screening appointments, which 
were identified as a barrier to screening uptake. Conversely, those who attended for screening 
found the procedure largely acceptable. There was a tendency to consider T2D as lacking in 
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severity, and the idea that T2D is easily controllable was evident, particularly in non-
attendees (Eborall et al., 2012). This study highlighted the barriers to diabetes screening 
attendance, demonstrating that beliefs about susceptibility to, and severity of, the condition 
affect whether people attend for screening, lending further support to how well social 
cognition model components can predict screening behaviour. 
 
The psychological impact of screening 
As with any screening programme the overall benefits should outweigh any physical and 
psychological harm associated with the programme (Eborall, Davies, Kinmonth, Griffin, & 
Lawton, 2007). It is important to identify possible adverse psychological effects of screening, 
and the resulting diagnosis and treatment in order to be able to deliver a successful screening 
programme with high levels of participation. It is therefore important to consider that a small 
adverse effect for the majority of participants who screen negative may outweigh a large 
benefit to the few diagnosed as having the condition, thus an assessment of the potential 
harms among all those invited to participate in screening is warranted.  
 
An early systematic review of prospective studies of the psychological harms that can arise 
from screening across various conditions found that anxiety was often raised, at least in the 
short term, when a positive result is received, although it was unlikely to be raised by 
receiving a negative result (Shaw, Abrams, & Marteau, 1999).  
 
More recently, Bond and colleagues carried out a systematic review in 2013 looking at the 
psychological effects on women receiving a false-positive mammography screening result. 
Eleven studies concluded that this disease-specific screening result consequently led to a 
negative psychological impact which had the potential to last for up to three years. However, 
this review only looked at screening results specific to breast cancer screening and to a false 
positive result (Bond et al., 2013). Therefore, due to the prolonged uncertainty throughout the 
screening process (French, Maissi, & Marteau, 2004), multistage screening programmes, 
such as those adopted in diagnosing diabetes were said to have the potential to cause 
increased distress. In 2015, Bond and colleagues interviewed twenty-one women, who had 
experienced false-positive screening mammograms to assess its psychological consequences. 
They concluded that whilst mammography screening-related anxiety could last for up to 12 
years, breast cancer screening produced what they described as a ‘crisis of visibility’ whereby 
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accepting the screening invitation is taking a risk that you may experience unnecessary stress, 
uncertainty, fear, anxiety, and physical pain, but not accepting the invitation is taking a risk 
that malignant disease will remain invisible (Bond, Garside, & Hyde, 2015). 
 
There is a continued uncertainty for example, concerning the feasibility, uptake and overall 
benefits and costs of screening for diabetes (Goyder, Wild, Fischbacher, Carlisle, & Peters, 
2008). Screening for diabetes may affect physical and psychological morbidity and 
behavioural outcomes at the population level (Bankhead et al., 2003). Although screening 
programmes are often assessed on participation and attendance (Waugh et al., 2007), 
previous studies suggest that the method of screening for diabetes may influence uptake into 
the screening programme, with more invasive methods such as blood tests often being 
associated with lower attendance compared with non-invasive methods of screening such as 
the use of questionnaires (Engelgau et al., 2000; Lawrence, Bennett, Young, & Robinson, 
2001). By using non-invasive procedures, such as looking at routinely available data to 
stratify a population according to diabetes risk and screening only those at highest risk for 
further assessment could potentially reduce the economic costs and possible psychological 
harms associated with some screening tests (Shaw et al., 1999).  Patient characteristics have 
also been shown to influence attendance (Jepson et al., 2000), therefore by identifying factors 
that can influence uptake at these levels the facilitation of more appropriate organization and 
targeting of screening programmes can commence.  
However, Adriaanse and colleagues concluded in a review of the impact of such screening 
programmes, that screening for T2D in the general population has no serious psychological 
side effects (Adriaanse & Snoek, 2006). In order to quantify these effects further, Eborall, 
Griffin, Prevost, Kinmonth, French and Sutton (2007) assessed both the short and long-term 
psychological effects of screening in a large cohort of people at high-risk of developing T2D. 
Further, they assessed the psychological impact of being invited to attend for screening at a 
general practice and of experiencing the screening tests and obtaining the results (Eborall et 
al., 2007). A total of 7380 adults, aged 40-69, in the top fourth for risk of having undiagnosed 
T2D (6416 invited for screening, 964 controls) were invited for T2D screening or not invited 
(controls). Those who attended completed questionnaires after a random blood glucose test 
and at 3-6 months and 12-15 months later. Controls were also sent questionnaires at the same 
time points. Those who did not attend for screening were sent questionnaires at 3-6 months 




Results showed that there were no significant differences between the screening and control 
participants at any of the time points on any of the outcomes for anxiety, depression, 
diabetes-specific worry, or self-rated health. After the initial test, compared with participants 
who screened negative, those who screened positive reported significantly poorer general 
health, higher state anxiety, higher depression and higher diabetes-specific worry, although 
effect sizes were small. This implies that being required to return for further tests after an 
initial positive test result may have a small negative psychological impact. 
 
Those screening negative at the initial test self-reported the best health and those with a 
diagnosis of diabetes self-reported the poorest health, however, this trend was no longer 
evident at 12-15 months, thus showing that the impact is unlikely to be of clinical, or long-
term significance. The more screening tests that participants had before screening negative, 
the higher their worry scores were at 3-6 months about developing T2D, and this trend was 
maintained at 12-15 months. 
 
The findings confirmed the position that screening for T2D does not create psychological 
costs (Adriaanse et al., 2004). On the basis of these findings, the authors commented that the 
implementation of a national diabetes screening programme based on the stepwise screening 
procedure used in their trial is unlikely to have significant consequences for patients’ 
psychological health, therefore giving reason to support a potential screening programme for 
T2D. Again, more recently, the potential for harm from diabetes screening that is, anxiety, 
depression, and a decreased quality of life, are reported to appear to be minimal regardless of 
the diagnosis (Paddison et al., 2011).  
 
Where can diabetes screening take place? 
Exploring key opportunities to detect disease and carry out screening programmes through 
providing alternative locations as a setting for screening, means we may widen access to 
those at risk who do not have access to healthcare or those who do not routinely access 
conventional healthcare settings (Howse, Jones, & Hungin, 2011b). 
 
In 1997, The American Diabetes Association proposed the screening of all patients over 45 
years of age, by measuring fasting blood glucose every three years, in addition to screening 
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patients from high-risk ethnic groups and younger patients with hypertension, obesity, a 
family history of diabetes in a first degree relative, or a family history of gestational diabetes 
(The Expert Committee On The Diagnosis And Classification Of Diabetes Mellitus, 1997). 
Lawrence, Bennett, Young and Robinson (2001) undertook a study to assess the feasibility of 
implementing the American Diabetes Association's policy in the UK, in a local general 
practice with a relatively low risk population. They also assessed the cardiovascular risk 
profile of patients diagnosed as having diabetes as a result of screening to see whether they 
were identifying a previously unrecognised high-risk population (Lawrence et al., 2001). A 
total of 2481 patients aged over 45 not known to have diabetes were invited for screening. Of 
those invited, 876 were subsequently screened for diabetes, and cardiovascular risk profiles 
of patients diagnosed after screening were also assessed. Prevalence of diabetes in patients 
with age as a sole risk factor was 0.2%. Prevalence of diabetes in patients with age and one or 
more other risk factor such as hypertension, obesity, or a family history of diabetes, was 
2.8%. The authors reported the feasibility of screening for diabetes in the practice's 
population would take four hours a week for a year. About half this time would be needed to 
screen patients with risk factors other than age. More than 80% of patients newly diagnosed 
as having diabetes had a ten-year risk of coronary heart disease, 73% were hypertensive, and 
73% had high cholesterol. The authors concluded that screening for diabetes in general 
practice by measuring fasting blood glucose is feasible but has a very low yield in patients 
whose only risk factor for diabetes is being over 45 years of age. In addition, they added that 
screening in a low risk population would best be targeted at patients with multiple risk 
factors. 
 
Unconventional settings, outside of the general medical practice, are an underutilised source 
to attempt to identify people with undiagnosed diabetes. Howse, Jones and Hungin (2011) 
investigated the feasibility of using optometry practices as a setting to screen for diabetes. 
Adults attending high street optometry practices in northern England who self-reported at 
least one risk factor for diabetes were offered a RBG test. Those with raised RBG levels were 
asked to visit their GP for further investigations. Of the 1909 adults attending practices for 
sight tests, 68.2% reported risk factors for diabetes, of which 76.9% had RBG measurements 
taken. Of these, 318 (31.7%) were found to have a RBG level of ≥6.1mmol/l, suggestive of 
the need for further investigations. Of these, 1.6% of previously undiagnosed individuals 
were diagnosed with diabetes or pre-diabetes as a result of the service. The authors suggested 
that even if they had refined the number of risk factors for inclusion which would have 
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reduced those requiring screening by half, the screening programme would have still 
identified nearly 70% of the new cases of diabetes and pre-diabetes (Howse, Jones, & 
Hungin, 2011a). The results demonstrated that screening in optometric practices provides an 
efficient opportunity to screen at-risk individuals who do not present to conventional medical 
services, and is acceptable and therefore appropriate suggesting that optometrists represent a 
skilled resource that could provide such a screening service. The success of this study 
represents how transferable such a screening programme can be and opens up the possibility 
of testing such a programme in other alternative settings. 
 
A few small studies have examined the utility of the emergency department in screening for 
T2D. To determine if screening for undiagnosed T2D and pre-diabetes was feasible in an 
Australian emergency department, Jelinek and colleagues estimated the prevalence of T2D 
and pre-diabetes (Jelinek et al., 2010). A convenience sample of adult patients were screened 
with finger-prick RBG and HbA1c. Those with a result over 6.0 mmol/L and 6.0% were 
referred for an oral glucose tolerance test (OGGT). Those not attending for OGTT were 
contacted by phone, and interviewed about their reasons for not attending. Seven hundred and 
twenty-five patients were recruited. Of these, 135 had known T2D, subsequently leaving 590 
to be screened; consequently, 210 screened positive. Of the 192 referred for OGTT, 77% did 
not attend despite several telephone reminders. Of the 45 completing OGTT, pre-diabetes 
was present in 17.8% and T2D diagnosed in 13.3%. Although the emergency department had 
a high prevalence of T2D, diagnosed and undiagnosed, with as much as half of the population 
possibly affected, it was concluded that opportunistic screening was not feasible due to the 
difficulties in patient follow up for diagnostic testing. 
 
In 2012, NICE published preventative T2D guidance which highlighted a shift towards 
identifying at-risk individuals in different settings and supplying lifestyle interventions to 
reduce the numbers of people developing T2D (NICE, 2012). It suggested that screening 
would ensure those with undiagnosed T2D are made aware of their condition and receive 
appropriate treatment to help prevent complications. Dental surgeries were highlighted in the 





Screening for Diabetes in Dental Settings 
Diabetes is very relevant to dental professionals and to patients seen in the dental setting. As 
noted earlier in this chapter, diabetes as an established risk factor for periodontal disease, 
when poorly controlled, can complicate periodontal treatment outcomes (Mealey & Rose, 
2008). Studies have revealed that periodontal disease is an early complication of diabetes 
(Lalla et al., 2007a, 2007b) and that pre-existing periodontitis predicts poor cardiovascular 
and renal outcomes in patients with established diabetes (Lalla, Kunzel, Burkett, Cheng, & 
Lamster, 2011).  
 
Currently, population-based screening for diabetes is not recommended, though identification 
of high-risk persons and opportunistic screening for instance, during routine contact within 
the healthcare system is suggested as a more suitable strategy (Engelgau et al., 2000). 
Improvements in the detection of dysglycaemia in undiagnosed individuals can be achieved 
by increasing the number of contact points from a range of healthcare professionals (Lalla et 
al., 2011). Identification of early diabetes can no longer be the sole responsibility of medical 
professionals, therefore considering the bi-directional relationship that has been found 
between diabetes and periodontal disease, and other oral manifestations that develop from 
diabetes, it is important to consider the role that dental care professionals can now play in this 
context.  
 
Dentists have an important role in detecting and preventing oral and systemic diseases both 
because of their diagnostic and screening abilities and the frequency of patient visits 
(Tavares, Dewundara, & Goodson, 2012). Dentists already offer lifestyle advice to their 
patients as part of a preventive package of care. By extending this to cover general healthy 
eating and activity advice a broader reach of effect is offered to the patient; thereby 
addressing not only their oral health but also behaviours which may increase risk of T2D 
through the common risk factor approach. Traditionally, oral health promotion has focused 
on the care of the teeth and gums, in isolation from other health programmes. The Common 
Risk Factor Approach (CRFA) to health promotion takes a broader view and targets risk 
factors common to many chronic conditions and their underlying social determinants. The 
key concept of this approach is that rigorous action against common health risks and their 
underlying social determinants will achieve improvements in a range of chronic health 
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conditions more effectively and efficiently than isolated, disease-specific methods (Sheiham 
& Watt, 2000). 
 
A large number of patients with periodontal disease visit a dental provider regularly for 
periodontal maintenance, again suggesting that the dental office may be an opportune site for 
systemic health screening (Rosedale & Strauss, 2012). Recent figures show that 61% of 
adults in England, 60% in Northern Ireland and 69% in both Wales and Scotland now attend 
their dentists regularly. In 1978, the figure was just 44% in England and 39% in Wales. Half 
of adults say they visit their dentist every 6 months and 21% of adults say they visit their 
dentist annually. The UK is one of the most likely nations in Europe to visit their dentist for a 
check-up; the UK was ranked second after only the Netherlands (Oral Health Foundation, 
2017). Previously, it had also shown that a large proportion of the UK population see a 
dentist at least once a year and healthcare utilisation patterns indicate that individuals tend to 
seek routine and preventive oral health care more often than routine and preventive medical 
healthcare (Glick & Greenberg, 2005). The dental visit is therefore an excellent opportunity 
for dentist professionals to offer screening to their patients. They may be able to detect 
undiagnosed diabetes early by recognising features of gingivitis and periodontitis that are 
consistent with diabetes-related conditioning of periodontal responses to plaque. In a survey 
examining health and nutrition, researchers revealed that simple periodontal measures that are 
only available in the dental setting, and risk factors that are readily known by patients may 
well offer an opportunity to identify diabetes in patients who are undiagnosed (Borrell, 
Kunzel, Lamster, & Lalla, 2007).  
 
It is now well known that the mouth may exhibit signs or symptoms of a poorly controlled or 
undiagnosed diabetes -related condition. It is also clear that there is a link between oral and 
systemic health, therefore there is support for the importance of the dental practitioner in 
detecting undiagnosed diabetes, and so the dental practitioner should become an integral part 
of the diabetes multidisciplinary team, enquiring about an individual's family history and the 
presence of signs and symptoms. Using periodontal disease is said to be a clinically effective 
and cost-effective screening method (Chauhan & Haslam, 2012).  
 
Despite the known link between diabetes and periodontal disease, and that dental surgeries 
were highlighted in the 2012 NICE guidance as a suitable setting for encouraging people to 
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have a T2D risk assessment, dental practitioner involvement in diabetes care have not been 
officially incorporated into UK practice (Chauhan & Haslam, 2012). The UK Prospective 
Diabetes Study has shown that intensive glucose control which starts at the point of diagnosis 
is associated with reduced risk of microvascular complications over time (Holman et al., 
2008). Dental practitioners should therefore be encouraged to promote diabetes screening so 
that earlier and more effective management of diabetes can be enabled, alongside the 
improvement of periodontal disease (Chauhan & Haslam, 2012).  
 
It has long been argued that there is a need to address the relationship between general health 
and oral health in the dental setting (Page, 1998). Research has shown that general dentists 
lack knowledge about diabetes and the effects of diabetes on periodontal health (Al-Khabbaz 
& Al-Shammari, 2011; Al-Khabbaz, Al-Shammari, & Al-Saleh, 2011; Kunzel, Lalla, Albert, 
Yin, & Lamster, 2005). Dentists have an ethical obligation and a duty of care to protect the 
well-being of their patients. A screening procedure to detect a serious, underlying, 
undiagnosed systemic condition, and that does not cause any harm to the patient, is in the 
patient’s best interests (Sultan, Warreth, Fleming, & MacCarthy, 2014). 
 
A patient with diabetes may have a number of specific direct implications for the dental 
professional: 
• Patients with (particularly T1D) diabetes may be at risk of hypoglycaemic episodes while 
attending the dental surgery 
• People with diabetes are at higher risk of oral disease, particularly periodontitis, and 
particularly if their diabetes is poorly controlled 
• Patients with undiagnosed diabetes may present at the dental surgery and provide an 
opportunity for referral for opportunistic screening based on the presence of periodontal 
disease and other diabetic risk factors 
• Patients with diabetes may experience some improvement in their glycaemic control 
following successful periodontal treatment (Casanova, Hughes, & Preshaw, 2014). 
 
Recent studies suggest that the majority of dentists feel it is important and that they are 
willing to conduct screening for medical conditions that patients are unaware of (Greenberg, 
Glick, Frantsve-Hawley, & Kantor, 2010). It must be made clear that the dentist’s role stops 
here. A reliable diagnosis of diabetes mellitus cannot be made by a glucometer and 
furthermore the dentist is not covered legally to make such a diagnosis. The dentist has an 
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obligation to refer a patient who tests positive to an appropriate medical service for formal 
diagnosis and management (Sultan et al., 2014).  
 
Dentists’ views on screening for diabetes in dental settings 
Esmeili, Ellison and Walsh (2010) aimed to determine general dentists’ attitudes and 
practices related to patients with diabetes. A survey on 265 dentists randomly selected in 
California showed that 61% believed that addressing diabetes was important to their role as a 
dentist, 86 % advised patients with diabetes about periodontal risks, 18 % provided diabetic-
related services, 47% reported they knew how to assess for diabetes, and 42% felt well 
prepared to intervene with patients with diabetes. Adjusting for number of patients with 
diabetes and adult patients seen in the past month, dentists’ formal training in diabetes 
assessment and management, and belief in the importance of their role as a dentist to 
intervene with patients with diabetes were both significant factors in providing services for 
patients with diabetes (Esmeili, Ellison, & Walsh, 2010). Similarly, dentists’ formal training 
and belief in the importance of their role were both significant factors in advising patients 
with diabetes about periodontal risk associated with diabetes. The authors concluded that 
formal training and personal beliefs were important factors related to dentists’ behaviour 
toward patients with diabetes in the dental setting. The finding that over half of the dentists 
surveyed believed that intervening with patients with diabetes was important to their role as a 
dentist, is encouraging in that the will to participate in addressing this important health issue 
in the dental setting appears to exist, however, fewer than half believed that they had enough 
knowledge to assess and intervene with patients with diabetes in the dental setting, suggesting 
the need for intervention to increase  or update dentist's knowledge of diabetes. 
 
Patients’ views on screening for diabetes in dental settings 
In order to implement screening in the dental setting, an understanding of patient attitudes in 
different key dental settings is essential. Greenberg, Kantor, Jiang and Glick (2012) assessed 
patient attitudes toward medical screening in a dental setting using questionnaires with eight 
five-point response scale questions given to a convenience sample of adult patients attending 
an inner-city dental school clinic and two private dental practice settings. The majority of 
respondents were willing to have a dentist conduct screening for heart disease, high blood 
pressure, diabetes, human immunodeficiency virus infection, and hepatitis infection. They 
were also willing for the dentist to discuss the results immediately, provide oral fluids, finger-
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stick blood, blood pressure measurements, and height and weight (Greenberg, Kantor, Jiang, 
& Glick, 2012a). Patients were also willing to pay up to 20 US dollars for these screening 
tests. Respondents reported that their opinion of the dentist would improve regarding the 
dentist’s professionalism, knowledge, competence, and compassion by carrying out these 
tests. Results additionally showed that the test not being done by a physician was ranked as 
the least important potential barrier to being screened by a dentist. These recent results show 
that patients are willing to participate in chair side medical screening in a dental setting. The 
authors concluded that screening for various medical conditions in this setting is an approach 
that could be effective in disease prevention and control which integrates health professionals 
across disciplines.  
 
These findings are invaluable to the progression of such a strategy as patient and dental 
acceptance of medical screening in a dental setting is a critical element to successfully 
implement screening for diabetes in the dental setting. However, patient and dental 
professional attitudes and willingness to participate in screening involve only anticipated 
responses and does not examine dental provider and dental patient attitudes and experiences 
regarding the actual implementation and receipt of diabetes screening at the dental visit. 
This information is vital to be able to inform diabetes screening practice in the dental setting, 
and for it to become an accepted routine practice. Therefore, Rosedale and Strauss (2012) 
examined patients and dental providers’ experiences of diabetes screening using the 
collection of gingival crevicular blood and finger stick blood for HbA1c testing during the 
periodontal visit. Patients attending a periodontal clinic were screened for diabetes; 102 
patients gave gingival crevicular blood samples, and 120 patients gave finger stick blood 
samples to be sent to the laboratory for analysis. Results of the tests were subsequently sent 
to patients directly from the laboratory. The results of the study showed that both patients and 
the dental providers believed that the dental visit was a good place to be screened for 
diabetes. Dental providers were willing to collect blood samples for testing, while most 
patients appreciated being provided with diabetes screening and the time-saving manner in 
which it was delivered (Rosedale & Strauss, 2012). Both dental providers and patients 
preferred gingival crevicular blood as a method of sample collection for screening. This was 
seen as simpler during the periodontal examination where there is considerable bleeding on 
probing, so it was seen as more convenient and less invasive. Overall, patients and providers 





Friman and colleagues conducted interviews following diabetes screening at a dental clinic in 
Sweden. The interviewees described the dental care service as providing continuity and they 
expressed a wish to have regular medical screenings at their regular dental appointments to 
identify risks of cardiovascular disease and diabetes. However, they expressed that it was 
important for the dental care staff to have the necessary medical knowledge. They also 
wanted good co-operations between the dental and health care services, with clear feedback 
to the patients about both positive and negative results and, when appropriate, referrals to the 
health care service (Friman et al., 2015). 
 
Research into diabetes screening in dental settings is being conducted more and more. In a 
recent study conducted in the USA, Bossart and colleagues assessed the effectiveness of 
diabetes screening using an instant A1c analyser, a diabetes risk questionnaire and 
periodontal findings at point of care by a dental hygienist. Point-of-care HbA1c screenings by 
dental hygienists were found to be effective and convenient for identifying undiagnosed 
prediabetes (Bossart et al., 2016). However, there was no relationship between the diabetes 
risk scores and HbA1c results indicating that it may not have been a desirable screening 
questionnaire for use in the dental setting. 
 
In another US based study, Herman and colleagues screened dental patients for prediabetes 
and diabetes using information that was readily available to the dental practitioner and a 
random capillary blood glucose test to assess risk. A sample of participants then went on to 
receive a definitive diagnosis using A1c information. The results showed that patients at risk 
of prediabetes or diabetes could be identified rapidly using the risk questions alone or with 
the random capillary glucose test (Herman, Taylor, Jacobson, Burke, & Brown, 2015). This 
study did not go beyond identifying those at risk of diabetes and the HbA1c test was not 
administered during the dental visit. They also did not use a validated risk questionnaire to 
assess diabetes risk. Therefore, it would be interesting to see if using a two-step screening 
approach involving a self-report risk questionnaire during the dental visit would be 
acceptable and successful, and whether those identified as at risk of diabetes, acted on this 
risk information. 
 
It has been noted that US patients are more willing to let dentists perform a screening test that 
yields immediate results and are less willing to have a screening test done if the samples have 
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to be sent out to an outside laboratory (Greenberg et al., 2012a), as seen in the procedure used 
in the study discussed above. Genco and colleagues (2014) aimed to determine whether 
point-of-care measurement of HbA1c from a finger-prick blood sample, in combination with 
use of the ADA Diabetes Risk Test; demographic and health data; and periodontal evaluation, 
would be useful in establishing a feasible method of screening for undiagnosed diabetes and 
prediabetes in dental practices. They found that their results also supported the notion that 
screening for prediabetes and diabetes is feasible in a dental office, with acceptance by the 
dentist, patients’ physicians and patients (Genco et al., 2014). Again, this study did not 
follow-up patients found to be at risk of diabetes, so it was not known whether the screening 
test had an effect on subsequent behaviour.  
 
Wright, and colleagues aimed to assess the feasibility of implementing a T2D risk screening 
pathway in dental settings using the NICE guidance tool. The study was carried out over two 
weeks in June 2013 in London, UK. The validated tool in the NICE guidance was used to 
determine risk. This included a questionnaire and BMI measurement used to determine a risk 
score. Patients were rated low, increased, moderate or high risk; patients who were moderate 
or high risk were referred to their GPs for further investigation. Participating dental teams 
were asked to nominate a member who would be responsible for overseeing the screening 
and training the other team members. A total of 166 patients took part in the pilot; twenty-six 
low risk patients, 61 increased risk patients, 49 moderate-risk patients and 30 high-risk 
patients were identified during the pilot. Fifteen of the 49 patients identified as moderate-risk 
and 6 of the 30 high-risk patients had visited their GP to discuss their type 2 diabetes risk in 
response to the screening. The pilot suggested that people at risk of developing T2D could be 
identified in primary, community and secondary dental care settings (Wright, Muirhead, 
Weston-Price, & Fortune, 2014).  
 
In this single UK study carried out in GDPs in London using a self-report risk measure, it was 
found that notwithstanding the manpower challenges facing dental teams and the fairly low 
uptake of further screening by patients, the identification of diabetes in dental practices was 
possible. One explanation for the low uptake of further diagnostic testing in this study could 
be the fact that patients tend to judge the severity of the illness by cues such as the 
complexity of the diagnostic tool used, In the case of diabetes in particular, previous work 
(Parry, Peel, Douglas, & Lawton, 2006) showed that diabetes patients used their diagnosis 
journey to judge how serious their diabetes was; the more complex the diagnosis, (where for 
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e.g. the diagnosis was made by a hospital consultant rather than a GP) the more serious 
patients thought was their diabetes. On the basis of these findings, it was reasoned that 
supplementing a self-report diabetes risk assessment with a more invasive, instant HbA1c 
blood test might improve the uptake of further formal GP testing.  
 
These recent studies demonstrating the success of screening for diabetes in dental settings has 
provided evidence to base future studies on. Current recommendations for screening for 
diabetes in the UK suggests a step-wise method like those mentioned above. Using more than 
one screening test to assess risk is helpful and allows further screening tests to be targeted 
towards those identified as at risk of developing diabetes. A future study could utilise a non-
invasive screening test first such as a self-report risk questionnaire, before administering an 
invasive test, such as an Hba1c test. It could also involve a point of care test where results 
would be instantaneous rather than having to inform patients of their result at a later date. A 
further study could also be conducted within a dental setting but not be conducted by a dental 
practitioner whose time is often short when with a patient already. Finally, there is scope for 
follow-up of patients found to be at risk of diabetes, to see if they acted on the screening 
information they received. These issues will be the basis for the rationale for the studies that 
follow in this thesis; the purpose of which will be to investigate these issues. 
 
To conclude, dentists and patients alike have a favourable attitude toward point-of-care 
medical screening in the dental office; dentists are willing to incorporate it into their practice 
and patients are willing to participate in chairside medical screening. The 2010 Patient 
Protection and Affordable Care Act aims to slow increasing health care costs while 
improving the health care delivery system with a strong emphasis on prevention and primary 
care (Greenberg, Kantor, & Bednarsh, 2016; Greenberg, Thomas, Glick, & Kantor, 2015). 
These recent studies demonstrate that screening for diabetes in dental settings is acceptable 
by both patients and dental professionals, and when considering how important it is to 
diagnose diabetes early to prevent diabetes-related complications, there is clear support that 
diabetes screening in the dental setting is both timely and overdue.  
 
Conclusion 
In conclusion, this literature review has shown that screening for diabetes is unlikely to cause 
psychological harm, it may be helpful in identifying people at risk of diabetes or pre-diabetes, 
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it can take place in a non-routine setting such as the dental practice and can probably involve 
the use of easy to use tools such as instant HbA1c measures and a self-report risk 
questionnaire.  
The next chapter presents the results of a systematic review on how risk of disease should be 
communicated in order to increase the chances that people will act on the screening 





What are the most effective of individualised risk communication strategies to increase 




It is important to explore key opportunities to detect disease and carry out screening 
programmes. By providing alternative locations as a setting for screening, we can widen 
access to those at risk who do not access conventional healthcare settings for whatever 
reason. The dental setting is somewhere we can offer screening and is an underutilised 
source. As seen in chapter two, research has shown that screening for diabetes in this setting 
is acceptable to both patients and General Dental Practitioners (GDPs). We are however 
unaware of the sort of patient who will pursue screening and those who will need support 
after initial screening, so the psychological predictors of subsequent diagnostic testing are 
unknown and needs to be explored. A systematic review is a high-level overview of primary 
research on a particular research question that tries to identify, select, synthesize and appraise 
all high quality research evidence relevant to that question in order to answer it. Therefore, a 
systematic review might be a good way to address the issue of identifying what will most 
likely make an individual pursue subsequent diagnostic testing following screening by 
attempting to identify the most effective way to communicate an individuals’ risk of a 
particular condition.  This chapter therefore describes a systematic review that was conducted 
to address this issue. By addressing this issue, an intervention was designed so that a dental 
patients risk of diabetes could be communicated in the best possible way to ensure that 
diagnostic follow-up would be adhered to.  
 
The results of the work presented in this chapter have been published in ‘Health Psychology 
Research’, and the paper appears in appendix one.  
 
Background  
Social cognition models (SCMs) are used to help understand, predict and change health-
relevant behaviours. A considerable amount of research in health psychology has focussed on 
the role of social cognitive factors and their ability to predict health behaviour. The reason for 
this is that a significant proportion of mortality from the leading causes of death in the 
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industrialised world is due to particular behaviour patterns, of which are certainly modifiable 
(Webb, Sniehotta, & Michie, 2010). Individuals can make a contribution to their own health 
and wellbeing though adopting particular health-enhancing behaviours (e.g. screening), and 
avoiding health-compromising behaviours (e.g. smoking). The factors which underlie health 
behaviours have been targeted by interventions to change the prevalence of such health 
behaviours and improve health at an individual and a population level, and to understand the 
reasons why individuals perform such a variety of health behaviours. Several models which 
have been designed in health psychology to specifically predict health behaviour focus on the 
notion of threat or risk perception (Lopez, Tolley, Grimes, & Chen-Mok, 2009). By this, SCMs 
seeking to predict adherence to health behaviours suggest that people consider their risk for a 
particular condition, whether it is expressed as their perceived risk, perceived susceptibility, or 
their perceived severity for developing a disease, before engaging in any health behaviour. 
Therefore, risk is an important concept to examine, so that an individual's understanding of 
their own risk for a particular disease or condition can be targeted to inform the decision to 
undergo screening. 
 
There is a diverse range of tests that can be used to identify individuals and groups at 'high risk' 
of developing various diseases or conditions. With the development of screening programmes, 
many of these tests and procedures aim differentiate between apparently well people who 
probably have a disease, and those who probably do not, or aim to highlight a risk of disease 
rather than intend to diagnose a disease or condition (Edwards et al., 2006).  
 
Some screening programs provide information about population or ’average’ risks of 
developing a disease to discuss or inform decision-making about attending for screening, whilst 
others look to motivate people to attend for tests which are alleged to be in their best interests 
(Edwards et al., 2013). Another way to target screening uptake is to provide information which 
is more personally relevant to the user in question. 'Individualised risk communication’ also 
known as 'personalised risk communication’ is based on the individual’s own risk factors for a 
condition (such as age or family history) (Edwards et al., 2013). In this case, risk can be 
comprehensively calculated from an individual’s risk factors using formulae derived from 
epidemiological data. An example of this would be the Gail model for predicting the risk of 
developing breast cancer; here a risk score is given or presented as an absolute risk, the risk of 
developing a disease over a time period (Gail et al., 1989), or an individual's relative risk; 
comparison of risk to others, can be categorised into, for example, above average, average or 
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below average risk, which is less comprehensive. Risk information can also be more simply 
presented, for example, where a list of personal risk factors is discussed and used as the basis 
for intervention (Rothman & Kiviniemi, 1999). When presented in this way, it is expected that 
because the information is thought to be more applicable to the individual, individualised risk 
communication may be more useful when deciding whether or not to participate in screening 
(Edwards et al., 2006). 
 
Given the importance of risk and risk communication in healthcare (Moher, Liberati, Tetzlaff, 
& Altman, 2009; Waldron, van der Weijden, Ludt, Gallacher, & Elwyn, 2011), it is important 
to identify the most effective strategies for risk communication at an individual level. 
Understanding however of how best to present and discuss risks and benefits of health care in 
general, and screening in particular, for an individual is still limited. Effective risk 
communication can improve awareness of health risks and promote risk-reducing behaviour in 
support of health promotion and disease prevention (Waldron et al., 2011). 
 
There is a variety of ways risk information can be communicated to patients. Numerical 
expressions can be presented in percentages, natural frequencies or numbers needed to treat 
(Gigerenzer & Edwards, 2003), whilst graphical representations can also be displayed. These 
can involve the use of bar graphs and pictograms or icon arrays (Lipkus & Hollands, 1999). 
There is a need for the risk information to be presented in a simple and balanced way, and it is 
important to communicate the risk appropriately and effectively, as poor representation of risk 
information may result in sub-optimal choices and treatment (Edwards, Elwyn, Covey, 
Matthews, & Pill, 2001; Lipkus & Hollands, 1999). Individualised risk communication has 
been incorporated into several healthcare interventions, including the areas of treatment, 
prevention and screening. Therefore, it is vital to look at the effectiveness of interventions that 
aim to increase screening through individualised risk communication interventions. 
 
A recent updated systematic review of forty-one studies by Edwards and colleagues, aimed to 
assess the effects of different types of personalised risk communication for consumers making 
decisions about taking screening tests, and concluded that there was weak evidence, consistent 
with a small effect, that personalised risk communication in which a risk score was provided 
(6 studies) or the participants were given their categorised risk (6 studies), increases uptake of 
screening tests (Edwards et al., 2013). They also found that the interventions seemed to increase 




This systematic review successfully answered the question as to whether individualised risk 
communication is more effective than generalised risk communication, and also found that 
when the personalised risk information disclosed was more detailed, the uptake of tests was 
lower than when the risk communication was less detailed or numerically unspecific (i.e. when 
categorised into risk groups). However, its focus was not on assessing how best to present and 
communicate individualised risk in terms of the format (e.g. such as written, over the telephone 
or verbally in person, or about the overall presentation and detail). Rather, the purpose of their 
review was to assess the effects of personalised risk communication on informed decision 
making by individuals taking screening tests. Additionally, proxies of screening uptake were 
considered in the review, but the theoretical background of the reviewed studies was not 
investigated. 
 
In a systematic review looking specifically at communicating cardiovascular risk (Waldron et 
al., 2011), the aim was to compare different interventions used to communicate cardiovascular 
risk in order to identify effective communication strategies, and assess their impact on patient 
related outcomes. Although heterogeneity in study design and outcomes were found in a review 
of fifteen studies, the results from individual studies suggested that presenting patients with 
their cardiovascular risk in percentages or frequencies, using graphical representation and short 
timeframes, is best for achieving risk reduction through behaviour change. However, this 
review focused on cardiovascular risk only and did not attempt to explore whether theory-based 
interventions were more effective than atheoretical work in eliciting behaviour change or 
whether certain presentation details such as who delivered the risk information and whether it 
was simple of complex details that were given were best. If the purpose of risk communication 
is to lead to behaviour change such as screening uptake, then theoretical work, such as social 
cognition models designed to inform behaviour change interventions may be useful in 
designing risk communication interventions.  
 
Given the importance of risk communication in healthcare (Rothman & Kiviniemi, 1999), it is 
important to identify the most effective strategies for risk communication at an individual level. 
Understanding however of how best to present and discuss risks and benefits of health care in 
general, and screening in particular is still limited. The previous systematic reviews though 
informative, have not sought to explain why less detailed risk information (Edwards et al., 
2013) presented in graphs, scores or categories (Waldron et al., 2011) is effective in 
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maximizing screening uptake. Given that social cognition models describe key cognitions, such 
as risk and susceptibility, and their inter-relationships in the regulation of behaviour, 
individualised risk communication interventions informed by social cognition models may lead 
to different outcomes than those not informed by social cognition models, such as, the extent 
to which an individual will respond to the threat of risk. If the purpose of risk communication 
is to lead to behaviour change, then psychology theory such as, for example, social cognition 
models designed to inform behaviour change interventions, may be useful in understanding 
what combinations of individualized risk communication (IRC) components work best. 
 
Following the aims, approaches and the findings from these previous reviews, the purpose of 
this study was to identify the most effective ways of presenting risk information to 
subsequently maximise screening uptake. Additionally, the present review evaluated whether 
individualised risk communication affects psychological proxies that have been proposed, 
through theoretical models, to mediate the increase in screening uptake.  
 
Aim: 
The aim of this narrative systematic review is to evaluate the most effective way to 
communicate individualised risk information to maximise either actual screening uptake or 
psychological predictors of screening uptake. This aim therefore addresses the first research 
question given in chapter 1:  
1. What is the most effective way to communicate individualised risk information to 
increase screening participation or its psychological predictors? 
 
Objectives: 
• Identify RCT studies whereby the communication of individualised risk information is 
delivered for the purpose of increasing screening participation; 
• Identify effective individualised risk communication strategies to maximise either actual 
screening uptake or potential psychological predictors. 
 
Research Question: 
What is the most effective way to communicate individualised risk information to maximise 






The review is laid out in accordance to the Preferred Reporting Items for Systematic Reviews 
and Meta-analyses (PRISMA) statement. A review protocol was used as a template in order to 
collect relevant information from papers for inclusion.  
 
Eligibility Criteria: 
For studies to be included in the review, they were required to meet certain criteria.  
 
Types of studies 
Papers where individualised risk communication was defined as conveying probabilistic 
information intended to support decision-making with an educational component of either a 
disease, personal risk factors, inheritance of susceptibility, benefits and limitations of tests, 
risks of testing, limitations of prevention, or surveillance were sought to answer the review 
question. Studies were considered for inclusion if they evaluated interventions that were 
randomised controlled trials (RCTs). It is well recognised that some research designs are more 
powerful than others in their ability to answer research questions on the effectiveness of 
interventions. The randomised controlled trial (RCT) is considered to provide the most reliable 
evidence on the effectiveness of interventions because the processes used during the conduct 
of an RCT minimise the risk of confounding factors influencing the results. Because of this, 
the findings generated by RCTs are likely to be closer to the true effect than the findings 
generated by other research methods (Evans, 2003). 
 
Types of participants 
Studies that either used people facing real life decisions or where participants were studied in 
hypothetical situations about whether to undergo screening were included. They could be 
individuals making decisions alone or on another’s behalf (for example, for a young child), or 
couples making decisions together. The screening activities had to involve an investigation 
performed by a health professional for example, mammography, cervical ’Papanicolaou’ 
smears, colorectal cancer screening, prostatic cancer screening (PSA test), antenatal screening, 





Types of interventions 
Studies were included where interventions were providing information on individualised risk, 
such as an individualised risk score or individual actual risk information, categorisation of risk 
status based on these estimates such as, high, medium, or low risk status, such as for colorectal 
cancer, or a discussion of personal risk factors relevant to the screening decision, such as the 
individual's own characteristics being taken into account when assessing their actual risk or 
heightened risk status relative to others, for example, risk factors for breast or prostate cancer 
that are relevant to the individual. Individualised risk communication could be delivered via 
oral, written, video, or via electronic media. 
 
Studies with interventions providing information on individualised risk compared with another 
individualised risk arm, a control arm receiving usual care or generalised risk information, 
including average or population risk estimates (such as risk of breast cancer), general 
information on risk factors, and general encouragement to acknowledge risks or change risk 
behaviour were considered for inclusion. Studies were rejected if general, rather than 
personalised risk communication was the main basis of the intervention. 
 
Types of outcomes 
Studies were required to measure and primarily focus on behavioural outcomes such as uptake 
of screening tests. Additionally, studies were considered for inclusion if there was a theoretical 
basis to the intervention, such that it focussed on a particular social cognition model or 
particular model components such as knowledge about a disease or screening test, motivation, 
fear or coping to predict screening participation. In order to address the research question, if 
screening uptake was not measured, studies were required to measure one or more 
psychological factors or predictors of screening uptake such as knowledge, fear or screening 
intention.   
 
It was decided that papers were to be excluded if they were published on or before 31st 
December 2005, as we did not want to include papers that were featured in the systematic 
review by Edwards 2006 where the search strategy included papers published up until this date. 




Finally, studies were required to be available in the English language as translation into English 
was not feasible within the timeframe of this review. 
  
Information Sources: 
To access a large number of possible studies, five electronic databases were systematically 
searched: EMBASE, MEDLINE, PsycINFO (using Ovid), Web of Science and PubMed. 
Comprehensive search strategies were devised and conducted in July 2012, aiming for a high 
recall of literature which were low in specificity in the field of risk communication in screening, 
and social cognition model elements. Subject heading and keyword searches were utilised, and 
were adapted to each of the databases used. A manual search was also conducted of the journals 
and authors encountered most frequently in the field. Additionally, the reference lists of 
included papers and past systematic reviews in the area of risk communication were also 




To conduct effective searches, comprehensive search strategies were developed with the 
assistance of an Information Systems expert for each database which included MESH heading 
and key words. These were chosen to cover areas regarding screening tests, risk, social 
cognition components, and communication. Boolean operators were utilized to identify the 
most relevant literature.  
 
Study Selection: 
Eligibility assessment was performed independently by two reviewers. Titles and abstracts of 
articles identified from the systematic search were examined in relation to the relevance to the 
topic and duplicates were removed at this stage. The full texts of articles were then screened to 
identify whether or not they were eligible, and those not meeting the inclusion criteria were 
excluded at this stage, leaving a final number of studies for inclusion in the systematic review.  
 
Data Collection Process: 
Data were extracted from the reports by two independent reviewers (KB and KA) to minimise 
reporting bias. Authors of the included articles were contacted directly if questions arose about 
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the reported data. A search protocol data sheet was developed and used to extract all important 
and relevant information from the studies. 
 
Data Items: 
Detailed information was extracted from each of the studies, primarily on the characteristics of 
the participants (such as gender, age, and ethnicity, if available), the characteristics of the 
intervention (including format, type, presentation and delivery mode of the risk information) 
and comparison groups, and the types of outcome measures assessed (including screening 
outcomes and psychological predictors of screening outcomes). 
 
Risk of Bias in Individual Studies: 
To ascertain the validity of the eligible interventions, two reviewers worked independently, to 
determine the adequacy of the studies included at the study level using the Cochrane's Risk of 
Bias tool. No studies were excluded from the review on the basis of their risk of bias. 
 
Summary Measures: 
The primary outcome measured was actual screening uptake. Secondary outcomes measured 
psychological predictors of screening uptake such as knowledge, perceived risk and intentions. 
Observed and total numbers from studies with dichotomous outcomes such as screening 
uptake, and means or mean change and standard deviations for studies with continuous 
outcomes, such as knowledge and cancer worry, were considered in order to arrive at the 
narrative conclusion.    
 
Synthesis of Results: 
Due to the heterogeneous nature of the studies included in this review, in terms of the wide 
variety of dependent variables and the nature of the designs, it was not deemed possible to 
perform a meta-analysis on the full set of studies, and meta-analyses on a small number of sub-
sets was deemed unworthy. For example, the interventions that measured actual screening 
uptake at 1 year follow up were heterogeneous and not comparable, with the interventions 
being 'computer based risk assessment' compared with a' mailed risk assessment' intervention 
or an 'individualised risk score' compared with a 'discussion of risk factors'. Thus, it was 
thought to be more appropriate to perform a narrative synthesis on all interventions. No meta-




Risk of Bias across Studies: 
No further analysis was performed to assess risk of bias as the Cochrane’s risk of bias tool was 
considered to be sufficient. 
 
Additional Analyses: 




Eligibility assessment was performed independently by two reviewers. Disagreements between 
reviewers (KB and KA) were resolved in a discussion. Figure 1 shows the PRISMA flow 
diagram of study selection. The systematic search revealed a total of 7408 articles. Each article 
title and abstract was examined in relation to the relevance to the topic, which resulted in a list 
of 107 articles retained at this stage. The full texts of articles were then read to identify whether 
or not they met the inclusion criteria, and 86 studies were excluded at this stage, with a total of 







The main elements of each study were extracted (such as intervention content and outcome 
variables). Each of the articles was summarised to highlight the main issues of interest, and the 
data can be found in Tables 1 and 2. Although 21 articles were identified as relevant, in some 
cases, articles were reporting the same study and data as another. There were three studies 
which were each reported in two articles, therefore in total, there were 18 studies. Table 2 
reports articles where the same data and study is reported together.    
 
Study Characteristics: 
Table 1 contains details of the features of the 21 articles included in the review. 
 
7408 records identified through 
database searching 
110 full‐text articles 
assessed for eligibility 
5948 records excluded 6058 records screened 
3 additional records identified 
through other sources 
89 full‐text articles excluded  
12 = not an RCT  
37 = not individualised risk  
5 = not looking at screening 
7 = protocol/ conference 
abstract  
28 = pre-2006  
 
21 studies included in 
qualitative synthesis 







































Figure 1 - PRISMA flow diagram – PRIS A flo  diagra  
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Participants and Settings: 
The studies had a total of 22,557 participants, with the number of participants in each study 
ranging from 262 to 5500. In terms of gender, overall, the number of women included was 
higher than the number of men, with 16,064 women compared to 4,716 men. The majority of 
studies recruited healthy participants, whilst seven studies recruited participants thought or 
known to be at higher risk than average for the screened condition (Bodurtha et al., 2009; 
Bowen, Burke, Culver, Press, & Crystal, 2006; Glanz, Steffen, & Taglialatela, 2007; Glenn et 
al., 2011; Lipkus & Klein, 2006; Manne et al., 2009; Rawl et al., 2012). The age of participants 
was from 18 years and above, with the highest reported mean age of around 74 years. Whilst 
some studies did not report the study setting, the majority of interventions were delivered in 
primary care or primary care practices, hospitals and clinics (n=7) or participants own 
environment (n=5). Finally, the majority of studies were conducted in the USA.   
 
Interventions: 
Table 2 gives details of the 22 interventions and the risk presentation information.  
 
Interventions addressed several screening programmes and diseases. The most common was 
screening for colorectal cancer by colonoscopy, Fecal Occult Blood Test (FOBT) or 
Sigmoidoscopy. Second most common was screening for breast cancer or the breast cancer 
gene, where five studies looked to increase screening for breast cancer through mammography 
screening, One study specifically looked at screening for the breast cancer gene through genetic 
testing, and one study addressed screening through genetic testing and mammography. Further, 
one study addressed osteoporosis screening, one addressed prostate cancer screening and 
finally, two studies addressed a mixture of diseases or conditions and screening behaviours 


























Details / Comments 
 

















the workplace  
 
Control 






1. Decisional status - significantly more men in 
intervention arm had made a screening decision 
at follow up. 
2. Knowledge - increased significantly more in 
intervention arm. 
3. Decisional self-efficacy - no significant 
changes over time in either arm. 
4. Preference for control in decision making - 
no significant changes over time in either arm. 
5. Decisional conflict - reduced (non-
significant) in intervention arm. 
6. Consistency between values and screening 
decision - no changes between arms over time 
 
Although an ITT analysis was used, 
among the men in the intervention 
arm, men who actually used the 
decision aid were significantly more 
likely to have made a screening 
decision than non-users, 
Knowledge was significantly higher 
in the men who used the decision aid 
compared to non-users, and 
significantly greater decisional self-
efficacy compared to the control arm. 
 
Bodurtha 




























1, 6 and 18 
months 
 
1. Post intervention Mammogram - no 
significant differences between arms. 
2. Post intervention clinical breast 
examination - no significant differences 
between arms. 
3. Post intervention breast self-examination - 
no significant differences between arms. 
 
Intervention based on HBM 
constructs.  
 
Women who reported breast cancer 
worry as 'often' or 'all of the time', 
reported greater mammography rates 
if they were in the intervention arm. 
Those who worried about breast 
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4. Mammography intentions - no significant 
differences between arms.  
5. Perceived risk - no significant differences 
between arms. 
6. Breast cancer worry - no significant 
differences between the arms.  
cancer only 'sometimes', reported 
lower mammography rates if they 
were in the intervention arm. 
There was a significant trend for 
women with high breast cancer worry 











163 females - 
higher than 
average risk of 
developing 
breast cancer 
due to having a 
sister diagnosed 
with breast 
cancer at aged 

















1. Mammography maintenance - no 
significant differences between arms. 
2. Clinical Breast Examination maintenance - 
no significant differences between arms. 
3. Perceived risk - no significant differences in 
risk overestimates between study arms.  
4. Breast cancer worry - no significant 
differences between study arms. 
5. Fruit and vegetable consumption - no 
significant differences between study arms. 
6. Reported physical exercise - significantly 
higher in the intervention arm. 
  
 
Intervention based on TTM, HBM 
and Self- Regulation theory.  
 
More women in the intervention arm 
reported that they had reinforced their 
conviction to maintain good breast 
health than women in the control 
arm.  
 
The intervention was effective in 
reducing risk overestimates but only 





























1. Perceived risk  
2. Cancer worry  
3. Awareness of genetic testing   
4. Interest in genetic testing  
 
Trained genetic or health counsellors 
delivered the interventions.   
 
Results showed 2 significant 











risk assessment.  
5. Candidacy for genetic testing  
Outcomes 1-5: there was a significant time and 
arm interaction, both intervention arms 
changed significantly more from baseline to 
follow-up, compared to the control comparison 
arm.  
6. Beliefs about genetic testing - 'Stigma' - no 
significant differences between study arms; 
'Access' - no significant main effects of study 
arm or time, however, women in control arm 
increased their endorsement of beliefs about 
unrestricted access to testing compared to 
intervention arm women over time, whereas 
women in intervention arms decreased these 
beliefs compared to control arm women over 
time; 'Information flow' -  no significant main 
effects of study arm, however, women in the 
control arm significantly decreased their belief 
about information flow more than women in the 
intervention arms did.  
7. General anxiety - NOT REPORTED. 
genetic testing: low levels of 
religious identity lead to low levels of 
change in interest, whereas low 
beliefs about free access lead to 





























1. Quality of life - mental health scores 
improved significantly more so in the 
intervention arm. 
2. Cancer worry - NOT REPORTED 
3. Mammography uptake - significantly 
increased in intervention arm.  
4. Monthly breast self-examination - 
significantly increased in intervention arm.  
 
No results reported for two of the 
outcomes measured.   
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5. Knowledge - NOT REPORTED 
6. Interest in genetic testing - decreased in 































1. Mammography screening - significantly 
increased in intervention arm compared to 
control arm. 
2. Breast self-examination - significantly 
increased in intervention arm compared to 
control arm. 
3. Quality of life - significantly increased in 
intervention arm compared to control arm. 
4. Genetic testing interest - significantly 
decreased in the intervention arm. 
5. Knowledge of breast cancer - higher 
knowledge was associated with higher screening 
rates at follow-up. 
6. Cancer worry - greater reduction in cancer 
worry was associated with higher screening 
rates at follow-up. 
7. Knowledge of genetic testing - higher gains 
in knowledge of genetic testing were associated 
with lower interest in genetic testing. 
 
Intervention based on Self-
Regulation Model.  
 
Due to level of risk, some women did 
not receive risk information via the 
website, rather in writing when 

















4 and 12 
months 
 
1. Screening adherence - significantly higher 
in intervention arm at 4 months but not 
significant at 12 months.  
 
Intervention based on the Precaution 





66 male first 
degree relatives 












health promotion  
2. Risk comprehension - perceived risk 
increased in the intervention arm and mediated 
the change in screening adherence at 4 months.  
3. Cancer worry - NOT REPORTED 
4. Knowledge - knowledge and its general 
knowledge subscale mediated the change in 
screening adherence at 4 months.  
5. Health behaviours - significant drop in 
physical activity by participants in the 
intervention arm at 4 months; significantly 
fewer smokers in intervention arm compared to 
control arm at follow-up.  
 
Procedural errors reported - resulted 
































Control arm - 




6 and 12 
months 
 
1. Screening receipt - significantly higher in 
the intervention arm. 
2. Perceived risk - significantly higher in the 
intervention group; significant increases in 
perceived risk were observed in intervention 
participants who remained unscreened at 12 
months compared to those who received 
screening.  
 
Secondary analysis article, primary 
analysis unpublished. 
 


































1. Health risk behaviours - no significant 
differences between groups on all of the listed 
behaviours, except small significant difference 
in exercising >5 times a week in intervention 
arm. 
- physical activity   -eating fat foods 
 
No detail of what control arm 
received. 
 
The concurrent comparison arm  
differed significantly from the 








comparison arm - 
usual care  
- smoking     -eating fruit/fibre items 
-alcohol use    -wearing seat belt 
2. Preventative care measures - no significant 
differences between groups on all the listed 
measures, except receipt of a pneumococcal 
vaccine which was significantly higher in the 
intervention group. 
-BP check       - cholesterol measurement 
-FOBT            - pneumococcal vaccine 
-blood glucose    - dental check-up 
-influenza vaccine   - mammogram 
-hearing check   -vision check 
respect to cholesterol measurement 
within 5 year, fasting glucose within 
3 years and influenza vaccine in the 































3 months  
 
1. Screening intentions - no significant 
difference between the three study arms. 
2. Cancer worry - decreased significantly more 
in the two intervention arms from baseline to 
follow-up than the control arm. 
3. Risk perceptions - significantly decreased 
from baseline to follow-up in two intervention 
arms.  
4. Interest in pursuing genetic testing - 
significant difference between the two 
intervention arms and control arm; control arm 
increased intentions whilst the intervention arms 
decreased intentions. 
 
In-person counselling was more well 
received, preferred.  
 
The same genetic counsellor was 
used for the entire study in order to 
minimise any variation in counselling 














160 participants;  






















Control arm - 
receiving general 






and 1 month. 
 
1. Screening Intentions - significantly higher in 
the higher comparative risk arm compared to the 
absolute risk arm and control arm, but not 
significantly different compared to the lower 
comparative risk arm; although this group was 
significantly higher than the absolute and 
control arm. 
2. Return of a completed FOBT screen - 
Those in the 'absolute plus comparative' 
intervention arm were more likely to return a 
completed test but, no significant differences 
overall between study arms.  
3. Cancer worry - no significant differences 
between study arms. 
4. Perceived severity - no significant 
differences between study arms.  
5. Perceptions of absolute risk - no significant 
differences between study arms.  
6. Perceptions of comparative risk - 
significantly higher in those told they had more 
than average number of risk factors than lower 
risk comparative arm and control arm. 
7. Barriers to screening -  people reporting 
more barriers were less likely to return a 
completed FOBT.  
8. Attitudinal ambivalence - significantly 
stronger in the control arm.  Significantly 
predicted return of a FOBT. 
 
Perception of comparative risk 
analysis reran after removing cases in 
the comparative risk arm who 
incorrectly responded to the 
manipulation check, and was 
significantly higher in those told they 
had more than average risk factors 
than others, compared to the lower 
comparative risk arm, the absolute 
risk arm and the control arm.    
 
Perceived absolute or comparative 
risk was not related to ambivalence or 
intention.  
 
No significant differences between 
study arms on the evaluation of the 
risk factor information.  
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9. Strength of association between basic and 
lifestyle risk factors and colorectal cancer - 
no significant differences between study arms. 
10. Distribution of risk factors in the 
population - Those informed they had more 
than average compared with others reported 
higher number of risk factors than any other 
arm. People perceived others as having more 
risk factors than themselves but there was no 
































1. Screening adherence - significantly higher 
in both intervention arms compared to control 
arm.  
2. Physician support for screening - not a 
significant moderator of treatment effect on 
screening effect.  
3. Perceived risk 
4. Perceived severity                  no 
5. CRC knowledge                     results 
6. Procedural knowledge          reported 
7. Perceived preventability 
8. Decisional balance - the combined 
intervention arm was a significant predictor of 
decisional balance, significantly higher (more 
screening pros) in the combined intervention 
arm. Those with higher scores were 
significantly more likely to be adherent.    
 
Intervention based on TTM, HBM 



















up to date with 



















1.CRC knowledge - significantly greater 
increase in intervention arm.  
2. Perceived risk - significantly greater increase 
in intervention arm. 
3. Perceived barriers to FOBT - significantly 
greater decrease in intervention arm. 
4. Perceived benefits of FOBT - no significant 
difference between study arms. 
5. Self-efficacy for FOBT - no significant 
difference between study arms. 
6. Perceived barriers to Colonoscopy - no 
significant difference between study arms.  
7. Perceived benefits of Colonoscopy - 
significantly greater increase in intervention 
arm. 
8. Self-efficacy for Colonoscopy - no 
significant difference between study arms. 
 

























for 6 diseases.  
 
Control arm -  
Received standard 
prevention 
messages for the 




1. Screening adherence - no significant 
differences between the percentage of 
participants moving from non-adherent to 
adherent to any of the cancer screening tests or 
methods in any of the familial risk categories. 
Participants in both study arms equally 
increased their adherence to risk-based 
 
The population under study had far 
higher screening adherence than a 




screening but there were no significant 
differences between study arms. 
2. Consultation with specialist about their 
cancer risk - no significant differences between 






















for 6 diseases. 
 
Control arm -  
Received standard 
prevention 
messages for the 




1. Screening behaviour - Cholesterol 
screening: the intervention arm was 
significantly less likely to have had a cholesterol 
test in the last 3 years compared to the control 
arm. Blood pressure testing: no significant 
differences between study arms. Blood glucose 
testing: no significant differences between 
study arms.  
2. Behaviour changes - fruit and vegetable 
consumption: intervention arm significantly 
more likely to move from not at goal status to 
goal status compared to control. Physical 
activity: intervention arm significantly more 
likely to move from not at goal status to goal 
status compared to control. Smoking cessation: 









































1. Knowledge - no significant differences 
between the three study arms, but the two study 
arms together were significantly higher post-test 
compared to the control arm. 
 










minimise risk of 
disease online.  
post-
intervention.  
Mean increase of scores from pre-test to post-
test were significantly higher in the two 
intervention arms compared to the control arm. 
2. Patient test preferences - overall 
colonoscopy was the preferred screening 
method but there were no significant differences 
overall. 
3. Satisfaction with the DMP - significantly 
higher in the two intervention arms compared to 
the control arm, but the two intervention arms 
were comparable.  
4. Screening intentions - significantly higher in 
the two intervention arms compared to the 
control arm, but the two intervention arms were 
comparable. 
5. Test concordance - the two intervention 
arms were significantly more likely to have a 
test ordered compared to the control arm 


































than screening to 
minimise risk of 
disease online. 
 
1, 3, 6 and 12 
months. 
 
1. Test ordering - the DA along arm were 
significantly more likely to have a test order at 
1, 3, 6 and 12 months compared to the control 
group, and significantly more likely at 1, 6 and 
12 months compared to the DA plus 
personalised risk assessment arm. 
2. Completion of an actual screening test - no 
significant differences between the two 
intervention arms at 6 or 12 months, but the DA 
 
Assignment to the DA alone arm, 
black race and preference for patient 
dominant decision making approach 
were independent predictors of test 







alone arm was significantly higher at 6 and 12 

















904 males who 
were members 
























6 weeks and 6 
months. 
 
1. Actual and planned uptake of screening - 
no significant differences between study arms at 
6 months. 
2. Informed choice - significantly more likely 
in the intervention arm at 6 months. 
3. Knowledge - intervention arm significantly 
more likely to report 'good' knowledge 
compared to the control arm at 6 weeks.  
4. Attitude towards screening - Intervention 
arm had a significantly less positive attitude 
about screening at 6 weeks. 
 
 
No baseline assessment of 
questionnaires.  
 
Planned and actual uptake of 
screening were assessed together due 



























1 and 2 years. 
 
1. Mammography coverage (1 post-
intervention mammogram) - no significant 
differences between study arms in ITT analysis, 
but for MITT and PP analysis, there was a 
significant difference between targeted only 
intervention arm and the control arm.  
2. Mammography compliance (2 post-
intervention mammograms) - women in the 
both intervention arms were significantly more 
likely to report receiving 2 post intervention 
mammograms 6-16 months apart compared to 
 
Intervention based on the TTM. 
 
Logistic regression showed that 
compared with the control arm, the 
targeted intervention arm had 
significantly higher mammography 
coverage and the targeted and 
tailored intervention arm had 
significantly higher mammography 
compliance (PP analysis).  
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women in the control arm. There was no 











169 females, 93 
males eligible 
for bone mineral 











risk assessment.  
 
Control arm - 
usual community 







1. Actual screening test (BMD) or new 
prescription medication for osteoporosis - 
significantly higher rates in the intervention 
arm. 
2. Calcium intake - significantly higher in the 
intervention arm. 
3. Vitamin D intake - higher in the intervention 
arm but not significant.   
 
Primary outcome endpoint was a 
combination of a screening test or 
start of osteoporosis medication, 
although the result was driven by 











169 females, 93 
males eligible 
for bone mineral 













Control arm - 
usual community 







1. Health related QoL 
2. Physician visits  
3. Vitamin D Uptake 
4. Calcium uptake 
5. Knowledge 
6.Actual screening test (BMD) 
Of 129 intervention arm patients, 46% had an 
abnormal QUS result indicating low bone mass, 
and 33% of these patients had a follow-up BMD 
test compared to only 12% of those with a 
normal QUS result.  
The strongest predictor of having a follow-up 
BMD test was, an osteoporosis specific doctors 
visit.  
 
Other than intervention arm status, 
those with a follow-up BMD test 
were significantly more likely to be 
women, have a family history of 
osteoporosis or have a higher 









After adjusting for intervention arm status, only 
female sex and osteoporosis specific physician 
visit were independently associated with receipt 
of a BMD test.  
In the intervention arm, an abnormal QUS result 
was significantly associated with the receipt of a 
follow-up BMD test.  
88 
 
All of the 18 studies had a control arm, however, 4 of the 18 studies had 2 individualised risk 
intervention arms, meaning there was a total of 22 individualised risk interventions. Within 
studies, intervention arms tended to differ in the way the risk was presented to participants or 
in the additional information presented. Results in this sub-section will be discussed out of a 
total of 22 intervention arms.      
 
Out of the twenty-two interventions arm in the eighteen studies, seven interventions presented 
an individualised risk score, seen as the most detailed type of risk to present, such as a score 
calculated through an algorithm used in the Gail Model for breast cancer risk. Six interventions 
presented participants with a categorisation of their level of risk such as above average risk, 
average risk or below average risk. Finally, whilst a further four interventions simply listed or 
discussed personal risk factors, five interventions were unclear as to the type of risk presented.  
 
The format of the risk presentation also varied largely across intervention arms. Of the 22 
intervention arms, two communicated the risk verbally in person only, whilst two interventions 
communicated the risk verbally in person then additionally provided the risk in written format. 
One intervention utilised a computer aid to present the risk information, whilst a further three 
interventions used a computer aid first, followed by a printout, to provide written risk 
information. Seven interventions provided their participants with written risk information only, 
two interventions provided written risk information and then reviewed the information verbally 
in person, two interventions provided written risk information followed by a discussion of this 
during a telephone call, two interventions communicated the individualised risk through a 
specialised website, and finally, one intervention communicated risk solely over the telephone.  
 
Interventions where the risk information was presented in person or over the telephone were 
delivered by a variety of people. Characteristics of those who delivered risk information in this 
format were largely omitted in terms of the number of people involved, gender, age and 
ethnicity. "Profession" however was a characteristic reported more commonly in such 
intervention studies, where the range was wide, from qualified counsellors and nurse educators 
to health educators and staff specifically recruited and trained for the intervention studies. 
 
All studies provided individualised risk information in conjunction with other information, 
such as educational material, and the presentation of the individualised objective risk was 
presented and framed in several ways. Though, the amount of detail that each study provided 
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their participants with did all vary, therefore studies and their intervention material varied in 
the complexity. A total of thirteen studies (Allen et al., 2010; Bodurtha et al., 2009; Bowen et 
al., 2006; Bowen & Powers, 2010; Bowen et al., 2011; Glenn et al., 2011; Harari et al., 2008; 
Helmes, Culver, & Bowen, 2006; Lipkus & Klein, 2006; Rawl et al., 2012; Schroy et al., 2011; 
Schroy et al., 2012; Steckelberg, Hulfenhaus, Haastert, & Muhlhauser, 2011; Yuksel, 
Majumdar, Biggs, & Tsuyuki, 2010; Yuksel, Tsuyuki, & Majumdar, 2012) provided 
participants with some form of educational material regarding a particular disease or condition 
or screening test. In two studies (Allen et al., 2010; Schroy et al., 2011; Schroy et al., 2012) the 
main focus was to aid decision making and a decision aid tool was used, where educational 
information was provided alongside a decision aid tool to assist in the decision making process 
about attending for screening. Six studies discussed theoretical constructs alongside the 
individualised risk information, such as barriers to, and benefits of screening and self-efficacy 
information (Bloom, Stewart, Chang, & You, 2006; Bodurtha et al., 2009; Glanz et al., 2007; 
Glenn et al., 2011; Manne et al., 2009; Vernon et al., 2008).. Two studies also provided 
personalised screening recommendations bases on a persons' level of risk (Glanz et al., 2007; 
Rawl et al., 2012). Two studies provided follow-up/ check-in calls to their participants (Bowen 
& Powers, 2010; Glanz et al., 2007), whilst six of the total eighteen studies tailored the 
additional material to the individual, such as incorrect knowledge about disease or screening 
test (Bowen et al., 2011; Glenn et al., 2011; Lipkus & Klein, 2006; Manne et al., 2009; Rawl 
et al., 2012; Vernon et al., 2008).  In terms of the actual presentation of the individualised risk 
information, five studies reported presenting a relative risk (Allen et al., 2010; Bowen & 
Powers, 2010; Helmes et al., 2006; Lipkus & Klein, 2006; Steckelberg et al., 2011), one study 
(Steckelberg et al., 2011) presented the risk in natural frequencies, and three studies reported 
presenting lifetime risk (Bloom et al., 2006; Bodurtha et al., 2009; Bowen & Powers, 2010). 
Two studies described reporting the individualised risk numerically (Bowen et al., 2011; 
Helmes et al., 2006), whilst five studies reported presenting the information graphically (Allen 
et al., 2010; Bowen & Powers, 2010; Bowen et al., 2011; Helmes et al., 2006; Vernon et al., 
2008). Finally, one study (two articles) reported using colour-coded categories to present the 
risk information (Rubinstein et al., 2011; Ruffin et al., 2011).     
 
Seven out of the eighteen studies used theory to inform their interventions. Table 2 shows 
whether or not there was a theoretical basis to the intervention. The theoretical models 
addressed were the Health Belief Model (Bloom et al., 2006; Bodurtha et al., 2009; Manne et 
al., 2009; Rawl et al., 2012; Vernon et al., 2008), Transtheoretical Model (Bodurtha et al., 2009; 
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Manne et al., 2009; Vernon et al., 2008), Self-Regulatory Theory (Bodurtha et al., 2009; Bowen 
et al., 2011), Precaution Adoption Process Model (Glanz et al., 2007) , and Dual Process 
Theory (Manne et al., 2009). One study described having based their intervention on several 
theoretical concepts (Bowen & Powers, 2010), whilst one other study used their results to 
support a theory; the Risk Reappraisal Hypothesis (Glenn et al., 2011).  
 
Overall, reporting of intervention details was average to poor. In some interventions, it was 
unclear how the risk was presented to participants and further details of what participants 
received were simply not reported in the article (Glenn et al., 2011; Manne et al., 2009; 






Table 2- Intervention Details 





Type of risk presented Additional details about the intervention 
Developed and informed by 
theory / Theory-based 
intervention 
Significant effect 
of intervention on 
outcome 
 




- Prostate cancer 
 






- Categorisation of risk 
 
- Greater than average, / 
average / less than average 
 
- Relative risk - compared to other men their age. 
 
- educational components, prevalence, risk factors, 
screening methods and  recommendations. 
 
- On-screen graph  
 
















- Computer plus 
information sheet 
 
- Categorisation of risk  
 
- Usual / moderate / strong 
 
- Based on Gail model of risk 
- Lifetime risk of developing breast cancer 
- information sheet also described constructs of the 
HBM, such as barriers to mammography, breast 
cancer seriousness, benefits of yearly 
mammograms, self efficacy and cues to action.  
 



















- Individualised risk score 
 
- Based on Gail model of 
risk 
 
- Lifetime risk 
 
- Discussed in relation to pre-test perceived risk, 
de-escalation of tension regarding a breast cancer 
check up, evaluation of coping skills and 
information on health protective behaviours and 
screening guidelines 
 
- information on genetic testing if requested.  
 
- Health Belief Model, Self-














- BRCA gene 
testing 
 
1.  Individual 
genetic counselling 
arm:  
Verbally in person 
by a qualified 
genetic counsellor 
 
- 1. Individualised risk 





- 1. Focus on the genetic background, and 
educational component of genetic mutation in 
Jewish population, non-genetic risk factors and 
screening.   
 
 
No theoretical model 




Cancer worry  
 
Awareness of 







Written - session 
led by qualified 
health counsellor 
- 2. Individualised risk 
score based on Gail model 
 
- 2. Educational component, stress management and 
problem solving, and social support 
 
  




genetic testing  
 
 














- Those at mixed 
risk or genetic risk 
received the written 
report in person by 
a counsellor. 
 
- Individualised risk score  
based on Gail model 
 
- Lifetime risk presented in a bar graph, with an 
average woman's risk estimate also presented.  
 
-Intervention pack included personal risk sheet, 
screening information, BSE shower card, Cancer 
Institute flyer.   
 
- Check in call to discuss personal risk and worry 
 
- Counselling offered to those at mixed or genetic 
risk. 
 
- Based on theoretical 
concepts - perceived risk, 
potential distress at learning 
about personal risk and coping 
with breast cancer risk by 









Interest in genetic 
testing 
 








Website - personal 
risk sheet 
 
- Those at mixed 
risk or genetic risk 
received the written 




- Individualised risk score 
based on Gail model 
 
- lifetime risk estimate presented both numerically 




- bar graph of a women's estimated risk of 
developing breast cancer. 
 
- Tips, personal stories, facts tailored to risk level 
and health news.  
 
 
- Self-Regulation Model 
 
Knowledge of 






breast cancer  
 















- Verbally in person 
and written in a 
counselling session 
 
- Categorisation of risk  
 
- Risk level 1, 2 or 3.  
 
- follow up phone call 
 
 








- FOBT / 
Colonoscopy / 
Sigmoidoscopy 
by a nurse educator 
or trained health 
educator.  
 
- feedback about perceived barriers and benefits to 
screening, personal screening recommendation 
























- 6-month telephone call - 
discussion of personal risk 
factors if participant still 
unscreened.  
 
- Educational components - information on 
colorectal cancer, risk factors and screening  
 
- Tailored inserts - motivational statements tailored 
to readiness to screen and listed barriers to 
screening.  
 
No theoretical model 
mentioned in the development 
of the intervention but Risk 
Reappraisal Hypothesis 
applied to evaluate results.  
 














- Discussion of personal 
risk factors with 
personalised preventative 
health checklist.   
 
- Feedback included advice on modifying health 
risks. 
 
- No theoretical model 








Helmes et al. 
2006 
 




- Genetic testing / 
Mammogram 
 
- Intervention arm 
1. In-person risk 
counselling: 
Verbally in person 
plus mailed risk 
sheet. 
 
- Intervention arm 
2. Telephone risk 
counselling: 
Mailed risk sheet 
and over telephone. 
 
- Individualised risk score  






- Individualised risk score  
- Based on Gail model 
 
- presented both graphically and numerically, and 
compared with the personal risk of an average-risk 
woman and a high-risk woman.  
 
- Conducted by a board certified genetic counsellor.  
 
- booklet also contained educational information 
and discussion of genetic testing. 
 
- No theoretical model 






Interest in genetic 
testing 
 









- Intervention arm 
1. Absolute risk: 
written information 
 
- Absolute risk; list of 
personal risk factors that 
may increase chances of 
developing CRC. 
 
- Booklet - contained educational materials 
 
- Plus tailored messages about lifestyle risk factors  
 
 
- No theoretical model 








first then reviewed 
verbally in person. 
 




first then reviewed 
verbally in person. 
 
 
-  Absolute risk; list of 
personal risk factors that 
may increase chances of 
developing CRC plus 
comparative risk - more or 
less risk factors compared 
to others.  
- Reviewed after reading the written information by 
the research assistant who emphasised the risk 
factors relevant to each individual (as well as how 
those risk factors compared with others for the 
absolute and comparative risk group only). 
Perceptions of 

















- Intervention arm 
1. 
Tailored print: 
Written in tailored 
pamphlet 
 
- Intervention arm 
2. 
Tailored print and 
telephone 
counselling: 











- Picture of a gender and ethnically matched 
individual with a caption discussing the participants 
highest ranking barrier 
- tailored to incorrect CRC knowledge, benefits and 
barriers, stage of adoption and commitment to 
screening.   
- Telephone counselling by health educators. Used 
motivational interviewing to motivate readiness to 
have screening, discuss benefits, correct 
knowledge. 
 
- Tailored newsletter 1 month after tailored 
pamphlet reviewed stage of adoption, reinforce 




- Health Belief Model 
 














- Mixed  
 
- Presented on a 
portable computer 
plus printout  
 
- Discussion of personal 
risk factors  
 
- personalised recommendations for screening 
presented also. 
 
- delivered messages, graphics and videos tailored 
on the assessment of their perceived risk, family 
history, age, barriers to screening.  
 
- Educational component through animation and 
narration. 
 
- Coloured printout imported visuals and data from 
computer summarising personal risk factors and 
risk appropriate test recommendations.  
 








to FOBT  
 
Perceived benefits 





al. 2011 / 








- Presented on a 
website  
 
- over the telephone 
in 9% of 
participants  
 
- printed prevention 
messages  
 
- Categorisation of risk 
 
- Strong / moderate / weak 
 
- qualitative framing 
 
- colour-coded categories (strong displayed in red) 
 
- Tailored prevention messages based on familial 
risk level, sex, age, reported health behaviours and 
screening history.  
 
- No theoretical model 





Schroy et al. 
2011 / Schroy 










decision aid with 
risk assessment and 
feedback. 
 
- Categorisation of risk 
 
- Above average / average 
/ below average 
 
- suggestions for behaviour modification 
 
- DA consisted of educational information about 
CRC and screening tests with audio and visual 
comparisons, decision making tool to identify a 
screening preference 
 
- No theoretical model 






















- FOBT and 
Colonoscopy 
 







- 38-page brochure covering personalised risk of 
CRC, all available screening options with possible 
benefits and harms, and prevention of CRC.  
 
- Access to two interactive interned modules 
offering the opportunity to read more on the topic.  
 
- Natural frequencies with comparable reference 
populations and timeframes.   
 
- No theoretical model 





















- graphical illustrations of objective risk and 
perceived risk for breast cancer 
 
- messages designed to help reconcile perceptions 
with actual risk 
 
- Transtheoretical Model 
 











HBM - Health Belief Model 
TTM - Transtheoretical Model 
CRC - Colorectal cancer 
FOBT - Fecal Occult Blood Test 
BMD – Bone Mineral Density 
DA - Decision aid 
DMP - Decision making process 
ITT - Intention-to-Treat analysis 
MITT - Modified Intention-to-Treat analysis 
PP - Per-protocol analysis 
QoL – Quality of life 
*Same data, two articles reporting two different outcomes. 
^Same study, the first of which reports results of the first 666 participants enrolled in study, and the second reports results of different outcomes 
of all 825 participants enrolled. 
#Same study, first article reports the primary analysis and the second article reports on a secondary analysis. 
 
- feedback on self-efficacy to get a mammogram 
and strategies to increase confidence to overcome 
identified barriers, review use of processes of 
change and list of activities tailored to stage of 
change, and reminder of date of next due 
mammogram.  
 
Yuksel et al. 
2010 / Yuksel 





Verbally in person 
by a community 
pharmacist 
 
- Categorisation of risk 




- Tailored education programme on aspects of 
osteoporosis such as risk factors, BMD testing, 
lifestyle measures, calcium and vitamin D intake, 
and medications.  
 
- QUS measure - to aid risk assessment  
 
- encouragement to follow-up with their doctor for 
further management.  
 
- No theoretical model 







KEY:   
             Type of Risk presented:                              Individualised risk delivery format: 
             Categorisation of risk                           Verbally in person                Computer plus printout           Computer only 
             Individualised risk score                       Written                             Telephone                                      Written then verbally in person 




All 21 studies took baseline measures and follow-up measures post intervention, although 
timing varied among studies. Table 1 shows the outcome measures for each study. There was 
a lot of variation in the outcomes measured. No two studies measured the exact same outcomes. 
In terms of a primary outcome, eleven of the eighteen studies measured actual screening 
uptake, while four studies measured screening intentions, and one study measured actual 
combined with planned screening uptake. Secondary outcomes varied even more so. Perceived 
risk was measured in eight studies, while other common outcome measures included 
knowledge; reported in nine studies, and cancer worry, measured in eight of the studies. 
Beyond these, there was a range of outcomes for which only one or two studies provided data 
such as for perceived severity and quality of life. 
 
Risk of Bias: 
Data was extracted to assess the risk of bias of the included studies using Cochrane’s risk of 
bias tool derived from the Cochrane Handbook for Systematic Reviews of Interventions 
(Higgins & Green, 2011). Differences were resolved in assessment of the risk of bias included 
studies by discussion. The principal elements used for this review were: 
• Random sequence generation (selection bias): Studies that describe the random sequence 
generation were marked as low risk. If there was no mention of this, then the studies were 
marked as unclear. Quasi-randomised trials were marked as high risk. 
• Allocation concealment (selection bias): Studies that describe allocation concealment were 
marked as low risk. If there was no mention of this, then the studies were marked as unclear. 
Studies were marked as high risk if an allocation concealment procedure was clearly not 
followed. 
• Blinding of participants and personnel (performance bias): Studies that describe blinding in 
detail were marked as low risk. If there was no mention of this, then the studies were marked 
as unclear. Studies were marked as high risk if a blinding procedure was clearly not followed 
or the trialists described the participants and personnel in the study as unblinded. 
• Blinding of outcome assessment (detection bias): Studies that describe blinding in detail were 
marked as low risk. If there was no mention of this, then the studies were marked as unclear. 
Studies were marked as high risk if a blinding procedure was clearly not followed or the 
researchers described the outcome assessment procedure as unblinded. 
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• Incomplete outcome data (attrition bias): Studies were marked as low risk if there was a low 
attrition rate (less than 20%) or if an intention-to-treat principle was adopted. If there was no 
description of attrition in the study, this element was marked as unclear. If no adjustments were 
made despite a signiﬁcant dropout rate studies were marked as high risk for attrition bias. 
• Selective reporting (reporting bias): Studies were marked as low risk if the protocols were 
available and all outcomes listed in it were addressed. They were marked as unclear if protocols 
were not available. High risk status was assigned if there was clear evidence of selective 
reporting based on the outcomes mentioned in the methods section of the included studies. 
• Other biases, e.g. baseline comparability, measure against contamination and funding for the 
screening test: Studies that describe the components in detail were marked as low risk. If there 
was no mention of this, then the studies were marked as unclear. Studies were marked as high 
risk if the components were clearly not addressed, or demonstrated biases. 
 
This review found that the included studies were of variable quality, but generally average to 
good. The majority of studies were adequate for random sequence generation, but only some 
of the studies reported adequate concealment of allocation to intervention or control groups. 
Most studies were also unclear about the blinding of assessors in outcome measures although 
many used patient-reported or objective measures for key outcomes such as assessing test 
uptake from computerised registers. There was adequate incomplete outcome data across 
studies. Finally, there appeared to be some selective reporting across studies, however, there 
were no major concerns about the risk of bias, therefore no studies were excluded on the basis 
of the risk of bias.  
 
Results of Individual Studies: 
Most (N=14/18) studies reported some degree of positive findings; IRC-based interventions 
had a significant effect on screening uptake (N=2), its psychological predictors (N=6), or both 
(N=6). One study found no effects on either outcome (Bloom et al., 2006), whilst N=3 found 
no effect on either screening uptake or its psychological predictors but saw a significant 
increase in related health behaviours such as fruit and vegetable consumption (Rubinstein et 
al., 2011; Ruffin et al., 2011), exercise (Bodurtha et al., 2009; Harari et al., 2008; Rubinstein 
et al., 2011; Ruffin et al., 2011) and vaccination uptake (Harari et al., 2008). 
 




It would appear that in some of interventions, the use of tailored risk based information had 
some effect on participants’ screening behaviours or psychological predictors of screening 
uptake compared to generalised risk information or a control arm. 
 
Conceptually, a meta-analysis uses a statistical approach to combine the results from multiple 
studies in an effort to increase power (over individual studies), improve estimates of the size 
of the effect and/or to resolve uncertainty when reports disagree. There was insufficient 
homogeneity among the interventions in either the risk presentation types, formats and methods 
adopted or the outcome measures used to undertake a meta-analysis of the trials, thus it is not 
possible to provide a clear overall statement of the impact of the interventions. In order to 
conduct a meta-analysis, more than one study which has estimated the effect of an intervention 
or of a risk factor is needed. The participants, interventions or risk factors, and settings in which 
the studies were carried out need to be sufficiently similar in order to say that there is something 
in common to be investigated.  
  
Screening uptake was significantly higher in the intervention arms compared to control arms 
in seven of the studies, and one or more studies also reported other significant intervention 
effects such as higher screening intentions, greater or more accurate risk perceptions, lower 
levels of cancer worry, greater knowledge, higher decisional status, greater informed choice 
and reduced interest in genetic testing. Therefore, it appears that individualised risk 
communication may have a positive impact on screening uptake and factors that can mediate 
the decision to attend for screening.  
 
Type of risk presented: 
It is possible that studies using an individualised risk score or categorising risk may be more 
successful at increasing uptake of screening tests compared to simply listing personal risk 
factors. However, this conclusion is made with caution as some studies reporting an increase 
in screening uptake were unclear about the type of risk presented i.e. risk category or 
individualised risk score, or this detail was simply not reported.  
 
Five studies (seven intervention arms) presented participants with an individualised score. Of 
these five studies, two studies (Bowen et al. 2010; Bowen et al. 2011) reported an increase in 
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screening uptake, and three studies (Bowen et al. 2010; Bowen et al. 2011; Helmes et al. 2006) 
reported better psychological outcomes such as cancer worry and quality of life.   
 
Six studies presented participants with a categorisation of their individual risk. Of these six 
studies, two studies uptake (Glanz et al. 2011; Yuksel et al. 2010/Yuksel et al. 2012) reported 
an increase of screening uptake, whilst three studies (Allen et al. 2010; Glanz et al. 2011; 
Schroy et al. 2011/Schroy et al. 2012) reported better psychological outcomes such as 
knowledge.   
 
Three studies (four intervention arms) presented participants with a list of personal risk factors. 
Of these three studies, there was no report of any increase in screening uptake, whilst two 
studies reported better psychological outcomes such as fewer barriers to screening (Lipkus & 
Klein, 2006; Rawl et al. 2012). There were no studies which had two intervention arms where 
different types of risk were presented and compared.   
 
Disease or condition and Screening test: 
The most common disease being screened for was colorectal cancer, followed by breast cancer. 
Results from the studies did not indicate more favourable outcomes for any particular disease 
or condition. Interventions successfully increased screening uptake in a variety of diseases. 
However, it appears that the two interventions providing individualised risk information about 
a number and variety of diseases or conditions were less successful at having an effect on 
screening uptake of particular diseases or conditions compared to interventions which only 
focused on one particular disease or condition such as breast cancer. There were insufficient 
data to report on other psychological outcomes at this level of synthesis.   
 
Type of participants: 
Seven studies recruited a participant sample thought to be at greater risk of developing a 
particular disease or condition due to their family history or non-adherence to screening, for 
example. Of these seven studies, three reported an increase in screening uptake with 
individualised risk (Glanz et al. 2011; Glenn et al. 2011; Manne et al. 2009), whilst six reported 
improved psychological outcomes (Bowen et al. 2006; Glanz et al. 2011; Glanz et al. 2011; 
Lipkus & Klein, 2006; Manne et al. 2009; Rawl et al. 2012). Eleven studies recruited average 
risk participants from the general population. Of these, 4 studies reported an increase in 
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screening uptake with individualised risk (Bowen et al. 2010; Bowen et al. 2011; Vernon et al. 
2008; Yuksel et al. 2010/Yuksel et al. 2012), whilst six of the studies reported improved 
psychological outcomes (Bowen et al. 2010; Bowen et al. 2011; Helmes et al. 2006; Schroy et 
al. 2011/Schroy et al. 2012; Steckelberg et al. 2011). Therefore, these studies did not seem to 
suggest any greater increase of screening uptake utilising a sample of participants at greater 
risk for a disease or condition over studies utilising an average risk participant sample. 
However, there was heterogeneity between the studies in the way the risk was presented, and 
the outcomes measured, adding to the difficulty in providing a definitive conclusion.  
 
Risk information delivery format: 
Although there were a variety of formats in which the risk was presented, there does seem to 
be more support some risk information formats than others. Seven intervention arms presented 
risk information in a written format, of which four of the interventions reported an increase in 
screening uptake (Bowen et al. 2010, Glenn et al. 2011; Manne et al. 2009; Vernon et al. 2008), 
and five interventions reported improved psychological outcomes (Bowen et al. 2006; Bowen 
et al. 2010; Glenn et al. 2011; Manne et al. 2009; Steckelberg et al. 2011). Two intervention 
arms provided written risk information first, followed by a discussion of the risk verbally in 
person, but did not increase screening uptake, although they did report better psychological 
outcomes (Lipkus and Klein, 2006). One study reported presenting the individualised risk 
information on a computer aid alone, which did improve several psychological outcomes such 
as knowledge and screening intention, but screening uptake did not increase (Schroy et al. 
2011/Schroy et al. 2012). A further three interventions used a computer aid first, followed by a 
printout, to provide written risk information, which resulted in no increase in screening uptake, 
yet two of the interventions reported better psychological outcomes (Allen et al. 2010; Rawl et 
al. 2012). Two intervention arms communicated the risk verbally in person only and whilst one 
intervention (Yuksel et al. 2010/Yuksel et al. 2012) reported an increase in screening, the other 
reported better psychological outcomes (Bowen et al. 2006). For the two interventions 
communicated the risk verbally in person then additionally provided the risk in written format 
(Glanz et al. 2011; Helmes et al. 2006), both studies reported better psychological outcomes, 
whilst one intervention reported an increase in screening uptake also (Glanz et al. 2011). Two 
interventions provided written risk information followed by a discussion of this during a 
telephone call. Both interventions reported better psychological outcomes (Helmes et al. 2006; 
Manne et al. 2009), and one intervention reported an increase in screening uptake (Manne et 
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al. 2009).  Two interventions communicated the individualised risk through a specialised 
website, and whilst one intervention reported no increase in outcomes (Rubinstein et al. 
2011/Ruffin et al. 2011), the other reported both an increase in screening uptake and improved 
psychological outcomes (Bowen et al. 2011). Finally, one intervention communicated risk 
solely over the telephone (Bodurtha et al. 2009), but this intervention reported no increase in 
screening uptake or any psychological outcomes. 
 
Overall, all individualised risk information formats utilised within the 22 intervention arms, 
except that of risk communication solely over the telephone, had a significant effect on 
psychological outcomes. It appears though, that where individualised risk information is 
presented in written format, or indeed in a combination with another format such as 
communication verbally in person or over the telephone, it appears to have an increase in 
screening uptake also.   
 
Details of risk presentation: 
Thirteen of the eighteen studies provided educational information for participants, and all 
except two studies (Bodurtha et al. 2009; Harahi et al. 2008) reported some effect of better 
outcomes compared to the control arm. There appear to be similar findings with the addition 
of several other components to the interventions. Both interventions using a decision aid 
reported better psychological outcomes compared to the control arm, and the six studies which 
discussed theoretical model constructs with participants all reported increased screening uptake 
or psychological outcomes. The two studies using a check in follow-up call as part of the 
intervention also both reported increases in screening uptake and better psychological 
outcomes outcomes (Bowen et al. 2010; Glanz et al. 2011), and finally, those studies tailoring 
the intervention to individuals as well as presenting individualised risk information all reported 
some level of better outcomes either increased screening uptake or better psychological 
outcomes(Bowen et al. 2011; Glenn et al. 2011; Lipkus & Klein, 2006; Manne et al. 2009; 
Rawl et al. 2012; Vernon et al. 2008). .  
 
The same can be said for other details of risk presentation reported in the studies, such as 
presenting a relative risk, where all five studies reported positive effects on screening or 
psychological outcomes, lifetime risk, where one study reported positive screening uptake and 
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better psychological outcomes, and where one study reported natural frequencies, and found 
positive effects on psychological outcomes.   
 
Therefore, it is difficult to conclude which intervention strategy results in the best overall 
outcome for increasing screening uptake, and which is the best way to visually present the risk 
information, as there is very little by way intervention presentation that is not effective.  
 
Simple versus complex Individualised risk interventions: 
Four of the eighteen studies each compared two intervention arms both receiving individualised 
risk information, with a control arm (Bowen et al. 2006; Helmes et al. 2006; Lipkus & Klein, 
2006; Manne et al. 2009). The two interventions in each of the four studies varied in their 
complexity. In one study, both intervention arms received the same individualised risk 
information but in different settings; one arm received their written risk information with one-
to-one non-directive counselling, whereas the other group received it with group psychosocial 
counselling. Results showed there to be no significant differences between either counselling 
method in the overall increase of screening uptake that both arms showed compared to the 
control group.  
 
In one of the other studies both intervention arms received the written individualised risk 
information, but whilst one intervention arm received theirs during in-person counselling, the 
other intervention arm was mailed the intervention packet containing the individualised risk 
information, and received telephone counselling (Helmes et al. 2006). However, results showed 
that there was no difference in psychological outcomes between the two intervention arms, 
although both had better outcomes compared to the control arm. 
 
In another study (Lipkus & Klein, 2006), both interventions arms received individualised 
absolute risk information, but one of the arms was more complex and received more relative 
risk information also. Here, results showed that although the more complex intervention 
increased screening intentions compared to the simpler intervention arm, but there was no 
difference in actual screening uptake between the two intervention arms. 
 
Finally, in the other study, both intervention arms received individualised risk information in 
tailored print, however, one of the intervention arms also received telephone counselling, the 
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more complex intervention of the two arms (Manne et al. 2009). Again, results showed that 
both intervention arms increased screening uptake compared to the control arm.      
 
Therefore, it seems that, more complex interventions do not seem to have an additive effect on 
overall outcomes. They appear to be just as effective as the simpler individualised risk 
interventions.  
 
Interventions with a theoretical basis: 
Seven studies (Bloom et al., 2006; Bodurtha et al., 2009; Bowen et al., 2011; Glanz et al., 2007; 
Manne et al., 2009; Rawl et al., 2012; Vernon et al., 2008)  used theoretical models to inform 
the development of their intervention, one study used several psychological concepts (Bowen 
& Powers, 2010), whilst ten did not.  These ten studies, measured outcomes related to 
behaviour-change psychology theory such as knowledge, perceived risk, and worry.   
 
There did not appear to be any significant differences in the success of interventions to increase 
screening uptake or better psychological outcomes, between those that were informed using a 
theoretical model, and those that were not. For example, increases in knowledge, perceived 
risk and screening uptake and reductions in cancer worry and interest in genetic testing, were 
seen in both studies that used theory to inform their intervention, and studies that did not.  
 
Overall, there was a higher level of risk information presentation detail omitted in the studies 
which lends to the difficulty in concluding the most effective individualised risk 




Summary of Evidence: 
Notwithstanding the moderate quality of reviewed studies, and the heterogeneity in outcomes, 
there does seem to be support for a wide range of individualised risk communication strategies.  
 
Following a systematic review of 21 articles, there does appear to be evidence that 
individualised risk communication is more successful than generalised risk communication at 
increasing screening uptake and its psychological predictors. There is also limited evidence to 
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suggest that more detailed types of risk presented, such as an individualised risk score or a risk 
category, are slightly more successful at increasing screening uptake and its psychological 
predictors compared to simply listing personal risk factors. However, there were interventions 
that were successful at increasing screening uptake and its psychological outcomes that did not 
report on the type of risk presented so this result is to be taken with caution (Manne et al., 2009; 
Steckelberg et al., 2011; Vernon et al., 2008). 
 
The results also suggest that interventions may not be any more successful for participants 
identified at greater risk for a particular disease or condition, rather than average-risk 
individuals, even though in this current review, there were a number (n=7) of studies recruiting 
participants thought to be at greater risk. 
 
Interventions that provide individualised risk about a number of conditions may not be as 
successful as those which focus on a particular disease or condition, providing further support 
for the findings from a previous systematic review (Edwards et al., 2006). This might be 
because individuals cannot take in risk information about several conditions and process the 
information properly in order to make a screening decision about every disease. As Kahneman's 
theory of attention and effort suggests, attention can either be focussed on one particular 
activity or divided between a number of activities (Kahneman, 1973). Attention is limited, and 
therefore, the more activities, the less attention is paid to each individual activity. Where the 
risk of just one disease is presented, individuals are more likely to be able to focus and process 
the information in order to make a decision about attending for screening.  
 
There also seems to be support for the presentation of the risk information in a written format, 
or in a combination with another presentation format such as verbally in person. This may be 
because participants preferred to have the information to hand to review again, or to take in at 
their own pace.   
 
Complex interventions which involve other components such as counselling and educational 
information about a particular disease or condition or methods of screening, presented in 
addition to the risk information, although successful in terms of screening and psychological 
outcomes, appear to be no more successful than more simple interventions which do not utilise 




Psychology theory has been used in designing IRC interventions to increase screening uptake 
or its psychological proxies and such studies are as effective in improving screening or its 
psychological proxies, as a-theoretical studies. There seems to be no evidence to suggest that 
using theory to inform intervention development is more likely to increase screening uptake, 
nor does the use of any particular visual presentation detail such as numerical or graphical risk 
representations appear to be more successful at affecting psychological predictors of screening 
uptake and actual screening uptake. This could be because theory is truly unhelpful in 
predicting outcomes, or because intervention fidelity was poor in the reported interventions, or 
possibly because of improper use of behaviour change techniques. Interestingly, all of the 
atheoretical studies measured outcomes that are supported by theory (such as e.g. attitudes) 
albeit the absence of theory to actually drive the design of the intervention per se. 
 
This systematic review compliments and builds on the findings from Edwards and colleagues 
in many ways. Firstly, they reported that only a limited number of clinical topics were targeted 
in risk communication work, namely breast cancer. Since their review, there have been a few 
other clinical topic areas examined, such as prostate cancer and osteoporosis and mixed clinical 
topic conditions, where studies have examined risk of developing several diseases or conditions 
together. Secondly, he found that a lot of interventions used the most basic form of 
individualised risk communication, where there was simply a discussion of personal risk 
factors. He reported fewer cases of categorising risk or using an individualised risk score, 
whilst at the same time reporting that the more detailed the risk i.e. using an individualised risk 
score to be smaller the effect on increasing screening uptake. Studies published since their 
review findings appear to have communicated individualised risk in more detailed ways, and 
this current review found there to be more individualised risk scores and categories of risk 
being utilised rather than simply listing personal risk factors. This observation suggests that 
this area of research has changed and taken note of the previous findings.  
 
The findings in the current review support those previously reported in a recent selection of 
RCTs, in that individualised risk communication seems to be more effective in increasing 
screening uptake than generalised risk communication or no communication. In addition to 
supporting the findings of Edwards and colleagues, the current review suggests that 
individualised risk communication can significantly impact the psychological predictors of 
screening uptake. It also proposes that presenting the individualised risk in a written format or 
in deed in a combination with another format such as verbally in person, that this may be more 
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effective that other methods of delivery such as communicating the risk solely over the 
telephone or viewing the risk on a website.  
 
The current review also builds on the findings from the systematic review conducted by 
Waldron et al. (2011). They made recommendations for more studies to assess a person's actual 
risk profile rather than carry out analogue studies, and although their focus was communicating 
individualised cardiovascular risk, their recommendations appear to have been noted, as in this 
review, there were no analogue studies found in the search of studies for inclusion. The findings 
of this review also support their results; they found that presenting patients with their 
cardiovascular risk in percentages or frequencies; numerically, using graphical representation 
and short timeframes was best for achieving risk reduction through behaviour change. Indeed, 
this review found that studies utilising graphical or numerical representations or risk were 
successful at increasing screening uptake or resulting in better psychological outcomes, 
although neither were found to be superior due to lack of reporting in many studies at this level 
of detail, and the heterogeneity of studies and outcomes. On the other hand, they suggested that 
numerical presentation of risk as opposed to simple risk categories might lead to more accurate 
risk perceptions and can influence treatment decisions (Waldron et al., 2011). Conversely, this 
current review suggests that categories of risk as not necessarily superior, as previously 
suggested (Waldron et al., 2011), to numerical presentation; in this review we call 
individualised scores, but might be equally as effective at influencing screening decisions, and 
both better than simply listing personal risk factors.  However, this conclusion is made with 
caution, as some studies were unclear as to the type of risk presented.  
 
Quality of the Studies: 
It is important to consider the conclusions made in this review in light of critical analysis of 
the study quality. Overall, individualised risk communication interventions were poorly 
reported, and the presentation detail was not described in order to answer the review question 
and identify a full effective strategy for communicating individualised risk information.  
 
Further to this, there were several problems noted for studies included overall. Firstly, not all 
studies measured screening uptake, but those studies that did were largely based upon self-
reported receipt of a screening test. Within studies measuring screening uptake, only a few 
studies confirmed receipt of a screening test by consulting physicians or medical records. 
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Secondly, follow up times varied massively between studies from immediately post-
intervention up to two years. A lack of an appropriate post-test measure can reduce clarity of 
conclusions, and that it is useful to have longer term measures, to see whether the impact of 
the intervention does stay with the participant. This is especially important when assessing 
follow-up screening uptake as many screening tests are only carried out annually or even every 
two or three years, meaning that shorter follow-up times might not be sensitive enough to detect 
changes in screening adherence.  
 
Conversely, all scales and measures used in the studies were validated and checked for 
reliability and validity, which increases the confidence we can place in the results obtained. 
Additionally, all 18 of the studies were RCTs, and had an adequate control group. 
 
Limitations: 
The conclusions of this review are based on a relatively small number of studies. This is, even 
though it had been several years since the topic was last systematically reviewed. Albeit a few 
additions, the variety of clinical topics is still quite narrow, with the majority of studies 
producing results in the field of colorectal cancer and breast cancer. Additionally, there is a 
possible selection bias in the current review with the exclusion of papers pre-2006 and of non-
English language studies. Papers that were published pre-2006 were excluded because it was 
decided that papers up to this point were included in a previously published systematic review 
and the findings of these had been evaluated adequately by the author. Further to this, there 
were several problems noted for studies included overall. Firstly, not all studies measured 
screening uptake, but those studies that did were largely based upon self-reported receipt of a 
screening test. Within studies measuring screening uptake, only a few studies confirmed receipt 
of a screening test by consulting physicians or medical records. Secondly, follow up times 
varied massively between studies from immediately post-intervention up to two years. A lack 
of an appropriate post-test measure can reduce clarity of conclusions; therefore, it is useful to 
have longer term measures, to see whether the impact of the intervention does stay with the 
participant. This is especially important when assessing follow-up screening uptake as many 
screening tests are only carried out annually or even every two or three years, meaning that 
shorter follow-up times might not be sensitive enough to detect changes in screening 
adherence. Whilst the risk of bias tool was used to assess the quality of the studies included in 
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the review, a full quality assessment of the studies to assess the strength of the evidence could 
have been conducted using CASP checklists for instance (CASP, 2014). 
 
However, the strength of the results lies in the fact that the studies have been gathered from 
systematic searches of several key databases and contact with key authors in the field, and 
represent a narrative synthesis of the most recent literature. 
 
Implications for Healthcare Settings:  
There is a need simple risk calculators to be incorporated into healthcare in order to deliver risk 
information to individuals. The Gail model and methods for calculating cardiovascular risk 
such as the UKPDS Risk Engine for diabetes patients are examples of those currently 
developed, but only the latter has been incorporated into routine clinical practice. Models that 
allow calculation of individualised risk estimates for individuals about other conditions, such 
as cervical or prostate cancer are needed so that further evaluation of the effects of providing 
such individualised risk information to consumers can be explored. Further, it is important to 
encourage informed decision making rather than just focussing on increasing screening rates 
to meet policy requirements, as some studies have shown a decrease in interest in screening 
tests post-risk communication intervention.   
 
There are of course cost implications to any intervention. What is promising is that the more 
complex interventions (which presumably, by their very nature, are more costly) do not appear 
to be any more effective than simpler interventions. However, it would be useful to formally 
assess the cost-effectiveness of the reviewed interventions in order to inform the feasibility of 
implementation of integrating IRC into screening programs. Insufficient information is 
provided in the existing studies to perform such an evaluation. Future risk communication 
intervention studies should aim to include this information so that the cost effectiveness of the 
intervention can be assessed. 
 
Conclusion: 
This review demonstrates a lack of well-reported studies in individualised risk communication. 
This has been due to a combination of diverse methodological quality and contradictory results. 
It is likely that the heterogeneity of study characteristics, such as the design, sample and types 
of individualised risk presented have contributed to this. A wide range of outcomes have been 
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measured too, and there has been little consistency in risk presentation. Therefore, there is a 
need for more individualised risk communication interventions in more diverse clinical topics. 
RCTs comparing different risk presentation formats are needed to examine whether peoples’ 
intentions, perceptions and other psychological screening predictors vary by risk presentation 
and format as these are possibly more responsive to change. There is a lack of well-reported 




August 2015 Update: 
The systematic review reported above was conducted in 2012. Due to the objective of this 
systematic review to inform the next chapter of the thesis, it was deemed unnecessary to fully 
update the review for thesis submission as the findings of the review were already followed 
to design the next part of the project. However, for the purposes of good practice, the search 
strategies used originally were re-run to see what research had been conducted since. Six 
additional studies were deemed eligible based on the original inclusion criteria set.  
 
On examination of the six additional papers, very little has changed from previous studies 
included in the review in that the majority of studies reported some degree of positive 
findings; that individualised risk communication-based interventions had a significant effect 
on participants’ screening uptake and/or its psychological predictors.  
 
Overall, there were 3274 participants in the six additional studies, ranging in age, level of risk 
of disease and gender. Diseases that were examined included colorectal/bowel cancer, skin 
cancer, prostate cancer and coronary heart disease (CHD). CHD and skin cancer did not 
appear in the papers originally included in the review so these are new developments in the 
field suggesting that risk communication is now being investigated in a greater number of 
diseases. Several theoretical concepts featured in the recent papers and were measured 
similarly to previous studies. The outcomes measured were also very similar to those 
measured in the original papers. Where actual screening uptake was not measured, screening 
predictors were. Length of follow up varied again, ranging from 2 weeks to 12 months.   
As with the original papers included in the review, risk delivery format varied from written to 
web based formats and numerical to categorical representations of personalised risk. The 
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majority of personalised risk interventions were complex and featured several components 
alongside a participants personalised risk information. 
 
The quality of the studies was average to good, as assessed by the Cochrane’s risk of bias 
tool. After close inspection of the six latest papers that were found using the original search 
strategy, it was decided that these papers did not add anything new to the conclusions reached 
from the original papers.  
 
Colorectal cancer still features heavily in the literature, however, skin cancer and CHD were 
new diseases being screened for in these studies and did not feature in the original set of 
studies. In summary, although the quality of these RCTs was average when considering 
Cochrane’s ROB assessment, there is still a lack of detail about the interventions and how 




This chapter has presented the findings of a systematic review on how best to communicate 
risk in order to increase screening participation. On the basis of these findings, it was decided 
that a simple intervention be conducted where dental patients receive individualised diabetes 
risk information in the form of a risk score with a corresponding risk category, both verbally 
in person, and in writing. The use of this systematic review informed communication 









The rest of this thesis reports on one major study with various components. The work 
described here aimed to screen dental patients for diabetes, using two different screening 
tests. It also examined whether post-screening, participants followed up the advice to attend 
their GP for formal diagnostic testing where necessary. The psychological profile of attenders 
and non-attenders was also explored seeking to identify psychological predictors of 
diagnostic testing. This aspect of the thesis relied on the use of quantitative methods. 
Additionally, the thesis reports on qualitative studies undertaken with patients who either 
attended or did not attend for diagnostic testing after screening, and with the dentists who 
participated in this programme of research.  
 
This project set out to incorporate the use of both quantitative and qualitative methods to 
answer the research questions outlined in chapter one. The project involved collecting 
qualitative data after a quantitative phase in order to explain and follow up on the quantitative 
data in more depth. Health care research published in the last decade has included many 
studies that combine quantitative and qualitative methods (Sale, Lohfeld, & Brazil, 2002). 
Mixed methods research is defined as the class of research where the researcher mixes or 
combines quantitative and qualitative research techniques, methods, approaches, concepts or 
language into a single study (Johnson & Onwuegbuzie, 2004). Combining qualitative and 
quantitative methods in a single study is widely practiced and accepted in many areas of 
health care research (Sale et al., 2002). By using a mixed method design, the researcher was 
able to address several questions and meant that any limitations of using a single design were 
overcome. The goal of mixed methods research is not to replace either of these approaches 
but rather to draw from the strengths and minimise the weaknesses of both quantitative and 
qualitative methods in single research studies and across studies. Mixed methods research 
offers great potential for practicing researchers who would like to see methodologists 
describe and develop techniques that are closer to what researchers actually use in practice. 
Mixed methods research can also help bridge the division between quantitative and 




The impact of using a self-report screening measure and HbA1c information as preliminary 
screening tools for possible diabetes in general dental practice, on patients’ health behaviours 
was investigated in a non-experimental design. The primary outcome of the study was uptake 
of further diabetes diagnostic testing by the patients GP. A secondary outcome of the study 
was the amount of variance that psychological variables can predict uptake of further 
diagnostic testing following the receipt of a positive result on the FINDRISC and/or a high 
HbA1c reading. 
In particular, the research questions in bold were addressed. 
 
1. What is the most effective way to communicate individualised risk information to 
increase screening participation or its psychological predictors?  
2. What proportion of dental patients accept an offer to be screened for type 2 
diabetes in a primary care dental setting? 
3. What is the risk of type 2 diabetes in primary care dental patients as assessed 
through self-report and physiological measures? 
4. What is the effect of personalised diabetes risk communication on subsequent 
health behaviours? 
5. What is the psychological profile of patients at risk of diabetes? 
6. To what extent do psychological variables predict post-screening further testing 
or health behaviours? 
7. What are patients’ and dentists’ views on screening for diabetes in dental 




This research study had a longitudinal design with a qualitative element. In order to address 
the outcomes and subsequently answer the research questions, it was necessary to use both 
quantitative methods and qualitative methods. When undertaking a mixed methods study, the 
researcher uses qualitative research methods for one phase or stage of a research study and 
quantitative research methods for the other phase or stage of the research study. When used in 
combination, quantitative and qualitative methods complement each other and allow for a 
more robust analysis, taking advantage of the strengths of each (Sale et al., 2002). 
Researchers have argued that the complexities of most public health problems or social 
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interventions, such as health education and health promotion programs require the use of a 
broad spectrum of qualitative and quantitative methods (Sale et al., 2002). 
Mixed-methods sequential explanatory design, is highly popular among researchers and 
implies collecting and analysing first quantitative and then qualitative data in two consecutive 
phases within one study (Ivankova, Creswell, & Stick, 2006).  
 
The mixed-methods sequential explanatory design consists of two distinct phases: 
quantitative followed by qualitative. In this design, a researcher first collects and analyses the 
quantitative data. The qualitative data are collected and analysed second in the sequence and 
help explain, or elaborate on, the quantitative results obtained in the first phase. The second, 
qualitative, phase builds on the first, quantitative, phase, and the two phases are connected in 
the intermediate stage in the study. The rationale for this approach is that the quantitative data 
and their subsequent analysis provide a general understanding of the research problem. The 
qualitative data and their analysis refine and explain those statistical results by exploring 
participants’ views in more depth (Ivankova et al., 2006).  
 
Quantitative methods were used to address research questions one to six. Qualitative methods 
were then adopted sequentially to answer question seven with an aim to complement and try 
to further understand more about the patients’ and dentists’ views on what they thought about 
the method of screening that was being used and additionally, to further explain any 
psychological variables that might predict subsequent health behaviour following screening.  
The intention of this was to complement the quantitative results answering question six by 
having those participants who actually received the screening intervention contribute in their 
own words their reasons for any subsequent health behaviours following the screening 
intervention.  Quantitative data was collected to start with. Qualitative data was only 




Five hundred and twenty (N=520) dental patients gave written consent to take part in the 
study. Participants were either NHS or private dental patients attending one of the two dental 




General Dental Practitioners  
Six (N=6) General Dental Practitioners gave verbal consent to take part in the qualitative 
phase of the study. All dentists were fully qualified, and treated both NHS and private dental 
patients in one of two dental practices.  
 
Inclusion and Exclusion Criteria 
There were 3 criteria that were chosen in recruiting dental patients. They are outlined and 
fully justified below. 
• Fluent in English language 
It was important that participants could understand written and spoken English 
language so that they could give informed consent to participate in the research as no 
translation facilities were available. Additionally, the psychological measures used in 
the study had been written and validated in English only. Their level of understanding 
was assessed in two ways. Firstly, dental staff and patient notes were used to confirm 
any language problems. Secondly, if a dental patient arrived and confirmed they 
would like to participate in the research, it was checked that they had read and 
understood the participant information sheet sent to them with the recruitment letter. 
A translation service was an option which could have been considered if the measures 
to be used had been validated in several languages although this was not the case, and 
would have been costly and time consuming.   
• Aged 45 or over 
This age limit was set because the risk of type 2 diabetes increases with age (Harris et 
al., 1998), therefore it would be more likely to find those at risk by using this age 
limit. Additionally, this age is used as the earliest age that risk points are assigned to 
an individual on the risk assessment tool used in the current study. No upper age limit 
was set because diabetes risk does not decline again at a particular age, but also to 
maximise recruitment.  
• No previous diagnosis of diabetes or pre-diabetes 
Due to the nature of the research, participants were required not to have had a 
diagnosis of diabetes or pre-diabetes as the purpose was to screen for these conditions 




Setting - Choice of dental practice 
Data collection took place at two different locations over 118 days during September 2013 
and March 2014 and between January 2015 and May 2015. There was a gap in data 
collection when moving and setting up the research study from one dental practice to the 
other and whilst the researcher was on maternity leave. An NHS dental practice in South East 
London, and an NHS dental practice in Staffordshire were recruited to take part in the 
research. Both dental practices had three Dental Practitioners seeing both NHS and privately 
paying patients during the recruitment period. They both conducted routine dental work as 
well as cosmetic dentistry, whilst the practice in Staffordshire also had a Hygiene Therapist.   
Dental practices were recruited through opportunistic sampling. Firstly, dental practices in 
the South East were contacted through professional contacts within the Dental Institute at 
King’s College London. A dental practice in Catford, South East London was recruited first. 
A second dental practice was recruited in Stone, Staffordshire after contacting dental 
practices in the area through an information letter containing a reply slip where the Principal 
dentist or practice manager could return to register their interest in their practice participating 
in the research. The remaining participant sample was recruited at this practice. There was 
difficulty in recruiting dental practices, hence why there were only two practices involved in 
the study. Though more than fifty dental practices were contacted to participate in London 
and in Staffordshire, it was thought that the idea of research being conducted within a 
potentially busy primary care dental setting would be off-putting to dental practice owners; 
and this was confirmed when two potential practice owners replied to our information letter 
via the reply slip saying just this.  
 
Recruitment 
Quantitative phase of study 
Patients were identified by dental practice staff through inspection of medical records, to 
ensure that they did not have diabetes, were English speakers and were aged 45 and over. 
Those who met these inclusion criteria and were soon to be attending for their general dental 
appointment were sent a letter of invitation and an information sheet explaining the nature of 
the research, inviting them to take part at their next appointment (see appendix 3).  Due to the 
practice demands, it was not always possible to check the medical records for a history of 
diabetes or proficiency in English, therefore in some cases, in the first instance, the age limit 
was the only criterion used when sending invitation letters. The only negative impact this had 
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on the research was that some dental patients who had diabetes arrived for their appointment 
were unable to participate, thus recruitment letters were sent out needlessly in some cases. 
Overall, this did not happen that often, but when it did, the researcher was only met with keen 
interest from dental patients that such research was being conducted.   
 
Due to additional interest from people who had not been formally invited to participate 
through the recruitment letter i.e. those patients scheduling appointments after recruitment 
letters were sent, the recruitment method was amended through a minor amendment approved 
by the National Research Ethics Service to include patients who were in clinic on the day of 
data collection who expressed an interest in partaking in the study but who had not received 
the information sheet in the post to read before they arrived at their appointment. This 
amendment to the recruitment method was made to allow for a more satisfactory patient 
experience; in that those patients who were interested in the study were able to take part in 
research that they were eligible for, and could receive screening for diabetes at no extra cost. 
Recruiting additional participants this way was not considered problematic as dental patients 
were still only recruited if they met the inclusion criteria, read the information sheet and 
provided informed consent.  The amendment also meant that the sample would be more of an 
accurate representation of the patient population who attended the practices (rather than 
limited to those with a long-standing booked appointment).   
 
Qualitative phase of the study 
In order to collect qualitative data, a selection of participants was asked to take part in a semi-
structured interview. Participants were selected using consecutive and purposeful sampling 
whereby it was specified before recruitment the kind of participants needed for interview, and 
then the researcher consecutively recruited those participants as they came along after 
completing the quantitative phase of the study. Once quantitative data was collected for a 
selected participant, they were contacted by telephone to ask for them to take part, being 
reminded and directed back to the participant information sheet which detailed this phase of 
the study. The purposeful sampling matrix specified a variety of risk score participants were 
needed, from those who did or did not have the second screening test conducted and those 
who did or did not visit their GP for follow up diagnostic test if needed. Having participants 
who fell into each of these categories meant that rich qualitative data could be compared 
between and within different participants with similar and different experiences. Participants 
could have been recruited via several other methods such as convenience sampling or 
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theoretical sampling but recruiting consecutively and purposefully was seen as the best 
recruitment method here so that the data would contribute to the specific topic of the 
questions, and to ensure that participants with a varied FINDRISC score were captured and 
those who did and did not attend for GP follow up to contribute different perspectives and 
experiences. Data collection continued until it reached saturation, where no new information 
was collected, and no new themes were identified.  
 
Dentists were also asked to participate in the qualitative phase of the study. They were 
recruited via convenience sampling due to the small number of dentists working in the two 
dental practices where dental patients were recruited from. After all quantitative data had 
been collected from dental patients, dentists were approached and asked if they were 
available to be interviewed about the screening intervention that had been conducted. They 
gave verbal consent when the interview commenced and was recorded.   
The interview schedule can be found in appendix 4.  
 
Equipment and measures 
Check Diagnostics A1c Now+ Multi-test A1C System -  
The A1c Now+ Multi-test A1C system was used for the instant measurement of a 
participants’ HbA1c. This equipment was selected because it provides individual testing of 
HbA1c outside of the laboratory. Due to recent calls for HbA1c to be used for diabetes 
screening (Saudek et al., 2008) and the ease of use, the kit was deemed suitable. Each kit 
provided 20 tests. A lancet was used to draw blood from the finger. A droplet of blood was 
then collected using the blood collector provided and the whole thing was then inserted into 
the sampler body which contains the solution to analyse the sample. Once this was mixed by 
shaking the unit, a test cartridge was inserted into the monitor, and once it is ready, the 
sampler body dispenses the diluted sample onto the test cartridge. The kit then took five 
minutes to analyse the blood sample, after which time the participants HbA1c result is 
displayed as a percentage. A1CNow+ is accessible, accurate, and easy to use (Bode, Irvin, 
Pierce, Allen, & Clark, 2007). Study results with health care professionals showed that the 
laboratory accuracy of A1CNow+ with finger stick samples was, on average, 99%. This 
means that, on average, a true 7.0% A1C could read approximately 6.9% A1C. An individual 
A1CNow+ result may differ by as much as –1.0 to +0.8% A1C from the true result. The 
A1CNow+ is National Glycohemoglobin Standardisation Program certified (Leal & Soto-
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Rowen, 2009). Good correlations have been seen between the A1CNow+ and laboratory 
values with a correlation coefficients ranging from r = 0.893-0.989 (Arrendale, Cherian, 
Zineh, Chirico, & Taylor, 2008; Knaebel, Irvin, & Xie, 2013; Leal & Soto-Rowen, 2009).    
 
Demographics Questionnaire -  
A demographics questionnaire was designed to collect participant information such as 
gender, ethnicity, age, and GP information. This information was required for statistical 
purposes and so the GP of the participants’ who took part could be contacted to inform them 
of their patients’ involvement in the study and of their screening results (see appendix 5).  
 
FINDRISC Questionnaire -  
The FINDRISC questionnaire (Lindstrom et al., 2003) was selected as a suitable personalised 
diabetes risk assessment tool to use in the study (see appendix 6). Noble et al. (2011) judged 
the FINDRISC to be one of the most promising for use in clinical or public health practice. In 
contrast to other risk assessment tools such as the QDScore, intended for use by general 
practitioners, FINDRISC was developed as a population screening tool intended for use 
directly by lay people, and assesses a person’s risk of developing type 2 diabetes in the next 
10 years. Whilst the QDScore is composed entirely of data items that are routinely recorded 
on general practice electronic records (including self-assigned ethnicity, a deprivation score 
derived from the patient’s postcode, and clinical and laboratory values) (Hippisley-Cox et al., 
2009), the FINDRISC consists of 8 questions, asking about age, BMI, waist circumference, 
use of blood pressure medication, history of high blood glucose, physical activity, family 
history of diabetes, and daily consumption of fruit, vegetables and berries. It is scored 
between 0 and 26; scores of less than 7 suggest a person is at a low risk of developing 
diabetes; just 1 in 100 is estimated to develop diabetes in this risk category. Scores between 7 
and 11 put an individual at a slightly elevated risk, with 1 in 25 people estimated to develop 
the disease. Scores between 12 and 14 put an individual at a moderate risk where it is 
estimated that in in 6 people will develop diabetes. Scores between 15 and 20 put an 
individual at high risk where it is though that 1 in 3 will develop diabetes, and scores of 20 or 
higher put a person at a very high risk with a 1 in 2 chance of developing the disease (see 
appendix 7 for scoring sheet). In a review of risk tools, it was concluded that the FINDRISC 
tool was currently the best available tool for use in clinical practice in Caucasian populations 
(Schwarz et al., 2009). Janghorbani and colleagues also reported that the FINDRISC showed 
a reasonably good ability to predict MetS in a cohort of first-degree relatives of patients with 
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T2D, with an area under the ROC of 65% (Janghorbani, Adineh, & Amini, 2013). At the time 
of designing the study, research suggested that further testing be conducted in participants 
with a FINDRISC score of 10 or higher (Tankova, Chakarova, Atanassova, & Dakovska, 
2011).  
 
An extra item asking participants about their views regarding the routine use of the measure 
in dental settings was added with a 6-point likert scale ranging from 0 to 5, not at all useful to 
extremely useful, respectively. This was added to give a simple rating of a participant’s view 
of the usefulness of the questionnaire.  
 
Height and Weight Equipment -  
A mobile stadiometer was used to accurately measure a participant’s height, and a set of 
digital scales was set up to check their weight so that the researcher could accurately check 
these measurements to calculate BMI, rather than rely on self-report. 
 
Tape Measure –  
A flexible tape measure (with centimetre units) was used to measure waist circumference. 
Starting at the top of the hip bone, the tape measure is bought all the way around level with 
the naval, ensuring it is not too tight and that it is straight. Again, this was checked rather 
than relying on self-report or trouser measurement.   
 
Extended Parallel Processing Model (EPPM) questionnaire-  
EPPM variables were measured using a 29-item questionnaire called ‘your views about 
diabetes and diabetes screening’, based on a scale previously used to assess PMT constructs 
in relation to screening for cervical cancer (Orbell & Sheeran, 1998), but adapted specifically 
for this study to assess beliefs surrounding diabetes and diabetes screening (see appendix 8).  
The questionnaire consists of 8 sub-scales, representing components of the EPPM (perceived 
severity of diabetes, perceived vulnerability to diabetes, fear of diabetes, rewards which may 
results from failing to attend their GP for a blood glucose test, barriers which may prevent 
attendance at their GP for a blood glucose test, belief that a blood glucose will help identify 
diabetes and reduce diabetes-related complications and perceived ability to attend their GP 
for a blood glucose test, and intention to attend their GP for a blood glucose test).  
Participants were asked to what extent they agreed with each statement (e.g. "The benefits of 
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having a blood glucose test outweigh the costs"; "I am unlikely to have diabetes") on a 5-
point likert scale ranging from 'strongly agree' to 'strongly disagree'. Item scores in each sub-
scale were summed to produce a total score for each EPPM component (for scoring, see 
appendix 9). The reliability of the questionnaire was assessed using Cronbach’s alpha.  
 
Centre for Epidemiologic Studies for Depression (CES-D) Scale - 
The CES-D Scale (Radloff, 1977) was used to screen participants for low mood (see 
appendix 10). A depression scale was selected for use in this study because mood, in 
particular low mood has been shown to be a reliable predictor of screening attendance 
(Calderwood, Bacic, Kazis, & Cabral, 2013). The CES-D scale is a short self-report scale 
designed to measure depressive symptomatology in the general population. The items of the 
scale are symptoms associated with depression that have been used in previously validated 
longer scales (Radloff, 1977). The new scale was tested in household interview surveys and 
in psychiatric settings and was found to have very high internal consistency and adequate 
test- retest repeatability. It is also freely available to use in the public domain. The 20 item 
scale asked participants about their mood over the past week, for example, “I felt happy” or 
“I felt lonely”.  Scores over 16 indicate mild depression, scores over 27 are indicative of 
major depression. A cut-off score of 16 was used in the study and the GP of participants 
scoring 16 or over were informed of the result (for scoring sheet, see appendix 11).  
 
Interview schedule –  
An interview schedule was developed of questions to explore further a participant’s views 
about screening, the process, receiving their risk result, and if appropriate any views about 
further screening and health behaviours. The aim of the questions was to collect insight into 
the views of patients to help understand better the reasons that prompted people to engage in 
screening and their reaction to the screening measures exposed to in the study. The intention 
was to additionally understand why people did or did not attend for subsequent screening at 
the GP and to contribute to the theoretical understanding of screening uptake in practice; a 
bottom up method to find out what people said actually motivated then to attend or not attend 
the GP, as opposed to what was predicted by psychological variables; by a top-down method 
which would find out the percentage of variance that is explained by a set of predictor variables.  
An interview schedule was also developed of questions to explore the views of dentists on the 




Digital recorder / Dictaphone - 
A Dictaphone was used to accurately record the telephone interviews in order to allow 




Data collection Procedure 
Figure 1 below shows the flow of participants through the enrolment process, the quantitative 
phase of the study and then into the qualitative phase. 
  





On arrival, participants wishing to take part were asked to read the patient information sheet 
and subsequently gave written informed consent if they wished to take part (see appendix 12 
and 13, respectively). They were then asked to complete a demographics questionnaire and 
part of the FINDRISC questionnaire (Qs 4-8). The researcher then completed Qs 1-3 of the 
FINDRISC with the participant by measuring the participants’ height and weight in order to 
calculate their BMI and took their waist measurement. The participant then proceeded to see 
the dentist for their routine appointment. At the end of their appointment, the participant 
returned to the researcher to receive the result of the FINDRISC questionnaire. The 
individualised risk result was fed back to participants using a pre-prepared verbal script (see 
appendix 14) and a written risk sheet, both of which were developed following the result of 
the systematic review described in chapter 3.  Participants were given their individualised risk 
score, their risk category and subsequent absolute risk that was linked to being in a particular 




 If the participant scored less than ten on the FINDRISC they were debriefed about their low 
risk result, reassured and thanked for their participation. The participants' GP was informed 
of their participation and of the outcome.  
 
If the participant scored ten or more on the FINDRISC (a positive result) their risk result was 
explained, and they were subsequently offered an HbA1c test using the A1c NOW+ kit. 
Those participants wishing to receive the HbA1c test were informed about the test by a 
member of the research team who then administered the HbA1c test in a private office. If a 
participant did not wish to have the HbA1c test, they were fully debriefed, thanked for their 
participation, and because of their risk result, were advised through a standard letter to visit 
their GP for a blood glucose test (Appendix 15). Further information on diabetes was 
provided. The participants' GP was informed of their participation and a blood glucose test 
was sought by letter (see appendix 16). 
 
Participants who had the HbA1c test and showed a normal HbA1c reading (<6%) were 
informed of what their result meant, but due to the high risk result on the FINDRISC, were 
still advised in person and through a debrief sheet to visit their GP for a blood glucose test. 
Participants who showed an elevated HbA1c reading (>6%) were also informed of what their 
result meant, and were also advised in person and through a debrief sheet to visit their GP for 
a blood glucose test (see appendix 15). Their GP was also informed of the patient’s 
FINDRISC and HbA1c results through a standard letter, and a blood glucose test was 
suggested (see appendix 16). 
 
Participants who were identified as at risk of developing diabetes through either the 
FINDRISC alone or through the HbA1c test as well, were asked to complete a bundle of 
questionnaires comprising of the mood measure (CES-D scale) and the psychological 
measure assessing constructs of the Extended Parallel Process Model (EPPM). Participants 
were asked to complete the measures at the dental practice, but if they declined, they were 
offered the chance to complete them at home and return them to the researchers in the 
freepost envelope provided. If the participant scored 16 or higher on the CES-D scale, their 
GP was sent the standard CES-D referral letter to inform them of their patient’s risk for 
clinical depression (see appendix 17).  Additionally, a referral letter was sent to the GP if a 




One month after the receipt of an ‘at risk’ result, participants were contacted to determine 
whether they had contacted their GP for a blood glucose test and what happened as a result of 
this contact. The researcher made a note of their responses.  
 
For those participants who indicated that they had not visited their GP, this telephone call 
often acted as a reminder to contact their GP regarding further glucose testing.  One month 
after this reminder, those participants were contacted again and their attendance at, and 
outcome of the recommended blood test was noted (see appendix 19 for follow-up call 
script).  
 
Three months after the ‘at risk’ result, the researchers contacted the GP’s of those participants 
who were asked to attend for a blood glucose test in order to verify any contact made and to 
obtain a definitive diagnosis. A standard letter was sent to GP’s requesting the information to 
support any self-report data collected from the participant (see appendix 20). 
 
For patients eligible for the qualitative study, the researcher contacted the participant via 
telephone to arrange a suitable time to conduct the telephone interview. Dental patients were 
recruited using purposive sampling. It was specified in advance the type of dental patients 
that were needed, therefore a method of quota sampling was used. Patients of both low and 
high risk were needed for sampling and of the high risk patients, both those who attended for 
GP follow-up and those that did not were required. Therefore, participants meeting these 
selection criteria were consecutively recruited as they came through the screening programme 
once they had completed the quantitative stage of the study. Using this method of sampling 
allowed for participants in each of the subgroups to be sampled.  
 
The participant was informed that the interview was being recorded and they gave additional 
verbal consent after giving written consent earlier in the study. The interview followed the 
structure of the interview schedule, and once all questions had been answered, the participant 
was thanked and the interview recording was stopped. All participants were interviewed over 
the phone and the data was recorded using a Dictaphone. Data was transcribed verbatim 
immediately after each interview was conducted. It was then played back and checked against 




The interviews took place over the telephone for dental patients. Semi-structured interviews 
were conducted and recorded using a digital voice recorder. Questions were open-ended and 
asked dentists and patients about their experiences of the screening programme conducted 
Question format was designed to use open-ended descriptive questions which were not fixed 
but were allowed to develop as a result of the exchange between the participant and the 
researcher.  
 
Dentists eligible for the qualitative phase of the study were invited to participate in a face-to-
face interview. GDPs were sampled opportunistically; other sampling methods were 
considered such as random sampling and snowball sampling, but due to the small number of 
practices and subsequently, the small number of GDPs where the screening programme was 
carried out, these methods were not possible.  After agreeing, they were informed that the 
interview was being recorded and they gave verbal consent. The interview followed the 
structure of the interview schedule, and once all questions had been answered, dentists were 
thanked and the interview recording was stopped. Data was transcribed verbatim immediately 
after each interview was conducted. It was then played back and checked against the 
transcription notes to ensure its accuracy.  
 
Risks of the Study 
There were no additional risks or burdens other than the need to complete the questionnaire 
bundle after the dental appointment and receive the finger-prick HbA1c blood test. The 
receipt of personalised risk information may have caused some worry to several participants, 
nevertheless, patients were given the time to discuss how they felt about their risk of diabetes 
with a member of the research team and were also be given details of the research team for 
further contact, if they felt it necessary. 
 
Incentive and Benefits 
Although there was no monetary incentive, participants were given the opportunity to be 
screened for diabetes whilst attending for a routine dental appointment which they would not 
usually have been offered. Therefore, there was a potential benefit for early detection, 





Participant data were stored on encrypted secure electronic media. A separate file recording 
participant contact details was protected by password. All personal data of participants were 
stored on password protected computers at the University. Paper copies of questionnaire data 
were stored in secure locked filing cabinets in a locked office.  Personal data held on 
password-protected university computers, were anonymised. 
 
Research Ethics 
The study was reviewed and given a favourable opinion by the National Research Ethics 
Service Committee West Midlands- Black Country in August 2013. The letter giving 




IBM SPSS Statistics© Version 22 (Statistical Package for the Social Sciences) was used to 
analyse the quantitative data. All of the data were inputted into one dataset. 
 
In order to determine how many participants were needed for the study, a sample size 
calculation was performed on the primary outcome. A prevalence rate of 10% for diabetes 
and pre-diabetes was assumed based on published prevalence of diabetes of 5% and an 
assumed prevalence of pre diabetes of another 5%. Additionally, published data evaluating 
the FINDRISC as a screening tool and demonstrating specificity and sensitivity of the 
FINDRISC of .7 was considered (Tankova et al., 2011). N=520 participants were therefore 
needed so that we could expect N=176 participants to be at risk and needing to be referred to 
their GP for a diagnostic test. This sample size would then allow for approximately 80% 
power, and around a probability of .05 of participants actually attending the GP for a 
diagnostic test. 
 
Data was screened and preliminary analyses relating to parametric assumptions for particular 
tests were conducted. Descriptive and inferential statistics were used to address all 
quantitative research questions. Frequencies were used to calculate the number of people 
participating in screening, and to calculate the number of those at risk of diabetes based on 




Descriptive statistics were used to calculate the proportion of patients who attended the GP 
after being advised to do so as a result of their risk result. Pearson’s Chi square test was used 
to determine if attendance at the GP was informed by the type of test taken, or the test result. 
 
Participants were only referred to their GP if they had a positive risk result (that being ≥10 on 
the FINDRISC measure and either no result or any HbA1c result from the finger prick 
measure). Therefore, not all of the study sample data needed to be analysed to answer the 
research question. However, in order to conduct the chi square test, a 2 x 2 contingency table 
needed to be created, therefore, the categorical predictor variable; patients referred to their 
GP needed to have two categories, and so did the categorical outcome variable; GP 
attendance. The two categories for the predictor variable were, GP referral based on a risk 
result from a positive FINDRISC measure alone (≥10 on the FINDRISC measure and either 
no result or < 5.7% result from HbA1c finger prick measure), and GP referral based on a risk 
result from a positive FINDRISC and positive HbA1c measure (≥10 on the FINDRISC and > 
5.7% from HbA1c finger prick measure). It was decided that these two categories were of 
interest to see if having either one or two positive risk screening results would have an effect 
on whether participants went to see their GP as advised. Therefore, the predictor variable was 
called patient risk result. The outcome variable also had two categories. In order to analyse 
the data on GP attendance, it was necessary to combine data that had been collected from 
participants and their GP. One overall outcome variable was created; Contact made with GP; 
this therefore had two categories; yes – contact made and no- no contact made. This outcome 
variable was created by combining patients’ self-reported response to whether they had seen 
their GP and responses made from contacting GPs to find out what the outcome of our 
referral was, if there was data from both the patient them self and the GP. In some cases, 
there was only self-report data, and in others, only the GPs response. Therefore, in some 
cases there was no option but to rely on the self-report data despite its drawbacks.  Where 
there was a response from both patient and GP, it was checked whether both responses 
corroborated. In cases where they didn’t, the GP response was taken as correct.  
This variable yielded several kinds of responses ranging from participants having made no 
contact at that point, having an appointment in the near future, having seen the GP and now 
awaiting blood tests, to having seen the GP and had diagnostic test results back and having 
seen the GP who advised it not necessary to follow up the screening with diagnostic tests. 
The latter response made it difficult to code the data; the participants had in fact followed the 
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recommended advice to see their GP, however, the GP did not conduct a diagnostic test. 
Therefore, it was decided that some level of GP contact, whether it be having made an 
appointment to see the GP or having had an appointment or had a diagnostic test was 
acceptable as having followed the advice to see the GP following the screening tests 
conducted at the dental practice. The outcome variable was renamed; Contact made with GP.   
 
To assess the psychological profile of those at risk of developing diabetes, the psychological 
variables measured were CESD scores, a measure of depression, and EPPM variables: fear, 
intention, self-efficacy, severity, vulnerability, response costs, response efficacy, and rewards 
for maladaptive response. Data for these variables were only collected from dental patients 
who were at risk of developing diabetes following the screening tests conducted. Therefore, it 
was not possible to compare those patients at risk to those not at risk on these psychological 
variables. Means and SDs and minimum and maximum values were reported. To assess any 
apparent differences inferentially, independent samples t-tests were conducted to compare 
those who contacted their GP for diagnostic testing with those who didn’t, on these 
psychological variables.   
 
In order to predict whether any of the study variables were predictors of patient contact with 
the GP following a positive risk screening result, a binary logistic regression was conducted. 
Logistic regression is used when an outcome variable is categorical as opposed to continuous 
as with multiple regression, and predictor variables that are either continuous or categorical 
(Field, 2013). Binary logistic regression predicts which of two categories a person is likely to 
belong to given certain other information; in this case whether someone is likely to make 
contact with their GP based on psychological variables.  
 
Following statistical advice, a stepwise regression method was adopted. Stepwise regression 
was deemed appropriate as the study did not have any firm theoretical predictions about the 
relative value or importance of each of the predictors used here. Therefore, the order of the 
predictor variables was entered into the model was based on mathematical criteria conducted 
in SPSS. The predictor variables were entered using the backward likelihood ratio method as 
follows: CES-D score, and the eight EPPM variables; fear, intention, self-efficacy, severity, 
vulnerability, response costs, response efficacy, and rewards for maladaptive response. The 
backward method begins with all predictors included in the model and removes predictors if 
their removal is not detrimental to the fit of the model. When using the stepwise method, the 
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backward method is preferable because forward methods are more likely to exclude 
predictors involved in suppressor effects (Field, 2013). The outcome variable was, contact 
made with GP.   
 
The psychological measures were assessed for internal consistency. Cronbach’s alpha was 
performed on the CES-D scale and each of the subscales on the EPPM measure. Cronbach’s 
Alpha could not be calculated for the EPPM Severity subscale as this subscale only had one 
item. Cronbach’s α for each scale and subscale calculated are reported in chapter 5. 
 
Qualitative analysis 
Question format was designed to use open-ended descriptive questions which were not fixed 
but were allowed to develop as a result of the exchange between the participant and the 
researcher. 
Inductive thematic analysis was used to analyse the individual interview transcripts. Thematic 
analysis is a method for identifying, analysing and reporting patterns within data (Braun & 
Clarke, 2006). In contrast to qualitative analytic approaches such as interpretative 
phenomenological analysis or grounded theory, thematic analysis is not wedded to any pre-
existing theoretical framework (Braun & Clarke, 2006).  
 
Analysis of the interviews followed closely the six phase process outlined by Braun and 
Clarke (2006), which involved familiarising oneself with the data, generating initial codes, 
searching for and reviewing themes, defining and naming these themes, and finally producing 
the reports. The themes were checked by another member of the research team to ensure 
credibility of the interpretation and validated through discussion and reading through the 
transcripts. Once themes had been identified for both dentist and patient data, they were 
combined for discussion purposes where similarities existed between both sets of themes. 
This was simply done by linking similar themes and discussing both in the same context.  
 
This approach was adopted as the overall aim of the study was to explore dentists and 
patients views and experiences and therefore it represents a useful tool through which 
patterns and themes within the dataset can be identified and described. 
Other analytic methods of qualitative data analysis such as Grounded theory and 
Interpretative Phenomenological Analysis were considered. However, whilst these two 
methods seek patterns in the data, they are theoretically bounded. In the current study, the 
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aim was not to develop a new theory. Therefore, inductive thematic analysis was used from a 
realist/ essentialist epistemological point of view as opposed to a constructivist point of view 
because experiences and meanings of the participants were to be gathered. In order to 
undertake the inductive analysis at the semantic level the responses to the questions were 
transcribed, read and re-read, with dominant and contrasting features of the data being coded 
manually.  
Themes were generated to form links between the separate codes and reviewed to check for 
consistency by KB. Final themes were then produced upon further refinement and discussion 
with KA. In undertaking the analysis, it was found that the data generated by the respondents 
was sufficient to allow theoretical saturation to take place and for all the themes to be well 
formulated. To ensure the credibility of the qualitative research, once the themes had been 
formulated, the transcribed data was re-read and checked again with the themes created in 
mind. Ideally, this would have been conducted by a second, independent researcher, but there 
were insufficient resources for this. As the screening, interviews and analysis were conducted 
by one researcher, a reflexive commentary was written and included in the discussion of this 
chapter. Credibility could have also been assessed by using member checking, whereby 
participants’ judge how well the results describe the participants’ perspective. The researcher 
aimed to enhance transferability of the qualitative data by clearly describing the research 
context and the assumptions that were central to the research so that the results might be 
generalizable.  
Themes or patterns within data can be identified in one of two primary ways in thematic 
analysis: in an inductive or ‘bottom up’ way, or in a theoretical or deductive or ‘top down’ 
way (Braun & Clarke, 2006). Inductive thematic analysis was used here because an inductive 
approach means the themes identified are linked strongly to the data themselves (Patton, 
1990), and is a process of coding the data without trying to fit them into a pre-existing coding 
frame, or the researcher’s analytic preconceptions (Braun & Clarke, 2006). It is also a useful 
method due to its flexibility and theoretical freedom, along with its ability to create a detailed 
account of data (Braun & Clarke, 2006).  
 
Finally, for the purpose of a discussion of the findings from the current study as a whole, the 




In summary, this thesis used quantitative methods to explore RQ 2-6, and qualitative methods 
to explore RQ7. Chapter 5 that follows reports on RQ2, 3 and 4, chapter 6 report of RQ5 and 





Uptake of Screening for Diabetes Risk in General Dental Practice, and the effect of diabetes 
risk communication on subsequent health behaviour. 
 
 
Background to the Chapter 
The literature review in chapter 2 highlighted the fact that screening for diabetes is likely to 
bring about benefits rather than cause psychological harm. It was further argued that 
screening in non-traditional settings such as the opticians and the dental practice was an 
option that might be acceptable to patients seen in that setting.  It was also argued that 
screening for diabetes can be done in either invasive or non-invasive ways, however the use 
of both measures and the uptake of each in non-traditional, dental settings has not yet been 
explored. Chapter 3 then systematically reviewed literature in the area of risk communication 
to find the best possible way to communicate the risk of diabetes to dental patients so that if 
advised to do so, they followed up screening with a diagnostic test at their GP practice.  
 
This chapter presents data on the uptake of diabetes screening by dental patients at the dental 
practice, describes how dental patients are at risk of developing diabetes through receiving 
screening tests. Following an ‘at risk’ diabetes screening result, patients were advised to seek 
a diagnostic blood test from their GP. Health advice is not guaranteed to be followed up or 
accepted by a patient. When a person is faced with a health threat, they must make a decision 
as to whether they will address the risk or ignore it. This chapter examines the extent to 




T2D has become a huge burden for the adult population with ever-increasing prevalence 
(Wild et al., 2004), however, there is no screening programme policy in place in the UK 
despite the fact that detecting diabetes early on is key to health outcomes (Harris & Eastman, 
2000). 
 
Screening for diabetes can potentially allow for early diagnosis and treatment, which can 
prevent diabetes-related complications (Marre & Travert, 2010). Although screening for 
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disease can sometimes have adverse effects on an individual, screening for diabetes has been 
shown not to have any long-term adverse effects (Adriaanse et al., 2004). Therefore, it is 
suggested that screening for diabetes is essential to identify diabetes and importantly, its 
precursors, earlier and more efficiently.  
 
Diabetes can be screened for using a variety of methods; in addition to traditional diabetes 
screening methods such as the Oral Glucose Tolerance Test (OGTT) where patients are 
required to consume glucose and then have blood samples taken afterward to determine how 
quickly the glucose is cleared from the blood, the use of HbA1c as a measure of glycaemic 
control over the past 12 weeks, has also been recommended as a viable means of diagnosing 
diabetes (Saudek et al., 2008). Although an invasive test, as it requires a sample of blood, 
fasting is not needed for A1C assessment and no acute perturbations (e.g., stress, diet, 
exercise) affect A1C. A1C is said to capture chronic hyperglycemia better than two 
assessments of fasting or 2-h oral glucose tolerance test plasma glucose, it is better associated 
with chronic complications than FPG (Bonora & Tuomilehto, 2011). However, diabetes is 
clinically defined by high blood glucose and not by glycation of proteins, and within-day 
biological variability of plasma glucose might unveil disturbance of glucose metabolism 
(Bonora & Tuomilehto, 2011).  
 
Furthermore, whilst traditionally HbA1c tests require laboratory facilities to take place, the 
recent introduction of point of care measurement through finger prick devices has made the 
measurement of A1c more accessible (Sicard & Taylor, 2005; Wensil, Smith, Pound, & 
Herring, 2013). Point-of-care HbA1c testing systems are relatively new to the market, but 
there are a handful of monitors available for HbA1c evaluation, with the primary advantage 
being the readily available result. Some provide a result within minutes, while others use a 
mail-in laboratory with the result available in days. HbA1c is routinely used for assessment 
of control and treatment rather than as a screening tool for diagnosis (Sicard & Taylor, 2005), 
however, it has practical advantages and is less burdensome than the OGTT, and may 
therefore be associated with a higher participation in screening. One particular study 
investigated the difference in the uptake between 18–60-year-old South Asian Surinamese 
men and women offered screening by means of an HbA1c measurement and those offered 
screening by means of an OGTT (van Valkengoed, Vlaar, Nierkens, Middelkoop, & Stronks, 
2015). Among men and women and across age groups, the authors found a higher response 
and participation among those invited for screening by means of an HbA1c measurement 
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than among those invited for a screening consisting of an OGTT; in line with the assumption 
that a more burdensome test is associated with a lower response (Malkani & Mordes, 2011). 
Ideally, a screening method efficiently identifies people with previously undiagnosed type 2 
diabetes mellitus and, in light of the potential effectiveness of early lifestyle intervention 
(Schellenberg, Dryden, Vandermeer, Ha, & Korownyk, 2013), people at risk of T2D (e.g. 
those with prediabetes). Based on the higher uptake, an invitation for screening by means of 
an Hba1c measurement would seem a better strategy than screening by means of an OGTT 
(van Valkengoed et al., 2015). 
 
Cagliero and colleagues evaluated the improvement in patients’ glycemic control as a result 
of an immediately available HbA1c value (Cagliero, Levina, & Nathan, 1999). The 
improvement in glycaemic control was studied in 200 insulin-treated patients with diabetes 
utilizing a point-of-care monitor. Patients were randomized into 2 groups. One group had the 
HbA1c result immediately available at their visit, and treatment changes were done prior to 
the patient leaving the office. The second group had their HbA1c measured at the laboratory, 
and treatment changes were done via telephone or follow up visit. At the 6-month follow-up, 
the immediate-assay group had statistically significant improvements in their HbA1c values 
(p < 0.01). Sicard and Taylor (2005) compared a point-of-care HbA1c monitor with 
standardised laboratory testing. Twenty-three patients with diabetes were required to obtain 
both a standardised laboratory HbA1c evaluation and a point-of-care A1c Now value within a 
week of each other. Results showed the A1c Now monitor to be well correlated (r = 0.758) 
with the standardised laboratory test. The authors found that the most accurate A1c Now 
values were within a range of 6–8%. However, the results obtained in this study were not as 
positive as those published by the manufacturer of the A1c Now kit. A possible confounder 
may be that participants in the study were allowed up to a 7-day period between HbA1c 
evaluations, therefore, it is unclear how much the value would change within that time. 
 
One particular point-of-care technology is the A1cNow+ test kit. It is a small, portable, 
disposable handheld immunoassay device which is certified by the National 
Glycohemoglobin Standardisation Programme, and is Clinical Laboratory Improvement 
Amendments (CLIA) waived. Requiring no calibration, it uses a small (5μl) blood sample 
that is mixed with a reagent provided with the test kit, and then transferred with a pipette to a 
sample well in the testing device (Bode et al., 2007). Results are then provided in 5 minutes. 
Although some studies have demonstrated that the A1cNow assay results are not comparable 
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to those obtained in laboratory studies (Schwartz, Monsur, Bartoces, West, & Neale, 2005), 
other studies have found a high level of such comparability (Bode et al., 2007). In addition, 
the ease of use of the A1cNow test kit has been examined among both healthcare 
professionals and lay users in achieving accurate HbA1c measurements (Chang et al., 2010).  
 
 
Diabetes is known for its long pre-diabetic period. Research has demonstrated that 
intervention at prediabetic state such as medication or lifestyle modifications can prevent or 
at least delay the progression of the disease, meaning the identification of those at high risk of 
T2D is warranted to allow for timely action to reduce risk (Paulweber et al., 2010). 
Measuring plasma glucose or glycosylated haemoglobin levels has so far been recommended 
methods for screening the general population, however, as well as being invasive, they are 
said to be costly and time consuming and therefore not suitable for mass screening. 
Additionally, because they solely measure glycaemia they may detect diabetes too late when 
complications of the disease are already occurring (Haffner, Stern, Hazuda, Mitchell, & 
Patterson, 1990).   
 
Alternative methods of Screening 
Many attempts have been made to develop simple, fast, non-invasive and practical screening 
tools for identifying those at high risk of developing T2D in the future (Makrilakis et al., 
2011). Validated risk calculators to quickly identify and subsequently follow-up people at a 
high risk of T2D are also now recommended by several international organisations (Alberti et 
al., 2007; Paulweber et al., 2010).  
 
One alternative to an invasive blood test is the validated Finnish Diabetes Risk Score 
(FINDRISC). FINDRISC is a non-invasive screening tool that provides a measure of the 
probability of developing type 2 diabetes over the next 10 years (Lindstrom et al., 2003). It 
has traditionally been used as a predictor of T2D. It is a brief questionnaire consisting of 
several questions about variables correlated with the risk of developing diabetes: age, body 
mass index (BMI), waist circumference (WC), physical activity, dietary consumption of 
fruits, vegetables, and berries, use of antihypertensive medication, history of high blood 
glucose, and family history of diabetes. FINDRISC has been successfully implemented as a 
practical screening instrument to assess diabetes risk and to detect undiagnosed T2D in 
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European populations (Tankova et al., 2011; Wang, Stancakova, Kuusisto, & Laakso, 2010; 
Witte, Shipley, Marmot, & Brunner, 2010), and its reliability and validity have been clearly 
established (Gomez-Arbelaez et al., 2015; Janghorbani et al., 2013). 
 
Screening for diabetes in the dental setting 
Opportunistic screening is carried out at a time when people are seen by health care 
professionals, for a reason other than the disorder in question. Screening for diabetes can be 
carried out in various health settings (Howse et al., 2011b). As diabetes is recognised as a 
significant risk factor for serious, progressive periodontal disease (Southerland et al., 2005) 
and as periodontal disease may contribute to the progression of impaired glucose tolerance to 
diabetes (Dunning, 2009), the dental setting seems like a plausible context for the 
identification of people at risk for diabetes. Additionally, dentists have an important role in 
detecting and preventing oral and systemic diseases both because of their diagnostic and 
screening abilities and the frequency of patient visits (Tavares et al. 2012). 
 
Recent research from the US has examined the usefulness of screening for diabetes in dental 
settings. Four US studies (Bossart et al., 2016; Genco et al., 2014; Greenberg, Kantor, Jiang, 
& Glick, 2012b; Herman et al., 2015) reliably supported the notion that screening for pre-
diabetes and diabetes using a combination of invasive and / or self-report methods was 
feasible, acceptable to patients and the dental team and effective in US dental offices. 
 
In the U.K., dental surgeries are highlighted in the 2012 NICE guidance Preventing type 2 
diabetes: risk identification and interventions for individuals at high risk, as a suitable setting 
in which to encourage people to have a T2D risk assessment. Dentists already offer lifestyle 
advice to their patients as part of a preventive package of care. By extending this to cover 
general healthy eating and activity advice a broader reach of effect is offered to the patient; 
thereby addressing not only their oral health but also behaviours which may increase risk of 
type 2 diabetes and cardiovascular disease through the common risk factor approach. Dentists 
are not going to diagnose or treat a systemic disease but early detection will result in better 
medical and dental outcomes and it is the dentist’s role to help reduce the incidence and 
adverse impact of diabetes (Ali & Kunzel, 2011). When screening is only opportunistic, the 
screened positive cases are usually subjected to undergo confirmatory tests by different 
methods to confirm the diagnosis. But, whether the individual will return another day to 
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undergo the said tests is uncertain (Savitha, Gopalakrishnan, Umadevi, & Rama, 2016). In a 
recent UK study, Wright and colleagues were the first to assess the feasibility of 
implementing a T2D risk screening pathway in dental settings using the NICE guidance tool. 
The validated tool in the NICE guidance was used to determine risk. This included a 
questionnaire and BMI measurement used to determine a risk score. Patients were rated low, 
increased, moderate or high risk. A total of 166 patients took part in the pilot; twenty-six low 
risk patients (15.7%), 61 increased risk patients (36.7%), 49 moderate-risk patients (29.5%) 
and 30 high-risk patients (18.1%) were identified. The findings suggested that people at risk 
of developing T2D could be identified in primary, community and secondary dental care 
settings (Wright et al., 2014). However, notwithstanding the manpower challenges facing 
dental teams and the fairly low uptake of further screening by patients, the identification of 
diabetes in dental practices was possible. One explanation for the low uptake of further 
diagnostic testing in this study could be the fact that patients tend to judge the severity of the 
illness by cues such as the complexity of the diagnostic tool used, In the case of diabetes in 
particular, previous work (Parry et al., 2006) showed that diabetes patients used their 
diagnosis journey to judge how serious their diabetes was; the more complex the diagnosis, 
(where for e.g. the diagnosis was made by a hospital consultant rather than a GP) the more 
serious patients thought their diabetes was. 
   
On the basis of these findings, supplementing a self-report diabetes risk assessment with a 
more invasive, instant HbA1c blood test might be an acceptable method of diabetes screening 
in UK dental practices. The extent to which this is the case however, remains unexplored. 
The number of screening tests conducted or the more invasive the screening test it, might 
influence how serious they perceive their risk to be and whether that person sees their GP 
following screening. 
 
The previous study also only followed up patients four weeks after the initial screening tests. 
Considering the length of time it can take to get an appointment at the GP surgery, this short 
follow up period might not have been able to capture all those who might not have had an 
appointment yet. Additionally, follow up in the previous study relied solely on self-report of 
patients which might not be accurate. Finally, the detail as to how diabetes risk was 
communicated to patients was not detailed in the previous study’s methods therefore it is not 





The study aimed to screen patients for diabetes whilst attending their routine dental 
appointment. Screening was conducted initially by a questionnaire, which aimed to assess a 
person’s risk of developing diabetes and if necessary, a further screening test measuring a 
participant’s HbA1c was offered, to further identify individuals at risk for developing 
diabetes. It is important to communicate the risk of diabetes to the individual in an effective 
way to maximise the chance that individuals will follow up the initial screening with further 
diagnostic tests in General Practice. Since the systematic review described in Chapter 3 
identified certain individualised risk communication strategies that appear to increase 
screening uptake and its psychological predictors, these strategies were used to communicate 
individualised diabetes risk to individuals attending dental practices for routine dental 
appointments and diabetes screening were utilised. 
 
 
This study builds on recent work in the field by assessing dental patients’ risk of developing 
diabetes through a non-invasive self-report questionnaire; the FINDRISC, and whether if 
offered an invasive ‘point of care’ HbA1c blood screening test they accept.   
 
The objective of this study was to determine the uptake of patients using the Finnish Diabetes 
Risk Score (FINDRISC) and HbA1c information as preliminary screening tools in general 
dental practice, in screening for possible diabetes, and determine the number of patients at 
risk of diabetes. Further, the study also aimed to explore whether those participants who were 
advised to see their GP for a diagnostic test following an increased risk result from the 
FINDRISC screening measure alone or the FINDRISC and HbA1c screening measures 
followed the recommendation to did so. In doing so, the study aimed to answer the following 
research questions in bold as set out in the PhD aims and objectives (Chapter 1): 
 
1. What is the most effective way to communicate individualised risk information to 
increase screening participation or its psychological predictors?  
2. What proportion of dental patients accept an offer to be screened for type 2 
diabetes in a primary care dental setting? 
3. What is the risk of type 2 diabetes in primary care dental patients as assessed 
through self-report and physiological measures? 
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4. What is the effect of personalised diabetes risk communication on subsequent 
health behaviours? 
5. What is the psychological profile of patients at risk of diabetes? 
6. To what extent do psychological variables predict post-screening further testing or 
health behaviours? 
7. What are patients’ and dentists’ views on screening for diabetes in dental settings, and 

























































The image above represents the part of the study that is applicable to this chapter and is 
highlighted in yellow.  
 
Results: 
The results below are set out by research question. The results demonstrate the number of 
dental patients who consented and agreed to be screened for diabetes when attending a 
routine dental appointment. It also reports the risk of diabetes in those participating and 
completing the screening measures. Finally, results are presented on the number of 
participants attending their GP practice for subsequent follow-up diagnostic tests. 
 
Research question 2  
What proportion of dental patients accept an offer to be screened for type 2 diabetes in 
a primary care dental setting? 
 
Data were collected on the number of people who were eligible to take part in the study.  
These data appear in a flow chart, as Figure 1 in chapter 4 showing the flow of participants 
through the study.  
 
The data were obtained from two dental practices in two geographically different areas of 
England.  N=244 of consenting participants were recruited from a dental practice in Catford, 
Figure 3-  Flow diagram of study method highlighted to indicate relevant methods for this 
part of the study 
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South East London. N=3700 NHS and private patients were seen by six General Dental 
Practitioners during the nine-month recruitment period. N=1292 patients who were eligible 
for inclusion based on the age eligibility criteria, attended routine dental appointments over 
118 days of recruitment at two General Dental Practices in the UK.  N=59 of these patients 
did not speak fluent English and a further N=162 already had diabetes or Pre-diabetes as 
assessed through dental notes and patient self-report, and were therefore excluded from the 
study. N=515 patients refused to participate whilst N=520 patients agreed to participate, 
consented for screening and completed the FINDRISC screening questionnaire. Reasons for 
refusal to participate included, having a recent blood glucose test, a recent health check-up 
such as the Well Man’s Check arranged through the GP, dental pain and fear, and lack of 
interest in the research. Table 1 below reports the recruitment statistics for two samples of 
participants from Catford, Stone and overall. Looking at the table it would seem that the 
number of participants eligible for participation, those refusing to participate, and those 
excluded by the criteria set were similar between both locations.  
 
Table 3 - Recruitment statistics of the two samples of participants recruited in Catford, Stone, 
and overall. 
Recruitment details  Practice 
 Overall Catford Stone 
Assessed for eligibility (N) 3700 2127 1573 
Declined participation (N) 515 304 211 
Excluded for age (N) 1888 1141 747 
Excluded for history of 
diabetes (N) 
162 91 71 
Did not speak English (N) 59 55 4 
Did not attend (N) 121 68 53 
Missed by researcher (N) 435 224 211 
Consented to participate 
(N) 





Table 4 shows demographic characteristics of the two samples of participants recruited in 
Catford, Stone and overall. N=276 (53.1%) participants consented and participated at the 
dental practice in Stone, Staffordshire. Of the 520 participants, N=374 (71.9%) were NHS 
dental patients, whilst N=146 were non-NHS dental patients. The participant sample 
consisted of slightly more females than males with N=304 (58.5%) female participants. The 
mean age of the sample was 58.8 years, with a range of age from 45 years to 86 years. In 
terms of ethnicity, 73.1% of the sample considered themselves to be White British (N=380). 
Demographic information overall and separately by practice, is given in Table 2 that follows. 
Whist ethnicity information was collected in detail using the recommended ethnic group 
question (The Office for National Statistics, 2015), for the purpose of reporting the samples 
ethnic background, they were grouped into the categories stated by The Office for National 
Statistics (2015).   
 
 
Table 4 - Demographic characteristics of the participants recruited from Catford, Stone and 
overall. 
Demographic characteristic  Practice Sig (p.) 
 Overall Catford Stone  
Age 
M years (SD) 


































Mixed / Multiple ethnic groups 
Asian / Asian British 
Black / African / Caribbean / Black 
British 































Mean FINDRISC Score (SD) 9.92 (4.10) 10.10 (4.48) 9.76 (3.74) .35 















FINDRISC risk score category (N) 
< 7 LOW risk 
7-11 SLIGHTLY ELEVATED risk 
12-14 MODERATE risk 
15-20 HIGH risk 

























Mean HbA1c score (SD) 5.67 (.50) 5.61 (.54) 5.72 (.45) .07 
 
 
On the basis of the results above, it was decided that the data from both locations would be 
combined for the rest of the analysis.  
 
The next section of the results presents data on the risk of diabetes and answers the following 
research question- 
 
Research Question 3  
What is the risk of type 2 diabetes in primary care dental patients as assessed through 
self-report and physiological measures? 
Around half of those recruited [N=261 (50.2%)] scored below the cut-off score of 10 on the 
FINDRISC questionnaire, and therefore were not offered any further screening. N=259 
(49.8%) patients were found to be ‘at risk’ of developing diabetes based on the cut off 
FINDRISC score of 10, and were therefore offered the further screening test, and were 
subsequently referred to their GP for formal diagnostic testing.  
 
Table 5 shows the number of participants who fell into each risk category based on their 
FINDRISC score. The most popular risk category with 47.5% of participants was the slightly 
elevated risk category, where N=247 participants scored 7-11 on the FINDRISC. The mean 





Table 5 - Number of participants and Mean HbA1c score by FINDRISC risk score category 
FINDRISC risk category N Mean HbA1c score 
< 7 LOW risk 
7-11 SLIGHTLY ELEVATED risk 
12-14 MODERATE risk 
15-20 HIGH risk 






TOTAL: 520  
FINDRISC score of ≥10 as current cut 
off for further screening 
259(49.8%) 5.67% 
 
Table 5 shows the number of participants falling into each FINDRISC risk score category. It 
appears that the majority of participants fell into the slightly elevated risk category. When 
using the recommended cut off score available at the time of the study of 10, N=259 scored 
10 or higher and therefore were identified as being at risk of developing diabetes.  
 
Of the N=259 found to be at risk of developing diabetes, N=241 received the further 
screening HbA1c test, whilst N=18 refused this further screening test. Based on cut off 
values, N=123 had an HbA1c of lower than 5.7% suggesting it was unlikely that they had 
diabetes. N=46 were found to be at risk of pre-diabetes with an HbA1c score of between 5.7-
5.9%, N=54 had a score of 6.0% or higher suggesting they may have diabetes. The mean 
HbA1c score was 5.67%. 
 
The final section of the results presents data on the effect that receiving an ‘at risk’ result on 
the screening measures had on participants in terms of their subsequent actions and answers 
the following research question- 
 
Research question 4: What is the effect of personalised diabetes risk communication on 




Based on FINDRISC and HbA1c scores, 259 participants were advised to see their GP for a 
diagnostic test. Of those 259, N=124 had a positive FINDRISC and a negative A1c, N=118 
had both a positive FINDRISC and positive A1c result, and N=17 had a positive FINDRISC 
but refused the A1c test.  
Of N=259 advised to do so, N=155 made contact with their GP, N=93 did not, and there was 
no outcome data for N=11.   
 
Assumptions for a chi square test were checked. The data had independence and the expected 
frequencies were above 5. With a 2 x 2 contingency table, no expected values should be 
below 5, in order to not reduce the power of the test.  
 
Table 6 - Frequencies of participants making contact with their GP by type of positive risk 
result received 














result (or refused 














 114 134  
N=11 patients had no follow up data 
 
 
Table 6 shows the number of cases which fell into each combination of categories. N=118 
patients were referred to their GP with a positive FINDRISC and a positive HbA1c risk 
result, N=88 of these patients made contact with the GP, whilst 26 did not. There was no 
patient or GP response for N=4 of these patients.  As the table shows, N=141 dental patients 
were referred to their GP with a positive FINDRISC risk result but either a negative HbA1c 
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risk result or no risk result due to the test being refused. Of these N=141, N=67 patients made 
contact with their GP, whilst 67 did not. 
 
There was a significant association between the type of risk result being referred to GPs and 
whether or not a patient would follow recommendation and contact their GP. χ2 (1) = 19.43, 
p<0.0001. The number of positive risk scores was significantly associated with GP contact; 
patients were more likely to contact their GP if they had received two positive risk scores. 
 
Based on the odds ratio, the odds of patients contacting the GP was 3.38 times higher (95% 
CI [1.95,5.89]) if they were referred with two positive risk results (both a positive FINDRISC 
and positive HbA1c risk result) as opposed to just one (a positive FINDRISC but negative or 
no HbA1c). An indication of statistical significance, does not provide information about the 
strength of the association. Unlike significance tests, effect size is independent of sample size 
and can help to understand the magnitude of differences found. Odds ratios measure how 
many times bigger the odds of one outcome is for one value of a variable compared to the 
other. If there is no association between two variables, then the odds ratio = 1.When the odds 
ratio is above or below 1, it is possible that there is a significant association.  According to 
the literature, this odds ratio indicates a medium effect size (Chen, Cohen, & Chen, 2010). 
Confidence intervals provide an indication of how reliable an odds ratio is (Field, 2013). The 
confidence level is the probability that the confidence interval contains the true odds ratio. 
The wider the confidence interval the greater the uncertainty associated with the estimate.  If 
the 95% confidence intervals do not contain the value 1, then the association is significant. 
The odds ratio above is bigger than one, and the confidence intervals do not contain the value 
1, therefore, it suggests the result is significant. The confidence intervals here also quite 
narrow, therefore we can be confident that the actual OR that we report is likely to be correct 
and reflect the true value. 
 
Calculating the odds ratio: 
Odds (contacting GP when referred  
with Positive FINDRISC and Positive HbA1c) =      number that contacted GP 
       number that didn’t contact GP 
 
        = 88 




        = 3.38 
 
Odds (contacting GP when referred  
with Positive FINDRISC & Negative HbA1c result) = number that contacted GP 
                                number that didn’t contact GP 
 
         = 67 
            67 
 
         = 1.00 
 
Odds ratio = odds contacting GP referred with Positive FINDRISC and Positive HbA1c result 
          odds contacting GP referred with Positive FINDRISC and Negative HbA1c result 
 
  
        = 3.38 
           1.00 
 
       = 3.38 
 
 
It was also calculated as a x d / b x c to check the calculation.  
 




The first objective of this study was to determine the uptake of dental patients using 
FINDRISC and HbA1c information as preliminary screening tools in screening for possible 
diabetes, and determine the number of patients at risk of diabetes.  
 
As with the previous US and UK studies, the current study found that many dental patients 
were happy to participate and receive one or more diabetes screening tests offered to them. 
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The results showed that 50% of eligible patients consented to participate. The refusal rate of 
N=515 was, however higher than the figure stated in Wright et al. (2014). Several reasons for 
this can be offered, such as, that potential participants are much more likely to take part in 
research that is concerned with an issue which is particularly relevant to the participants’ 
lives, overall there is a decline in willingness to participate in scientific studies in Western 
countries, which may hold little immediate benefit to the participant (Galea & Tracy, 2007). 
Participants may be wary of committing their involvement to research in an endeavor that is 
likely to take up a substantial amount of their time given how scientific research has become 
increasingly demanding over the last decade (Galea & Tracy, 2007). When attending the 
dental surgery for appointment, the last thing some patients want to be doing is looking at 
other aspects of their health when they might be nervous about their dental appointment. 
After reading the participant information sheet sent to them before their appointment they 
may have seen the detail in the information and though that it would take up too much of 
their time. Finally, the number of participants who were unable to participate due to not 
meeting the inclusion criteria was expected due to the prevalence of diabetes and the age 
limit set for the study. Dental patients aged under 45 years were not eligible for the study and 
so a large number of patients attending the surgery could not even be approached.  
 
In the current study, almost half of dental patients screened using the FINDRISC were found 
to be at significant risk of developing diabetes based on the current cut-off score of 10 that 
was available at the time of the study. In line with previous work, the majority of participants 
fell into the slightly elevated risk category, with a personalised risk score of between 7 and 11 
(Costa et al., 2013). Wright et al. (2014) found that 84% of dental patients screened had at 
least some increased level of risk of diabetes, based on the NICE guidance tool which 
included a risk questionnaire and BMI measurement.  The current sample, based on the risk 
questionnaire alone showed a similar result; that N=419 (81%) of the 520 participants had 
some level of elevated risk of diabetes.  
 
The use of a FINDRISC cut off score of 10 to go on to conduct further screening test had 
been recommended in the literature (Tankova et al., 2011). When evaluating the performance 
of this test in a representative sample of high-risk Bulgarians, the ROC curve analysis 
indicated good performance of FINDRISC in predicting diabetes with AUC 0.708 (95% CI 
0.685–0.731). For a cut-off point on FINDRISC of ≥12, sensitivity was 0.78 (95% CI 0.71–
0.84) and specificity was 0.62 (0.58–0.68). The ROC curves indicated good performance of 
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FINDRISC also in predicting both prediabetes and diabetes with AUC 0.701 (95% CI 0.672–
0.731). For a cut-off point on FINDRISC of ≥10, sensitivity was 0.84 (95% CI 0.71– 0.90) 
and specificity – 0.61 (0.54–0.71). Therefore, they recommended that further laboratory 
testing for detecting undiagnosed prediabetes and diabetes in subjects with FINDRISC of 10 
or higher. As the results in the current study showed, using this cut-off meant that almost half 
of those screened using FINDRIC were found to score ≥10. It could be argued that this cut-
off score was set too low. A more recent study assessing the performance of the FINDRISC 
found that the optimal cut-off point was ≥13 (sensitivity = 63.8%, specificity = 65.1%) 
(Salinero-Fort et al., 2016). 
   
When looking at the results the point of care HbA1c measure, N=118 (45% of those taking 
the test) had a score of ≥5.7% suggesting a risk of pre-diabetes and diabetes. Compared to 
30% found by Herman and colleagues (Herman et al. 2015) and 40% in the participant 
sample of Genco and colleagues (Genco et al. 2014), the result in the current study was 
slightly higher, probably because only those with FINDRISC score over 10 were offered the 
HbA1c test. Additionally, recruitment was carried out in two separate, geographically 
different locations where people might have been considered a higher risk due to factors such 
as ethnicity. The majority of participants (94%) scoring 10 or higher on the FINDRISC were 
happy to have their HbA1c measured by the researcher. Therefore, these results support the 
notion that dental patients are happy to be screened for diabetes using a combination of a 
simple questionnaire and a more invasive finger-prick blood test.   
 
When screening with a self-report risk questionnaire, over half of participating dental patients 
were found to be at risk of developing diabetes when using a cut-off score of 10. The 
majority of participants scoring 10 or higher on the FINDRISC were then happy to have their 
HbA1c measured by the researcher for further screening too, with only 17 out of 259 refusing 
the blood screening test.  When screened using the instant HbA1c measure, of the 242 
participants having their blood screened, N=54 (22.4%) were found to be at risk of 
developing diabetes when using a cut-off of 6.0%. In an acute-care setting, an HbA1c of 
5.7% was the optimal screening cut-off for prediabetes, and 6.0% was the optimal screening 
cut-off for diabetes (Silverman et al., 2011). These findings were very similar to a number of 
previous studies in which individuals from different ethnic and racial groups and geographic 
regions were tested in outpatient settings. The findings that indicated an HbA1c of 6.0% as 
the optimal diabetes-screening cut-off were consistent with data from other studies that use 
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the finger prick blood samples or OGTT to define diabetes (Ginde, Cagliero, Nathan, & 
Camargo, 2008; Mohan et al., 2010). The diabetes-screening cut-off that these previous 
studies identified is lower than the diagnostic mark of 6.5% that the ADA guidelines 
recommend. The difference in cut-offs can be explained in part by the desired outcome of a 
diabetes screening test to miss fewer people with diabetes, and, therefore, screening cut-offs 
typically are lower than diagnostic cut-offs. When the current study was approved by the 
Ethics committee, they dictated that these cut-off scores be used due to current published 
literature, expertise, and a lack of definitive cut-offs at that time.  
 
A recent study testing the utility of the HbA1c when used as a screening tool in pregnancy for 
gestational diabetes found that pregnant women with an HbA1c of ≥5.4% showed sensitivity 
of 61% and specificity of 68% and sensitivity of 27% and specificity of 95% when using 
HbA1c cut-off value of 5.4%. They concluded that those with an HbA1c of ≥5.4% should 
proceed with an OGTT (Khalafallah et al., 2016). This should then result in a significant 
reduction in the burden of testing on both patients and testing facility staff and resources. On 
the other hand, another recent study evaluated the diagnostic value of HbA1c measurements 
in screening of diabetes and prediabetes, and determine the cut-off point of HbA1c in a 
Chinese population (Liu et al., 2016). The results suggested an optimal HbA1c cut-off point 
of 6.3% in screening diabetes, consistent with a previous study, the authors also proposed an 
ideal HbA1c cut-off point of 5.8% in screening prediabetes. The findings from these recent 
studies suggest that there is not a definitive agreed cut-off for screening for diabetes. The 
result of the current study may well have been different if these other suggested cut-offs had 
been used. However, because the aim of the study was to screen for risk of diabetes in an 
otherwise unknown risk population and then recommend further diagnostic testing by their 
GP in those patients scoring above the cut-offs, the cut-offs used in this study were deemed 
satisfactory.  
 
In terms of the study limitations, there was a discrepancy in the numbers of patients who 
were eligible to participate and those that did consent not only because there were patients 
who refused to participate, but because the method of data collection meant that some 
patients who were eligible to participate were missed because the researcher was not able to 
approach them before their appointment with the dentist. Therefore, the number of dental 
patients who would have participated might be different. If the study were to be replicated, 
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ideally, the study would have more than one researcher working on the study approaching 
participants, recruiting patients and assessing risk and screening.  
 
A strength of the study could have also been a limitation where the researcher had an 
awareness of risk communication and used systematic review-informed ways to communicate 
risk. Existing staff at the dental practices may not have had this background which limits the 
ecological validity of the work. Other dental practices would need their existing staff trained 
on how to deliver the risk communication.  
 
The other aim of the current study was to explore whether those participants who were 
advised to see their GP for a diagnostic test following an increased risk result from the 
screening measures, followed the recommendation to do so. More specifically, was there a 
difference in follow-up GP rates between those referred to their GP with just one increased 
risk result (positive FINDRISC) and those with two risk results (positive FINDRISC and 
positive A1c result).  
 
Results showed a high proportion (59.85%) of those advised to visit their GP for further 
formal diabetes testing followed this advice and contacted their GP regardless of screening 
method. This is a much more promising result than found previously. For instance, Wright et 
al. (2014) reported that only 20% of patients identified as at risk of developing diabetes 
attended their GP. Genco et al. (2014) reported that 35% attended their GP for follow up; 
though there was a significant difference in follow-up rates between patients referred from a 
community health centre where over 78% attended their GP compared to only 21% from 
private dental offices. The higher follow-up rate in the current study could be attributed to the 
detail of the risk communication given to patients. Individualised risk communication is 
known to be more effective than generalised risk communication at increasing screening 
participation (Bould, Daly, Dunne, Scott, & Asimakopoulou, 2016; Edwards et al., 2013). 
 
The number of positive risk scores significantly influenced GP contact; patients were more 
likely to contact their GP if they had received two positive risk scores. The odds ratio of 
patients contacting the GP was 3.38 times higher if they were referred with two positive risk 
results (both a positive FINDRISC and positive HbA1c risk result) as opposed to just one (a 




Screening failures occur not only from a lack of screening but also from breakdowns in 
follow-up on positive tests, which hinder the benefits of screening (Green et al., 2014). There 
are several reasons why dental patients in the current study did not follow up their positive 
screening tests with a follow up at their GP. The colorectal cancer literature has found that 
the general public have a preference for non-invasive screening tests (Benning, Dellaert, 
Severens, & Dirksen, 2014) and that having a choice of test would have the greatest impact 
on screening participation (Marshall et al., 2007).  In the current study, having two positive 
screening tests, one non-invasive and one invasive, might have made participants feel more 
susceptible to diabetes so they contacted their GP. On the other hand, having a positive 
FINDRISC result followed by a negative HbA1c result might have led to confusion in some 
participants, making them unsure of what to think and whether to contact their GP for follow-
up. Conversely, the negative HbA1c result may have taken president over the positive 
FINDRISC result if it was seen as more reliable being an invasive test, therefore not being 
motivated to contact their GP. There may have also been a tendency to consider diabetes as 
lacking in severity and being easily controllable leading to participants not contacting their 
GP. Previous studies have argued this perception to be more pronounced in the screening 
context, which aims to identify diabetes at an early stage and, as such, could minimise the 
impact of diagnosis (Eborall et al., 2007). 
 
There are several limitations to this part of the study. Firstly, the outcome variable that was 
created from follow up data was simplified. Initially, the outcome of whether those asked to 
see their GP for a follow up diagnostic test actually received the test. However due to the 
complexity of the follow up data, for example, some GPs didn’t feel a diagnostic test was 
necessary despite the patient seeing the GP for follow up, and some patients having had an 
appointment with their GP but awaiting the diagnostic test appointment, the outcome variable 
was simplified to cover all aspects of contact made with the GP. Patients were identified as 
having taken the advice to seek a follow up test from their GP if they had made contact with 
the GP which covered anything from having an appointment made, to having received a 
diagnostic test and the result. The problem with this outcome is that it might not have 
measured the component of actual behaviour; instead it may have only measured intention for 
some patients. Therefore, the findings should be considered with caution, that the screening 
tests may not have led to actual follow up behaviour, it may have led to behavioural intention. 
Additionally, in cases where there was no follow up data received through GP confirmation, 
the results relied on self-report data from the patient; they may have said they had made 
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contact with their GP because they had been advised to do so, and didn’t want to be seen as 
non-compliant.  
    
More work is needed to develop strategies to improve the follow-up at GP practices patients 
identified as at risk of developing diabetes therefore, behaviour change techniques could be 
employed here.  
 
Conclusion 
The study demonstrates a viable method of diabetes screening that shows an acceptable rate 
of uptake by dental patients.  It also demonstrates a relatively high number of patients ‘at 
risk’ of developing diabetes being referred to their GP when using a cut-off of 10 on the 





To what extent can psychological variables predict post-screening health behaviours in dental 
patients at risk of developing diabetes? 
 
Introduction to chapter 
The previous chapter documented the proportion of dental patients who attended their GP for 
diabetes diagnostic testing after being advised to do so and explored whether there was a 
difference in attendance behaviour according the type of risk information used to refer a 
patient to their GP (FINDRISC risk result vs. FINDRISC & HbA1c risk result). It is now of 
interest as to whether it is possible to predict what makes a person follow up the advice given 
to seek a diagnostic test from their GP from a set of theoretically driven psychological 
variables. This chapter explores the research questions set out in bold:  
1. What is the most effective way to communicate individualised risk information to 
increase screening participation or its psychological predictors?  
2. What proportion of dental patients accept an offer to be screened for type 2 diabetes 
in a primary care dental setting? 
3. What is the risk of type 2 diabetes in primary care dental patients as assessed through 
self-report and physiological measures? 
4. What is the effect of personalised diabetes risk communication on subsequent health 
behaviours? 
5. What is the psychological profile of patients at risk of diabetes? 
6. To what extent do psychological variables predict post-screening further testing 
or health behaviours? 
7. What are patients’ and dentists’ views on screening for diabetes in dental settings, and 
can this help to further explain post-screening further testing or health behaviours? 
 
Background 
The prevention of T2D is a challenge for healthcare professionals. Screening in those at risk 
for developing diabetes is thought to be necessary to implement preventive measures in 
patients prior to the manifestation of diabetes and to subsequently diagnose the disease 
(Karter et al., 2007). 
 
There is evidence to suggest that not only medical aspects, but also psychological factors, 
influence healthy or preventive behaviours, including the perception of risk; an individual’s’ 
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judgment of the likelihood of experiencing an adverse event (Branstrom, Kristjansson, & 
Ullen, 2006). Therefore, in prevention programs, communication about risk has been 
regarded as one of the key preventive strategies (Lavielle & Wacher, 2014). It is assumed that 
by receiving information, people will modify their behaviour to reduce their risk (Cook & 
Bellis, 2001). Specifically, this means that at the moment of making a decision concerning a 
specific behaviour, individuals will adhere to the basic principles of a rational choice, 
including understanding the received information, weighing its importance and making a 
decision that will optimise the expected value of the outcome (Lavielle & Wacher, 2014). 
However, evidence has demonstrated that people often fail to weigh the information; rather, 
their decision model is often intuitive, where individuals evaluate the consequences 
differently, according to their own values and priorities (Eiser, 1998). Therefore, even though 
knowing about risks is a first step for people to adopt and maintain behavioural changes other 
factors are involved in this process. In this sense, the relationship between knowing the risk 
factors for developing a disease and the adoption of preventive behaviours cannot be 
regarded as causal. People may know that they are exposed to a risk factor, but unless they 
perceive that some personal aspect is under threat, people often do not perceive themselves as 
being susceptible (Tate et al., 2003). As such, perceived risk is an essential component of the 
majority of models of health behaviour. 
 
It is unknown if diabetes risk perception can influence health behaviours aimed at reducing 
the risk of diabetes (Walker et al., 2007). Therefore, Lavielle and Wacher (2014) assessed the 
role that risk perception can play on health behaviours, and determined if risk perception 
influences an individual’s behaviour for preventing T2D, specifically glucose screening. 
Eight hundred interviews were conducted in Mexico, stratified by socioeconomic level. The 
perception of risk of developing diabetes, family history, health status and socioeconomic 
variables were evaluated, and also their association with glucose screening frequency. Results 
showed that risk perception was significantly associated with the frequency of blood glucose 
screening. Having a first-degree relative with diabetes, being older than 45 years and 
belonging to a middle socioeconomic level increased the probability of participants seeing a 
health professional for glucose screening. The authors concluded that blood glucose 
screening is a complex behaviour that involves a person’s perception of threat, defined as 
feeling vulnerable to the development of diabetes, which is determined by the person’s 




Effective risk communication depends not only on presenting general risk factors and 
preventive information but also on factors unique to the individual. Acceptance of a risk 
message depends on an individual’s knowledge, values, and beliefs (Berry, 2004). 
Personalised interventions in which the message is based on an individual’s beliefs about a 
disease, personal risk factors, and knowledge of the effectiveness of screening for a particular 
disease may be viewed as more salient and lead to the desired behaviour (Birmingham et al., 
2015; Noar, Benac, & Harris, 2007). 
 
Theory-based interventions addressing multiple determinants of behaviour are believed to 
have the highest likelihood of promoting healthy behaviours such as screening (Briss et al., 
2004). To maximise screening success, it is important to understand why some individuals 
fail to use screening services.  Mood, and in particular low mood (e.g. depression) has been 
shown to be a reliable predictor of screening attendance (Burton, Waddell, Tillotson, & 
Summerton, 1999). Social cognition models have also been used to understand and predict 
health-related behaviours such as adherence to screening (Boonyasiriwat et al., 2014b).  
 
One such model is the Extended Parallel Process Model (EPPM), which incorporates 
affective processes, such as fear, in risk communication (Witte, 1994) and derived from the 
Protection Motivation Theory (Rogers, 1983). The EPPM focuses on channelling fear in a 
protective direction rather than a maladaptive direction. The model is based on the idea that 
when individuals fear a threat, they will be motivated to take action to reduce the unpleasant 
state. Fear can then be reduced by adaptive actions to control the danger or by maladaptive 
actions to control the fear. The model posits that when an individual is presented with a fear-
arousing message two cognitive appraisal processes will be initiated: (1) threat appraisal and 
(2) efficacy appraisal. In the first appraisal, the individual considers two aspects of the 
perceived threat: severity and susceptibility. Severity appraisals involve determining the 
degree of harm expected from the threat (e.g., ‘Diabetes could kill me.’), while susceptibility 
appraisals involve determining how likely the threat could affect the individual (e.g. ‘I have a 
family history of diabetes so I can get this disease.’). If the perceived threat is determined to 
be low, the individual is unlikely to process the message further. However, if the perceived 
threat is high, the individual will enter the efficacy appraisal stage to evaluate response 
efficacy and self-efficacy (Birmingham et al., 2015). In response, efficacy of the individual 
assesses how effective the recommended behaviour will be in averting the threat. (‘A blood 
glucose test could detect diabetes early and reduce my risk of severe diabetes related 
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complications.’). In self-efficacy, the individual assesses their ability to perform the 
recommended behaviour to avert the threat (‘I am capable of getting a blood glucose test’). 
When both threat and efficacy appraisals are high, the individual will enter a cognitive 
process to control the danger and will engage in adaptive behaviour (e.g., undergoing a blood 
glucose test). If threat appraisals are high but efficacy is low, the individual will enter a 
cognitive process to control the fear rather than the danger. This process is likely to lead to 
maladaptive responses such as defensive avoidance (e.g., ‘I’m not going to think about that!’) 
(Birmingham et al., 2015; Grasso & Bell, 2015). 
 
When a message creates a high perceived threat but the perceived response efficacy remains 
low, fear control processes are engaged and will dominate a person's behaviour, resulting in 
message rejection, denial, or minimization. However, when a message creates high perceived 
threat and the perceived response efficacy is also high, danger control processes are engaged 
and will dominate a person's behaviour, resulting in message acceptance and attitude, 
intention, and behavioural changes. Thus, a person involved in danger control responds to the 
danger and not to his or her fear. The EPPM explains both emotional (fear control) and 
cognitive (danger control) reactions to fear appeals and it describes the conditions most likely 
to produce certain attitudinal or behavioural responses. 
 
Although other models, such as Protection Motivation Theory, Health Belief model etc. also 
consider threats as a means to behaviour change, EPPM is a particularly sound model to use 
in screening studies.  For example, previous studies have examined the EPPM in relation to 
early detection behaviours such as testicular self-exam (Morman, 2000), mammography 
(Hubbell, 2006), skin cancer screening, and sun protective behaviours (Cho & Salmon, 
2006). These previous studies suggest that the approach of promoting high threat and high 
efficacy may be effective in public health campaigns. Fear appeals which generate 
perceptions of threat and fear, as well as high levels of efficacy, have resulted in significant 
behavioural changes. A further study examined the fear control/danger control responses that 
are predicted by the EPPM (Gore & Bracken, 2005). In a campaign designed to inform 
students about the symptoms and dangers of meningitis, participants were given either a high-
threat/no-efficacy or high-efficacy/no-threat health risk message to test the extreme 
assumptions of the EPPM. The study supported the main predictions of the EPPM in the 
context of another health concern; meningitis, however, the results also provided new 
evidence that only a marginal amount of threat in a health risk message is needed to move the 
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target audience toward the anticipated protective measures. In addition, the results suggested 
that messages which contain only threat may scare the target audience further into fear 
control (Gore & Bracken, 2005). Nevertheless, there was a lack of follow-up data collected in 
the study to see if participants received the meningitis vaccine; the researchers instead 
anonymously tracked vaccine inquiries to act as the post-test measure.  
 
Little is known about how the EPPM may be used to explain post-diabetes screening or 
testing intention\s and behaviour. Glucose screening is said to be a complex behaviour that 
involves the person’s perception of threat, defined as feeling vulnerable to the development 
of diabetes, which is determined by their environment and their previous experience with 
diabetes (Lavielle & Wacher, 2014). 
 
In the context of diabetes screening, receiving a positive result on the FINDRISC (and 
therefore being identified as ‘at risk’ for having diabetes) and having a high HbA1c reading, 
can be conceived as threat information.  Visiting the GP to receive the FGBT and/or OGTT is 
considered the adaptive response and failing to visit the GP is considered to be the 
maladaptive response.  As such, the EPPM may be a useful theoretical model to understand 
uptake of diabetes screening following a positive test result on the FINDRISC and in turn 
may be used to develop methods to ensure maximum uptake. At present however, these 
hypothesised psychological factors underpinning attendance at a diabetes screening test have 
not been researched. 
 
When predicting future health behaviour, it is important that researchers are clear what 
variables predict any particular outcome, to include extraneous variables. Research has 
proposed that socio-demographic factors (e.g. age, marital status, education, income, and 
race), family history (e.g., family or personal history of chronic diseases), healthcare 
utilisation (e.g. health insurance coverage, regular contact with GP), awareness factors (e.g. 
knowledge of and attitude towards screening, perceived risk of developing a disease), past 
screening behaviour (e.g., mammography, pap smear, prostate cancer screening), and lifestyle 
(e.g. history of smoking, alcohol intake, and physical activity) may individually or in 
combination affect screening behaviours (Hategekimana & Karamouzian, 2016).  
 
Mental health disorders may also influence screening participation (Calderwood et al., 2013). 
Mental health patients have an increased rate of morbidity and mortality (Colton & 
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Manderscheid, 2006). For example, mental health conditions have been associated with lower 
mammography rates (Egede, Grubaugh, & Ellis, 2010), pap smears (Leiferman & Pheley, 
2006), and cholesterol testing (Lord, Malone, & Mitchell, 2010). This might mean that 
mental health conditions might serve as a potential barrier to health screening due to greater 
difficulties in adhering to behaviours related to long-term health goals or larger emphasis put 
on the management of the mental health condition compared to seeking preventive healthcare 
(Katon, 2003). Depression is one such variable that is known to interfere with risk 
information processing (Hammen & Zupan, 1984) and its influence on self-reports should be 
assessed in any work seeking to predict future behaviours. 
 
This study used EPPM as a theoretical model to explore the psychological variables that 
might have guided our sample of dental patients to undertake post-screening health 
behaviours. In particular, the study set out to address the following research questions: 
5. What is the psychological profile of patients at risk of diabetes? 




The study methods are described in detail in chapter 4. Briefly, participants who were found 
to be at risk of developing diabetes from the screening measures conducted, completed 
questionnaires to assess mood using the CES-D scale, and a further questionnaire measuring 
EPPM variables through asking participants about their views on diabetes and screening.  
The psychological measures were assessed for internal consistency. Cronbach’s alpha was 
performed on the CES-D scale and each of the subscales on the EPPM measure. Cronbach’s 
Alpha could not be calculated for the EPPM Severity subscale as this subscale only had one 
item. Table 5 below reports Cronbach’s α for each scale and subscale calculated. 
 
Table 7 - Cronbach's alpha for CES-D and EPPM subscales 
Scale or Subscale α 
CES-D measure .85 
EPPM Self-efficacy  .81 











Usual Cronbach’s alpha criteria were used to assess the data above (Kline, 1999). On the 
basis of these, the CES-D scale was found to have high internal consistency, with a 
Cronbach’s α = .85. EPPM subscales varied in levels of internal consistency. Self-efficacy, 
response efficacy, response costs, vulnerability and fear had high reliabilities, as all 
Cronbach’s α values were greater than .80. The intention subscale and rewards for 
maladaptive response subscale had lower reliabilities with Cronbach’s α = .68 and α = .61, 
respectively. Whilst these are just below the ideal cut-off point of .7, it is argued that values 
below this cut-off can realistically be expected because of the diversity of the constructs 
being measured (Kline, 1999). Additionally, whilst this questionnaire measure was created 
for the purpose of this study, it has also been suggested that in the early stages of research, 
values as low as .5 will suffice (Nunnally, 1978). 
 
Results 
The data collected are present by the respective research question that they each answer. 
These follow in the sections below. 
 
Research question 5 
What is the psychological profile of patients at risk of diabetes? 
It was of interest to look at the psychological profile of patients who were found to be at risk 
of developing diabetes from the screening measures conducted. The EPPM scale measures 
several constructs; severity, fear, self-efficacy, response efficacy, response costs, 
vulnerability, rewards for maladaptive response and intention. The overall scale range is 1 to 
136. The fear subscale range is 1 to 16, where a higher score represents greater fear towards 
diabetes. The vulnerability subscale range is 1 to 10, where a higher score represents a greater 
feeling of vulnerability towards diabetes. The intention subscale range is 1 to 10, where a 
higher score represents more intention to have a diabetes diagnostic test. The response costs 
EPPM Response efficacy .88 
EPPM Rewards for maladaptive response .61 
EPPM Fear .93 
EPPM Response costs .87 
EPPM Vulnerability .87 
Overall EPPM measure .81 
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subscale ranges from 1 to 40, where a higher score represents a greater belief in the potential 
costs to of receiving a diabetes diagnostic test to an individual. The severity subscale range is 
1-5, where a higher score represents the belief that diabetes is a severe condition. The 
rewards for maladaptive response subscale range is 1-10, where a higher score represents the 
belief that there is a greater reward for a maladaptive response to a diabetes diagnostic test. 
The response efficacy subscale range is 1 to 25, where a low score represents a person’s 
belief in the efficacy of a diabetes diagnostic test. The self-efficacy subscale range is 1 to 20, 
where a higher score represents a persons’ self-confidence to have a diabetes diagnostic test.   
The CES-D scale measures the presence of significant mild depression. The scale uses a cut-
off score of 16, whereby a score of 16 or higher is indicative of significant mild depression. 
Scores can range from 0 to 60. 
 
Table 8 - Mean and SDs for psychological variables in patients at risk of diabetes, T values and P values for each 
psychological variable by level of contact made with GP; that being some contact or no contact. 
  Mean SD t P 












Some contact with GP 
(N=138 
13.81 9.10 
EPPM Severity All at risk patients 
 
4.67 .64   







Some contact with GP 
(N=147) 
4.71 .52 















EPPM Rewards for 
Maladaptive response 











Some contact with GP 
(N=147) 
5.93 1.83 











Some contact with GP 
(N=148) 
9.08 3.32 











Some contact with GP 
(N=147) 
16.37 2.98 











Some contact with GP 
(N=143) 
15.60 4.94 
EPPM Intention All at risk patients 
 
8.23 1.61   







Some contact with GP 
(N=146) 
8.13 1.62 
EPPM Fear All at risk patients 
 





Table 8 above shows the mean scores of the psychological variables measured. The mean 
CES-D score was 13.2; that was below the cut-off of 16 which indicates mild depression. 
Therefore, those at risk of diabetes did not have a score indicative of significant mild clinical 
depression. No patient with a score over 16 were excluded from the analysis.  
 
When independent samples t-tests were conducted to compare the psychological variables in 
high risk patients who did and those who did not contact their GP for further diagnostic tests, 
there was no significant difference between those patients who made contact with their GP 
and those that did not with regards to CES-D score (t (216) = -1.15, p>.05). This meant that 
there was no significant difference in whether patients were depressed based on CES-D 
scores between those that made contact with their GP and those that did not regarding follow-
up to the screening measures carried out.  
 
Mean scores for each EPPM subscale are also displayed in the table. All patients seemed to 
believe that diabetes was severe, with a mean severity score of 4.67 out of a maximum score 
of 5. There was no significant difference in severity scores between patients who did make 
contact with their GP and those who did not (t (229) = -1.02, >.05).   
 
Patients mean score for rewards for maladaptive response, meaning the reward for not having 
a diagnostic test, was 5.94 out of 10. There was no significant difference in rewards for 
maladaptive response scores between patients who did make contact with their GP and those 
who did not (t (227) = .414, >.05).   
 
Patients’ response efficacy mean score was 8.91 out of 25; where the lower the score, the 
more efficacious they though having a diagnostic test would be. There was no significant 
difference in response efficacy scores between patients who did make contact with their GP 
and those who did not (t (230) = -.54, >.05).    













Mean intention score was 8.23 out of 10, suggesting that most participants intended to have a 
diagnostic test as advised. There was no significant difference in intention scores between 
patients who did make contact with their GP and those who did not (t (228) = 1.19, >.05).   
 
Mean fear score for patients was 8.20 out of 16, suggesting that patients felt some level of 
fear at the thought of having diabetes. There was a significant difference in fear scores 
between patients who did make contact with their GP and those who did not (t (229) = -2.66, 
<.01).  Those who made contact with their GP were significantly more fearful of diabetes 
than those who did not make contact with their GP. 
 
Mean score for response costs was 15.42 out of 40, suggesting that on average, patients didn’t 
view great potential cost to having a diagnostic test. There was no significant difference in 
response costs scores between patients who did make contact with their GP and those who 
did not (t (224) = -.67, >.05).   
 
The mean score for self-efficacy was 16.47 out of 20, suggesting that participants felt 
confident in their ability to receive a diagnostic test.  There was no significant difference in 
self-efficacy scores between patients who did make contact with their GP and those who did 
not (t (227) = .14, >.05).   
 
Finally, mean vulnerability score was 6.05 out of 10, suggesting that patients did report some 
feelings of vulnerability to diabetes. There was a significant difference in vulnerability scores 
between patients who did make contact with their GP and those who did not (t (228) = -9.10, 
<.05).  Those who made contact with their GP felt significantly more vulnerable to diabetes 
than those who did not make contact with their GP. 
 
In summary, vulnerability and fear were the only two EPPM variables which differed 
significantly between those who contacted their GP and those who did not. Those who made 
contact with their GP reported significantly higher vulnerability scores and a significantly 
higher fear score than those who did not make contact with their GP for a follow up 
diagnostic test. This meant that those people who made contact with their GP felt 
significantly more fearful of, and more vulnerable to diabetes than those who did not make 





Research question 6 
To what extent do psychological variables predict post-screening further testing or 
health behaviours? 
 
Table 9 shows the coefficients of the model predicting whether a patient made contact with 
their GP regarding a diagnostic test. The model explained 41% (Nagelkerke R2) of the 
variance in GP contact.   
 
Table 9 - Coefficients of the model predicting whether a dental patient contacted their GP following diabetes screening 
    95% C.I 
Variables β p Exp(B) Lower Upper 
Vulnerability  .996 <.001 2.71 1.99 3.65 
Fear .150 .034 1.16 1.01 1.34 
Severity  .197 .50 1.22 .69 2.16 
Rewards for Maladaptive response 1.43 .21 1.14 .93 1.41 
Response efficacy .04 .53 1.04 .92 1.19 
Self-efficacy .06 .40 1.22 .92 1.06 
Response costs -.01 .85 .99 .90 1.09 
Intention -.07 .67 .93 .68 1.28 
CES-D .01 .66 1.01 .97 1.05 
 
When the predictor variables were entered into the model, CES-D score, intention, self-
efficacy, severity, response costs, response efficacy, and rewards for maladaptive response 
were not significant predictors of whether a dental patient made contact with their GP for a 
follow up diagnostic test following diabetes screening.  
 
However, the results suggest that a high risk dental patient’s fear of diabetes score and 
vulnerability to diabetes score were able to significantly predict whether a patient contacted 
their GP.  This means that the more vulnerable people felt about the chance of developing 
diabetes in the future and the more fearful they were of the disease, the higher the chance 




The odds of a patient contacting their GP was 2.71 (95% CI [1.99,3.65]) times higher for 
every 1-point increase in score of vulnerability to developing diabetes. The odds of a patient 
contacting their GP was 1.16 (95% CI [1.01,1.34]) times higher for every 1-point increase in 
score of fear of developing diabetes. The odds ratios are greater than 1, therefore this 
suggests that fear and vulnerability was higher in those who contacted their GP. Whilst these 
results are statistically significant, the odds ratios are only small, and small to medium in size 
respectively, according to Chen et al (2010). However, small effect sizes aren’t unusual in 
behavioural research. Confidence intervals measure the precision of an effect estimate, which 
here is expressed as the odds ratio. Confidence intervals are used because a research study 
recruits only a small sample of an overall population, so by having an upper and lower 
confidence limit, it is possible to infer that the true population effect lies between the two 
confidence intervals. Here, the 95% confidence intervals are narrow, particularly for the fear 
variable, which means that this is the range within which the true value is likely to lie with 
95% confidence, and that our OR is likely to reflect the true value in the population.   
 
Following the result that fear and vulnerability were able to significantly predict GP contact, 
these two variables were used to further explore their relationship with the number of positive 
risk screening tests a patient received. 
 
Table 10 - Correlation coefficients for the relationship between the number of positive screening tests patients received and 









Table 10 reports the results of a Point Biserial correlation looking at the relationship between 
the presence of two positive screening tests as opposed to just one, and the variables found to 
significantly predict GP contact in the binary logistic regression reported above.  
 









P = .73 
 




P < .05 
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There was a strong significant positive correlation between having two positive screening 
tests and EPPM vulnerability. This result suggests that those patients who received a positive 
risk result on both the FINDRISC screening measure and a positive risk result from the finger 
prick blood test felt more vulnerable to developing diabetes than those who received only a 
positive risk result on the FINDRISC screening measure, in other words, as the number of 
positive screening tests increased from one to two tests, vulnerability toward diabetes scores 
increased. There was a weak, non-significant positive correlation between having two 
positive screening tests and EPPM fear. This result suggests that those patients who received 
a positive risk result on both screening tests did not feel significantly more fearful of diabetes 
than those who received just one positive risk screening result, in other words, fear of 
diabetes did not significantly increase when the number of positive screening tests increased 
from one to two tests.  
 
Summary of results 
The data suggested that patients found to be at risk of diabetes did not report scores indicative 
of significant clinical depression, but did report the belief that diabetes was a severe 
condition, reported a high level of intention to receive a diagnostic test, and reported feeling 
some level of fear and vulnerability to diabetes. Fear of diabetes score and vulnerability to 
diabetes score were able to significantly predict whether a patient contacted their GP for a 
diagnostic test; albeit with small effect sizes. Finally, of these two significant predictors, 
vulnerability was significantly correlated with having received two positive screening tests as 




The aim of this study was to predict what makes a person follow up the advice given to seek 
a diagnostic test from their GP from a set of theoretically driven psychological variables. 
Risk communication involves raising awareness of increased diabetes risk and creating a 
sense of efficacy. The EPPM contains both components and has been effectively used across 
a variety of topics such as cancer screening, and sun protection behaviour but had not 
previously been examined in the context of diabetes diagnostic testing and behaviour 
following diabetes screening. Hence, this research question was set and the results from the 
binary logistic regression showed that both fear and vulnerability were able to significantly 
predict whether a patient found to be at risk from the screening measures would contact their 
171 
 
GP. When a Pearson’s correlation was conducted to look into this further, a relationship was 
found between the number of positive risk screening tests and vulnerability to diabetes. Those 
patients who received a positive risk result on both the FINDRISC measure and the finger 
prick blood test felt significantly more vulnerable to developing diabetes than those who 
received a positive risk result on the FINDRISC measure alone. None of the other EPPM 
components were found to be able to significantly predict whether a patient found to be at 
risk from screening would contact their GP; as well as no statistical significance, those EPPM 
components also had very small effect sizes, therefore having little or no impact on the 
decision to seek a diagnostic test from the GP.    
 
The findings in the current study can be compared and contrasted to previous work assessing 
the predictors of screening. Recently, Leung and colleagues conducted a study which aimed 
to describe the prevalence of CRC screening and examine the risk factors in a Chinese 
population. Guided by the Health Belief Model and Extended Parallel Processing Model, 240 
adults aged 60 or older were asked to complete a questionnaire which collected information 
on demographic variables, CRC-related psychosocial variables and whether or not they had 
received a CRC screening test in the past 10 years. Results of a logistic regression suggested 
that participants with lower perceived knowledge barriers and severity-fear (severity relating 
to mental status and negative effects to their current personal and family lives) were 
significantly associated with participation in CRC screening (Leung, Wong, & Chan, 2016). 
But there were no significant associations between cancer fear and screening, as seen in the 
current study. The insignificant result of fear on CRC screening was contradictory to findings 
from the review on older adults which had showed that fear may either be a facilitator of, or a 
barrier to participation (Guessous et al., 2010). Another recent study looking at the factors 
associated with prostate cancer screening behaviour through a self-report questionnaire 
assessing screening behaviour cancer in Iranian men found that knowledge and perceived 
threat consequences of prostate cancer were psychological predictors of prostate cancer 
screening behaviours among men over 50 years of age (Barati et al., 2016). Whilst 
knowledge and perceived threat weren’t directly measured in the current study, they are 
variables that are important to screening uptake and can be associated with other EPPM 
components.  
 
Guided by the EPPM, Birmingham et al. (2015) examined the impact of a personalised, 
remote risk communication intervention on behavioural intention and colonoscopy uptake in 
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relatives of CRC patients, assessing the original additive EPPM model and an alternative 
model in which each theoretical construct contributed uniquely. The intervention involved 
participants receiving tailored print materials and a cancer risk assessment and counselling 
telephone call by a genetic counsellor. Screening intentions and actual screening behaviour 
verified through medical records were measured. Results from structural equation modelling 
showed there to be a poor main model fit where an additive relationship exists between 
perceived severity and susceptibility (i.e., threat) and between perceived response and self-
efficacy (i.e., efficacy). When an alternative model was used in which perceived 
susceptibility, severity, self-efficacy, and response efficacy each contribute individually to 
the model, perceived susceptibility was significantly associated with intention to screen while 
perceptions of CRC severity were not. Additionally, perceived self-efficacy but not perceived 
response efficacy was significantly associated with intention to screen. 
 
According to the EPPM, self-efficacy may be viewed as the degree to which the individual 
perceives he or she can perform the recommended response to avert the threat. In the case of 
diabetes and for the purposes of our study, self-efficacy is the degree to which the individual 
perceives he or she is capable of obtaining a diagnostic test, and response efficacy is the 
degree to which the individual believes that the diagnostic test can early-detect and prevent 
diabetes. In fear-arousing communications aimed to increase health-promoting lifestyle 
choices, self-efficacy is often associated with the self-control, self-regulation, and self-
motivation needed to perform the behaviour. However, many of these health-promoting 
lifestyle behaviours need to be performed on a regular basis, while diabetes screening need be 
performed less regularly. Whilst, self-efficacy would include the self-motivation to actively 
seek a diagnostic test following the recommendation to do so, it also involves being able to 
get an appointment to get the test done, and any other barriers that might exist such as 
problems with transportation and time for example. Therefore, while one may strongly agree 
that a diagnostic test can detect diabetes and reduce the risk of diabetes related complications 
through early detection, without the ability to get the diagnostic test done, belief in the 
effectiveness of diagnostic testing would not likely predict GP contact. Therefore, barriers to 
getting a diagnostic test must be overcome in messages to increase efficacy. 
 
The finding from the current study that increased fear of diabetes was a significant predictor 
of GP contact is notable. This result is consistent with a finding that increased apprehension 
about developing breast cancer is a modest but reliable predictor of increased likelihood to 
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get screened (Hay, McCaul, & Magnan, 2006). Guided by the EPPM, another study 
examined cognitive, affective, social, and behavioural predictors of intention to undergo 
colonoscopy screening in individuals with a family history of CRC (Boonyasiriwat et al., 
2014a). Relatives of colorectal cancer cases eligible for colonoscopy screening completed a 
survey assessing constructs from several theoretical frameworks. Results suggested that 
perceived CRC risk, past colonoscopy, fear of CRC, support from family and friends, and 
health-care provider recommendation were determinants of colonoscopy intention in the next 
six months. Whilst their study did not assess actual colonoscopy uptake, even though 
readiness for colorectal screening is a predictor of future behaviour, intention to screen was 
determined by fear of CRC; like fear of diabetes was predictive of GP contact in the current 
study. In practice, these findings here suggest that, if a patient is not fearful of diabetes, they 
are less likely to contact their GP; thus making the communication of diabetes risk in the 
dental setting important if the aim is to increase GP contact following positive diabetes 
screening results. If there is fear of diabetes following risk communication, then there is an 
increased chance that a person will contact their GP for further testing. The same can be said 
for vulnerability to diabetes; if a patient does not feel vulnerable to diabetes following 
screening tests and the communication of their risk, they are less likely to contact their GP. If 
there is a feeling of vulnerability to diabetes following risk communication, then there is a 
greater chance that a person will contact their GP for further testing. Therefore, it is important 
that the person in the dental setting delivering the risk communication does so effectively to 
convey a certain level of fear and vulnerability to diabetes. Whilst fear and vulnerability 
showed statistical significance, they only had small effects. Therefore, whilst these findings 
show that these two components of the EPPM might be important in the decision to make 
contact with the GP, they may only be slightly relevant, and they certainly do not fully 
explain the reasons why those making contact with their GP did so. This suggests that the 
EPPM variables are not always able to predict health behaviour, particularly in this case. In 
this study, the two significant predictors were only slightly associated with the outcome, and 
so this leads us to question what else might be causing an increase in the behavioural 
outcome. Research has now for a long time looked at factors beyond demographics and a lot 
of research has benefitted from the use of behavioural theories and models (Askelson et al., 
2015). Perhaps in this case, looking at psychological predictors of making GP contact is not 
the right way to investigate. This study does not lend much support to EPPM, and is not clear 
what it is that makes these dental patients at risk of diabetes actually make contact with their 
GP regarding a diagnostic test. Therefore, variables other than psychological factors might 
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have been able to explain GP contact, but these variables weren’t studied in this research. 
Recent research in other areas of screening uptake has suggested that other variables can lead 
to the uptake of health screening such as, family income (Marmara, Marmara, & Hubbard, 
2017) in breast cancer screening and age, education and smoking status in cervical cancer 
screening (Chang et al., 2017). However, diabetes screening studies have found that patient 
characteristics can influence attendance too (Christensen, Sandbaek, Lauritzen, & Borch-
Johnsen, 2004). The UK ADDITION study also found that male participants and those with a 
higher BMI were associated with lower attendance for testing. They also found that older age, 
prescription of antihypertensive medication, and a higher risk score were associated with 
higher attendance diagnostic tests (Sargeant et al., 2010). Whilst the current study measured 
demographic details and patient characteristics, these details were not used in the regression 
model. The reason for this was that whilst individual differences are known to exist in health 
behaviours, some are attributable to sociodemographic factors such as gender, and are not 
open to change, whilst others which are attributable to social cognitive variables, such as self-
efficacy or fear, are more amenable to change. Hence, why variables from a SCM model, in 
this case the EPPM, were considered to see if it was possible to predict how individuals 
would react when confronted with fear inducing stimuli. This however, might not be the case 
in the current study. It might be that factors which cannot be changed are what predicts GP 
contact following diabetes risk screening. Even if these variables might be psychological 
variables such as severity, it might not be possible to change this factor in an individual, 
therefore, it is not able to predict the outcome.     
 
The current study did not find that intention predicted actual behaviour; intention to get a 
diabetes diagnostic test was not a predictor of GP contact. This result does not support the 
finding from Birmingham et al. (2015) whose results indicated that motivation to screen was 
significantly associated with colonoscopy uptake. However, the result from the current study 
is similar to previous research which has suggested that people with positive intentions 
often fail to actually perform the behaviour (Webb & Sheeran, 2006).  
 
According to the tenets of the EPPM, when one is exposed to a fear-appeal message, an 
appraisal of the message’s threat is first performed and then an appraisal of the individual’s 
ability to prevent the threat. The results from the EPPM measure in the current study showed 
that most participants viewed diabetes as severe with little variability in perceived severity 
scores between those who did contact and those who did not contact their GP. Such high 
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severity scores create a ceiling effect that may affect the threat component of the theory. This 
might have contributed to the finding that severity of diabetes did not significantly predict GP 
contact following the screening tests. Thus, fear-arousing diabetes related messages need to 
focus on increasing levels of personal susceptibility which was done in the current study and 
which seemed to raise levels of perceived vulnerability to diabetes, particularly in those who 
received both a positive risk FINDRISC result and a positive risk finger prick blood test 
result.   
 
Mental health disorders such as depression are said to have the potential to influence 
screening participation (Calderwood et al., 2013). The mean score on the CES-D measure 
which screens for the presence of possible depression in the participant sample was below the 
cut-off for significant mild depression in those at risk of diabetes. This might be why in the 
current study, CES-D score was not a significant predictor of GP contact as there was no 
significant difference in CES-D scores between those making contact with GP and those not 
making contact. Diabetes is one of many medical conditions that appear to be adversely 
affected by comorbid depression (Andreoulakis, Hyphantis, Kandylis, & Iacovides, 2012). 
Numerous reports have indicated that patients with diabetes are 1.5–2 times more likely to 
have depression compared with people without diabetes (Brown, Majumdar, Newman, & 
Johnson, 2005). Onset of depression may result in increased weight gain as a result of the 
disorder or in relation to antidepressant medication, and decreased self-care behaviours such 
as exercise. Also, people with depression are more likely to abuse alcohol and smoke 
cigarettes compared to those without depression. These behaviours can potentially increase 
the risk of developing T2D. Comorbid depression in diabetes has been suggested as one of 
the possible causes of an inadequate glycaemic control, and the presence of depression seems 
to impact on the short-term control of T2D (Papelbaum et al., 2011). Therefore, while the 
mean CES-D score was below the cut-off for the presence of depression in the current study 
sample, it does not mean that there was a total absence of depression in those at risk of 
developing diabetes. Given that diabetes and depression are closely related, this finding might 
not have been expected; depression might have been expected to have been more prevalent in 
the study sample. However, the current study only screened for possible diabetes risk, and did 
not diagnose diabetes in participants. Given the nature that screening will identify more than 
just those who actually have the condition being screened for, the majority of participants 
screened as at risk of developing diabetes in this study likely did not have diabetes. 




The study in this chapter is not without its limitations. Whilst the CES-D measure had a 
strong Cronbach’s alpha, not all subscales on the EPPM measure showed high reliabilities. 
Intention and rewards for maladaptive response subscales did not reach the desired .7 
Cronbach’s alpha. Whilst not a limitation, the reliability of the severity subscale was not 
measured as it is not possible to calculate Cronbach’s alpha for single-item subscales. 
However, it might be possible to assess the items reliability through the test-retest approach 
in future. Nevertheless, the EPPM measure was created for the purpose of this study, and it 
has previously been said that in the early stages of research, values as low as .5 will suffice 
(Nunnally, 1978). On the other hand, the other subscales from the EPPM measure all 
exceeded the .7 Cronbach’s alpha level. In addition to this, the EPPM measure relied on self-
reported information, however, self-report measures are a necessary tool for behavioural 
research. Some of problems associated with self-report measures such as response bias, 
different interpretations of the rating scales for questions, understanding and honesty can be 
countered through the careful design and application of self-report measures. For example, 
response bias can be removed by ‘reversing’ half the questions on a questionnaire so that the 
variable is scored by positive responses on half the questions and negative responses on the 
other half, thus cancelling out any response bias (Hoskin, 2012)   
 
Birmingham et al. (2015) suggested that that the EPPM alternative model in which each 
component of the EPPM contributes individually was a better fit for motivating CRC 
screening intentions and CRC screening behaviour, and therefore there is no clear agreement 
on which model best predicts cancer screening behaviours. Whilst the current study has 
provided an examination of how the EPPM framework may aid in interventions to motivate 
diabetes testing behaviour, the current study might also suggest that the EPPM model might 
not be a good fit when it comes to predicting diabetes diagnostic testing, and that the wrong 
predictors are being considered. Thus, other models for predicting behaviour should be 
examined to look at the determinants of diabetes screening and testing. It would also be 
helpful to examine the pathways between the EPPM components within the nature of 
diabetes screening and testing. The number of EPPM components that did not have an effect 
on GP contact may mean that the EPPM model may not be a useful tool to use when trying to 




Another limitation to the study was how GP contact was measured. Whilst follow-up data 
were collected for 3 months to see if patients who were advised to seek a diagnostic test from 
their GP following initial screening, follow up data were complex and included several types 
of response, from having telephoned their GP surgery to make an appointment through to 
having received a diagnostic test. When collecting the follow up information, some data 
showed that although some patients had indeed gone to see their GP as advised, their GP had 
made a decision that a diagnostic test was not needed. Therefore, it was decided that as the 
aim of the study was to see if those asked to visit their GP actually did so, the outcome 
variable for the study would be adapted to be whether a participant made contact with their 
GP or not. So whilst the outcome of whether a diagnostic test was carried out as 
recommended wasn’t the final outcome measure, we were able to still capture more than just 
behavioural intention; in fact, data on actual behaviour was still collected and recorded, as the 
behaviour of contacting their GP as advised was measured. Additionally, the current study 
did more than rely solely on self-report. Final outcome data was sought from patients GP’s to 
back up the self-reported outcome.  Ideally, everyone who had been recommended to have a 
diagnostic test by the researcher and who did in fact contact their GP would have been given 
the test and their result. Additionally, ideally every participants’ outcome would have been 
verified by the GP too at the time of follow-up data collection. However, this just cannot be 
guaranteed when GPs ultimately have the final say on whether to issue a patient with a 
diabetes diagnostic test. If they do not feel it is necessary, they won’t conduct the blood test. 
Furthermore, those seeking a diagnostic test from their GP potentially have to attend for 
several appointments, from seeing their GP in the first instance, to having the blood test 
appointment, to then possibly having to see the GP for results follow-up. As a consequence, 
this can take a considerable period of time when having to consider the busy nature of GP 
surgeries when trying to get appointments, and an individual’s own time constraints for 
attending appointments; thus follow-up outcome data for every participant can be difficult to 
obtain within a set period of time.  
 
An important extension to this study would include determining what other factors beyond 
those considered in the EPPM inhibit or enhance diabetes testing behaviour. A qualitative 
study might therefore identify such factors and would be useful to explore an individuals’ 
reasons for having a diagnostic test or not. The quantitative results in the current study can 
only explain so much of the reasons for a participants’ decision to make contact with their GP 
or not. Whilst a person might feel significantly vulnerable to diabetes and perceive it to be a 
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severe enough condition to warrant following up a recommendation to receive a diagnostic 
test, there may still be barriers that exist which prevent a person from acting on the 
recommendation. A qualitative study would therefore need to explore the reasons behind the 
decisions made to follow-up the recommendation for a diagnostic test or not.  This would 
certainly add valuable insight to the small effects found in the current quantitative study, and 
might give further ideas of factors to look at when considering predictors of GP contact.  
 
In conclusion, the results presented in this chapter show that the more fearful and vulnerable 
dental patients feel towards diabetes, the more likely they are to attend post-screening 
diagnostic testing for diabetes at their GP surgery. Reason for attendance and non-attendance 
are discussed in the qualitative study that follows in chapter 8. The chapter also presents also 







What are dentists and patient’s views and experiences of the on practicality and acceptability 
of screening for diabetes in dental settings? 
 
Introduction  
The main aim of this PhD study was to screen patients for diabetes whilst attending their 
routine dental appointment. In this chapter, a qualitative study is described whereby the views 
on the practicality and the experiences of screening for diabetes in dental settings were 
explored by conducting interviews with the GDPs and dental patients who took part in the 
screening programme.  
The aim of this study was to address RQ7, the last of the research questions set in Chapter 
one: 
 7. What are patients’ and dentists’ views on screening for diabetes in dental settings, and can 
this help to further explain post-screening further testing or health behaviours? 
 
Whilst research has already been conducted on the views of dentists and patients on diabetes 
screening (Greenberg et al., 2012a; Greenberg et al., 2015), the intention of the current study 
was to explore what dentists and their patients thought about the specific two-step diabetes 
screening method that they had personally recently experienced. The study is described in 
two parts; Part 1 focuses on views and experiences of patients who experienced the 
screening; Part 2 focuses on views and experiences of dentists. These are outlined below. 
 
Part 1: Dental patients’ views and experiences 
Previous research has suggested that patients are willing to have a dentist conduct screening 
and counselling for a variety of medical conditions including diabetes (Creanor et al., 2014; 
Friman et al., 2015; Greenberg et al., 2012a; Sansare et al., 2015). One particular study did 
explore patient experiences of blood glucose screening during a secondary care periodontal 
visit, and found patients to be happy to receive diabetes screening in such an environment, 
but preferred the collection of gingival crevicular blood for testing as opposed to a finger 
prick blood sample being collected (Rosedale & Strauss, 2012). The intention of the current 
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study was to evaluate patients’ views on the specific screening programme used here in 
primary dental care where screening test results were given almost instantaneously as 
opposed to a screening method used in secondary care and where blood samples were sent to 
the lab for analysis like in the study mentioned above (Rosedale & Strauss, 2012).  
The previous chapters reported the results that dental patients welcomed the chance to be 
screened for diabetes when attending routine dental appointments, that over half of those 
patients screened for diabetes risk were in fact considered at risk of developing diabetes 
based on the results of the two screening tests used, and that of those patients advised to seek 
further diagnostic testing from their GP, the majority did in fact do so. In this chapter, the aim 
was to further explore these findings using qualitative methods to complement the 
quantitative findings to gain rich qualitative data of real life experience of being involved in a 
diabetes screening programme when attending a dental appointment and their thoughts on 
such a service, and try to further explain why patients did or did not attend the GP for follow-
up diagnostic testing when it was recommended to do so.  
 
Part 2: Dentists’ views and experiences 
Previous research has suggested that dentists hold a positive attitude toward diabetes 
screening in the dental setting (Greenberg et al., 2010). Some studies have shown the 
majority of dentists are willing to do such screening (Hema, Prasad, & Shetty, 2014). Trainee 
dentists’ attitudes toward activities related to diabetes counselling, monitoring, and screening 
have been found to be generally positive when it comes to screening for undiagnosed 
diabetes; trainee dentists report that this is within the scope of dental practice (Anders, Davis, 
& McCall, 2014). The current study differed from previous research in that dental 
practitioners were interviewed in an attempt to gather rich qualitative data on their views, 
attitudes and experiences of diabetes screening. Additionally, the dentists who were 
interviewed had recently been exposed to a specific diabetes screening programme and 
therefore were able to comment on actual knowledge and experience as opposed to a 





The methodology for this qualitative study is detailed in Chapter 4; Methods chapter. In 
summary, the chapter reports thematically-analysed interview data from patients who either 
attended or failed to attend their GP for diagnostic testing and the participating dentists.  
 
Results  
Dentist and Patient Sample 
Eighteen dental patients were recruited for this qualitative part of the current study from the 
dental practice in Staffordshire. No dental patients were recruited from the practice in London 
due to the length of time since the screening programme had taken place. It was decided that 
recollection of experiences may not have been as accurate as the more recent experiences 
from dental patients at the second data collection site in Staffordshire. There were 10 females 
and 8 male participants. Mean age was 59.3 years. The mean FINDRISC score was 10.67, 
and the mean HbA1c score of those who received the test was 5.89%.  
There were eight GDPs in total at the two dental practices. However, due to working hours, 
only six were asked to participate, all of who agreed to participate.  
Of the 6 GDPs recruited; 4 were from the dental practice in Staffordshire and 2 were from the 
practice in South East London. Four of the dentists were male, whilst two were female; 4 of 
the GDPs were from a British Asian background, whilst 2 GDPs were of White ethnic 
background. The mean age was 40 years, and the mean length of time since qualifying was 
9.3 years. All GDPs were practicing general dentistry, however, all practitioners specialised 
in other areas such as, cosmetic dentistry, implant dentistry and restorative dentistry.  
 
Part one: What are dental patients’ views on screening for diabetes in the dental 
setting? 
Five themes were identified reflecting patients’ thoughts about diabetes screening, and what 
their own individual experiences of it were in the dental setting: knowledge and seriousness 
of diabetes; diabetes screening worth; changes in perception of one’s susceptibility and risk; 





1. Knowledge and seriousness of diabetes 
Whilst the majority of dental patients were in agreement that diabetes is a serious condition, 
knowledge of what diabetes is, was overall quite poor.  
“Diabetes is when you need to take injections every day or tablets” (Patient 5, male, 
low risk) 
“yeah it’s from poor diet and being overweight” (Patient 9, female, high risk, GP 
attender) 
There was some understanding of causal factors and of what treatment for the condition 
usually entails, but there were also some incorrect descriptions of what the condition actually 
is and what it involves.  
 “It’s to do with the pancreas isn’t it, it doesn’t work properly and you need to have 
insulin. I know it’s serious.” (Patient 7, female, high risk, GP attender) 
“Too much sugar in your diet, too much chocolate!” (Patient 17, male, high risk, GP 
non-attender) 
Dental patients overall had very little idea of what diabetes is, and so were unaware of how it 
can affect their overall health.  
 
2. Diabetes screening worth 
Dental patients seemed to acknowledge that detection of diabetes would indeed lead to better 
health outcomes in terms of access to treatment and management options.  
“If you can catch it early enough, you can receive treatment and manage it.” (Patient 
8, female, high risk, GP attender) 
They acknowledged that detection would be the most important positive outcome from 
screening for the condition and that it could be seen as something rather routine in terms of 
health surveillance. 
 “It’s worth doing, just routinely to keep an eye on your health definitely.” (Patient 3, 




Several patients discussed positive outcomes of screening for diabetes regardless of the 
result; in that if they were screened for diabetes and found to be at a low risk, then they would 
feel some level of reassurance from the result. Similarly, if they were found to be high risk 
for developing diabetes, then such knowledge would lead to further necessary investigations.  
“It’s a win win sort of situation, you get screened, best case scenario, you’re all fine. 
Worst case, there’s something there, in which case, thank goodness you got screened 
so can get it checked out.” (Patient 12, male, high risk, GP attender) 
 
“It’s good because if there’s no risk found then you can rest assured and if not then 
you can receive further investigation and treatment. (Patient 6, male, low risk) 
 
However, not everyone saw such value in screening for diabetes.  Some patients felt there 
was not much point to getting screened for diabetes as it would by picked up by a GP 
anyway.  
“I just think my doctor would investigate if there was something he was worried 
about so it just seemed a bit pointless.” (Patient 18, male, high risk, GP non-attender) 
 
3. Changes in perception of one’s susceptibility and risk 
Interestingly, patients’ perceptions of their own risk of, and susceptibility to diabetes changed 
over the duration of the screening programme.  
- Perceived susceptibility 
Several patients reported feeling more or less susceptible to diabetes after receiving their risk 
result.  
“I didn’t realise I was at such a high risk before the tests, knowing that I 
actually am, that was a shock.” (Patient 10, female, high risk, GP attender) 
 
Patients described how they did not feel susceptible initially due to a lack of symptoms or 
risk factors that they were personally aware of, however, following the risk questionnaire and 
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finger prick blood test, they felt their perceived susceptibility changed after learning certain 
lifestyle factors would indeed increase risk of developing diabetes.    
“I hadn’t realised that my waist measurement was that big and that it would 
have so much of an influence on my risk than it did. I definitely thought well I 
don’t feel ill so I can’t be diabetic.” (Patient 11, male, high risk, GP attender) 
 
On the other hand, some patients reported feeling rather susceptible initially to the condition 
based on certain risk factors, and that they would have a much larger effect on their risk than 
they actually would. Therefore, after learning of their risk, they felt less susceptible to the 
condition.  
 
“I thought I would be at a higher risk than I actually was as I’m carrying 
more weight than I should be at the moment, so I was pleasantly surprised and 
a little relieved to be honest when you said I wasn’t really at risk.” (Patient 4, 
male, low risk) 
 
Here it seems that the screening result, which in this case was a low risk result, gave the 
patient some reassurance that their susceptibility to diabetes was not high.  
 
- Perceived risk 
As with susceptibility, several patients reported a change in perceived risk over the duration 
of the screening programme also. Some patients felt that following the personalised risk 
information, they felt more at risk of developing diabetes. 
 
“I guess I am more at risk than I thought I was.” (Patient 13, female, high 
risk, GP non-attender) 
 
On the other hand, others felt less at risk following their personalised risk result.  
“I feel better knowing I’m not at a greater risk than I first thought because of 




Some patients felt that by gaining an understanding of their risk, their perceived risk changed 
and they were able to make an informed decision about what needed to be done following 
receipt of such information.  
 
“I didn’t know that I was high risk before the screening and that the things on 
the questionnaire would affect my risk. I know now and that means I can go to 
my doctor and share my concerns now I know what affects my risk and what I 
need to do to improve my lifestyle like lose weight.” (Participant 12, male, 
high risk, GP attender) 
 
In most cases patients recalled their risk result correctly and discussed this in light of their 
perceived risk. However, one particular patient misunderstood their risk information. They 
described how their finger prick blood screening test was within a “normal range”, and so felt 
at low risk, despite the risk result from the questionnaire identifying a high risk of developing 
diabetes. This patient saw the finger prick test as more definitive. 
 
“Yeah I knew I didn’t have diabetes and then from your tests I am low risk 
because my blood test was within the normal range.” (Participant 15, female, 
high risk, GP non-attender) 
 
Here it seems that the patient has disregarded the high risk questionnaire result in favour of 
the low risk blood test result, despite the patient still being referred for further diagnostic 
testing based on their high risk FINDRISC result; most likely the reason for not attending the 
GP for follow-up as recommended.  
 
 
4. Acceptability of the screening programme 
Analysis of patient experiences of the screening programme conducted identified three sub-
themes; positive aspects; negative aspects; and emotional reactions from taking part in the 
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screening programme. Overall, patients described the screening programme as broadly 
acceptable and made some positive comments as to its usefulness and acceptability.  
 
- Positive aspects 
Some patients described how by receiving an invitation to take part in the screening 
programme, they felt it was a good idea to act on professional advice.  
 
“When I got the letter, I though how strange but if my dentist is asking me to 
go and thinks it’s a good thing then I’ll do it.” (Participant 4, male, low risk) 
 
This participant clearly sees their dentist as a meaningful healthcare professional.  
 
“I got a letter asking me to come for screening which was addressed from the 
researchers and my dentist and I thought I’d take what the professionals were 
suggesting.” (Participant 8, female, high risk, GP attender) 
 
Again, similarly, another patient described that after being told their initial risk was high and 
that a screening blood test was recommended, they went ahead with the second blood test 
because they felt it was good to act on the advice of the researcher who they felt was a 
knowledgeable professional. 
 
“I just thought, hey you know what you’re on about, you’re the expert, you 
said I need a blood test so I agreed and I just let you do the test.” Participant 
12, male, high risk, GP attender) 
 
Another patient felt that be offering the screening programme, their dentist obviously cared 




“I think it shows the dentist is enthusiastic and cares about my health and not 
just my teeth.” (Participant 6, male, low risk) 
 
Other positive comments were made regarding the screening programme. One patient 
described the idea of a ‘one-stop shop’. Demanding home and work lives of people means 
that time is probably an issue for many people. Combining several services was seen as 
convenient and time saving.  
 
“It’s like a one stop shop, everything under one roof. Get your teeth checked, 
see if you have diabetes. It’s a great idea!” (Participant 2, female, low risk) 
 
Patients also commented on the thoroughness of the screening programme. Here, one patient 
described how having two screening tests could only be seen as a good thing. 
 
“I liked the idea of two tests, it was very thorough, my answers to the 
questions let you start to see how I could be affected then the blood sample 
being taken let you look a little bit closer.” (Participant 7, female, high risk, 
GP attender) 
 
Others felt that it was a good idea to offer this kind of service outside of the GP practice to 
reach out to more people and take the strain off of the GP service whose workload was 
already stretched without trying to encompass screening for several conditions. 
 
“Offering this outside the GP medical practice is good as you can get more 
people involved with it who aren’t seeing their doctor regularly.” (Participant 
3, female, low risk) 
 
“Yeah it’s a good idea, the doctors at the surgery have enough work to 
contend with without checking for other illnesses so it’s good for it to be doing 




- Negative aspects 
Some patients did talk negatively about the screening programme they experienced. Negative 
comments tended to come from those who were found to be high risk for developing 
diabetes, downplaying the seriousness of their risk. For instance, patients talked about how 
they did not see the point of having to complete the questionnaire risk assessment if a second 
screening test, in this case, the finger prick blood test, was needed. They felt that that it would 
be better to do the more accurate test straight away.  
 
“I didn’t really see the point of the questionnaire if I needed the blood test, 
why not just skip straight to that?” Participant 14, female, high risk, GP non-
attender) 
 
“Just do the test that’s more accurate in the first place I think.”(Participant 
16, male, high risk, GP non-attender)  
 
Another patient described how they did not like having two screening tests as it just allowed 
them to become anxious in between the first screening result and waiting for the second 
screening result.  
 
“It just made me a bit anxious I think because after the first test I had to wait 
again knowing that you thought my risk was high and then waiting to see what 
the blood test was going to say.” (Participant 9, female, high risk, GP 
attender)  
 
Participants seemed to undergo a process of psychological adjustment in between the two 
screening tests without, as their perceived risk and susceptibility changed, to, for some, being 
faced with the possibility of having diabetes. 
 
- Emotional reactions from taking part in the screening programme  
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Several emotions were expressed when patients talked about their experience of taking part in 
the screening programme.  
One patient described feeling confident following her low risk result, suggesting that 
screening was beneficial to her.  
“You gave me a bit of confidence in my health I think, that my risk was low.” 
(Participant 2, female, low risk) 
 
Another described feeling relieved that after one screening test, there was no further action 
needed.  
“Oh yes it was a relief to be told I was ok and didn’t need to have any further 
tests.” (Participant 1, female, low risk) 
 
However, others described feeling of fear and worry at the thought of being at risk of 
diabetes.  
 
“I did feel rather worried when you said I should see the GP. He reassured me 
though when I’d had the blood test and he said it was all normal and that I 
didn’t have diabetes.” (Participant 10, female, high risk, GP attender) 
 
The quote below, although evidence of negative emotional reactions to the screening tests 
show that the nature of the step-wise screening programme used in the study enabled gradual 
psychological adjustment. The patient had to go through a process of readjusting their 
expectations of personal risk. 
 
“I felt a bit scared at first from my score on the questionnaire but then when 
you said the blood test was high too, I thought to myself gosh, what if I am 
diabetic? I panicked a little. I was worried so went to see my doctor like you 
said, and having his reassurance that the next test that he did was ok, I’m fine 





5. Reasons for GP follow-up attendance and non-attendance 
Due to the nature of the screening programme, those patients who were identified as high risk 
for developing diabetes based on the screening tests, were advised to visit their GP for a 
diagnostic test. Therefore, this final theme is expressed through the following sub-themes: 
‘Why I went to my GP’; and ‘Why I did not go to my GP’.   
 
- ’Why I went to my GP’ 
Often patients reported the need for reassurance and a sense of security that they knew they 
would get from their GP if they indeed acted upon the advice to seek a further diagnostic test.  
 
“I wanted the reassurance from my doctor.” (Participant 11, male, high risk, GP 
attender) 
 
Patients seemed to have trust in their GP to put an end to the screening programme and give 
them a definitive diagnostic result. They felt they needed final reassurance that they did not 
have diabetes.  
 
“I wanted to see the doctor myself so I knew then I was clear.” (Participant 12, male, 
high risk, GP attender) 
 
Patients also described the benefit of attending for reasons of early detection if necessary due 
to a lack of symptoms. 
 
“Yeah it’s good to get checked, I mean if my risk is high I need to know if I actually 
do have it because I don’t have the symptoms so I wouldn’t know if I didn’t get 
checked.” (Participant 10, female, high risk, GP attender) 
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The above quote also suggests that the patient had trust and confidence in the screening tests 
and the high risk result it had given, and acknowledged the importance of knowing about the 
presence of such a condition. 
 
Altruistic reasons were also given as the reason for attending for a diagnostic test. Some 
patients were motivated to seek a diagnostic test for the sake of their family. 
 
“I needed to know really. I mean, I have to care for my husband at home twenty-four 
hours a day so I can’t afford to be ill else I wouldn’t be able to look after him any 
longer.” (Participant 8, female, high risk, GP attender) 
 
“If I was diabetic, it would affect my children wouldn’t it. I need to know if I have 
something that would impact on them or increase their risk in the future.” 
(Participant 7, female, high risk, GP attender) 
 
A popular reason for attending was because patients knew others who have or had diabetes so 
they understood the seriousness of the condition. Having known friends or relatives with 
diabetes led to a strong desire to prevent a similar fate for themselves.  
“My friend is diabetic; she suffers awfully because of it.” (Participant 9, female, high 
risk, GP attender) 
 
“My father had diabetes when he was alive, so I know what it can do to you. He lost 
his legs.” Participant 11, male, high risk, GP attender) 
 
Finally, several patients explained that the reason for their attendance at the GP for follow-up 
was because they perceived their risk of diabetes to be high and they felt more susceptible to 
diabetes. This knowledge of their personal risk lead them to follow the advice they had been 





“I think I went because I felt my risk was probably high after seeing you and doing 
the tests.” (Participant 12, male, high risk, GP attender) 
 
“Yeah I went because you said my risk was high on both tests and you recommended I 
go and have another blood test so I just made an appointment as soon as I could. It’s 
a good job I did isn’t it.” (Participant 9, female, high risk, GP attender) 
 
 
- ‘Why I did not go to my GP’  
Those patients who did not follow the advice to attend for GP follow-up reported several 
reasons for not doing so. One patient put it down to having low perceived risk and therefore 
did not feel the need to seek further investigation, despite the fact that the screening 
questionnaire identified a high level of risk.  
 
“I know myself that my risk is low, so no I’m not at risk of it.” (Participant 16, 
male, high risk, GP non-attender) 
 
There was evidence of denial and avoidance in some patients’ explanations for not going for 
GP follow-up. They downplayed the personalised risk information they had been given due to 
a lack of symptoms and feeling well in themselves.  
 
“No I feel fine, like I don’t think I’ve got any of the symptoms so I doubt I’ve got it, I 
think I’m at low risk of it.” (Participant 14, female, high risk, GP non-attender) 
 
“I don’t have it, I know I don’t because I feel fine and I’m fit and healthy. You 
wouldn’t if there was something up would you?” (Participant 18, male, high risk, GP 
non-attender) 
 




“No one in the family is diabetic, so I doubt I’d get it.” (Participant 15, female, high 
risk, GP non-attender) 
 
“I didn’t think there was much point in going, I mean there isn’t a history in the 
family of it so no I didn’t think I needed to.” (Participant 13, female, high risk, GP 
non-attender) 
 
There were also reasons for non-attendance that seemed to be external to the individual. 
Several external barriers were given by non-attenders as reasons for not seeing their GP for 
follow-up. One of these barriers was a lack of time to see the GP due to work commitments.  
 
“I work Monday to Friday eight till six. I can’t spare the time off unless I’m really 
ill.” (Participant 18, male, high risk, GP non-attender) 
 
Additionally, there was a general dissatisfaction in some patients with their GP practice and 
appointment system.  
 
“You want to try getting an appointment at my doctors’ surgery, it’s ridiculous! You 
can never get an appointment, even when you’re on deaths door.” (Participant 17, 
male, high risk, GP non-attender) 
 
Finally, whilst being rather belief-based, one patient described that having to make the 
follow-up appointment themselves made it seem unimportant. The was a lack of seriousness 
and importance placed on the responsibility of seeking a follow-up diagnostic test if the GP 
wasn’t going to get in contact with them. 
 
“Because you said to make the appointment myself, it just made it seem like it wasn’t 
that important if the GP wasn’t gonna follow it up and contact me” (Participant 15, 




Part two: What are dentists’ views of screening for diabetes in dental settings? 
Thematic analysis revealed two themes that reflected diabetes and its association to dentists 
as healthcare professionals: Diabetes as a major health concern; Dentists as responsible 
healthcare professionals. In addition, two themes were identified which reflected an 
evaluation of the screening programme conducted: Ideal screening method to be easy, quick 
and can be administered by anyone; Limitations of such a screening programme.  
 
1. Diabetes is important in the dental setting. 
Dental practitioners acknowledged that diabetes is a major health concern by reflecting on the 
knowledge that diabetes is a condition that is increasing in prevalence.  
 
“The number of people developing it is definitely increasing. It’s becoming so 
common, it’s worrying” (Dentist 2, Staffordshire) 
 
This can be seen again in the comment below too.  
 
“We’re seeing more and more people marking it on their medical history forms.” 
(Dentist 3, Staffordshire) 
 
Dentists also commented on their awareness of how diabetes affects other aspects of a 
person’s health. This demonstrated that dentists seemed to have a good working knowledge 
of how diabetes affects a person’s oral health. “ 
 
We know; It’s well documented you know, that diabetes affects other aspects of a 
person’s health, and we know it can impact upon the oral health of a person in 
several ways.” (Dentist 6, London) 
It was also mentioned by dental practitioners that diabetes was a condition that was 
specifically documented in dental records and important to know. Dentists from the practice 
in Staffordshire described how the condition features on the medical history form that 
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patients complete or update before their appointment. Likewise, Dentists from the practice in 
London stated that there was a specific function on their computer software that allowed them 
to note a patient’s diagnosis of diabetes. 
“That’s why we ask about a history of diabetes on our medical history form that all 
patients have to complete; it’s major, it’s essential to know isn’t it” (Dentist 1, 
Staffordshire) 
 
It was evident that knowing a patients’ diagnosis of diabetes was important in the dental 
setting for potential treatment.  
“Our patient medical history form requires patients to explicitly state if they have 
diabetes or not” (Dentist 4, Staffordshire) 
Dentists from the practice in Catford stated that there was a specific function on their 
computer software that allowed them to note a patient’s diagnosis of diabetes. Dentists 
seemed to demonstrate that diabetes is a condition that is well documented in a patient’s 
dental notes so that they are aware of its existence and importance to a patient’s overall 
health.  
 
2. Dentists as responsible Healthcare Professionals 
It was common for the dentists to acknowledge responsibility and that there is a place for 
them to intervene and be involved with diabetes screening or management of the condition.  
“When it’s linked to what we know and what we do, of course we should be involved 
in detection and management.” (Dentist 5, London) 
 
“We have a responsibility, a duty of care to our patients to ensure their health is the 
best it can be. I know I am responsible for my patient’s oral health but if I can help in 
any other aspects of their health when I see them, then yeah, I’ll feel it’s my 




“I told a patient the other day that they should probably see their GP to get tested, if 
they’re showing signs of diabetes risk then I’m definitely responsible to recommend 
screening or follow-up.” (Dentist 1, Staffordshire) 
 
Dentists also talked about the significance of having a good rapport with patients and how 
this would help patients to understand the importance of the risk of diabetes that was being 
conveyed to them.  
“When you get on with patients, they trust you, they accept what you tell them 
whether that be to use a certain product or whether they risk developing diabetes; 
they’ll listen and hopefully do something about it.” (Dentist 2, Staffordshire) 
 
The dentists expressed a belief that a good rapport would lead to patients accepting advice 
given by them and follow up any recommendation given; in this case, to follow up screening 
tests with diagnostic tests from their GP. The following quotes below are an example of this.  
 
“I’d like to think if I told one of my patients they might be at an increased risk of 
diabetes, they’d see I was being responsible for their overall health as well as their 
oral health and go see their doctor.” (Dentist 3, Staffordshire) 
 
 
3. Ideal screening method to be easy, quick but thorough, and can be administered by 
anyone 
Dentists described their experience and views on the screening method that was conducted at 
their practices. They described the screening programme as ideal in that it was quick and easy 
and that it needed to be able to be administered by anyone who needed to do so. 
“I was really impressed with the screening protocol that was done here. It was quick 
and easy, and the patients seemed to approve.” (Dentist 5, London)  
Overall, the dentists had positive comments about the screening programme conducted at 
their practice. They liked the idea of the initial risk assessment questionnaire because of its 
ease and non-invasive nature.  
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“Yeah the questionnaire is great; it’s easy to do isn’t it for patients, like it’s not 
invasive is it so it’s good…most people can manage that.” (Dentist 4, Staffordshire) 
They felt that the majority of patients would be happy to complete a questionnaire of this 
nature. 
“The questionnaire…yes anyone can get the patient to fill it out; that’s the main 
advantage I think.” (Dentist 6, London) 
 
Dentists also commented on the use of having two screening tests and that it was a good idea 
as it gave their patients the feeling of more options.  
“Two different screening methods looks more thorough; it shows we are taking it 
seriously.” (Dentist 3, Staffordshire) 
 
“Yeah like I think it’s good that there’s two tests, you don’t have to do both if you 
don’t want. Patients will like that I think.” (Dentist 1, Staffordshire) 
 
“A questionnaire followed by a finger prick blood test I think is a good combination 
you know.” (Dentist 6, London) 
 
Although the use of two tests was favoured by dentists, some believed that the finger prick 
tests would be seen to have more credibility or importance by patients.  
 
“The questionnaire is good for speed and a quick assessment of risk, but I think 
patients see the blood test as more reliable, like that’s the result they’d pay attention 
to most, it’s like its more official; like that’s what their GP would do you know.” 
(Dentist 4, Staffordshire) 
 
Several of the dentists described how they had received positive feedback from their patients 
about their experience of the screening programme. It was conveyed as being patient-friendly 




“We’ve had some great feedback from patients…like how it’s quick and easy to 
complete and that.” (Dentist 1, Staffordshire) 
“I had patients say how easy it was to do, and that it was a good idea” (Dentist 5, 
London) 
 
“They seem to really like the idea” (Dentist 2, Staffordshire) 
 
Some of the dentists talked about the idea that the screening programme was a way of 
working together with a patients GP by working together with a patients GP on something 
that affects the work of both professionals and that there is some level of shared 
responsibility.  
“Referring at risk patients to their GP for diagnostic testing is a good collaborative 
approach” (Dentist 6, London) 
“It’s kind of reassuring that we can let GPs know of any patients we are concerned 
about to follow up. We can just screen for risk, then let the GP know and so they can 
check and diagnose. We can work together.” (Dentist 2, Staffordshire) 
 
4. Limitations of such a screening programme 
Although dentists generally talked about the screening programme positively, they did 
acknowledge several limitations that would need to be addressed.  
Funding and cost of running the screening programme was a limitation that was mentioned 
by all dentists interviewed. Dentists were concerned about who would cover the cost of 
equipment and materials used and the costs of administration for conducting the screening 
programme.   
“It’s all money isn’t it; it all costs.” (Dentist 4, Staffordshire) 
 
“The thing is, who’ll cover the cost for the screening to be done if this were to 




“The problem is who pays for it; we would need some kind of funding from 
somewhere” (Dentist 1, Staffordshire) 
 
Other practicalities such as a specific location in the dental setting for screening to take place 
was an issue raised with the dentists. If it was someone other than the dentist doing the 
screening, then the dental surgery itself is not necessarily practical. Privacy would also be 
needed too, therefore a private consultation room would be more ideal.  
 
“Do we have a special area dedicated for screening to be done, in surgery, in 
an office; where; it’s those practicalities that need addressing too” (Dentist 5, 
London) 
 
Another limitation that was discussed was the issue of time.  
“Time is a big issue; we are a busy practice…appointment length for NHS patient 
appointments are short as it is.” (Dentist 6, London) 
 “It’s all extra time isn’t it.” (Dentist 1, Staffordshire) 
 
They acknowledged the fact that patients needed to arrive early in time to participate before 
their appointment, and the importance of keeping to time so not to interfere with time set 
aside for the actual dental appointment where in the case of NHS patient appointments, the 
appointment length is already short and time is precious.  
 
“We asked people to arrive early specially to take part didn’t we, but we couldn’t 
realistically do that, or could we? I’m not sure.” (Dentist 3, Staffordshire) 
 
Finally, the idea of lack of man-power to administer the programme was addressed by 
dentists. There was concern over who would dedicate the time to carry out the screening. 
They questioned who’s job role it would come under, and also whether a dedicated member 
of staff would be needed to take on the responsibility of the work needed to go into running 
the screening programme successfully.  
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“Right now, we don’t have the man-power to properly carry this out currently…. not 
someone dedicated to do this properly……not with all the administration that goes 
with it.” (Dentist 6, London) 
 
The dentists did not want any of the responsibility for conducting the screening programme 
themselves or the workload that would be involved. They saw it as a job responsibility that 
another member of the team would need to take on.  
“The downside I guess is who would be in charge of doing it….in who’s job 
description?” (Dentist 1, Staffordshire) 
 
Discussion 
The aim of this study was to explore dentists and patient’s views and experiences of the 
feasibility and acceptability of screening for diabetes in dental settings. To date, research in 
the area has been limited; largely relying on brief self-administered questionnaires (for 
example, Greenberg et al. 2015) or lacking experience of being involved in a screening 
programme itself (for example, Creanor et al. 2014). Therefore, this study represents a unique 
contribution to the understanding of dentist and dental patients’ actual experiences of 
screening for diabetes in the dental setting, and further, explores why dental patients did or 
did not follow up screening test results with diagnostic tests at their GP surgery.  
The qualitative analysis revealed that knowledge of diabetes seemed to be high in the dentists 
interviewed and that they were aware of the seriousness of diabetes to their patients, therefore 
highlighting the importance of the condition featuring in the education of dentists. Dentists 
were aware of the increasing rates of diabetes and its relationship to oral health. Their 
knowledge and understanding therefore seems to be the reason behind why their practice 
involves noting the presence of diabetes when collecting a patient’s medical history 
information.   
In contrast, whilst all of the patients said that they had heard of diabetes, correct knowledge 
of what the condition was somewhat poor, although there tended to be some agreement over 
the seriousness of the condition. Some of those interviewed were aware of the causal factors 
and treatments for diabetes, however, overall this finding is in line with previous research 
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suggesting that the general populations’ knowledge of diabetes and its risk factors and 
complications is low (Deepa et al., 2014; Diabetes UK, 2000).     
The dentists demonstrated in the interviews that they believed dental practitioners were 
responsible healthcare professionals who were accountable for all aspects of their patients’ 
health where able and not just for their oral health. They also believed that having a good 
rapport with their patients would assist in being a responsible healthcare professional and that 
it would make it easier to talk to their patients if they had a good relationship with them as 
they would be more likely to take any advice given to them on board. Establishing rapport is 
an important step in the communication between doctor and patient, resulting in a positive 
effect on patient satisfaction and overall clinical outcomes (Al Ali & Elzubair, 2016). Good 
doctor communication skills are important in all aspects of patient care, including the dental 
setting. Good rapport helps to achieve an accurate diagnosis, build trust with patients, and 
improve compliance to treatment, overall patient satisfaction, and therapeutic outcome (Beck, 
Daughtridge, & Sloane, 2002). Dentists tend to focus on the diagnosis and treatment of oral 
diseases and tend to overlook their patient’s other health problems, which are regarded the 
responsibility of medical practitioners. Likewise, doctors too tend not to deal with the oral 
health problems of their patients (Lo, 2014). Dentists in the current study believed that by 
screening for diabetes, they were working together with their patients GP, and that there was 
a shared level of responsibility. Oral health and systemic health are closely related (Lalla et 
al., 2011). These health problems can only be satisfactorily managed by treating both the oral 
disease/problem and the systemic disease at the same time through collaboration between 
dental and medical practitioners (Lo, 2014). 
With regard to dental patients, whilst some did not see the worth of diabetes screening, the 
majority of those interviewed reported that screening for the condition was worthwhile, 
acknowledging that detection of diabetes would lead to better health outcomes. Again, this 
adds to previous research which found that in general, dental patients support the concept of 
diabetes screening in a dental setting (Creanor, 2014; Rosedale & Strauss, 2012). Here, some 
patients described the benefit of screening to be a win-win situation in that the outcome of 
knowledge of one’s risk could only be seen as a positive outcome, despite the result.  
The screening programme conducted in this research study was overall acceptable to dental 
patients with the majority of those asked recalling only positive experiences. The finding here 
adds to the previous research by indicating that patients found diabetes risk screening showed 
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the dentist was taking an interest in their overall health, therefore increasing satisfaction with 
the overall experience. Research suggests that patients have more confidence in dentists who 
have the ability to communicate care and compassion (Epstein 2003). Patients tended to 
believe it was a good idea to be screened and therefore acted on the advice to do so, therefore 
demonstrating the importance of satisfaction on adherence. Dentists have an ethical 
obligation and a duty of care to protect the well-being of their patients. A screening procedure 
to detect a serious, underlying, undiagnosed systemic condition, and that does not cause any 
harm to the patient, is in the patient’s best interests (Sultan et al., 2014). This was apparent in 
the discussion of the acceptability of the screening programme by dental patients.  
Traditionally, research has shown that the more invasive a screening test is, the more accurate 
it is perceived to be. An example of this was seen when compared with colonoscopy, an 
invasive colorectal cancer screening test, stool-based DNA testing, a far less invasive 
screening tool, received more favourable ratings on preparation and test-related features such 
as sample collection, perceived embarrassment and anxiety except for perceived accuracy, 
where the more invasive test, colonoscopy, was rated higher than the non-invasive test 
(Schroy & Heeren, 2005). In the current study, it seems that some patients agreed with this 
notion as some negative views that were expressed, were concerned with the idea of having 
to complete the questionnaire if a second screening test was still needed. It seems that these 
patients thought it was better to just do what was perceived as the more accurate test, which 
in this case was the invasive finger prick blood test.  
In contrast, dentists liked the idea of an easy to administer questionnaire and having two tests 
for patient choice as opposed to just one, but with that came the need for reliable measures to 
be used and so dentists too felt that the finger prick blood test would be seen as more reliable 
and believable. Dental practitioners also agreed that the best screening method would be one 
that is quick and easy to administer, and one that anyone in the practice could administer. In 
this study the procedure was conducted by the researcher. Dentists appeared to like the idea 
of having someone else being able to carry out the screening measures on their patients rather 
than them having to do it themselves. They reported that patients had responded positively to 
the screening tests in discussions with them and so they placed an importance on the need for 
patient-friendly screening tests. Previous research has suggested that, whilst uptake may be 
influenced by the method used for screening, with less invasive methods associated with a 
higher uptake (van den Donk et al., 2011), greater perceived accuracy is placed on more 
invasive measures used (Schroy & Heeren, 2005). Finally, in evaluating the screening 
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method used, dentists seemed to feel a level of reassurance in referring their at-risk patients to 
the GP for further diagnostic testing. It was a way of helping patients identify any risk of 
diabetes without having to be responsible for, and involved in diagnosing the condition.   
 
Dentists also discussed the limitations of the screening programme used. Whilst the 
programme was readily accepted by the dental practitioners, they were concerned about 
several issues: time taken to screen patients, the cost of offering such a service to their 
patients and having enough staff to carry out the duties involved in conducting such a service. 
It is well known that appointment times for NHS patients are short, and that dentists are 
pushed to carry out their work in such a short space of time allocated for appointments 
(Newton & Gibbons, 1996). Dentists were also concerned about having to find funds for such 
a service and that their NHS budget was already tight. Finally, whilst they liked the idea of a 
screening method that could be administered by any member of staff, they were concerned 
about having a member of staff available to carry out the screening. Extra duties might mean 
having to cut other responsibilities of some staff, or it may involve having to increase staff 
numbers in order for someone to be able to be fully responsible for the screening programme 
and the administrative duties that come with it.   
Individuals can react with concern, anxiety and even depression when informed that they 
have an elevated risk of developing a disease (Collins, Wright, & Marteau, 2011). This 
distress can potentially interfere with the processing of the screening information such as risk 
results and hence the ability to be reassured or to make informed choices regarding future 
screening, follow-up or treatment. There was a mix of emotional reactions report in the 
results of this study. Positive emotions such as reassurance and relief were reported however, 
fear and worry were some of the negative emotional reactions to screening that were reported 
also. Interestingly, the dentists did not mention the possibility of negative reactions to the 
screening.  It is not known whether the negative emotional reactions were short lived or not, 
however, several reviews in the area of psychological effects of screening suggest that any 
report of distress are not sustained long term (Collins et al., 2011), and of more significance, 
screening for type 2 diabetes has limited psychological impact on patients (Eborall et al. 
2007). However, if dental practitioners are not consciously aware of any possible negative 
reactions to screening and its outcomes, it could mean that patients would not value their 
dentist and any rapport that has been built could be lost. On the other hand, dental 
practitioners may hold the belief that they have an ethical obligation and a duty of care to 
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protect the well-being of their patients, and when it comes to a screening procedure to detect 
a serious, underlying, undiagnosed systemic condition such as diabetes, the benefit to a 
patient outweighs any potential negative reaction. 
Patients reported that their perceived risk and susceptibility changed over the duration of the 
screening programme. This seemed to be coming from learning of one’s risk and the 
knowledge of risk factors that was seen from the screening questionnaire. This finding may 
show some support that perceived risk and susceptibility are in some way linked and have an 
association with screening participation, in that by participating in screening, a patient 
becomes aware and starts to think about how a particular condition, in this case, diabetes; can 
affect their health.  
When discussing how their perceived risk changed over the duration of the screening 
programme, some patients recalled their risk information. Research has demonstrated that 
memory for medical information is a prerequisite for good adherence to recommended 
treatment (Kessels, 2003); in this case, seeing their GP for diagnostic follow-up. According to 
Ley’s model of effective communication in medical practice (Ley, 1988), a significant 
proportion of the variance in compliance to medical advice can be accounted for by 
comprehension and memory, but research suggests that medical information tends to be 
forgotten immediately (Kessels, 2003). However, in this study, there was evidence of 
accurate recall of risk information by some patients. In the case where one patient 
inaccurately recalled the information given, the patient had misunderstood the risk 
information, downplaying it which lead to not adhering to the recommended advice to seek a 
diagnostic test from their GP.  
There were several reasons given for attending or not attending the GP follow-up from those 
interviewed where it was recommended they do so. The fear of life threatening underlying 
disease has been reported to be a reason to seek help or advice (Wareing, 2005).  
Reasons given in this study for attendance included the need for reassurance, the importance 
of early detection, altruism, high perceived risk, knowing others with diabetes, and simply 
following the recommendation to do so. Eborall et al. (2007) reported similar findings in that 
diabetes screening participants talked about diabetes screening being a good thing as it 
enabled the disease to be detected at an early stage. Altruism  has often been a reason given 
for participating in cancer trials (Jenkins et al., 2013), however, altruistic reasons have also 
been given for lung cancer screening participation (Patel et al., 2012). In this qualitative study 
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looking at attitudes to participation in a lung cancer screening trial, the authors found that 
altruism was expressed by participants as the desire to help other people by taking part in the 
research and also as helping relatives by reassuring them that they did not have lung cancer. 
The finding that some patients reported attending the GP for diagnostic follow-up because 
they perceived their risk to be high, or because they were simply following the advice to do 
so suggests that these patients had some level of belief and credibility in the risk information 
they had been given. This finding is in contrast to a suggestion made by Eborall et al. (2007) 
that there may have been a lack of accepted professional understanding as the authors 
reported that participants with either some level of impaired fasting glucose or impaired 
glucose intolerance or those who tested negative for diabetes tended to downplay their risk, 
had no intention to change their lifestyle and lacked awareness of a diagnosis.  
For publicly funded healthcare systems such as the NHS in the UK, when assuming adequate 
healthcare services exist to meet patient demand, access to these services is primarily 
dependent on patients’ decisions (Shaw, Brittain, Tansey, & Williams, 2008). In this study, 
reasons for non-attendance for GP diagnostic follow-up in those patients who were 
recommended to do so included low perceived risk and severity, denial, and the belief that a 
lack of family history of diabetes was a protective factor. The latter supports the notion of 
unrealistic optimism; a cognitive bias that causes a person to believe that they are less at risk 
of experiencing a negative event compared to others. It has been shown that highlighting 
previously unknown risk factors for diseases is ineffective at altering peoples’ optimistic 
perception of their medical vulnerability (Sharot, 2011). Underestimating risk is also thought 
to potentially reduce precautionary behaviour such as attending medical screenings (Sharot, 
2011). This could therefore explain why those patients who believed that a lack of family 
history of diabetes was a protective factor did not attend for diagnostic follow up at the GP 
surgery.  
 
In the wider literature, reasons given for non-help-seeking are often that symptoms are too 
mild, or not felt to be serious enough (Scott & Walter, 2010; Teunissen & Lagro-Janssen, 
2004). This reason was somewhat reflected in the findings of this study in that severity of the 
disease was not enough to make the high risk patients attend the GP as recommended. A lack 
of symptoms was also reported as a reason for non-attendance in this study too. 
Unfortunately, as diabetes often occurs without the known presence of symptoms, this will be 
a barrier that will be hard to overcome unless addressed directly. Additionally, a lack of 
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awareness of both symptoms and treatment has been identified as barriers to help-seeking 
(Horrocks, Somerset, Stoddart, & Peters, 2004; Moser et al., 2006; Smith, Pope, & Botha, 
2005; Teunissen & Lagro-Janssen, 2004). Therefore, often if symptoms do occur in those 
with undiagnosed diabetes, they are not easily recognised by the patient as a symptom, 
therefore there is a need for greater education and awareness of diabetes, its seriousness and 
its symptoms. 
Previous negative experiences with health care providers (Rickwood, Deane, Wilson, & 
Ciarrochi, 2005; Teunissen & Lagro-Janssen, 2004) has also been reported in the literature as 
a barrier to help-seeking behaviour. In this study, participants described negative experiences 
with being able to make an appointment to see their GP. Whilst there may be other factors 
contributing to their reason for not seeing their GP for a diagnostic test as recommended, this 
is something that is almost out of the patients control as they are reliant on their being an 
adequate service provision to meet patient demand for appointments. Another common 
barrier to seeing a physician is a doctor’s lack of responsiveness to patient concerns 
(Fitzpatrick, Powe, Cooper, Ives, & Robbins, 2004). Satisfaction with provider services may 
therefore impact perceptions of access to health care (Akinci & Sinay, 2003) and play a part 
in a patient deciding whether to seek help from their GP. 
In a study carried out by Zhang and colleagues in the US, using a nationally representative 
sample, they found that lack of access to care significantly elevated the risk of going 
undiagnosed with diabetes. Limited access to health care, especially being uninsured and 
going without insurance for a long period was significantly associated with being a “missed 
patient” with diabetes (Zhang et al., 2008). In contrast, this is something that the UK 
population do not have to concern themselves with due to the provision of the NHS providing 
free healthcare for all. Therefore, this barrier should not apply to patients in the UK.  
 
 Strengths and weaknesses of the study  
Qualitative methods are well suited to exploring attitudes and opinions. Data saturation was 
achieved and a range of participants who participated in the screening programme were 
interviewed. Whilst the validity of the findings was not checked through respondent 
validation by feeding findings back to a group of respondents, the interviews were digitally 
recorded and transcribed, thus eliminating potential bias through note-taking during 
interviews and steps were taken to ensure the credibility of the analysis.  
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Although questions were aimed at participants’ experiences of diabetes screening and seeking 
further diagnostic tests for diabetes where necessary, it must be borne in mind that whilst the 
findings may apply beyond screening for the possible presence of diabetes, they may only be 
representative of screening behaviours in patients at risk of developing a particular condition. 
Findings must, therefore, be corroborated in other clinical and non-clinical groups. It could, 
however, be considered a strength that all participants had experienced screening and risk 
assessment and possibly diagnostic testing in a similar context (following initial diabetes 
screening at the dentist) to allow comparison between participants. 
Age may also affect attitudes to health care and this study only sampled participants aged 
over 45 years due to the inclusion criteria set in the previous quantitative study from which 




The significance of reflexivity in qualitative research is well known. It is important to know 
how my position might have shaped the research process and outcome and acknowledge an 
important dimension of the research process and enhance the transparency of the research.  
My own experiences of diabetes are what gave me interest in pursuing this study. My own 
mother has had diabetes for the whole of my life and growing up with a parent living with the 
condition has allowed me to see the negative effects it has on a person, long term. It has made 
me aware of how serious diabetes can be, and its complications. As a trainee health 
psychologist, I understand the importance of screening for disease. Therefore, knowing the 
seriousness of diabetes and the importance of early detection, I myself would pursue any 
screening available and would follow advice following risk assessment. Having this personal 
experience of diabetes did make me feel disheartened if a participant downplayed the 
seriousness of the condition or dismissed the risk information or advice to seek further 
diagnostic tests. On the other hand, I felt really pleased when participants discussed how they 
understood their risk of diabetes and followed up the advice to seek further diagnostic testing. 
I think this positivity came across in my interviews when speaking to those who followed up 
my advice.   
My personal assumptions before conducting this study were that I would be met with 
participants not wanting to be interviewed. However, the majority of patients approached 
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were happy to be interviewed and this made the interview process pleasant and interesting. I 
felt at ease interviewing dental practitioners as I had been working alongside them for some 
time and had built a great rapport with all staff, and so they felt relaxed; this made me feel 
that what they were telling me actually was what they thought, rather than what they thought 
I may have wanted to hear. Whilst my rapport with them made the interviews seem informal, 
I was able to gather their thoughts and experiences on the screening conducted and their 
opinions and suggestions for its success in the future  
As the researcher for the project, I was the one to take participants through the process of the 
study from information and consent, to diabetes screening and through to follow-up 
interview. Being a part of the journey of the participants through the study meant that 
participants had got to know me at the dental practice if they were returning for further 
treatment with the dentist and when speaking with them on the telephone to record their 
follow-up outcome or interview them. I believe this enabled me to build rapport and allowed 
participants to talk to me as more of a member of the dental practice team rather than a 
researcher external to their dental practice. I think this made them feel a bit more comfortable 
talking to me about what they actually thought and had experienced as opposed to wanting to 
please the researcher by saying what they thought the researcher wanted to hear, although this 
may have been the case.  
After transcribing the data and when analysing and interpreting the data, I realised that some 
people really did not seem to have been affected in the way I would have hoped by the study; 
in that they still did not really see much point to diabetes screening and were not at all 
bothered by their risk results, whether they were high or low. By having these opinions and 
experiences though, it helped me realise that not everyone thinks about diabetes and its 
effects on a person like I do, and that helped me to not focus more so on the positives of the 
screening procedure that other talked about just because I shared the same views.  It was 
important to reflect on these responses in the results as well as the ‘success stories’. 
 
Conclusion 
Many dental patients and dental practitioners believe that the dental visit is an opportune site 
for diabetes screening. By exploring both dental patient and practitioner experience, this 
particular screening diabetes screening method has been shown to be well tolerated, 
convenient and largely acceptable to patients. Several reasons for attendance and non-
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attendance at the GP for diagnostic follow-up were identified by patients and practical 
limitations were noted by dental practitioners who experienced the screening method within 
their practice. This has implications for the uptake of screening within dental practice and 






Summary of Findings  
The overall aim of the research outlined in this thesis was to investigate the impact of using a 
self-report screening measure and HbA1c information as preliminary screening tools for 
possible diabetes in general dental practice, on patients’ health behaviours. The primary 
outcome of the study was uptake of further diabetes diagnostic testing by the patients GP. A 
secondary outcome of the study was the ability of psychological variables to predict and 
explain uptake of further diagnostic testing following the receipt of a positive risk result 
either the FINDRISC along or with the addition of a positive risk result on the finger prick 
HbA1c blood test. Therefore, in order to address these outcomes, several research questions 
were set to be answered through conducting the studies in this thesis.  
 
After an introduction to the topic of screening for diabetes in dental settings, chapter 3 
addressed the first research question- 
What is the most effective way to communicate individualised risk information to maximise 
either actual screening uptake or psychological predictors of screening uptake? 
The question was answered through conducting a systematic literature review which found 
that individualised risk communication is more effective than generalised risk information or 
no risk information at increasing screening uptake or resulting in better psychological 
outcomes. Whilst presenting individualised risk information in written format and expressing 
the risk as an individualised score or category may be more effective at increasing screening 
uptake, the results suggested that more complex interventions, with more intervention 
components such as counselling or education, are no more effective than more simple 
interventions.  These findings were then used to create the risk communication intervention 
which was designed to try to answer the subsequent questions. 
 
Chapter 5 addressed further research questions. The first question tackled in this chapter was-  
What proportion of dental patients accept an offer to be screened for type 2 diabetes in a 
primary care dental setting? 
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The results of the first part of the quantitative study showed that N=3700 NHS and private 
patients had a dental appointment during the 118-day recruitment period. N=2109 patients 
were excluded as they were either under 45 years of age (n=1888), did not speak fluent 
English (n=59), or already had diabetes/ pre-diabetes (n=162). A further 556 potential 
participants were not asked to take part as they either did not attend their appointment 
(n=121) or practically could not be tested by the single researcher (n=435).  
Of the remaining 1035 patients, 520 (50.2%) consented to participate and completed the 
FINDRISC screening questionnaire. Five hundred and fifteen patients refused to participate 
in the study. The main reasons for refusal were, a recent blood glucose test, a recent health 
check-up such as the Well Man’s Check arranged through the GP, dental pain and fear, and 
lack of interest in the research. 
 
Following this, the next research question addressed was- 
What is the risk of type 2 diabetes in primary care dental patients as assessed through self-
report and physiological measures? 
Two hundred and sixty-two participants scored below the cut off score of 10 on the 
FINDRISC questionnaire, and therefore were not offered any further screening. N=258 
patients were found to be at risk of developing diabetes based on the current recommended 
FINDRISC cut off score of 10, and so were offered the further screening test, and advised to 
visit their GP for formal diagnostic testing. The majority of participants (n=247, 47.5% of 
those who took part) fell into the slightly elevated risk category, whilst N=101 (19.42% of 
those who took part) fell in the low risk category and N=172 (33%) were seen as having a 
moderate, high or very high risk of developing diabetes. Of the N=258 found to be at risk of 
developing diabetes on the FINDRISC, the majority (N=242, 93.8%) accepted and received 
the further screening HbA1c test. On this A1c test, 10 participants (4.13% of those who took 
the test) had a result of ≥6.5%, 108 participants (44.6% of those who took the test) had a 
result of between 5.7% and 6.4%, whilst 124 participants (51.24% of those who took the test) 
had a result of less than 5.7%. 
 
Finally, the chapter addressed another research question- 




Of the N=259 participants who were advised to visit their GP for formal diabetes testing, 
N=155 (60%) contacted their doctor regarding an appointment for further testing. 
There was a significant association between the number of ‘at risk’ screening results a person 
received and whether or not a patient would follow recommendation and contact their GP. 
Furthermore, the number of positive risk scores significantly influenced GP contact; patients 
were more likely to contact their GP if they had received two positive risk scores. The odds 
ratio of patients contacting the GP was 3.38 times higher if they were referred with two 
positive risk results (both a positive FINDRISC and positive HbA1c risk result) as opposed to 
just one (a positive FINDRISC but negative HbA1c). 
 
Chapter 6 then addressed two research questions. Firstly-  
What is the psychological profile of patients at risk of diabetes?  
Using the CES-D as a tool for detecting mild clinical depression, the mean score on the CES-
D in those found to be at risk of diabetes on the screening measures was below the cut-off of 
16, suggesting that, in this sample, those who were found to be at risk of developing diabetes, 
overall, did not have a score above the cut-off value for clinical depression. The participants 
found to be at risk of diabetes showed high levels of the belief of diabetes severity, and 
intention to have a diagnostic test but those participants who contacted their GP following 
screening felt significantly more vulnerable towards developing diabetes and significantly 
more fearful of the condition than those who did not contact their GP as advised to do so 
following screening.   
 
The chapter then analysed the following question- 
To what extent do psychological variables predict post-screening further testing or health 
behaviours?  
The results of a binary logistic regression suggested that a high risk dental patient’s fear of 
diabetes score and vulnerability to diabetes score were able to significantly predict whether a 
patient contacted their GP.  This means that the more vulnerable people felt about the chance 
of developing diabetes in the future and the more fearful they were of the disease, the higher 
the chance they would make contact with the GP to arrange diagnostic testing. 
 
A final research question was addressed in chapter 7, whereby, qualitative data was collected 
to try to answer- 
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What are patients’ and dentists’ views on the practicalities of screening for diabetes in dental 
settings, and can this help to further explain post-screening further testing or health 
behaviours?  
Interviews with both GDP’s and dental patients found that many dental patients and dental 
practitioners believe that the dental visit is an opportune site for diabetes screening. By 
exploring both dental patient and practitioner experience, this particular screening diabetes 
screening method has been shown to be well tolerated, convenient and largely acceptable to 
patients. Several reasons for attendance and non-attendance at the GP for diagnostic follow-
up were identified by patients and practical limitations were noted by dental practitioners 
who experienced the screening method within their practice. 
 
Results in relation to previous research 
When comparing the findings from the current set of studies described here in this thesis to 
previous research, firstly, the systematic review results were in line with previously 
conducted systematic reviews on the subject which suggest that average and high risk 
participants do as well as each other in risk interventions whilst simple interventions are as 
effective as complex ones (Edwards et al., 2013). Equally, providing individualised risk about 
one rather than several diseases may be better for outcomes. The role of a limited capacity 
attention processor may explain this finding; where the risk of just one disease is presented, 
individuals are more likely to be able to focus and process the information in order to make a 
decision about attending for screening (Kahneman, 1973). The majority of successful studies 
presented IRC information in writing, or in combination with another format (e.g. such as 
verbally in person) so there seems to be a substantial amount of support of its effect on 
screening uptake. This may be because participants preferred to have the information to hand 
to review again, or to take in at their own pace. The systematic review also builds on the 
findings from Edwards et al. (2013) and compliments their latest review reporting that most 
risk communication work is on cancer, although a few other conditions have recently been 
examined (Edwards et al., 2013). Since their review, there have been some other clinical 
topic areas examined, such as prostate cancer and osteoporosis and mixed clinical topic 
conditions, where studies have examined risk of developing several diseases or conditions 
together. 
As with the previous US and UK studies, the first part of the quantitative study described in 
this thesis found that many dental patients were happy to participate and receive one or more 
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diabetes screening tests offered to them. The results showed a successful uptake of dental 
patients for diabetes screening, with 50% of eligible patients consenting to participate. 
However, the refusal rate of N=515 was higher than the figure stated in Wright et al. (2014). 
Several reasons for this can be offered, such as, that potential participants are much more 
likely to take part in research that is concerned with an issue which is particularly relevant to 
the participants’ lives, overall there is a decline in willingness to participate in scientific 
studies in Western countries, which may hold little immediate benefit to the participant  
(Galea & Tracy, 2007). Finally, participants may be wary of committing their involvement to 
research that is likely to take up a substantial amount of their time given how scientific 
research has become increasingly demanding over the last decade (Galea & Tracy, 2007). 
Almost half of dental patients screened using the FINDRISC were found to be at risk of 
developing diabetes based on the current cut-offs. In line with previous work, the majority of 
participants fell into the slightly elevated risk category, with a personalised risk score of 
between 7 and 11 (Costa et al. 2013). Wright et al. (2014) found that 84% of dental patients 
screened had at least some increased level of risk of diabetes, based on the NICE guidance 
tool which included a risk questionnaire and BMI measurement.  The sample used in the 
current study, based on the risk questionnaire alone showed a similar result; that N=419 
(81%) of the 520 participants had some level of elevated risk of diabetes. When looking at 
the results the point of care HbA1c measure, N=118 (45% of those taking the test) had a 
score of ≥5.7% suggesting a risk of pre-diabetes and diabetes. Compared to 30% found by 
Herman and colleagues (Herman et al. 2015) and 40% in the participant sample of Genco and 
colleagues (Genco et al. 2014), the current result is slightly higher, probably because only 
those with FINDRISC score over 10 were offered the HbA1c test. The majority of 
participants (94%) scoring 10 or higher on the FINDRISC were happy to have their HbA1c 
measured by the researcher. Therefore, these results further support the notion that dental 
patients are happy to be screened for diabetes using a combination of a simple questionnaire 
and a more invasive finger-prick blood test.   
Crucially, a high proportion (60%) of those advised to visit their GP for further formal 
diabetes testing followed this advice and contacted their GP. This is a much more promising 
result than found previously. For instance, Wright et al (2014) reported that only 20% of 
patients identified as at risk of developing diabetes attended their GP. Genco et al (2014) 
reported that 35% attended their GP for follow up; though there was a significant difference 
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in follow-up rates between patients referred from a community health centre where over 78% 
attended their GP compared to only 21% from private dental offices. 
A recent study looking at EPPM and HBM predictors involved in the prevalence of colorectal 
cancer screening among community dwelling Chinese older people (Leung et al., 2016) 
found that EPPM variables fear and fatalism were not significant in predicting colorectal 
cancer screening. However, the current study found that fear was able to predict whether a 
patient contacted their GP for a diagnostic test following diabetes screening. Another recent 
publication by Birmingham et al. (2015) examined the impact of a personalised, remote risk 
communication intervention on behavioural intention and colonoscopy uptake in relatives of 
colorectal cancer patients. The original additive model showed poor fit, but when an 
alternative model in which each theoretical construct contributes uniquely, the model showed 
good fit. Cancer susceptibility and colonoscopy self-efficacy perceptions predicted intention 
to screen, which was significantly associated with colonoscopy uptake; both of which were 
not able to significantly predict uptake of diagnostic testing in the current study. A further 
study which looked at the adoption of mammography screening in Iranian women and the 
effective EPPM factors on mammography session attendance found that self-efficacy could 
predict mammography behaviour in the sample (Vatannavaz & Taymoori, 2014). Again, this 
was another EPPM theoretical component which was not a significant predictor of GP 
contact in the current study. These findings casts uncertainty as to what else might be 
contributing to the decision for patients to contact their GP for a diagnostic test. It also 
suggests that the EPPM might not be a good model to use to predict GP contact following 
diabetes risk screening, as even when two of the model variables significantly predicted the 
outcome, their effects were small, and therefore only slightly relevant. 
Finally, the qualitative study described in this thesis represents a unique contribution to the 
understanding of dentist and dental patients’ actual real views and experiences of screening 
for diabetes in the dental setting, and further, explores why dental patients did or did not 
follow up screening test results with diagnostic tests at their GP surgery. Previous research 
has suggested that the general populations’ knowledge of diabetes and its risk factors and 
complications is low; the findings here found similar results. The findings also add to 
previous research which found that in general, dental patients support the concept of diabetes 
screening in a dental setting (Creanor et al., 2014; Rosedale & Strauss, 2012). The screening 
programme conducted in this research study was overall acceptable to dental patients with the 
majority of those asked recalling only positive experiences. The finding here adds to the 
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previous research by indicating that patients found diabetes risk screening showed the dentist 
was taking an interest in their overall health, therefore increasing satisfaction with the overall 
experience. 
Traditionally, research has shown that the more invasive a screening test is, the more accurate 
it is perceived to be. Schroy et al. (2005) demonstrated that when compared with 
colonoscopy, an invasive colorectal cancer screening test, stool-based DNA testing, a far less 
invasive screening tool, received more favourable ratings on preparation and test-related 
features such as sample collection, perceived embarrassment and anxiety except for perceived 
accuracy, where the more invasive test, colonoscopy, was rated higher than the non-invasive 
test. In this study, it seems some patients agreed with this notion as some negative views 
expressed were concerned with the idea of having to complete the questionnaire if a second 
screening test was still needed. It seems that they thought it was better to just do what was 




Issues related to the study sample 
The participants in the current research studies were all aged over 45 as it is a known risk 
factor that diabetes risk increases from this age. This age limit might mean that the findings 
cannot be generalised to those under the age of 45.  This is not a limitation of the research 
though as in the context of diabetes risk screening, there is a limit to the worth of screening 
for type 2 diabetes in those under the age of 45, as it is known that diabetes risk increases 
after the age of 45. However, as a methodological issue, restricting the age limit for 
participation might make recruitment more restrictive, where in a dental setting, there is a 
wide age range of patients being seen. However, if research was conducted which screened a 
wider range of the population, aged younger than 45 for instance to look at other risk factors  
for diabetes other than age, then the findings from the current studies would need to be 
generalised with caution as every participant in the current set of studies had at least one risk 
factor; that being aged 45 or over (Harris et al., 1998).  
The research was conducted at two dental practices in the UK; one in London and the other in 
Staffordshire. This means that the findings must be generalised with caution to other parts of 
the country where the socio-economic status, ethnicity, and other types of people who differ 
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in terms of diabetes risk, may differ. The locations of the dental practices where recruitment 
took place are geographically and socio-economically very different, meaning that risk 
factors throughout the population in both locations would be different. Future research would 
benefit from recruiting participants from other parts of the UK. 
One rationale for conducting the diabetes screening programme in a dental setting is because 
research has suggested that a large proportion of the UK population see a dentist at least once 
a year and healthcare utilisation patterns indicate that individuals tend to seek routine and 
preventive oral health care more often than routine and preventive medical healthcare (Glick 
& Greenberg, 2005). However, in the quantitative study conducted for this thesis, the 
researchers asked those participants identified as at risk of developing diabetes, to visit their 
GP for a diagnostic test. Therefore, the previous research might suggest that the visit to their 
GP for preventative medical healthcare is less likely to take place.  
 
Issues related to the intervention content 
The FINDRISC risk questionnaire is a self-report measure of diabetes risk. Whilst the 
researcher checked patients’ height and weight to calculate their BMI, other questions may 
not have been answered accurately, therefore not giving a true representation of their risk 
score.  
HbA1c was only measured in those participants who scored highly enough on the FINDRISC 
questionnaire to qualify for the further screening test. Thus, those in our sample who did not 
score highly enough on the FINDRISC to qualify for the second screening test (though 
accurate or exaggerated self-reports); the HbA1c test, may well have had an elevated HbA1c 
score, therefore increasing the percentage of overall participants with a high risk HbA1c 
score of ≥5.7%. 
 
Issues with the Quantitative study 
The screening procedure involved a validated risk questionnaire completed by all consenting 
participants and a fingerprick blood test measuring an individual’s HbA1c for those identified 
as at risk of developing diabetes from the questionnaire. One particular issue with this 
method was that it was not possible to compare FINDRISC scores and HbA1c blood test 
results because not everyone received the fingerprick blood test. This means that it was not 
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possible to see if there was a correlation between the two risk results and assess each of the 
screening tests’ performance. 
Another issue encountered through the recruitment of dental practices for access to dental 
patients was that General Dental Practitioners were not keen to participate when approached. 
Only two of 50 dental practices were recruited in the end from where data collected took 
place. However, those practitioners who did take part were pleased with the screening 
programme that was conducted and were positive about the study and how it worked. 
Therefore, it would be necessary to explore how to market such a screening process in dental 
practices in order to recruit more dental practices.  
 
Issues with the Qualitative study 
It is possible that the audio recording of the qualitative work did have an impact on 
participants.  It has been noted that participants’ awareness of the presence of recording 
devices is believed to have a detrimental effect on the ‘authenticity’ or ‘naturalness’ of the 
data collected (Speer & Hutchby, 2003). They describe the one-way mirror effect, which is 
based on the idea that there is a realm of social interaction that is natural which is disturbed or 
diluted by the presence of the researcher and more specifically, their recording device. Speer 
and Hutchby (2003) further explain that it is implied that ‘natural’ interactions may only be 
captured in research if the researcher is able to stand behind a one-way mirror unnoticed by 
the participants. Audio recording has also been found to make some participants anxious, and 
it has also been suggested that the use of a recording device may limit rapport and possibly 
“interfere with participant observation” (Judd, Smith, Kidder, & Kidder, 1991).. However, in 
the case of the qualitative study in the current research, interviews with dental patients were 
conducted over the telephone, therefore the presence of a recording device might have been 
lessened with the interviews not being conducted face to face. 
 
Strengths of the Research  
A major strength of the current research was the mixed methods approach. It was useful to 
capitalise on the benefits of both qualitative and quantitative methods. There is a lack of 
previous research carried out in the area of diabetes risk screening and follow-up behaviour in 
the UK, and so it was considered important to carry out thorough research to explore the 
impact of individualised diabetes risk information on participants’ subsequent behaviour. By 
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using both methods, it was possible to draw fuller conclusions about the effectiveness of the 
individualised risk communication and screening tests on subsequent behaviour. From the 
quantitative work, it was possible to measure high risk participant’s attitude to diabetes and 
screening and quantitative summarise contact made with their GP. From the qualitative work, 
it was possible to examine participants’ thoughts and feelings about the screening methods 
used and the effect this had on their subsequent behaviour in terms of making contact with 
their GP.  
Another strength of the research was the addition of GP confirmation to ascertain participant 
contact with their GP. When measuring the follow up outcome to see if those participants 
advised to see their GP for a diagnostic test actually did so, we contacted those participants 
and measured self-reported contact with their GP. However, we also wrote to all GP’s and 
asked them to return a reply slip confirming the outcome to either support the self-reported 
response or provide the outcome in instances where participants were unable to be contacted. 
The response rate for GP confirmation letters was 78.76%. This was higher than expected to 
complement the patient reported outcomes, as it was expected that GP’s would be too busy to 
respond. This response from GP’s meant that outcome data was strengthened by their 
confirmation.   
 
Implications for theory, research and practice 
Theoretical Implications 
The theory of risk homeostasis (Wilde, 1998) proposes that individuals adjust their behaviour 
based on their perceived level of risk of an outcome (risk perceptions) and the level of risk 
that they are willing to assume. The theory hypothesises that individuals who perceive that 
their risk of a negative outcome is low (for example, after receiving an intervention like 
diabetes screening) may participate in less safe behaviours such as visiting their GP for a 
diagnostic test, or eating more and exercising less. Therefore, by screening for diabetes and 
giving a person a low risk outcome, or telling a person that although their risk was high on 
one test, but low on another, they might decide that they do not need to visit their GP for a 
diagnostic test, or be so mindful of their diet and exercise regime.    
Currently, the EPPM frequently features in health and risk communication literature applied 
to many health behaviours such as smoking (Thrasher et al., 2016), cancer screening (Leung 
et al., 2016) and kernicterus risk (Russell, Smith, Novales, Massi Lindsey, & Hanson, 2013). 
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The EPPM has not been applied to diabetes diagnostic testing before now, therefore the 
findings from the current set of studies provide a starting point. The current set of studies 
provided an important examination of how the EPPM framework may aid in interventions to 
motivate diabetes screening and diagnostic testing intentions and behaviour. The findings in 
chapter six do support some of the key theoretical tenets of the EPPM and can be used to 
guide the development and implementation of effective interventions to promote diabetes 
screening, though they should not be relied upon, as due to small effect sizes, they are only 
slightly relevant. Not all EPPM components were predictive of post-screening diagnostic 
testing in the current set of studies. The question arises as to whether we should just abandon 
the theory, or whether another theoretical model would be more successful at predicting 
diagnostic testing. Further research is needed to continue to test the EPPM, because it has 
been successfully used to predict behaviour outcome in other health screening settings. 
Future research could also look to modify the predictors to see if a better model of fit can be 
found. The EPPMs theoretical concepts are thoroughly developed, but the theory lacks 
consistency in operational definitions of some of its constructs (Popova, 2012). The 
usefulness of this theory to communication researchers lies in its ability to generate research 




Due to the lack of interest from General Dental Practitioners to have their practice participate 
in the study, there might be problems with recruiting practices in the future should this study 
be repeated or screening programme be rolled out as a service. Therefore, it is important to 
explore how to market such a screening programme so that practitioners want their practice to 
be involved.  
The current research has demonstrated that it is possible to conduct a diabetes screening 
programme in a dental practice. However, in reality, there will always be issues with costs 
and funding.  
 
If the aim is to ensure patients found to be at risk of diabetes through screening tests to have a 
diagnostic test, then perhaps, rather than relying on psychological predictors to guide us, 
there might be more practical things that can be done in the dental setting to ensure this 
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happens. For example, as healthcare practitioners, it might be possible for a dentist or nurse 
with phlebotomy training to take blood for the diagnostic test themselves rather than rely on 
patients having to go to their GP. This would mean that GPs are less heavily relied upon, and 
dentists are seen as having more input on systemic health as well as oral health. However, 
there might be an issue with cost, and who might fund this; an issue which was raised by 
interviewed dentists in the qualitative study in chapter 7. Further to this, dentist are well 
equipped to offer health advice and education relating to diabetes (Tavares et al., 2012), and 
could help to educate their patient on the risks of T2D, advice on making lifestyle changes in 
order to reduce their risk of diabetes, and the importance of diagnostic testing if needed. This 
would mean that GDPs aren’t having to expect fear of diabetes to encourage their patients to 
see their GP for a diagnostic test. Finally, it might be possible to make arrangements for a 
patient to receive a diagnostic test from their GP over the phone, or have a direct referral 
system in place with GP surgeries, where once informed, the GP surgery can make contact 
with the patient to offer an appointment for a diagnostic test, rather than the patient having to 
make the initial contact. This might help patients to feel that the issue is more of a priority if 
the GP surgery makes contact with them rather than the other way around; a comment that 
was made by patients when interviewed in the qualitative study in chapter 7.  
 
Clinical Implications 
Current evidence suggests that discussing health risks using simple risk scores or categories 
and providing this information in writing, may be successful in supporting people to consider 
undertaking health screening. There are of course cost implications to any intervention. What 
is promising is that the more complex interventions (which presumably, by their very nature, 
are more costly) do not appear to be any more effective than simpler interventions.  
Unfortunately, the current studies were not able to say if the FINDRISC was correlated with 
HbA1c results, therefore we cannot say whether the questionnaire could replace the blood test 
in clinical settings to reduce cost and save time. However, the current set of studies showed 
that by being screened with two tests increased the likelihood of GP attendance for diagnostic 




Directions for future research  
Before clinical recommendations can be made as to the potential for diabetes screening to be 
incorporated into routine dental examination, future research is needed to assess the 
economic cost of screening via the methods conducted in the current study, and also the issue 
of the time it takes to conduct, especially in busy NHS dental practices. Consideration should 
also be given to the inclusion of diabetes screening in private dental practice where patients 
pay for non-NHS treatment where such a screening programme could be charged for 
additionally.  
Feasibility studies are appropriate when there is robust evidence to validate a larger study, 
and where the nature and structure of the study is known, but where important practical 
information is needed to make the potential study clearly fundable. Therefore, a study to 
assess the feasibility of screening for diabetes in the dental setting is needed to assess the 
economic cost and the time issues that have not yet been assessed. Bowen and colleagues 
discuss the several areas of focus that are addressed when conducting a feasibility study 
(Bowen et al., 2009). Whilst the current studies have focussed upon the acceptability of the 
screening intervention and the demand when looking at the number of dental patients 
accepting screening, other areas of focus such as adaptation, practicality and expansion were 
beyond the scope of this thesis, therefore further studies to assess the feasibility of the 
intervention are needed. 
 
Current Outlook 
A recent damning report by BBC Panorama suggested that Britain is in the grip of a health 
epidemic that is threatening to overwhelm the NHS. According to their broadcast on the 
issue, the number of people, especially children, diagnosed with type 2 diabetes is rising 
alarmingly fast, with one person being diagnosed in the UK every two minutes. Their report 
suggests around four million people in the UK have Type 2 diabetes. It’s a major problem 
that is costing the NHS roughly £10.3billion a year - almost 10% of its overall budget; with 
that, the BBC propose that the NHS will not survive the costs of this diabetes epidemic. The 
UK National Screening Committee’s policy is that general population screening for diabetes 
should not be offered. However, diabetes risk assessment is offered to people aged 40–74 
years in England as part of the NHS Health Check. 
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The studies described in this thesis do suggest that screening for diabetes is accepted by 
dental patients in primary care dental settings. We now know that receiving two positive 
screening tests influences GP contact compared to receiving just one positive screening test. 
In addition to this, fear of diabetes and feeling vulnerable towards diabetes does increase the 
chances that dental patients will seek a diagnostic test following initial diabetes screening. 
Therefore, individualised diabetes risk should be communicated to dental patients to reduce 
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Appendix 1: Search strategies and published article – Systematic review 
 
Medline Search Strategy 
 
1. Models, Psychological/  
2. social cognition*.mp. 
3. social cognition model*.mp. 
4. health belief model.mp. 
5. HBM.mp. 
6. theory of planned behavio?r.mp. 
7. TPB.mp. 
8. theory of reasoned action.mp.  
9. TRA.mp. 
10. perceived behavio?ral control.mp.  
11. protection motivation theory.mp.  
12. PMT.mp.  
13. protection motivation.mp. 
14. cues to action.mp. 
15. (knowledge adj5 screen*).mp. 
16. (knowledge adj5 risk*).mp. 
17. (knowledge adj5 attend*).mp. 
18. (attitude* adj5 intention*).mp. 
19. (attitude* adj5 screen*).mp. 
20. (attitude* adj5 attend*).mp. 
21. Self Efficacy/  
22. self efficacy.mp.  
23. exp Disease Susceptibility/  
24. (susceptibility adj5 screen*).mp. 
25. (susceptibility adj5 disease*).mp. 
26. ((susceptibility or severity) adj5 threat*).mp. 
27. (threat adj3 cop*).mp. 
28. ((adaptive or maladaptive) adj3 cop*).mp. 
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29. (barrier* adj5 health*).mp. 
30. (barrier* adj5 benefit*).mp. 
31. ((barrier* or benefit*) adj5 screen*).mp. 
32. (intention* adj5 attend*).mp. 
33. (intention* adj5 screen*).mp. 
34. (behavio?r* adj3 intention*).mp. 
35. subjective norm*.mp. 
36. Motivation/  
37. motivation*.mp.  
38. exp Health Behavior/ 
39. health behavio?r*.mp 
 
40. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 
17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 
31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 or 39  
 
41. Mass Screening/  
42. mass screen*.mp.  
43. screen* or screening* or health screen*.mp.  
44. (screen* adj5 (participat* or attend* or uptake)).mp. 
45. Genetic Testing/  
46. gene* test*.mp.  
47. screen* test*.mp.  
48. Mammography/  
49. mammo*.mp.  
50. Vaginal Smears/  
51. vaginal smear*.mp.  
52. cervical smear*.mp. 
53. Occult Blood/  
54. (fecal occult blood or occult blood).mp. 
55. Prostate-Specific Antigen/  
56. prostate-specific antigen.mp.  
57. Colonoscopy/ or Sigmoidoscopy/  
58. (Colonoscopy or Sigmoidoscopy).mp 
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59. exp early diagnosis/ 
 
      60. 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 
55 or 56 or 57 or 58 or 59  
 
61. exp risk/  
62. risk*.mp.  
63. ((tailor* or individual* or personal*) adj5 (message* or risk*)).mp. 
64. ((patient* or consumer* or recipient*) adj5 (tailor* or personal* or 
individual*)).mp. 
 
      65. 61 or 62 or 63 or 64  
 
66. Communication/  
67. Health Communication/  
68. Persuasive communication/ 
69. Counseling/  
70. Genetic Counseling/  
71. health education/ 
72. Patient Education as Topic/  
73. Health Knowledge, Attitudes, Practice/  
74. exp Decision Making/  
75. Choice Behavior/  
76. exp Attitude to Health/  
77. Health promotion/ 
78. health promotion.mp.  
79. exp "Patient Acceptance of Health Care"/  
80. Informed Consent/  
81. ((patient* or consumer*) adj3 (communicat* or counsel* or inform* or discuss* 




      82. 66 or 67 or 68 or 69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 
80 or 81  
 
      83. 40 and 60 and 65 and 82 
 
 84. randomi?ed controlled trial.pt 
 85. controlled clinical trial.pt 
 86. randomi?ed.ab 
 87. placebo.ab 
 88. trial.ti 
  
 89. 84 or 85 or 86 or 87 or 88 
  
 90. 83 and 89 
 91. exp animals/ not humans.sh. 
      92. 90 not 91 
 93. Limit 92 to English language 
 
EMBASE Search Strategy 
 
1. psychological model/  
 
2. social cognition/  
 
3. social cognition*.mp.  
4. social cognition model*.mp.  
5. health belief model/  
 
6. health belief model.mp.  
7. HBM.mp.  
8. theory of planned behavior/  
 
9. theory of planned behavio?r.mp 
10. TPB.mp.  
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11. theory of reasoned action/  
 
12. theory of reasoned action.mp. 
13. TRA.mp. 
14. perceived behavio?ral control.mp.  
15. protection motivation theory.mp.  
16. protection motivation.mp.  
17. PMT.mp.  
18. cues to action.mp. 
19. (knowledge adj5 screen*).mp. 
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21. (knowledge adj5 attend*).mp. 
22. (attitude* adj5 intention*).mp. 
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24. (attitude* adj5 attend*).mp. 
25. self concept/  
 
26. self efficacy.mp.  
27. cancer susceptibility/ 
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29. (susceptibility adj5 screen*).mp. 
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31. ((susceptibility or severity) adj5 threat*).mp. 
32. (threat adj3 cop*).mp. 
33. ((adaptive or maladaptive) adj3 cop*).mp. 
34. (barrier* adj5 health*).mp. 
35. (barrier* adj5 benefit*).mp. 
36. ((barrier* or benefit*) adj5 screen*).mp. 
37. (intention* adj5 attend*).mp. 
38. (intention* adj5 screen*).mp. 
39. (behavio?r* adj3 intention*).mp. 
40. subjective norm*.mp. 
41. motivation/  
 
42. motivation*.mp.  
43. exp health behavior/  
 




45. genetic screening/  
46. mass screening/   
47. screening/  
48. cancer screening/  
49. screening test/ 
50. mass screen*.mp.  
51. screen* or screening* or health screen*.mp.  
52. (screen* adj5 (participat* or attend* or uptake)).mp. 
53. gene* test*.mp.  
54. screen* test*.mp. 
55. mammography/  
 
56. mammo*.mp. 
57. vagina smear/  
 
58. vagina* smear*.mp.  
59. cervical smear*.mp. 
60. occult blood/  
 
61. occult blood or fecal occult blood.mp.  
62. prostate specific antigen/  
 
63. prostate-specific antigen.mp.  
64. Colonoscopy/ or Sigmoidoscopy/  
65. (Colonoscopy or Sigmoidoscopy).mp 
66. exp early diagnosis/ 
 
67. exp risk/  
68. risk*.mp.  
69. (tailor* or individual* or personal*) adj5 (message or risk).mp. 
70. (patient* or consumer* or recipient*) adj5 (tailor* or personal* or individual*).mp. 
 
 
71. interpersonal communication/  
 




73. verbal communication/  
74. medical information/  
 
75. counseling/  
 
76. genetic counseling/  
 
77. patient education/  
78. health education/  
79. health promotion/  
 
80. health promotion.mp. 
 
81. exp Attitude to Health/  
 
82. informed consent/  
 
83. decision making/  
 
84. ((patient* or consumer*) adj3 (communicat* or counsel* or inform* or discuss* or 




randomi?ed controlled trial.pt. 
 












exp animals/ not humans.sh. 
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Limit to English language 
 
 
Web of Science Search Strategy 
 
social cognition* 
social cognition model* 
health belief model 
HBM 
theory of planned behavio?r.mp. 
TPB.mp. 
theory of reasoned action.mp.  
TRA.mp. 
perceived behavio?ral control.mp.  
protection motivation theory.mp.  
PMT.mp.  
protection motivation.mp. 
cues to action.mp. 
(knowledge same screen*).mp. 
(knowledge same risk*).mp. 
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(knowledge same attend*).mp. 
(attitude* same intention*).mp. 
(attitude* same screen*).mp. 
(attitude* same attend*).mp. 
self efficacy.mp.  
Disease Susceptibility.mp. 
susceptibility 
(susceptibility same screen*).mp. 
(susceptibility same disease*).mp. 
susceptibility same threat* 
severity same threat* 
(threat* same cop* 
adaptive same cop* 
maladaptive same cop* 
(barrier* same health*).mp. 
(barrier* same benefit*).mp. 
((barrier* same screen* 
benefit* same screen*   
intention* same attend* 
intention* same screen* 
behavior* same intention* 









mass screen*  
screen* 
screening* 
health screen*  
screen* same participat*  
screen* same attend*  

















risk assess* .mp. 
genetic risk.mp. 
cancer risk.mp. 
((tailor* or individual* or personal*) same (message or risk)).mp. 










Attitude* to Health.mp. 
health promotion.mp.  
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((patient* or consumer*) same (communicat* or counsel* or inform* or discuss* or 
decision* or decide* or participat*)).mp. 
or/57-68 
36 and 49 and 56 and 69 
 
 
PubMed Search Strategy 
social cognition* 
social cognition model* 
health belief model 
HBM 
theory of planned behavior OR theory of planned behaviour 
TPB 
theory of reasoned action 
TRA 
perceived behavioral control OR perceived behavioural control 
protection motivation theory 
PMT 
protection motivation 










adaptive coping or adaptive coper* 
maladaptive coping or maladaptive coper* 
barrier*  
benefit* 
behavior*  intention* or behaviour* intention* 
subjective norm* 
motivation* 
health behavior* or health behaviour* 
 





health screen*  
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health promotion 
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The objective of this study was to determine dental patients’ uptake of two preliminary screening 
tools for risk of diabetes (the Finnish Diabetes Risk Score –FINDRISC- and HbA1c fingerprick testing) 
in general dental practice, and to determine the number of patients at risk of type 2 diabetes (T2D) 
based on the results of these screening tests.  
Methods:  
Patients aged 45 and over, who did not already have a diagnosis of diabetes, visiting primary dental 
practitioners for routine appointments in London (N= 244) and Staffordshire (N=276), were offered 
the chance to be screened for diabetes risk using the FINDRISC a self-report screening tool to assess 
risk of development of diabetes in the next 10 years. If a patient’s score showed them to be at risk, 
they were offered an instant HbA1c finger-prick test to further screen for possible type 2 diabetes 
where they were given their result instantaneously. Patients found to be at risk on either screening 
test, were referred to their GP for formal diagnostic testing. 
Results: 
N=1035 patients eligible for inclusion were asked to take part. N=520 patients consented to 
screening. Of these, N=258 patients (49.6%) were found to be at risk of developing diabetes based 
on FINDRISC scores and were referred to the GP for further testing and offered a further screening 
finger-prick blood test at the dental practice. N=242 (93.8% of those offered the test) accepted the 
on the spot finger-prick test.  On this A1c test, N=118 had a result of 5.7% or higher, indicating 
increased risk for diabetes. Of the N=258 who were referred to their GP for formal diabetes testing, 
N=155 (60%) contacted their doctor. There was a significant association between the number of ‘at 
risk’ screening results a person received and whether or not a patient contacted their GP (p<0.0001). 
The odds of patients contacting the GP was 3.22 times higher if they were referred with two positive 
diabetes risk results (positive FINDRISC, positive HbA1c) rather than just one (positive FINDRISC, 
negative HbA1c). 
Conclusions:  
The study demonstrates a two-step method of diabetes screening that appears to be acceptable by 
dental patients, a sizeable proportion of whom were identified as at risk of developing diabetes, and 
the majority following the recommendation for further testing with their GP. Whilst the majority 
followed the recommendation for further testing with their GP, patients were 3 times more likely to 






Diabetes is an illness characterised by chronically elevated levels of blood glucose concentration, a 
condition known as hyperglycaemia, for which there is no known cure. T2D has become a huge 
burden for the adult population with ever-increasing prevalence (Wild, Rolgic, Green, Sicree and 
King, 2004), however, there is no screening programme policy in place in the UK despite the fact that 
detecting diabetes early on is key to health outcomes (Harris and Eastman, 2000).  
 
Screening for diabetes can potentially allow for early diagnosis and treatment, which can prevent 
diabetes-related complications  (Marre & Travert, 2010). Although screening for disease can 
sometimes have adverse effects on an individual, screening for diabetes has been shown not to have 
any long-term adverse effects (Adriaanse, Snoek, Dekker, Spijkerman, Nijpels, Twisk et al. 
2004).Therefore, it is suggested that screening for diabetes is essential to identify diabetes and 
importantly, its precursors, earlier and more efficiently.  
 
Diabetes can be screened for using a variety of methods; in addition to traditional diabetes 
screening methods such as the Oral Glucose Tolerance Test (OGTT) where patients are required to 
consume glucose and then have blood samples taken afterward to determine how quickly the 
glucose is cleared from the blood, the use of HbA1c as a measure of glycaemic control over the past 
12 weeks, has also been recommended as a viable means of diagnosing diabetes (Saudek et al, 
2008). An invasive test, as it requires a blood sample, HbA1c testing does not require fasting or 
restriction to certain times of the day to be measured so in many respects it is easier to carry out 
than an OGTT. Furthermore, whilst traditionally HbA1c tests require laboratory facilities to take 
place, the recent introduction of point of care measurement through finger prick devices has made 
the measurement of A1c more accessible (Wensil, Smith, Pound & Herring, 2003; Sicard & Taylor, 
2005). As an alternative to a blood test, the FINDRISC is a non-invasive screening tool that provides a 
measure of the probability of developing type 2 diabetes over the next 10 years (Lindstrom, 
Louheranta, et al. 2003). It is a brief questionnaire consisting of eight questions about variables 
correlated with the risk of developing diabetes: age; body mass index; family history of diabetes; 
waist circumference; use of anti-hypertensive medication; history of elevated blood glucose; 
meeting the criterion for daily physical activity and daily consumption of fruit and vegetables. 
FINDRISC has been used successfully as a screening tool for diabetes (Tankova, Chakarova, 
Atanassova, & Dakovska, 2011) and its reliability and validity have been clearly established 
(Janghorbani, Adineh & Amini, 2013; Gomez-Arbelaez, Alvarado-Jurado, Ayala-Castillo, Forero-
Naranjo,Camacho, Lopez-Jaramillo, 2015). 
 
Screening for diabetes can be carried out in various health settings (Howse, Jones & Hungin, 2011). 
As diabetes is recognised as a significant risk factor for serious, progressive periodontal disease 
(Southerland, Taylor  & Offenbacher, 2005) and as periodontal disease may contribute to the 
progression of impaired glucose tolerance to diabetes (Andersen, Flyvbjerg, & Holmstrup, 2007), the 
dental setting seems like a plausible context for the identification of people at risk for diabetes. 
 
Some recent research from the US has examined the usefulness of screening for diabetes in dental 
settings. Four US studies [Genco et al. (2014); Greenberg et al. (2015); Bossart et al. (2015) and 
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Herman et al. (2015)] reliably supported the notion that screening for pre-diabetes and diabetes 
using a combination of invasive and / or self-report methods was feasible, acceptable to patients 
and the dental team and effective in US dental offices. 
   
In the single UK study carried out in GDPs in London using a self-report risk measure developed in 
the UK (Wright, Muirhead, Weston-Price & Fortune, 2014), it was found that notwithstanding the 
manpower challenges facing dental teams and the fairly low uptake of further screening by patients, 
the identification of diabetes in dental practices was possible. One explanation for the low uptake of 
further diagnostic testing in this study could be the fact that patients tend to judge the severity of 
the illness by cues such as the complexity of the diagnostic tool used, In the case of diabetes in 
particular, previous work (Parry, Peel, Douglas and Lawton 2003) showed that diabetes patients 
used their diagnosis journey to judge how serious their diabetes was; the more complex the 
diagnosis, (where for e.g. the diagnosis was made by a hospital consultant rather than a GP) the 
more serious patients thought was their diabetes.  
 
On the basis of these findings, we reasoned that supplementing a self-report diabetes risk 
assessment with a more invasive, instant HbA1c blood test might improve the uptake of further 
formal GP testing.  At the same time, we wished to explore the acceptability of such a double-
screening method in UK dental practices 
 
Thus the objective of this study was to determine the uptake of diabetes screening in dental 
patients, using FINDRISC and HbA1c information as preliminary screening tools, and to determine 
the proportion of patients who attend their GP for further, formal diabetes diagnostic testing.  
 
Methods 
Participants meeting the inclusion criteria were recruited from two General Dental Practices in 
London and Staffordshire, UK. Dental patients who were aged 45 and over, could speak fluent 
English and had no diagnosis of diabetes or pre-diabetes were sent an invitation letter with 
information explaining the nature of the research. These inclusion criteria were set due to an 
increase in diabetes risk with age and because the risk questionnaire had been validated in English. 
On arrival, participants wishing to take part met with the researcher, gave informed consent and 
completed a demographics and FINDRISC questionnaire. The participant then saw the dentist for 
their routine appointment. At the end of their appointment, the participant met with the researcher 
who gave the participant their result of the FINDRISC. Participants with a score of < 10 on the 
FINDRISC were debriefed about their risk result, reassured and thanked for their participation. 
Patients with a score of ≥ 10 on the FINDRISC were told about their increased risk and offered an 
HbA1c finger-prick test to explore their risk further. Participants receiving the blood test were given 
the result instantaneously, with an explanation of its meaning. Regardless of acceptance of the 
HbA1c or test the A1c test result, all patients with a FINDRISC of >10 were advised by the researcher 
to visit their GP for a formal diagnostic test via verbal advice and written information. All 
participants' GPs were informed of their participation through a standard letter from the dental 
practitioner and researcher, and a formal diagnostic test was recommended where results indicated 
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the need for this. One month after participants took part in screening, they were contacted by 
telephone by the researcher to find out if they had been to their GP for formal diagnostic testing as 
recommended. If they had not already been, a second call was made one month later to find out the 
outcome. Finally, three months after the initial screening was conducted, patients’ GPs were 
contacted through a standard letter and reply slip to find out if the patient had been in contact to 




Figure 1 shows the flow of participants through the study.  
 
------------ Fig 1 about here --------------- 
N=3700 NHS and private patients had a dental appointment during the 118 day recruitment period. 
N=2109 patients were excluded as they were either under 45 years of age (n=1888), did not speak 
fluent English (n=59), or already had diabetes/ pre-diabetes (n=162). A further 556 potential 
participants were not asked to take part as they either did not attend their appointment (n=121) or 
practically could not be tested by the single researcher (n=435).  
Of the remaining 1035 patients, 520 (50.2%) consented to participate and completed the FINDRISC 
screening questionnaire. Fife hundred and fifteen patients refused to participate in the study. The 
main reasons for refusal were, a recent blood glucose test, a recent health check-up such as the Well 
Man’s Check arranged through the GP, dental pain and fear, and lack of interest in the research.  
Two hundred and sixty two (N=262) participants scored below the cut off score of 10 on the 
FINDRISC questionnaire, and therefore were not offered any further screening. N=258 patients were 
found to be at risk of developing diabetes based on the current recommended FINDRISC cut off 
score of 10, and so were offered the further screening test, and advised to visit their GP for formal 
diagnostic testing. The majority of participants (n=247, 47.5% of those who took part) fell into the 
slightly elevated risk category, whilst N=101 (19.42% of those who took part) fell in the low risk 
category and N=172 (33%) were seen as having a moderate, high or very high risk of developing 
diabetes. Table 1 outlines the number of participants by risk score category on the risk 
questionnaire.  
 
--------------------------Table 1 about here ------------------------- 
 
 
Of the N=258 found to be at risk of developing diabetes on the FINDRISC, the majority (N=242, 
93.8%) accepted and received the further screening HbA1c test. These A1c test results are shown in 





------------------------ Table 2 here ---------------------------------------- 
 
On this A1c test, 10 participants  (4.13% of those who took the test) had a result of ≥6.5%, 108 
participants (44.6% of those who took the test) had a result of between 5.7% and 6.4%, whilst 124 
participants (51.24% of those who took the test) had a result of less than 5.7%. 
 
Of the N=258 participants who were advised to visit their GP for formal diabetes testing, N=155 
(60%) contacted their doctor regarding an appointment for further testing. 
There was a significant association between the number of ‘at risk’ screening results a person 
received and whether or not a patient would follow recommendation and contact their GP (χ2 (1) = 
16.84, p<0.0001).  Furthermore, the number of positive risk scores significantly influenced GP 
contact; patients were more likely to contact their GP if they had received two positive risk scores. 
The odds ratio of patients contacting the GP was 3.22 times higher if they were referred with two 
positive risk results (both a positive FINDRISC and positive HbA1c risk result) as opposed to just one 




The objective of this study was to determine the uptake of dental patients using FINDRISC and 
HbA1c information as preliminary screening tools in screening for possible diabetes, and determine 
the number of patients at risk of diabetes.  
 
As with the previous US and UK studies, the current study found that many dental patients were 
happy to participate and receive one or more diabetes screening tests offered to them. The results 
showed a successful uptake of dental patients for diabetes screening, with 50% of eligible patients 
consenting to participate. The refusal rate of N=515 was higher than the figure stated in Wright et al. 
(2014). Several reasons for this can be offered, such as, that potential participants are much more 
likely to take part in research that is concerned with an issue which is particularly relevant to the 
participants’ lives, overall there is a decline in willingness to participate in scientific studies in 
Western countries, which may hold little immediate benefit to the participant (Galea & Tracy, 2007). 
Finally, participants may be wary of committing their involvement to research that is likely to take up 
a substantial amount of their time given how scientific research has become increasingly demanding 
over the last decade (Galea & Tracy, 2007). 
 
Almost half of dental patients screened using the FINDRISC were found to be at risk of developing 
diabetes based on the current cut-offs. In line with previous work, the majority of participants fell 
into the slightly elevated risk category, with a personalised risk score of between 7 and 11 (Costa et 
al. 2013). Wright et al. (2014) found that 84% of dental patients screened had at least some 
increased level of risk of diabetes, based on the NICE guidance tool which included a risk 
questionnaire and BMI measurement.  Our sample, based on the risk questionnaire alone showed a 
similar result; that N=419 (81%) of the 520 participants had some level of elevated risk of diabetes. 
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When looking at the results the point of care HbA1c measure, N=118 (45% of those taking the test) 
had a score of ≥5.7% suggesting a risk of pre-diabetes and diabetes. Compared to 30% found by 
Herman and colleagues (Herman et al. 2015) and 40% in the participant sample of Genco and 
colleagues (Genco et al. 2014), our result is slightly higher, probably because only those with 
FINDRISC score over 10 were offered the HbA1c test. The majority of participants (94%) scoring 10 or 
higher on the FINDRISC were happy to have their HbA1c measured by the researcher. Therefore 
these results support the notion that dental patients are happy to be screened for diabetes using a 
combination of a simple questionnaire and a more invasive finger-prick blood test.   
Crucially, a high proportion (60%) of those advised to visit their GP for further formal diabetes 
testing followed this advice and contacted their GP. This is a much more promising result than found 
previously. For instance, Wright et al (2014) reported that only 20% of patients identified as at risk of 
developing diabetes attended their GP. Genco et al (2014) reported that 35% attended their GP for 
follow up; though there was a significant difference in follow-up rates between patients referred 
from a community health centre where over 78% attended their GP compared to only 21% from 
private dental offices.  
 
There are of course limitations to this study that should be considered. There was a discrepancy in 
the numbers of patients who were eligible to participate and those who took part, not only because 
there were patients who refused to participate, but because the method of data collection meant 
that some patients who were eligible to participate were missed because the researcher was not 
able to approach every potential participant before their appointment with the dentist. Therefore, 
the number of dental patients who would have participated might be different in a study using more 
than one researcher recruiting and testing at any one time. This also has implications for the 
adoption of diabetes screening in the dental practice. Recruitment and screening in the current 
study was carried out by a psychology researcher and as such, the manpower and time issues that 
were raised in the Wright et al study still need to be considered before these findings are taken to 
routine dental care. 
HbA1c was only measured in those participants who scored highly enough on the FINDRISC 
questionnaire to qualify for the further screening test. As the risk questionnaire is mainly self-report, 
there is always a chance that those participating may exaggerate their answers and therefore the 
questionnaire may not give a true representation of a person’s risk. Thus, those in our sample who 
did not score highly enough on the FINDRISC to qualify for the second screening test; the HbA1c test, 
may well have had an elevated HbA1cc score, therefore increasing the percentage of overall 
participants with a high risk HbA1c score of ≥5.7%.    
 
In conclusion, this study demonstrates a method of diabetes screening that shows an acceptable 
rate of uptake by dental patients.  It demonstrates a relatively high number of patients ‘at risk’ of 
developing diabetes and that the majority of these follow up their screening result with further tests 
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Tables and Figures 
Table 1: Number of participants by FINDRISC risk score category. 
 
FINDRISC category No. of participants 
< 7 LOW risk 101(19.42%) 
7-11 SLIGHTLY ELEVATED risk 247(47.5%) 
12-14 MODERATE risk 108(20.77%) 
15-20 HIGH risk 63(12.12%) 
>20 VERY HIGH risk 1(0.2%) 
TOTAL: 520 
FINDRISC score of <10 as current cut 

















HbA1c cut off 
category 
N 
<5.7 % 124 
5.7 – 6.4 % 108 
≥6.5 % 10 
273 
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We are writing to ask you to consider taking part in a novel research project currently running 
in our practice. The project is run in partnership with our colleagues at the Dental Institute, 
King’s College London.  
 
The project looks to screen our patients for diabetes. As you may know, diabetes is a serious 
illness which often remains undiagnosed as it does not normally present with obvious 
symptoms. Detected early, the illness can be managed successfully and lead to better long-
term health outcomes. This is a service we are offering to all our patients who are over 45 
years of age, do not already have diabetes and are fluent in English. This service is currently 
free of charge. We are very much hoping that you will take the opportunity to help with the 
work and get yourself screened.  
 
We have attached an Information sheet which tells you more about the study. If you do 
decide to take part, please would you kindly attend your next appointment 15 minutes 
early. This is to allow you time to meet with the researcher doing the screening and have any 
questions about the research answered. 
 






Dr. Amit Jilka 









Appendix 4: Interview Schedules  
 
Proposed Interview Questions for General Dental Practitioners 
 
1. What do you think about screening for diabetes in general? Is it a good or bad idea? 
Why? 
 
What do you think about screening for diabetes in dental practices? Is a good or bad idea? 
Why? 
 
2. What did you think about the screening programme we conducted at your practice? 
 
3. What do you think about using a self-report questionnaire to assess risk of developing 
diabetes in the first instance? 
 
4. What do you think about using a finger-prick blood test to screen for diabetes? 
 
5. Do you think that this screening programme could be incorporated into your routine 
practice? If not, why not? 
 
6. What would you change about the procedure that we adopted? 
 
Proposed Interview Questions for Participants 
 
1. What do you know about diabetes? 
 
2. How serious do you think diabetes is? 
 
3. Do you think that screening for diabetes is worthwhile? 
 
4. Before being offered the opportunity to be screened for diabetes, did you think you 
were susceptible to the condition? If yes why? If not why not? 
 
5. What did you think of the offer to be screened for diabetes at your dental 
appointment? What were your initial thoughts?  
 
6. What was your impression of the self-report questionnaire which assesses your risk of 
developing diabetes in the future? 
 
7. After being told your result from the questionnaire, did this change how you felt about 
your risk? In what ways? 
 
8. (for any participants declining the option for the second screening finger-prick test) 
Was there any particular reason you decided not to have the second screening (the 
finger prick) test that we offered you? 
 
9. (for participants who had the finger prick test) What made you decide to have the 
second finger-prick test that we recommended you to have? 
 




11. (for participants identified as low risk on the FINDRISC) How did you feel after 
being told you were currently at a low risk of developing diabetes in the future? Have 
you talked to a health-care professional about this since?  
 
12. (for participants identified as high risk on the FINDRISC alone or on the finger-prick 
test also) When we advised you to see your GP for diagnostic testing after initial 
screening at the dentist had shown you were at risk of diabetes; how did you feel? Did 
you feel more or less susceptible to diabetes than you did before screening? 
 
13. Did you see your GP following advice to do so? 
 
14. What made you go ahead and see your GP? 
 
15. What do you think about the screening programme that we adopted?  
 
16. What do you think about using a self-report questionnaire to assess risk of developing 
diabetes in the first instance? 
 
17. What do you think about using a finger-prick blood test to screen for diabetes? 
 
18. Do you have any comments about your experience that you would like to make and 











Study Title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours 
REC Study Number: 13/WM/0265 
 




                 
……………………………………………………………………………………………. 
Telephone: ………………………………………………………….  
Name of GP and Surgery: ……………………………………………... 
 
Demographic Details: 
Gender (please circle):    MALE        FEMALE   
DOB (dd/mm/yy): …………………………………………………... 
Type of patient (please circle):      NHS        PRIVATE 














(Office use only) 




FINDRISC score:                                                                                                                                                                        
 









1. English / Welsh 
/ Scottish / 
Northern Irish / 
British  
2. Irish  
3. Gypsy or Irish 
Traveller  




Mixed / Multiple 
ethnic groups 
5. White and Black 
Caribbean  
6. White and Black 
African  
7. White and Asian  
8. Any other Mixed 
/ Multiple ethnic 
background, please 
describe………….. 
Asian / Asian 
British 
9. Indian  
10. Pakistani  
11. Bangladeshi  
12. Chinese  




Black / African / 
Caribbean / Black 
British 
14. African  
15. Caribbean  
16. Any other 




Other ethnic group 
17. Arab  











(Version 1, 15.03.13) 
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Circle the right alternative  
 
1. Age 
 Under 45 years 
 45–54 years 
 55–64 years 
 Over 64 years 
 
2. Body-mass index (a BMI calculator will be attached to the questionnaire) 
 Lower than 25 kg/m2 
 25–30 kg/m2 
 Higher than 30 kg/m2 
 
3. Waist circumference measured below the ribs (usually at the level of the navel)  
 
 MEN      WOMEN 
 Less than 94 cm     Less than 80 cm 
 94–102 cm    80–88 cm 
 More than 102 cm    More than 88 cm 
 
4. Do you usually have daily at least 30 minutes of physical activity at work and/or during 




5. How often do you eat vegetables, fruit or berries? 
 Every day 
 Not every day 
 




7. Have you ever been found to have high blood glucose (eg in a health examination, during an 




8. Have any of the members of your immediate family or other relatives been diagnosed with 
diabetes (type 1 or type 2)? 
 No 
 Yes: grandparent, aunt, uncle or first cousin (but no own parent, brother, sister or  
                    child) 






How useful do you think it is to use this diabetes screening questionnaire in general dental practice? 
Please circle one number. 
           Not at all useful                   Extremely useful 




Appendix 7: FINDRISC Scoring  
 




0 p. Under 45 years 
2 p. 45–54 years 
3 p. 55–64 years 
4 p. Over 64 years 
 
2. Body-mass index (a BMI calculator will be attached to the questionnaire) 
0 p. Lower than 25 kg/m2 
1 p. 25–30 kg/m2 
3 p. Higher than 30 kg/m2 
 
3. Waist circumference measured below the ribs (usually at the level of the navel)  
 
MEN      WOMEN 
0 p. Less than 94 cm   Less than 80 cm 
3 p. 94–102 cm    80–88 cm 
4 p. More than 102 cm     More than 88 cm 
 
4. Do you usually have daily at least 30 minutes of physical activity at work 
and/or during leisure time (including normal daily activity)? 
0 p. Yes 
2 p. No 
 
5. How often do you eat vegetables, fruit or berries? 
0 p. Every day 
1 p. Not every day 
 
6. Have you ever taken medication for high blood pressure on regular basis? 
0 p. No 
2 p. Yes 
 
7. Have you ever been found to have high blood glucose (eg in a health 
examination, during an illness, during pregnancy)? 
0 p. No 
5 p. Yes 
 
8. Have any of the members of your immediate family or other relatives been 
diagnosed with diabetes (type 1 or type 2)? 
0 p. No 
3 p. Yes: grandparent, aunt, uncle or first cousin (but no own parent, brother, sister or 
child) 






Total Risk Score =………… 
 
The risk of developing type-2 diabetes within 10 years is: 





< 7   
  
Low  estimated 1 in 100 
will develop disease 
 
7–11  
   
Slightly elevated estimated 1 in 25 
will develop disease 
 




   
High  estimated 1 in 3 will 
develop disease 
 
> 20   
  






Appendix 8: EPPM measure 
 
Your Views About Diabetes & Diabetes Screening 
REC number: 13/WM/0265 
(Version 1, 15.03.13) 
 
We are interested in your own personal views of diabetes and taking a blood glucose test.  
Please indicate how much you agree or disagree with each of the following statements by 











1. Diabetes is a serious condition 
 
     
2. I am unlikely to have diabetes 
 
     
3. If I do not have a blood glucose test I will be able 
to carry on as usual 
     
4. If I do not have a blood glucose test I will be able 
forget about the possibility of having diabetes 
     
5. A blood glucose test is the best way of finding 
diabetes early 
     
6. Having a blood glucose test could help prevent 
diabetes related complications 
     
7. Having a blood glucose test could help prevent 
diabetes related illness 
     
8. By having a blood glucose test I will know if I 
have diabetes or not 
     
9. Having a blood glucose test will give me a peace of 
mind 
     
10. I feel confident in my ability to go to my doctor to 
have a blood glucose test 
     
11. It would not be difficult for me to go to my doctor 
to have a blood glucose test 
     
12. Going to my doctor to have a blood glucose test 
would be easy for me 
     
13. I am discouraged from going to my doctor to have 
a blood glucose test because I feel unable to do so 
     
14. The benefits of having a blood glucose test 
outweigh the costs 
     
15. Having a blood glucose test would cause me too 
many problems 
     
16. I am discouraged from having a blood glucose test 
as it would take too much time 
     
17. Having a blood glucose test would be unpleasant      
18. Having a blood glucose test would be inconvenient      
19. Having a blood glucose test would make me 
anxious 
     
20. I am discouraged from having a blood glucose test 
as the results may mean I have to I have to start 
changing my lifestyle 
     
21. I am discouraged from having a blood glucose test 
as the results may mean I have to start taking 
tablets 
     
22. I intend to have a blood glucose test 
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23. I do not wish to have a blood glucose test 
 
     
 












A little bit 
frightened 
Not at all 
frightened 






A little bit 
anxious 
Not at all 
anxious 






A little bit 
scared 
Not at all 
scared 







A little bit 
worried 
Not at all 
worried 
5. The thought of having diabetes makes me feel:     
 
 Yes No Unsure 








Appendix 9: EPPM measure Scoring  
 
Your Views About Diabetes & Diabetes Screening 
REC number: 13/WM/0265 
(Version 1, 15.03.13) 
 
We are interested in your own personal views of diabetes and taking a blood glucose test.  
Please indicate how much you agree or disagree with each of the following statements by 
ticking the appropriate box. 




















severity 24. Diabetes is a serious condition 
 
     
vulnerability 25. I am unlikely to have diabetes 
 




26. If I do not have a blood glucose test I will be able 
to carry on as usual 
     
27. If I do not have a blood glucose test I will be able 
forget about the possibility of having diabetes 
     
Response 
efficacy 
28. A blood glucose test is the best way of finding 
diabetes early 
     
29. Having a blood glucose test could help prevent 
diabetes related complications 
     
30. Having a blood glucose test could help prevent 
diabetes related illness 
     
31. By having a blood glucose test I will know if I 
have diabetes or not 
     
32. Having a blood glucose test will give me a peace of 
mind 
     
Self-efficacy 33. I feel confident in my ability to go to my doctor to 
have a blood glucose test 
     
34. It would not be difficult for me to go to my doctor 
to have a blood glucose test 
     
35. Going to my doctor to have a blood glucose test 
would be easy for me 
     
36. I am discouraged from going to my doctor to have 
a blood glucose test because I feel unable to do so 
     
Response 
costs 
37. The benefits of having a blood glucose test 
outweigh the costs 
     
38. Having a blood glucose test would cause me too 
many problems 
     
39. I am discouraged from having a blood glucose test 
as it would take too much time 
     
40. Having a blood glucose test would be unpleasant      
41. Having a blood glucose test would be inconvenient      
42. Having a blood glucose test would make me 
anxious 
     
43. I am discouraged from having a blood glucose test 
as the results may mean I have to I have to start 
changing my lifestyle 
     
44. I am discouraged from having a blood glucose test 
as the results may mean I have to start taking 
tablets 
     




46. I do not wish to have a blood glucose test 
 
     
 















vulnerability 47. I think my chances of having diabetes are:      
 
 






A little bit 
frightened 
[2] 
Not at all 
frightened 
[1] 
fear 48. The thought of having diabetes makes me feel:     
 






A little bit 
anxious 
[2] 
Not at all 
anxious 
[1] 
fear 49. The thought of having diabetes makes me feel:     
 






A little bit 
scared 
[2] 
Not at all 
scared 
[1] 
fear 50. The thought of having diabetes makes me feel:     
 
 






A little bit 
worried 
[2] 
Not at all 
worried 
[1] 
fear 51. The thought of having diabetes makes me feel:     
 
 Yes No Unsure 












Appendix 10: CES-D Questionnaire  
 
Mood Questionnaire 
REC number: 13/WM/0265 
(Version 1, 18.03.13) 
 
The following list contains statements of events you may have experienced over the past week. 
Please circle one number for each statement, to show how frequently you experienced the event 
in the past 7 days. 
 
 Rarely or none 
of the time 
(Less than 1 
day) 
Some or 
a little of 




amount of time   
(3-4 days) 
Most or all 
of the time  
(5 – 7 days) 




















3. I felt that I could not shake off the blues 


















































































































































19. I felt that people disliked me     
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0 1 2 3 





Appendix 11: CES-D Questionnaire Scoring 
 
CESD: The following list contains statements of events you may have experienced over the past 
week. Please circle one number for each statement, to show how frequently you experienced the 
event in the past 7 days. 
 Rarely or 
none of the 
time 










amount of time   
(3-4 days) 
Most or 
all of the 
time  
(5 – 7 
days) 




















3. I felt that I could not shake off the blues 



































































































































































Appendix 12: Participant information Sheet 
 
Participant Information Sheet 
 
The effects of screening for diabetes in the dental setting on subsequent health behaviours  
REC Study Number: 13/WM/0265 
 (Version 5, 31.07.13) 
 
You are being invited to take part in a research study carried out as part of an educational project for a 
PhD qualification. Before you decide, it is important for you to understand why the research is being 
done and what it will involve. Please take time to read the following information carefully. Talk to 
others about the study if you wish. Please ask if there is anything that is not clear or if you would like 
more information. Take time to decide whether or not you wish to take part. 
 
The study is only open to people who can read English. If you cannot read English proficiently, 
or if you have already been diagnosed with diabetes, please ignore this letter.  
 
What is the purpose of the study? 
Type 2 diabetes develops when the body does not produce enough insulin to maintain a normal blood 
glucose level, or when the body is unable to effectively use the insulin that is being produced. 
The illness does not present with clearly identifiable symptoms and as such, remains largely under-
diagnosed. Type 2 diabetes and oral health are related. Diabetes is known to adversely affect people’s 
oral health. Detecting diabetes early on, is key to better health and oral health outcomes.   
 
In this study we are looking at the feasibility of using a brief, self-report questionnaire and, where 
appropriate a finger-prick and a saliva test as preliminary screening tools for type 2 diabetes in 
general dental practice. We are also interested in the effects of these tests on patients’ subsequent 
health behaviours, that is, why following the receipt of a screening test result some people follow up 
the result with further diagnostic testing as advised and others do not, and on the relationship between 
diabetes risk and oral health status. 
 
Why have I been chosen? 
We are asking adult patients attending for a routine dental appointment who are over the age of 45, 
who are fluent in English and who do not have a diagnosis of diabetes, if they would like to take part. 
The records kept by your dentist suggest that you meet these criteria and this is the reason you are 




Do I have to take part? 
No. It is up to you to decide whether or not to take part. If you do, you will be given this information 
sheet to keep and will be asked to sign a consent form. You are still free to withdraw at any time and 
without giving a reason. A decision to withdraw at any time, or a decision not to take part will not 
affect the standard of care you receive. If you withdraw from the study, any data collected from you 
will not be retained or used in the study. 
 
What will happen to me if I take part? 
You will need to attend your usual dental appointment 15 minutes early and allow up to around 20 
minutes after your dental appointment.  Once you arrive the researcher will answer any questions you 
may have about the study. Then, if you are happy to help us with this research you will be asked to 
sign the consent form. 
 
There are five components to this study and you can choose to take part in one, more or all of 
them.  
 
Part 1: At the dental practice, we will give you a simple, brief questionnaire to complete known as the 
Finnish Diabetes Risk Score (FINDRISC). The questionnaire asks some very simple questions e.g. 
about your family history of diabetes and your diet. One of the questions is about your current Body 
Mass Index (BMI). To answer this, the researcher will collect weight and height information from you 
so she can work out your current BMI.  
 
This questionnaire will take about 5 minutes to complete and has been shown to predict people’s risk 
of developing diabetes or ‘pre-diabetes’, a condition related to a high risk of future diabetes. 
 
Part 2: We will also ask you to give us a small sample of your saliva, which we will collect in a 
plastic tube. We will send this sample to our labs at King’s College London along with the samples of 
other patients for analysis; scientists will use this sample and information from your dental history to 
examine the link between risk of diabetes and oral health. With your consent, we will store your saliva 
sample for use in other ethically approved research projects.  
 
You will then see your dentist for your appointment as usual.  During this time, the researcher will use 
your FINDRISC questionnaire answers to work out your risk of developing diabetes or ‘pre-diabetes’. 
 
After your dental appointment, we would like you to stay for up to 20 minutes. The researcher will 
tell you your personal risk from the result of the questionnaire and if at risk, discuss sources of 
support with you.  
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Part 3: Based on the questionnaire result, you may be offered a further screening test to further 
assess your risk of diabetes more precisely.  
 
This will involve taking a small drop of blood from your finger (finger-prick test). This test will give 
us information about your blood sugar levels over the past 8-12 weeks and can serve as an indication 
of whether you have diabetes or ‘pre diabetes’. Please note that this screening test does not totally 
rule out the possibility that you may have diabetes or may develop diabetes in the future.  If you 
are shown to be at risk of developing diabetes from either the results of the questionnaire or the 
finger-prick test, you will be advised to see your GP for a formal diagnostic test. We will write to your 
GP to explain that we have advised you to see them. This part of the research will take about 10 
minutes to complete. 
 
Part 4: If you are shown to be at risk of diabetes on either of the screening measures, you will be 
asked to fill in some additional, short questionnaires. There are no right or wrong answers to these 
questionnaires, they simply ask about your thoughts and feelings about diabetes and your current 
mood.  They will take about 10 minutes to complete. 
 
You can then leave the dental practice. 
 
If you were advised to see your GP for further diabetes testing, we will contact you one month after 
this dental appointment by phone, to ask if you went to see your GP following the advice to do so. If 
you haven't sought further testing from your GP, we will remind you to do so, and contact you again 
by phone one month later to see if you have done so. Finally, three months after your initial dentist 
appointment, we will contact your GP to see if you attended for further diabetes testing, and to find 
out the outcome of any tests conducted.   
 
The reason we ask you to visit your GP for a diabetes diagnostic test if found to be at risk for diabetes 
in our screening tests here is that screening tests only measure how much at risk someone is, rather 
than provide a firm diagnosis. A single, on the spot, blood test may not be reliable and might not rule 
out the possibility that you may have or develop diabetes in future, so it is important that you follow 
up your screening results with a visit to your GP, if found to be at risk. 
 
Part 5: You may be invited at a later date to share your views of the diabetes screening experience 
you received and to explore the reasons why you decided to take part and why you did or did not 






What are the possible benefits of taking part? 
There are no particular individual benefits in taking part in this study, other than the possible 
identification of risk of developing diabetes which can lead to a subsequent early diagnosis of 
diabetes. However, we hope that by taking part you will learn more about your current risk of 
developing diabetes, which may help you to maintain good health. 
 
What if there is a problem? 
We will ask your permission to contact your GP to inform them of your taking part in this study. We 
will also ask your permission to inform your GP of your results from the screening tests. If we are 
concerned by any of these results, we will write to your GP immediately to inform them of this 
concern so that your GP may follow up these results as appropriate. 
 
If you have a concern about any aspect of this study, you should ask to speak with the researcher, or 
any of the research team, who will do their best to answer your questions (see contact details below). 
 
Will my taking part in this study be kept confidential? 
All information that is collected about you during the course of the research will be kept strictly 
confidential. Any information about you will have your name and address removed so that you cannot 
be recognised from it. All questionnaires will be stored securely. The data collected will be made 
available for statistical purposes, however; your data will not be identifiable. With your permission, 
however, we will write to your GP to tell them that you have taken part in this research and whether 
the screening measures have told us that you might be at risk of developing diabetes or pre-diabetes. 
This is routine practice for patients taking part in NHS research. 
 
What will happen to the results of the research study? 
The data we collect from all patients will be analysed and presented in peer-reviewed conferences and 
scientific journals. Only group data will be presented. We hope that this research will help us 
understand our patients better and tailor our information and treatment to best meet each patient’s 
needs. If you wish to have information regarding the results of this study, these will be available to 
you upon request at completion. 
 
Who has reviewed the study? 
All research in the NHS is scrutinised by an independent group of people, called a Research Ethics 
Committee, to protect your interests. This study has been reviewed and given a favourable opinion by 
the National Research Ethics Service Committee West Midlands- Black Country. Scientists from 
Bayer, the pharmaceutical company have also reviewed the study. Bayer, the pharmaceutical 
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company, are contributing towards some of the costs of running this study. Bayer are interested in the 
feasibility and uptake of screening for diabetes using some of their new equipment in a novel setting 
i.e. in the dental clinic. 
 
What if I have concerns or complaints? 
If you have any concerns you should raise these with a member of the research team as soon as 
possible. You can also contact the person responsible for the practice complaints procedure. If you are 
an NHS dental patient you can contact the local Patient Liaison and Advisory Service (PALS) for 
advice. Never feel embarrassed to ask questions as we want to support you, and it may help us to 
improve future studies. 
 
Contact your nearest PALS: 
Floor 1, Morston House, The Midway, Newcastle-under-Lyme, Staffordshire. ST5 1QG. 
Telephone: 0800 783 2865. Email: customerservice@ssotp.nhs.uk   
 
Contact details for further information 
If you have any questions or would like to obtain further information about this study, please contact:-  
 
Kathryn Bould, BSc, MSc (PhD Researcher) at: Unit of Social and Behavioural Sciences, King's 
College London, Floor 18, Tower Wing, Guy's Hospital, London SE1 9RW. Telephone: 07816 
582089. Email: kathryn.bould@kcl.ac.uk or 
 
Dr. Koula Asimakopoulou, Senior Lecturer in Health Psychology and HCPC - Registered Health 
Psychologist, Unit of Social and Behavioural Sciences, King's College London, Floor 18, Tower 












Appendix 13: Participant consent form 
     
            
 
Unit of Social and Behavioural Sciences 
Floor 18 Tower Wing 
Guy’s Hospital 
London SE5 9RW 
 
Study Title: The effects of screening for diabetes in the dental setting on subsequent health 
behaviours 
REC Study Number: 13/WM/0265 
(Version 3, 02.05.13) 
 
 Patient Identification Number for this study  
 
Name of Researchers: Miss Kathryn Bould, Dr. Koula Asimakopoulou, Professor Stephen Dunne, Dr. 
Suzanne Scott and Professor Francis Hughes.  
          
                                                                                                                                                              PLEASE INITIAL BOX 
 
1. I confirm that I have read and understand the Participant Information Sheet for the above study and have 
had the opportunity to ask questions. 
 
   
2.  I understand that my participation is voluntary and that I am free to withdraw at any time without giving 
any reason, without my medical care of legal rights being affected. 
 
   
3. I agree to the processing of my personal information for the purposes explained to me. I understand that 
such information will be handled in accordance with the terms of the Data Protection Act 1998. 
 
   
4. I understand that my dental notes and data collected from this study may be looked at by responsible 
individuals/regulatory authorities where it is relevant to my taking part in research. I give permission for 
these individuals to have access to my records.    
 
   
5. I understand that you will contact my GP to inform them of my taking part in this research. I agree to 
you discussing any results from this study with them. 
 
   
6. 
 
I agree that my saliva sample can be stored by the research team pending ethical approval for use in 
further research projects. 
 
   
7.  I agree that the project named above has been explained to me to my satisfaction and that I agree to take 




 I would / would not (delete as appropriate) like to receive a copy of the results of the study once they are 
finalised.  
.................................      ........................               .............................. 
 Name of Participant      Date     Signature 
 
I confirm that I have carefully explained the nature, demand and the foreseeable risks (where applicable) of the 
proposed research to the volunteer. 
.................................        ........................               .............................. 




Appendix 14: Procedure Script 
Study Procedure Script 
Hi, my name is ……. (show badge),  I work for KCL as…………..(position) we are approaching 
people today to see if they are willing to help us with some research we are conducting looking at 
screening for diabetes when attending for dental appointments.  
Can I tell you a little bit more about it to see if this is something you may be interested in helping us 
with??  
YES  NO    No problem, thank you for your time. 
    
 
Great, can I just check you are aged 45 or over and you are not diabetic? 




The study we are conducting should take between 15 -30 minutes, which might seem like a long time 
however within this time, we will assess your risk of developing diabetes and I will be able to give you 
your screening test outcome whist you are here at the dental practice. 
Give participant the information sheet 
The reason we are conducting this research is because diabetes and oral health are related, in that, 
diabetes can affect oral health in many ways, therefore, early detection is important for better (oral) 
health outcomes. 
We reason  we are here is to look at the feasibility of screening for diabetes using three different 
methods (a simple questionnaire, a saliva sample and a finger-prick blood test) and we are interested 
in how the result of the screening tests affects health behaviours (who you talk to about it, what you 
do about it). 
You don’t have to take part; it won’t change the dental care you receive today or at any time in the 
future. If you do decide to take part, you can withdraw at any time and everything will be kept 
confidential. I’ve got an information sheet for you to read (in case you didn’t get a chance to look at 
the one sent to you in the post) which describes the study in detail which should cover any questions 
you may have. It’s got the contact details detail on the last page too in case you need them for future 
reference.  
If you have a look at the info sheet you’ll see the study has 5 parts which you can choose to take part 
in one, or more, or all of: 
- Firstly, there is a questionnaire to assess personal risk of developing diabetes, 
- We will ask you to provide for a saliva sample, 
- Based on the result of the questionnaire, you may be offered a further screening test to 
assess risk…this is a quick and easy finger-prick blood test, 
- We will ask you to complete two further questionnaires asking about your thoughts on 
diabetes and your mood. 
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- We may ask you at a later date to have a chat over the telephone about your experience 
today. Does this sound like something you would be interested in? 




Give participant the consent form. 
If you could just have a final look through the information sheet and then read through and sign the 
consent form just to confirm that you are happy to participate and that I’ve given you all the 
information. 
Participant signs the consent form. 
Here’s the first questionnaire for you to complete, this is a validated diabetes screening tool called 
the FINDRISC questionnaire which assesses you risk of developing diabetes. If you could just stand 
up, we’ll complete some of the questionnaire together by taking your height and weight measurements 
to calculate your BMI, and your waist circumference. 
Measure participants’ height against wall measure, ask them to stand on the scales to measure 
their weight, and use the separate tape measure to take their waste circumference.  
If you would like to take a seat again and just complete Q1 and questions 4-8 and the additional 
question at the bottom please 
Calculate BMI using the chart provided whilst participant completes the questionnaire. 
Take completed questionnaire from participant and hand them the saliva tube.  
Ok, whilst I score your answers, would you please spit into this tube as much as you can or until I ask 
you to stop? 
YES     NO                              No problem, if you bear with me then whilst I score your answers and 
assess your risk.  
Thank you. 
Score FINDRISC using the FINDRISC score sheet provided. 
If score is <10 select the low risk personalised risk sheet; if score is ≥10, select the high risk 
personalised risk sheet.  
Write the score on the personalised risk sheet, and the category, according to the FINDRISC 
score sheet.  
Take saliva sample from the participant, put the lid on, and write the participant number on the 
tube. 
The FINDRISC questionnaire is a validated screening tool to assess the probability of developing 
diabetes over the next 10 years. 
Hand the personalised risk sheet to the participant. 
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Your score on the FINDRISC questionnaire is……………(score). This means that from the answers 
you gave, your personal risk of developing diabetes in the next ten years is ………………..(category) 
which mean that about 1 in…..  (see risk category on scoring sheet) will develop the disease.  
It is currently recommended that if a person scores 10or higher on this questionnaire, they should 
have further screening tests for diabetes.  




























So what does this mean for you? 
 From this, we DO NOT recommend a further 
screening test to assess your risk of developing 
diabetes at this current time 
Your answers from the questionnaire suggest that 
your current lifestyle factors do not increase your 
risk of developing diabetes in the next 10 years. 
However, it is important to note that if your 
answers to the questionnaires change in the 
future, your risk of developing diabetes could 
change. If you are concerned about your risk of 
diabetes changing in the future, you should see 
your GP. 
Thank you for taking part. We will write to your 
GP just to let them know what we’ve done today.   
As I mentioned the contact details should you need 
them are at the bottom of the information sheet. 
We may contact you in the near future just to ask 
you about your experience today.  
 
So what does this mean for you? 
From this, we DO recommend a further screening 
test to assess your risk of developing diabetes.  
The test we are recommending requires a small 
droplet of blood from your finger in order to get a 
measure of your HbA1c; that is a measure of your 
blood glucose level over the last 2-3 months. The kit 
we are using provides us with a fast and easy way to 
get accurate A1C results rather than sending your 
blood sample off to the lab for testing. This means 
we can give you the result now. To get the blood, we 
will prick your finger to get just a small drop of 
blood, and this should just feel like a scratch. 








However, we do recommend you visit your GP for 
further testing due to your high risk score on the 
FINDRISC questionnaire.  
Would you please complete 2 short questionnaires 
before you go? There are no right or wrong answers 
and this should only take about 5 minutes to 
complete. 
If not, ask participant to complete at home and 
return to us in the freepost envelope provided. 
We will write to your GP to let them know what 
we’ve done today and what we recommend.  
Thank you for taking part. 
Follow infection control policy when 
administering finger-prick blood test. 
Once, we’ve got the blood sample, the machine 
will take five minutes to return the result.  
Follow kit instructions to administer the test. 
Whilst waiting for result, administer CES-D 
and EPPM questionnaire. 
Whilst we wait for the result to come back, would 
you mind just completing 2 questionnaires about 
your mood and thoughts on diabetes? 
Once result is returned, write result on 





















We will write to your GP just to let them know what we’ve done today and what we’ve recommended.   
As I mentioned the contact details should you need them are at the bottom of the information sheet. 
We may contact you in the near future just to ask you about your experience today.  
Ensure demographics sheet is completed before patient leaves. 
 
After the participant has left the surgery: 
Write results on appropriate first GP letter and Send letter with participant information sheet 
Score CES-D – if score 16 or more, send GP referral letter (CES-D) 
If HbA1c is 6% or higher, send GP referral letter (HbA1c) 
Complete information from dental records sheet  
Complete log sheet 
Enter follow up calls and follow up GP letter ‘triggers’ in the diary 
 
  
A result of lower than 6% 
suggests it is unlikely you 
have diabetes,  
If result is between 5.7% 
and 6% tell participant - 
HbA1c results between 
5.7% and 6.0% suggest you 
may have pre-diabetes. 
Although this screening test 
suggests it is unlikely you 
have diabetes, due to the 
risk result on the validated 
FINDRISC questionnaire, 
we recommend you visit 
your GP for a further 
diagnostic test to follow-up 
these initial screening tests.  
 
 
A result of 6% or higher 
suggests you may have 
diabetes. 
Therefore based on this 
result and due to the risk 
result given from the 
FINDRISC questionnaire, 
we recommend you visit 
your GP for a further 
diagnostic test to follow-






Appendix 15: Participant Briefing Sheet (LOW RISK) 
 
PERSONALISED RISK OF DEVELOPING DIABETES 
REC number: 13/WM/0265 
(Version 1, 15.03.13) 
 
ID Number  
 
You have completed the FINDRISC questionnaire which provides a measure of the 
probability of developing diabetes over the following 10 years. 
 
YOUR SCORE FROM THE FINDRISC QUESTIONNAIRE IS: 
 
Your answers from the FINDRISC questionnaire suggest that your PERSONAL RISK of 
developing diabetes in the next 10 years is: 
 
 
It is recommended that individuals with a score of 10 or higher on this questionnaire should 
have further screening for diabetes. 
 
Based on this information we DO NOT RECOMMEND a further screening test to assess 
your risk of developing diabetes at the current time. 
Your answers from the questionnaire suggest that your current lifestyle factors do not 
increase your risk of developing diabetes in the next 10 years. 
However, it is important to note that if your answers to the questionnaires change in the 
future, your risk of developing diabetes could change.  
If you are concerned about your risk of diabetes changing in the future, you should see your 
GP. 
More information about diabetes can be found on the UK's leading diabetes charity, Diabetes 








Appendix 15 (cont.): Participant Briefing Sheet (HIGH RISK) 
 
PERSONALISED RISK OF DEVELOPING DIABETES 
REC number: 13/WM/0265 
(Version 1, 15.03.13) 
 
ID Number  
 
You have completed the FINDRISC questionnaire which provides a measure of the 
probability of developing diabetes / prediabetes over the following 10 years. 
 
YOUR SCORE FROM THE FINDRISC QUESTIONNAIRE IS: 
 
Your answers from the FINDRISC questionnaire suggest that your PERSONAL RISK of 
developing diabetes in the next 10 years is: 
 
It is recommended that individuals with a score of 10 or higher on this questionnaire should 
have further screening for diabetes. 
Based on this information we RECOMMEND a further screening test to assess your 
risk of developing diabetes. 
The test we are recommending requires a small droplet of blood from your finger in order to 
get a measure of your HbA1c; that is a measure of your blood glucose level over the last 2-3 
months. A1CNow+® provides us with a fast and easy way of obtaining accurate A1C results 
rather than sending a blood sample for testing in a laboratory. This innovative technology 
mean we can tell you your result instantaneously. 
(Delete as appropriate) 
- You DECIDED to have the test: 
YOUR HbA1c RESULT IS:  
 
A result of 6% or higher suggests you may have diabetes. However, a result of lower than 
6% suggests it is unlikely you have diabetes, HbA1c results between 5.7% and 6.0% 
suggest you may have pre-diabetes. 
We RECOMMEND you visit your GP for a further diagnostic test to follow-up these initial 
screening tests.  
................................................................................................................................................... 
- You DECIDED NOT to have your HbA1c measured. However, we would RECOMMEND 







More information about diabetes can be found on the UK's leading diabetes charity, Diabetes 








Unit of Social and Behavioural Sciences 






Letter to GP (low risk) 






Your patient...............................................(DOB-…………..) has taken part in the following 
research study. 
 
Study Title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours  
REC Study Number: 13/WM/0265 
 
We attach an Information Sheet for your records.  
 
Your patient’s scores on the Finnish Diabetes Risk questionnaire (FINDRISC) was 
....................  Scores ≥10 indicate the risk of developing pre-diabetes and / or diabetes. 
 
Based on their FINDRISC score carried out today, your patient has shown to be at low risk of 
developing diabetes or pre-diabetes in the next ten years.  
 






Dr. Amit Jilka 






Miss Kathryn Bould 
(Researcher) 








Unit of Social and Behavioural Sciences 






Letter to GP (high risk) 






Your patient.................................................(DOB- …………….) has taken part in the 
following research study.  
 
Study Title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours  
REC Study Number: 13/WM/0265 
 
We attach an Information Sheet for your records.  
 
Your patient’s score on the Finnish Diabetes Risk questionnaire  (FINDRISC) was 
.................... Scores of ≥10 indicate the risk of developing pre-diabetes and/ or diabetes. 
 
 
Your patient’s instant HbA1c blood test information was..........................(refused).   
 
On the basis of these results which have been fully explained to your patient, they have been 






Dr. Amit Jilka 






Miss Kathryn Bould 
(Researcher) 
9 Abbey Street 
Stone 
ST15 8PA 




Appendix 17: Referral letter to GP for HIGH CES-D score 
                                 
 
 
Unit of Social and Behavioural Sciences 





Referral letter to GP (CES-D) 




Your patient………………………………… was recently seen by their dentist and took part 
in the following research study: 
 
Study title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours. 
REC study number: 13/WM/0265 
 
Date of participation:………………………… 
 
As part of the study, your patient completed the ‘Centre for Epidemiological Studies 
Depression Scale’ (CES-D). This is a screening measure (NOT a diagnostic tool) developed 




(The range of scores on the CES-D is 0-60, with a cut off score of 16 indicative of 
“significant” or “mild” depressive symptomatology.) 
 
I have informed the patient that I have written to you with this information and suggested that 





Dr. Amit Jilka 






Miss Kathryn Bould 
(Researcher) 





Appendix 18: Referral letter to GP for HIGH HbA1c result 
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Referral letter to GP (HbA1c) 




Your patient…………………………………(DOB -…………….) was recently seen by their 
dentist and took part in the following research study: 
 
Study title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours. 
REC study number: 13/WM/0265 
 
Date of participation:………………………… 
 
As part of the study, your patient received an instant finger-prick blood test to measure their 
HbA1c. We are using the Bayer A1c+ NOW kit to measure a patient’s instant HbA1c level as 





I have informed the patient that I have written to you with this information and have 








Dr. Amit Jilka 






Miss Kathryn Bould 
(Researcher) 
  






















                         
 












Is there a more convenient time to 
call back? 
Great, I shall call you ………… 
Thanks. 
Hello………………. 
Its…………………..calling from ………………………..regarding the research study you took part in at your dental 
appointment at The Broadway Dental Practice in Catford last month. 




When we screened you for diabetes at your last 
dental appointment, based on your risk result, we 
advised you to go and see your GP for further 
tests for diabetes. 
Can I ask, have you been and visited you GP based 
on this advice regarding your risk of diabetes? 
Ok, 
What did the GP say or do? 
Test result? 
 
We just need to ask as well, if 
you’ve received any other 
invitations to go for screening or 
testing for diabetes since we 
advised you of your risk? 
 
As well as going to see your GP, we 
are interested if you have made any 
other lifestyle changes since you 






Well we do recommend you see 
your GP based on the result of the 
screening tests we carried out. 
I will call you back in another month 









CALL AT 2 MONTHS 




            
            








     




















What did the GP say or do? 
Test result? 
We just need to ask as well, if 
you’ve received any other 
invitations to go for screening or 
testing for diabetes since we 
advised you of your risk? 
As well as going to see your GP, 
we are interested if you have 
made any other lifestyle 







Its…………………..calling from ………………………..regarding the research study you took part in at your dental 
appointment at The Broadway Dental Practice in Catford a few months ago. 
I’m just calling to ask you a couple of questions; this should only take a few minutes. Is now a convenient time? 
 
Great. 
When we screened you for diabetes at 
your last dental appointment, based on 
your risk result, we advised you to go 
and see your GP for further tests for 
diabetes. 
Can I ask, have you been and visited 
you GP based on this advice regarding 
your risk of diabetes? 
Is there a more convenient time to 
call back? 
Great, I shall call you ………… 
Thanks. 
Ok, 
Well we do recommend you see 
your GP based on the result of the 
screening tests we carried out. 
Thanks 
 
SEND 3 MONTH 
FOLLOW UP GP 









Unit of Social and Behavioural Sciences 
Floor 18 Tower Wing 
Guy’s Hospital 
London 
 SE1 9RW 
 
Follow-up Letter to GP 





Your patient........................................(DOB -……………) has previously taken part in the 
following research study.  
 
Study Title: The effects of screening for diabetes in the dental setting on subsequent 
health behaviours 
REC Study Number: 13/WM/0265 
 
We have previously written to you with the results of some initial diabetes screening tests 
that we conducted, and based on the results, we advised your patient to attend your GP 
practice for further diabetes diagnostic tests.  
 
In order to keep our medical records up to date and to ensure we provide our patient with the 
best possible treatment, could you please advise us on the following: 
 
Please tick all that apply: 
 
 Patient has not been in contact with the GP practice for a diagnostic test. 
 
 Patient has enquired about a diagnostic test but we felt it was not appropriate. 
 
 Patient has received a diagnostic test. 
  The outcome was: ......................................................................................... 
 
















Appendix 21: Favourable opinion for REC 
 
 
